data_1cee_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cee _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.798 0.332 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG13 ' CB ' ' A' ' 83' ' ' SER . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 19' ' ' LEU . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' OG ' ' CB ' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 169' ' ' PHE . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 24' ' ' THR . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 ' CG1' ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' HD12 ' B' ' 47' ' ' ILE . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.4 HD13 ' CB ' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.402 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.401 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.438 ' CB ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE1' HD21 ' A' ' 145' ' ' LEU . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.439 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.416 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 85' ' ' VAL . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.436 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.432 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.472 HD21 ' CE1' ' A' ' 90' ' ' PHE . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 111' ' ' LEU . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 142' ' ' ALA . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.445 HG23 ' CG1' ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' CB ' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.474 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.467 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' B' ' 4' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.434 HG12 ' CG1' ' A' ' 36' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' B' ' 34' ' ' LEU . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.51 ' CD1' ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 37' ' ' PHE . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.4 ' CB ' HD13 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.51 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.822 0.344 . . . . 24.83 111.016 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.414 HG21 ' N ' ' A' ' 4' ' ' ILE . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.72 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.19 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.46 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.3 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.478 HG12 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.3 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' CG1' ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.17 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.27 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.64 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.7 112.992 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HD3' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.69 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.19 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.05 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.97 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 21' ' ' ILE . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.15 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 HG23 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.94 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.79 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.6 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.11 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.51 112.461 -179.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.5 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.736 0.303 . . . . 23.47 111.248 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.06 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.28 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.53 111.787 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.33 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 43' ' ' THR . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 42' ' ' VAL . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.28 111.32 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' CG ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.62 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.45 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.88 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CG ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.19 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.1 110.749 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.78 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.06 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.96 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.61 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.88 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.24 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.15 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.51 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.67 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.12 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' CD1' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.94 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD11 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.69 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.39 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.01 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.26 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.87 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.51 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.42 111.281 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.62 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.21 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.72 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.97 110.94 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.57 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.26 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.03 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' HD22 ' A' ' 145' ' ' LEU . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.3 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.64 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.45 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.6 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.56 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.458 ' HB ' ' CD ' ' A' ' 99' ' ' PRO . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.3 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.29 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.13 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.04 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.47 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.83 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.04 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.1 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.63 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.6 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' A' ' 101' ' ' ILE . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.72 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.438 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.74 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.79 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.46 111.495 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.95 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.06 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.92 111.015 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.85 110.379 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.91 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.48 110.626 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.35 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.35 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.76 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.71 111.163 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.56 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.73 112.2 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.12 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.58 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.97 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.28 112.039 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.9 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.71 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.28 111.06 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.05 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.474 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.6 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.95 110.85 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.39 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.97 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 90' ' ' PHE . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.74 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.3 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.66 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.49 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.1 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' HD22 ' A' ' 111' ' ' LEU . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.4 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.53 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.63 111.256 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.1 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.88 110.486 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.27 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.47 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.7 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.55 112.296 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.55 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.12 111.184 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.45 110.731 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.21 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.7 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' ' CG1' ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.54 111.629 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.464 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.406 ' CG2' ' HB1' ' A' ' 41' ' ' ALA . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.43 HG11 ' CG2' ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.444 HG13 ' CD1' ' B' ' 34' ' ' LEU . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.499 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.521 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.854 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.427 ' CG1' HG23 ' A' ' 75' ' ' THR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.426 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG13 ' CE2' ' A' ' 64' ' ' TYR . 2.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 42' ' ' VAL . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.471 ' CG2' ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 36' ' ' VAL . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' NH1' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.56 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 HG23 ' CG1' ' A' ' 7' ' ' VAL . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.404 HD22 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 97' ' ' TRP . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG22 ' CB ' ' A' ' 82' ' ' PHE . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.464 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.447 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.414 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.45 HD12 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' HB1' ' A' ' 130' ' ' ALA . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.436 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 127' ' ' GLU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 135' ' ' LYS . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.415 HG22 ' CE2' ' A' ' 90' ' ' PHE . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.459 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.49 HD12 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.447 ' CG2' HD23 ' A' ' 111' ' ' LEU . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE1' ' HB1' ' A' ' 142' ' ' ALA . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CG2' ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 165' ' ' LEU . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.437 ' HB3' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.427 ' HB3' ' OD2' ' A' ' 118' ' ' ASP . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CD1' HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.428 ' CG1' HD12 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.44 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.442 HD11 HG13 ' B' ' 4' ' ' ILE . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.438 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 177' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.401 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.54 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' B' ' 34' ' ' LEU . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.477 HD11 ' CG ' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' B' ' 42' ' ' PHE . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 45' ' ' ALA . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.477 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.432 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.54 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.764 0.316 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.452 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 ' CG2' HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.424 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 64' ' ' TYR . 13.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.299 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CZ ' HD12 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 43' ' ' THR . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 42' ' ' VAL . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.429 HG12 ' CG2' ' B' ' 9' ' ' ILE . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 4' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.445 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.473 HG22 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CE1' HG22 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' HG23 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 145' ' ' LEU . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 82' ' ' PHE . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 101' ' ' ILE . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.465 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG23 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.452 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' A' ' 90' ' ' PHE . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.482 HD21 ' CE1' ' A' ' 90' ' ' PHE . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.412 HD21 ' CG1' ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 111' ' ' LEU . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.519 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.409 HG22 ' CG1' ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HG ' ' CE2' ' A' ' 28' ' ' PHE . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.401 ' O ' ' CG2' ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.431 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 171' ' ' GLU . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.443 ' CB ' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.429 ' CG2' HG12 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.438 ' CG1' ' HG ' ' B' ' 34' ' ' LEU . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.438 ' HG ' ' CG1' ' B' ' 31' ' ' VAL . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.47 HD12 ' CZ ' ' A' ' 37' ' ' PHE . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' B' ' 45' ' ' ALA . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.476 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.304 . . . . 24.83 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.72 111.12 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.19 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.46 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.3 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.3 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 16' ' ' LYS . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.17 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.27 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.64 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.7 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' CG ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.69 112.173 -177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.19 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 159' ' ' ALA . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.05 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.442 ' CB ' ' CD1' ' A' ' 165' ' ' LEU . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.97 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.15 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.423 ' OG1' ' CE2' ' B' ' 15' ' ' PHE . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.94 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.79 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.6 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.11 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.51 112.565 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 110.391 -0.225 . . . . 23.47 110.391 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 71' ' ' SER . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.06 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.28 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.53 110.925 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.33 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 43' ' ' THR . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 42' ' ' VAL . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.28 111.55 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.62 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.45 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.88 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' CB ' ' A' ' 2' ' ' GLN . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.19 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.1 110.798 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.78 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 53' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.06 110.856 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.96 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.61 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.88 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.24 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.15 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.51 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.67 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.12 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.94 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.69 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.39 111.744 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.01 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.26 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.87 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.433 ' HB ' ' CA ' ' A' ' 176' ' ' ALA . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.51 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CE2' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.42 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.62 110.558 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.21 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.72 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.97 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.57 111.208 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.26 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.03 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.3 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.64 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.45 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.6 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.56 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.3 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.29 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.472 HG21 ' CE2' ' A' ' 78' ' ' PHE . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.13 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.04 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.47 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.83 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.04 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.1 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.445 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.63 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.6 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.72 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.74 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.79 110.699 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.474 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.46 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.95 110.843 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.473 HD13 HG22 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.06 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.92 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.85 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.91 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.48 110.676 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.35 112.422 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.35 111.043 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.76 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.71 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.56 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.73 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.12 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.58 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.97 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.453 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.28 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.9 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.71 112.351 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.28 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.05 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.445 HG23 ' CE2' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.6 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.95 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.39 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.97 109.969 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.74 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.3 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.66 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' CD2' ' CG1' ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.49 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.1 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 111' ' ' LEU . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.4 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.53 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.425 HG21 ' CG1' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.63 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.1 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.88 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.27 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.47 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.7 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.446 ' CE ' ' N ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' N ' ' CE ' ' A' ' 163' ' ' LYS . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.55 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.442 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.55 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.12 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.45 110.573 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.476 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.21 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.7 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 172' ' ' ALA . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CA ' ' HB ' ' A' ' 77' ' ' VAL . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.54 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.423 ' CE2' ' OG1' ' A' ' 24' ' ' THR . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' B' ' 16' ' ' LYS . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 41' ' ' ALA . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' B' ' 34' ' ' LEU . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.433 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.4 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.847 0.356 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.413 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.475 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' B' ' 23' ' ' TRP . 2.5 m . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.849 0.357 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' LEU . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 42' ' ' VAL . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.434 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.506 ' CD1' ' CG2' ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 97' ' ' TRP . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.463 ' CZ ' HD23 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' A' ' 97' ' ' TRP . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG22 ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.489 ' CD ' HG22 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 99' ' ' PRO . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.465 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' CD1' ' CG2' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.427 ' CD1' ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.465 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.43 ' CB ' ' OD2' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.466 ' HA ' ' CB ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.474 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' ' CE2' ' A' ' 23' ' ' TYR . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.404 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 4' ' ' ILE . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.442 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.424 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.482 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.475 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.437 ' CB ' HG13 ' A' ' 36' ' ' VAL . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' B' ' 28' ' ' GLY . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 42' ' ' PHE . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' B' ' 39' ' ' ARG . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.443 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' B' ' 45' ' ' ALA . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.466 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CD1' HG23 ' A' ' 173' ' ' ILE . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 75' ' ' THR . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' CD ' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 159' ' ' ALA . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.401 ' O ' HG22 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 3.0 t30 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 43' ' ' THR . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 42' ' ' VAL . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 51' ' ' TYR . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 4' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 70' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.41 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.436 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 176' ' ' ALA . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 97' ' ' TRP . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.422 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CB ' HG23 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.423 ' CG2' ' HG2' ' A' ' 116' ' ' GLN . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 82' ' ' PHE . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.483 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 110' ' ' PHE . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.417 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.404 HD13 HG22 ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.413 HG23 ' CG2' ' A' ' 155' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.423 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 HD11 ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.468 ' HB2' ' CE1' ' A' ' 28' ' ' PHE . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.3 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HD3' HD11 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.432 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.456 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.431 ' CD1' HG13 ' B' ' 4' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.456 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.441 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 7.2 t-160 -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.449 HG12 ' CG ' ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' CG ' ' B' ' 39' ' ' ARG . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' B' ' 41' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.452 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 38' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' B' ' 29' ' ' PHE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.888 0.375 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' CG1' HG23 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' O ' HD11 ' A' ' 19' ' ' LEU . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.506 HG21 ' CE1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.459 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' B' ' 12' ' ' PRO . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 5' ' ' LYS . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' O ' HD21 ' B' ' 38' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 ' CG1' ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.432 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.478 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' CD2' ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 81' ' ' CYS . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HG2' HD22 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' OD2' HD21 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.415 HD22 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.518 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 145' ' ' LEU . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 111' ' ' LEU . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.437 ' CB ' HG11 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.409 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 157' ' ' CYS . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CE1' HD23 ' A' ' 20' ' ' LEU . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' A' ' 4' ' ' ILE . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . 0.4 ' HB2' ' NE2' ' B' ' 17' ' ' HIS . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.403 HG23 HG21 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.48 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.456 HG12 ' CG ' ' B' ' 34' ' ' LEU . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' B' ' 42' ' ' PHE . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' B' ' 48' ' ' SER . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.48 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.79 0.328 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.436 ' CG2' ' HE2' ' A' ' 5' ' ' LYS . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' B' ' 15' ' ' PHE . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 37' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.489 ' CE2' ' CD2' ' B' ' 17' ' ' HIS . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' B' ' 12' ' ' PRO . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' CD2' ' A' ' 51' ' ' TYR . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.417 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.424 ' CG2' HG21 ' A' ' 7' ' ' VAL . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 97' ' ' TRP . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CB ' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.427 ' CB ' HG11 ' A' ' 152' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 155' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.425 HD12 ' CA ' ' A' ' 146' ' ' ALA . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.408 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.419 HD22 ' CG1' ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.432 ' N ' HD12 ' A' ' 117' ' ' ILE . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.466 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' B' ' 9' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.434 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.43 ' CB ' HG12 ' A' ' 42' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 2.6 t-160 -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . 0.468 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.401 ' CB ' HG13 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.448 ' CG1' ' HG ' ' B' ' 34' ' ' LEU . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.463 HD21 ' CE1' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.413 ' CG ' ' HB3' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.474 HD11 ' CZ ' ' B' ' 29' ' ' PHE . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.833 0.349 . . . . 0.0 111.014 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.435 ' CD1' HG21 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.435 ' N ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.424 ' CA ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' B' ' 23' ' ' TRP . 83.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.133 0.492 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CE1' ' CD2' ' B' ' 17' ' ' HIS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 43' ' ' THR . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' B' ' 12' ' ' PRO . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 101' ' ' ILE . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.43 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.437 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.455 HG21 ' CE2' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.481 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.467 HG21 HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD2' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.441 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.484 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.47 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 HG21 ' CG1' ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 22' ' ' SER . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' B' ' 4' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.457 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.432 HG23 ' CG2' ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.575 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 4.1 t-160 -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.458 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 37' ' ' PHE . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' B' ' 43' ' ' SER . 81.0 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.434 HG23 ' CB ' ' A' ' 176' ' ' ALA . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 16' ' ' LYS . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 8' ' ' VAL . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD23 ' CE1' ' A' ' 169' ' ' PHE . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.465 HG23 ' CD1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.707 0.289 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' CB ' ' HE2' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 43' ' ' THR . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.434 ' N ' HG11 ' A' ' 42' ' ' VAL . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.439 ' CD2' HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 75' ' ' THR . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.464 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.486 HG11 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 90' ' ' PHE . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.486 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.526 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 101' ' ' ILE . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 129' ' ' LEU . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' A' ' 154' ' ' TYR . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 152' ' ' VAL . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.424 ' CG2' HG11 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.48 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 53' ' ' LEU . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.441 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' B' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.426 ' CB ' HG13 ' A' ' 42' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.436 ' HE2' ' CB ' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.419 ' NE2' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . 0.419 ' HB2' ' NE2' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' B' ' 34' ' ' LEU . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.443 ' CD1' HG13 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.297 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 19' ' ' LEU . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo . . . . . 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG13 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.698 0.285 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.46 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' B' ' 18' ' ' VAL . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.418 HG13 ' CG2' ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' CG2' HG13 ' A' ' 42' ' ' VAL . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 46' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 7' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CB ' HG22 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.489 ' CE1' ' CD2' ' A' ' 145' ' ' LEU . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG22 ' CB ' ' A' ' 82' ' ' PHE . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.488 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 ' CE2' ' A' ' 78' ' ' PHE . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' CB ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 126' ' ' ILE . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.48 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.422 ' CB ' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 90' ' ' PHE . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.489 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 109' ' ' PRO . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CE ' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CE1' ' HB1' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' HD13 ' A' ' 117' ' ' ILE . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 163' ' ' LYS . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' SER . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' TYR . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.434 HG23 ' CD1' ' A' ' 4' ' ' ILE . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.416 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' B' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.449 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' B' ' 18' ' ' VAL . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.439 ' CG2' ' HE3' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' B' ' 34' ' ' LEU . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.436 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.487 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 24.83 110.91 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.72 110.906 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.19 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.46 109.961 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.3 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 7' ' ' VAL . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.3 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.17 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.27 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.64 112.404 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.7 112.519 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.69 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.19 110.906 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.05 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HG ' HD22 ' A' ' 19' ' ' LEU . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.97 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.15 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.43 ' OG1' ' CD1' ' B' ' 15' ' ' PHE . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.94 111.621 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.79 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.6 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.11 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.51 112.459 -179.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.448 HG13 ' CE2' ' B' ' 29' ' ' PHE . 59.5 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.777 0.322 . . . . 23.47 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.06 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.28 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.53 111.555 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.33 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.28 111.197 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.62 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.45 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.88 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.19 110.937 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.1 110.936 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.78 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.06 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.96 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.61 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.88 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.24 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.15 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.51 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.67 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.12 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.94 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.69 111.992 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.39 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.542 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.01 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.26 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.477 HG21 ' CE1' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.87 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.51 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.42 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.62 110.454 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.21 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.72 111.008 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.97 111.038 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.57 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.26 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.03 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.3 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.64 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.45 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.6 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.56 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.3 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.29 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.13 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.04 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.47 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.83 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.04 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.1 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.63 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.6 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.72 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.74 110.935 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 154' ' ' TYR . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.79 110.549 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.46 111.676 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.95 110.778 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.06 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.92 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.85 110.878 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.91 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.48 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.35 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.35 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.76 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.421 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.71 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.56 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.73 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.12 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.58 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.97 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.28 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.9 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.71 111.954 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.28 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.05 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.6 111.715 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.95 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.39 110.358 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.97 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.487 HD21 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.74 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.3 110.597 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.66 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.49 111.194 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.1 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.4 110.963 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.53 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.63 111.475 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.1 112.052 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.88 109.914 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.27 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.47 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.7 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.55 112.38 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 22' ' ' SER . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.55 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.12 111.476 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.45 110.921 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.21 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.451 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.7 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.54 111.139 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.467 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' OG1' ' A' ' 24' ' ' THR . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.411 HG23 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.426 HG11 ' N ' ' B' ' 22' ' ' GLY . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.426 ' N ' HG11 ' B' ' 21' ' ' VAL . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' B' ' 34' ' ' LEU . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.438 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.436 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.466 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.843 0.354 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' HA ' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 19' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.468 ' HB ' ' CD1' ' B' ' 15' ' ' PHE . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG11 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.443 0.163 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 44' ' ' VAL . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 42' ' ' VAL . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' A' ' 42' ' ' VAL . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CA ' ' HB2' ' B' ' 45' ' ' ALA . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' CD2' ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 98' ' ' VAL . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.422 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.472 HD21 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.463 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 138' ' ' THR . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.4 ' N ' HG21 ' A' ' 137' ' ' ILE . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.492 HD11 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 109' ' ' PRO . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CD1' HD21 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.447 ' CG2' HD11 ' A' ' 4' ' ' ILE . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' B' ' 4' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.474 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.452 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.468 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 36' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' CD1' ' B' ' 34' ' ' LEU . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.462 ' CD1' HG13 ' B' ' 31' ' ' VAL . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.463 ' CB ' ' CD2' ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.426 ' HB2' ' CA ' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.745 0.307 . . . . 24.83 110.68 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.72 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.443 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.19 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.46 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.3 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.3 110.594 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.435 HG12 ' CE ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.17 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.497 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.27 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.64 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.7 112.868 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' CE ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.69 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.19 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.05 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' CD1' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 HD21 ' CZ ' ' A' ' 169' ' ' PHE . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.97 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 21' ' ' ILE . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.15 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.499 ' CG2' ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.94 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.79 111.441 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.6 110.857 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.11 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.51 111.736 178.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' B' ' 29' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 120.543 0.211 . . . . 23.47 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.06 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.28 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.53 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.432 ' CB ' ' HE2' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.33 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 43' ' ' THR . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.44 ' N ' HG12 ' A' ' 42' ' ' VAL . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.28 111.489 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.62 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.45 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.88 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.19 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.1 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.78 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.06 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.96 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.61 110.933 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.88 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.24 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.15 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.51 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.67 111.493 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.12 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' B' ' 47' ' ' ILE . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.94 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.69 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.39 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.01 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.26 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.454 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.87 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.51 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.42 111.152 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.62 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.21 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.72 111.059 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.97 111.433 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.57 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.26 110.85 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.03 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.3 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.64 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.45 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.6 111.672 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.497 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.56 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' CD ' ' A' ' 99' ' ' PRO . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.459 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.3 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.29 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.13 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.04 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.47 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.83 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.04 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.1 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.63 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.454 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.6 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.72 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.431 HD12 ' CG2' ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.74 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.79 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.46 111.757 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.95 110.884 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.433 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.06 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.92 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.85 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.91 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.48 110.362 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.35 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.35 111.477 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.76 110.85 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.71 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.56 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.73 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.12 112.061 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.58 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.97 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.28 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.9 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.71 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.28 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.05 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.6 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.95 110.784 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.39 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.97 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.523 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.74 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.3 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.66 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.49 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.1 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.431 ' CG2' HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.4 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.53 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.63 111.257 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.406 ' SG ' ' CD1' ' A' ' 19' ' ' LEU . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.1 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.88 110.64 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.27 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.47 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.7 111.091 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.433 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.55 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' CD1' ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.55 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 156' ' ' GLU . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.12 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.45 111.538 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.408 ' N ' HD21 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.443 HG23 ' CD1' ' A' ' 4' ' ' ILE . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.21 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.445 ' CD1' ' HG3' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.7 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CB ' ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.54 111.592 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.458 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.441 ' HB ' HD21 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.445 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.425 ' HB3' HG11 ' A' ' 42' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' THR . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CD1' ' CG2' ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' A' ' 41' ' ' ALA . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.429 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' B' ' 47' ' ' ILE . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.439 HG12 ' CG ' ' B' ' 34' ' ' LEU . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' B' ' 29' ' ' PHE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.825 0.345 . . . . 24.83 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.72 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.19 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.46 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.3 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.3 110.759 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.17 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.27 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.64 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.7 113.013 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.69 112.171 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' LEU . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.19 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.05 111.618 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 169' ' ' PHE . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.97 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 162' ' ' GLN . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.15 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.94 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.79 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.6 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.11 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo . . . . . 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.51 112.741 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.018 0.437 . . . . 23.47 110.561 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.06 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.28 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.53 110.998 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.476 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.33 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 44' ' ' VAL . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' CG2' HG13 ' A' ' 42' ' ' VAL . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.28 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.417 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.62 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.45 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.88 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.417 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.19 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.1 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.78 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.06 111.119 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.96 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.61 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.88 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.24 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.15 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.51 111.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.67 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.12 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' CA ' ' HB2' ' B' ' 45' ' ' ALA . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.94 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.69 110.835 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.39 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.01 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.26 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.87 109.669 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.51 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.459 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.42 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.62 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB3' HG23 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.21 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.72 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 137' ' ' ILE . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.97 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.57 111.724 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.26 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.03 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.3 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.64 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.45 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.6 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.537 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.56 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.3 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.29 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.13 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.04 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.47 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.83 110.863 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.04 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.1 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.63 111.352 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.437 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.6 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.72 111.901 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.436 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.74 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.79 110.827 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.458 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.46 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.95 110.946 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.43 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.06 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.92 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.85 110.094 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.91 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.48 110.746 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.35 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.35 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.76 110.138 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.453 ' HA ' HD12 ' A' ' 129' ' ' LEU . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.71 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 130' ' ' ALA . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.46 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.56 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.73 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.12 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.58 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.97 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.46 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.28 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.9 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.71 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.421 ' N ' HG11 ' A' ' 84' ' ' VAL . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.28 110.843 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.05 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.6 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.95 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.39 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.97 110.378 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.74 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.3 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.66 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.416 HD21 ' CB ' ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.49 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.1 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 111' ' ' LEU . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.4 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.53 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.63 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.427 ' CA ' HD12 ' A' ' 117' ' ' ILE . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.1 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.43 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.88 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.27 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.47 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 22' ' ' SER . 2.6 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.7 111.262 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.55 112.567 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.55 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.12 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.45 111.043 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.21 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.7 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.449 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.54 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' B' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.462 ' CD2' ' OH ' ' A' ' 64' ' ' TYR . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' B' ' 21' ' ' VAL . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' B' ' 42' ' ' PHE . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 42' ' ' PHE . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.423 ' O ' ' CB ' ' B' ' 45' ' ' ALA . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.438 ' HB2' ' CA ' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.469 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CB ' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 169' ' ' PHE . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 159' ' ' ALA . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.419 ' CG1' HG13 ' B' ' 21' ' ' VAL . 57.8 t . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG12 ' CG2' ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.425 ' N ' HG11 ' A' ' 42' ' ' VAL . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG2' HG12 ' A' ' 42' ' ' VAL . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.43 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 101' ' ' ILE . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 78' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD21 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 114' ' ' GLY . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.9 OUTLIER 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.418 ' N ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' CG2' HD21 ' A' ' 111' ' ' LEU . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.463 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.436 HD11 ' CD1' ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 4' ' ' ILE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.446 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.434 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' B' ' 4' ' ' ILE . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 179' ' ' PRO . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' B' ' 34' ' ' LEU . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.446 ' CD1' HG12 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' B' ' 45' ' ' ALA . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.498 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' CG1' HG22 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.531 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.475 ' CB ' ' CD2' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 21' ' ' ILE . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' B' ' 23' ' ' TRP . 38.3 t . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 43' ' ' THR . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 42' ' ' VAL . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.414 HD11 ' CB ' ' A' ' 51' ' ' TYR . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' CD2' HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' B' ' 47' ' ' ILE . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.51 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.424 HG22 ' CG1' ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' ' CD1' ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.43 HG21 ' CB ' ' A' ' 82' ' ' PHE . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.467 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.465 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.436 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.43 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.3 m-80 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.406 ' HB2' HD21 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 113' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.43 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' HB1' ' CA ' ' A' ' 19' ' ' LEU . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD2' ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 23' ' ' TYR . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' B' ' 9' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.467 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.424 HG12 ' CG2' ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.458 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' B' ' 34' ' ' LEU . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.414 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.414 HD12 ' CB ' ' B' ' 35' ' ' ASP . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 45' ' ' ALA . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.429 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.435 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' B' ' 21' ' ' VAL . 14.1 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' CB ' ' B' ' 12' ' ' PRO . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.421 ' N ' HG11 ' A' ' 42' ' ' VAL . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 46' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 72' ' ' TYR . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 64' ' ' TYR . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 HD22 ' N ' ' B' ' 42' ' ' PHE . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' HG23 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.519 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 96' ' ' LYS . 21.6 m120 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 82' ' ' PHE . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.469 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.443 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.442 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD21 ' CG1' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 111' ' ' LEU . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.427 ' CB ' HD12 ' A' ' 117' ' ' ILE . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 23' ' ' TYR . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.447 HG12 ' CD2' ' A' ' 53' ' ' LEU . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.439 ' CB ' HG13 ' A' ' 42' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.4 HG12 ' CG1' ' A' ' 36' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.441 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.428 HG11 ' CG ' ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.428 ' CG ' HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.414 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.416 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.439 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' B' ' 29' ' ' PHE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 24.83 110.926 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.72 111.024 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.19 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.46 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.3 110.239 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.3 110.774 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.17 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.27 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.64 112.634 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.7 113.259 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.69 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.19 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.05 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD12 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.97 110.251 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.15 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.94 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.79 111.438 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.6 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.11 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.51 112.116 179.828 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.376 . . . . 23.47 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE2' ' CD1' ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.06 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.28 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.53 111.633 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.33 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' B' ' 12' ' ' PRO . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.407 ' N ' HG13 ' A' ' 42' ' ' VAL . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.28 111.426 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.62 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.45 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.88 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.19 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.1 110.991 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 55' ' ' LEU . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.78 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.06 111.031 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.96 110.725 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.61 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.88 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.24 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.15 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.51 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.67 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.12 111.318 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.94 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.69 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.39 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.01 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.26 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.87 110.953 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.51 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.403 ' N ' ' CG2' ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.42 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.486 HG11 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.62 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' HB3' HG22 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.21 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.72 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.97 110.725 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.57 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.26 110.94 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.03 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.3 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.64 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.483 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.45 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.6 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.56 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.3 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.29 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.13 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.04 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.47 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.83 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.04 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.1 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.63 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' CB ' HG11 ' A' ' 152' ' ' VAL . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.6 111.729 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.72 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.74 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.528 ' CD2' ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.79 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.4 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.46 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.95 110.774 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.06 110.571 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.92 111.15 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.85 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.91 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.416 ' OD2' ' CG2' ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.48 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.35 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.35 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.76 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.71 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.56 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.73 110.713 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.12 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.58 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.97 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.478 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.4 mt-30 -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.28 108.337 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.9 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.71 111.921 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.28 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.05 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.6 110.864 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.95 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.39 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.97 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.74 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.3 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.66 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.49 111.329 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.1 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG2' HD23 ' A' ' 111' ' ' LEU . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.4 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.53 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.428 HG12 ' CG ' ' A' ' 171' ' ' GLU . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.63 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.1 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.88 110.49 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.27 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.47 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.7 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.55 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.55 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.12 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.428 ' CG ' HG12 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.45 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.21 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.7 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.54 111.072 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.46 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.428 ' CB ' HG12 ' A' ' 42' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.415 ' CD1' HG21 ' A' ' 24' ' ' THR . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' B' ' 34' ' ' LEU . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.445 ' CD1' HG12 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.423 ' CD1' ' HB3' ' B' ' 38' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.436 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.32 147.8 22.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HA ' H3B1 ' A' ' 181' ' ' GCP . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG13 ' CB ' ' A' ' 83' ' ' SER . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' HD11 ' A' ' 19' ' ' LEU . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.427 HG21 ' CG ' ' A' ' 34' ' ' PRO . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.421 ' HB3' ' N7 ' ' A' ' 181' ' ' GCP . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' OG ' ' CB ' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 169' ' ' PHE . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.01 -167.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.04 -47.5 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.17 159.71 22.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 40.3 t80 -129.25 98.15 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.795 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 170.22 60.7 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.409 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 48.9 Cg_endo -115.21 3.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.167 2.578 . . . . 0.0 114.105 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.5 m -91.58 90.47 7.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.955 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t -159.82 -70.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.514 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 24' ' ' THR . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 ' CG1' ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' HD12 ' B' ' 47' ' ' ILE . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.4 HD13 ' CB ' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.402 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.401 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.438 ' CB ' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE1' HD21 ' A' ' 145' ' ' LEU . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.439 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.492 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.416 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 85' ' ' VAL . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.436 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.432 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.472 HD21 ' CE1' ' A' ' 90' ' ' PHE . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 111' ' ' LEU . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 142' ' ' ALA . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.445 HG23 ' CG1' ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' CB ' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.474 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.467 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' B' ' 4' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.487 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.434 HG12 ' CG1' ' A' ' 36' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' B' ' 34' ' ' LEU . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.51 ' CD1' ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 37' ' ' PHE . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.4 ' CB ' HD13 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.51 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -99.7 14.04 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -73.63 -12.16 60.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.648 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 172.18 137.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.781 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -52.19 166.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 16.8 mt -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -131.35 9.47 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.07 99.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.89 126.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -65.59 153.01 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 44.8 p -66.92 134.25 51.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -75.53 117.95 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.455 H3B1 ' HA ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -88.19 140.24 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 24.83 111.016 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 HG21 ' N ' ' A' ' 4' ' ' ILE . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.72 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.19 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.46 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.3 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG12 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.3 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' CG1' ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.17 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.27 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.64 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.7 112.992 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HD3' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.69 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.19 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.05 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 ' CD2' ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.97 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 21' ' ' ILE . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.15 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 HG23 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.94 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.79 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.6 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.11 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.84 157.59 58.25 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.51 112.461 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.94 -18.23 11.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.935 -0.575 . . . . 41.89 111.17 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.21 162.04 0.78 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.829 0.347 . . . . 43.87 110.855 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -142.19 109.15 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 23.27 110.902 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 13.3 p -169.81 138.72 1.55 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 21.53 110.914 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 76.7 Cg_exo -48.17 149.73 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.613 2.209 . . . . 15.4 112.482 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -123.48 81.89 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 20.14 110.804 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.5 t -50.16 -78.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 23.47 111.248 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.06 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.28 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.53 111.787 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.33 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 43' ' ' THR . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 42' ' ' VAL . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.28 111.32 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' CG ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.62 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.45 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.88 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.447 ' CG ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.19 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.1 110.749 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.78 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.06 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.96 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.61 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.88 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.24 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.15 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.51 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.67 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.12 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' CD1' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.94 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD11 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.69 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.39 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.01 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.26 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.87 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.418 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.51 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.42 111.281 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.62 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.21 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.72 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.97 110.94 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.57 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.26 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.03 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' HD22 ' A' ' 145' ' ' LEU . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.3 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.64 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.45 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.6 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.56 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.458 ' HB ' ' CD ' ' A' ' 99' ' ' PRO . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.3 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.29 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.13 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.04 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.47 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.83 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.04 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.1 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.63 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.6 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.402 ' CE1' HD12 ' A' ' 101' ' ' ILE . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.72 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.438 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.74 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.79 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.46 111.495 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 115' ' ' THR . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.95 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.06 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.92 111.015 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.85 110.379 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.91 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.48 110.626 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.35 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.35 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.76 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.71 111.163 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.56 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.73 112.2 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.12 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.58 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.97 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.28 112.039 -176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.9 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.71 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.28 111.06 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.05 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.474 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.6 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.95 110.85 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.39 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.97 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.502 HD22 ' CE1' ' A' ' 90' ' ' PHE . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.74 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.3 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.66 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.49 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.1 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' HD22 ' A' ' 111' ' ' LEU . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.4 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.53 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.63 111.256 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.1 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.88 110.486 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.411 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.27 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.47 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.7 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.55 112.296 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.55 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.12 111.184 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.45 110.731 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.21 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.459 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.7 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' ' CG1' ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.54 111.629 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.464 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.406 ' CG2' ' HB1' ' A' ' 41' ' ' ALA . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.43 HG11 ' CG2' ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.444 HG13 ' CD1' ' B' ' 34' ' ' LEU . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.499 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.521 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p -77.77 -151.48 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.36 -22.64 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 74.18 125.03 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -71.36 169.79 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 mt -74.17 117.51 16.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 25.8 m -115.25 8.91 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.05 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.95 93.5 1.16 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.33 123.47 19.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.95 111.97 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 38.4 p -88.19 93.89 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.33 87.85 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.918 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -81.29 144.77 31.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.217 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.427 ' CG1' HG23 ' A' ' 75' ' ' THR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.426 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo -54.34 -164.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -147.02 -45.73 0.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.736 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.24 163.51 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.075 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 8.6 t80 -143.35 116.44 8.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 111.177 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.1 p -177.67 139.98 0.42 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.29 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 67.7 Cg_exo -28.28 145.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.031 3.154 . . . . 0.0 113.828 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.406 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 1.5 m -155.7 82.76 1.03 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.348 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG13 ' CE2' ' A' ' 64' ' ' TYR . 2.9 m -75.31 -43.04 43.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.804 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 42' ' ' VAL . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' CG1' ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.471 ' CG2' ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 36' ' ' VAL . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' NH1' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.56 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 HG23 ' CG1' ' A' ' 7' ' ' VAL . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.404 HD22 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 97' ' ' TRP . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG22 ' CB ' ' A' ' 82' ' ' PHE . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.464 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.447 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.414 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.45 HD12 HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' HB1' ' A' ' 130' ' ' ALA . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.436 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 127' ' ' GLU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 135' ' ' LYS . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.415 HG22 ' CE2' ' A' ' 90' ' ' PHE . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.459 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.49 HD12 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.447 ' CG2' HD23 ' A' ' 111' ' ' LEU . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE1' ' HB1' ' A' ' 142' ' ' ALA . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG21 ' CG2' ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 165' ' ' LEU . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' HB3' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.427 ' HB3' ' OD2' ' A' ' 118' ' ' ASP . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CD1' HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.428 ' CG1' HD12 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.44 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.442 HD11 HG13 ' B' ' 4' ' ' ILE . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.438 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.442 HG13 HD11 ' A' ' 177' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.401 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.54 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' B' ' 34' ' ' LEU . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.477 HD11 ' CG ' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' B' ' 42' ' ' PHE . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 45' ' ' ALA . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.477 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.432 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.54 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -89.55 -141.17 0.14 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -42.02 -25.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 76.33 -70.64 0.13 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 65.23 -175.84 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.01 130.31 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.04 116.05 0.16 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.906 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -77.33 99.97 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.853 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.72 105.54 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.93 121.65 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.5 66.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -104.07 22.21 15.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.008 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.204 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.88 0.372 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.73 158.5 15.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.812 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.452 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 ' CG2' HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.425 ' HD2' ' PG ' ' A' ' 181' ' ' GCP . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.424 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo -73.39 158.68 47.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.73 -4.49 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.589 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.19 167.97 1.57 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.49 -168.35 1.9 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.37 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 6.2 m 54.82 159.08 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.896 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -48.42 163.12 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.554 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 m -85.16 -26.88 26.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.644 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 64' ' ' TYR . 13.1 t 65.8 -70.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.833 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CZ ' HD12 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 43' ' ' THR . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 42' ' ' VAL . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.429 HG12 ' CG2' ' B' ' 9' ' ' ILE . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 4' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.445 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 67' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.473 HG22 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CE1' HG22 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' HG23 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 145' ' ' LEU . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 82' ' ' PHE . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 101' ' ' ILE . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.465 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG23 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.466 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.452 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' A' ' 90' ' ' PHE . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.482 HD21 ' CE1' ' A' ' 90' ' ' PHE . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.412 HD21 ' CG1' ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 111' ' ' LEU . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.519 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.409 HG22 ' CG1' ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HG ' ' CE2' ' A' ' 28' ' ' PHE . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.401 ' O ' ' CG2' ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.431 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 171' ' ' GLU . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' CB ' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.429 ' CG2' HG12 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.438 ' CG1' ' HG ' ' B' ' 34' ' ' LEU . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.438 ' HG ' ' CG1' ' B' ' 31' ' ' VAL . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.47 HD12 ' CZ ' ' A' ' 37' ' ' PHE . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' B' ' 45' ' ' ALA . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.476 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -75.84 -153.16 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.52 -27.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.26 -161.46 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.692 0.282 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -68.55 149.83 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.93 142.44 32.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -101.92 8.36 41.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.15 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t0 58.13 33.49 23.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.968 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 31.91 21.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 68.68 118.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.718 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.42 106.26 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.95 -165.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.671 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.425 ' PG ' ' HD2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.87 0.367 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 -160.33 159.25 31.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 24.83 110.857 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.72 111.12 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.19 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.46 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.3 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.3 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 16' ' ' LYS . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.17 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.27 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.64 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.7 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' CG ' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.69 112.173 -177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.19 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 159' ' ' ALA . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.05 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' CB ' ' CD1' ' A' ' 165' ' ' LEU . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.97 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.15 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.423 ' OG1' ' CE2' ' B' ' 15' ' ' PHE . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.94 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.79 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.6 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.11 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo -62.35 -168.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.51 112.565 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.77 -48.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 41.89 110.576 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.38 168.21 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 43.87 110.688 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.5 p90 -134.16 115.73 14.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.13 0.491 . . . . 23.27 110.73 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.14 124.14 0.5 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.66 -0.7 . . . . 21.53 110.397 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.71 123.62 14.16 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.509 2.139 . . . . 15.4 112.81 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 37' ' ' PHE . 1.1 m -61.43 -29.58 70.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 20.14 111.214 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 51.72 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.905 -0.589 . . . . 23.47 110.391 -176.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 71' ' ' SER . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.06 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.28 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.53 110.925 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.33 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 43' ' ' THR . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 42' ' ' VAL . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.28 111.55 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.62 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.45 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.88 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' CB ' ' A' ' 2' ' ' GLN . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.19 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.1 110.798 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.78 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 53' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.06 110.856 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.96 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.61 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.88 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.24 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.15 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.51 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.67 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.12 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.94 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.69 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.39 111.744 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.01 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.26 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 176' ' ' ALA . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.87 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.433 ' HB ' ' CA ' ' A' ' 176' ' ' ALA . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.51 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.472 ' CE2' HG21 ' A' ' 101' ' ' ILE . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.42 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.62 110.558 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.21 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.72 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.97 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.57 111.208 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.26 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.03 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.3 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.64 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.45 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.6 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.56 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.3 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.29 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.472 HG21 ' CE2' ' A' ' 78' ' ' PHE . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.13 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.04 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.47 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.83 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.04 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.1 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.445 ' N ' ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.63 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.6 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.72 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.74 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.79 110.699 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.474 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.46 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.95 110.843 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.473 HD13 HG22 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.06 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.92 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.85 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.91 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.48 110.676 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.35 112.422 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.35 111.043 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.76 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.71 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.56 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.73 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.12 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.58 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.97 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.453 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.28 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.9 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.71 112.351 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.28 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.05 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.445 HG23 ' CE2' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.6 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.95 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.39 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.97 109.969 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.74 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.3 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.66 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' CD2' ' CG1' ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.49 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.1 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.429 ' CG2' HD23 ' A' ' 111' ' ' LEU . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.4 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.53 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.425 HG21 ' CG1' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.63 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.1 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.88 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.27 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.474 ' HB2' ' N1 ' ' A' ' 181' ' ' GCP . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.47 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.7 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.446 ' CE ' ' N ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' N ' ' CE ' ' A' ' 163' ' ' LYS . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.55 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.442 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.55 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.12 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.45 110.573 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.476 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.21 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.7 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 172' ' ' ALA . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CA ' ' HB ' ' A' ' 77' ' ' VAL . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.54 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.423 ' CE2' ' OG1' ' A' ' 24' ' ' THR . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' B' ' 16' ' ' LYS . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 41' ' ' ALA . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' B' ' 34' ' ' LEU . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.433 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 4.4 p -82.6 -145.35 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.408 ' N ' ' OG ' ' B' ' 48' ' ' SER . 0.2 OUTLIER -45.19 -23.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 70.88 103.76 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 111.09 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.98 169.07 10.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.32 -9.29 17.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.599 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 60.38 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.576 0.703 . . . . 0.0 111.137 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.94 114.15 15.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.099 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.16 18.42 17.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.04 172.04 13.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.2 m 72.01 17.54 5.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 10.8 m -79.37 63.92 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.962 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.474 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -84.48 131.64 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.775 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.413 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.475 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 167.1 25.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -116.37 -23.76 8.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.242 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.35 159.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p90 -155.29 127.37 7.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.8 p -170.4 138.6 1.37 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 71.4 Cg_exo -49.08 101.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.51 2.14 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -94.21 117.4 30.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.702 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' B' ' 23' ' ' TRP . 2.5 m -88.11 -42.48 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' LEU . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 42' ' ' VAL . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.434 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.506 ' CD1' ' CG2' ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 97' ' ' TRP . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.463 ' CZ ' HD23 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' A' ' 97' ' ' TRP . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG22 ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.489 ' CD ' HG22 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.506 ' CG2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 99' ' ' PRO . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.465 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' CD1' ' CG2' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.427 ' CD1' ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.468 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.463 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.465 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.43 ' CB ' ' OD2' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.466 ' HA ' ' CB ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.474 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' ' CE2' ' A' ' 23' ' ' TYR . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.404 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 4' ' ' ILE . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.442 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.424 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.482 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.475 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.437 ' CB ' HG13 ' A' ' 36' ' ' VAL . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' B' ' 28' ' ' GLY . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 42' ' ' PHE . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' B' ' 39' ' ' ARG . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.443 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.42 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' B' ' 45' ' ' ALA . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.463 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.466 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER -101.03 33.39 2.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.9 -23.49 0.45 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.906 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 111.98 23.43 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -87.17 143.03 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 110.935 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 59.7 tp -91.37 103.22 15.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.937 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.8 m -107.41 7.83 29.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.043 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.68 130.85 44.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.815 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -123.02 67.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 p -123.56 -45.61 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -144.44 47.1 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.401 ' N7 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 -138.89 147.07 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CD1' HG23 ' A' ' 173' ' ' ILE . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' CG1' HG22 ' A' ' 75' ' ' THR . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' PB ' ' A' ' 181' ' ' GCP . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 159' ' ' ALA . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.46 -164.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 t -147.42 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.79 152.04 45.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.324 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 6.3 p90 -150.57 122.15 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 6.5 p 149.03 -31.8 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 124.182 0.926 . . . . 0.0 111.638 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 23.8 Cg_exo -66.43 -14.32 43.64 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.785 1.657 . . . . 0.0 112.701 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -51.0 121.01 5.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 p -155.41 -49.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.565 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.401 ' O ' HG22 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 3.0 t30 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 43' ' ' THR . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 42' ' ' VAL . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 51' ' ' TYR . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 4' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 70' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.41 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.436 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 176' ' ' ALA . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 97' ' ' TRP . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.422 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CB ' HG23 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.423 ' CG2' ' HG2' ' A' ' 116' ' ' GLN . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 82' ' ' PHE . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.488 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.483 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 110' ' ' PHE . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.417 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.404 HD13 HG22 ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.413 HG23 ' CG2' ' A' ' 155' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.423 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 HD11 ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.468 ' HB2' ' CE1' ' A' ' 28' ' ' PHE . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.3 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HD3' HD11 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.424 ' N ' ' CG ' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.432 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.456 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.431 ' CD1' HG13 ' B' ' 4' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.456 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.441 ' HG2' ' CE1' ' A' ' 23' ' ' TYR . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 7.2 t-160 -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.449 HG12 ' CG ' ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.452 ' HB3' ' CG ' ' B' ' 39' ' ' ARG . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' B' ' 41' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.452 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' B' ' 38' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' B' ' 29' ' ' PHE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -74.85 -151.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.41 -28.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.7 0.286 . . . . 0.0 111.685 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 61.0 118.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.434 ' HB2' ' CB ' ' B' ' 54' ' ' ASP . 4.7 mm-40 56.08 176.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.12 103.05 15.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.319 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' B' ' 53' ' ' THR . 63.3 m 64.46 10.96 6.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.434 ' CB ' ' HB2' ' B' ' 51' ' ' GLN . 12.0 t0 -71.96 120.06 17.03 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -163.06 -69.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.63 100.48 3.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -61.58 103.59 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.78 50.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.447 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.807 0.336 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.65 144.23 27.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' CG1' HG23 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' O ' HD11 ' A' ' 19' ' ' LEU . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.506 HG21 ' CE1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.459 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.9 164.13 20.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.57 -38.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.522 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -52.82 138.91 28.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' O2A' ' A' ' 181' ' ' GCP . 1.4 t80 -133.93 98.69 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 HG21 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -174.0 -61.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.065 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' CD ' HG21 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -68.31 82.37 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.637 2.225 . . . . 0.0 112.728 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 m -138.78 17.25 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.324 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.36 -70.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.478 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' B' ' 12' ' ' PRO . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' CZ ' ' HE2' ' A' ' 5' ' ' LYS . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' O ' HD21 ' B' ' 38' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 ' CG1' ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.432 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.478 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' CD2' ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 81' ' ' CYS . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HG2' HD22 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' OD2' HD21 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.415 HD22 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.518 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 145' ' ' LEU . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 111' ' ' LEU . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.437 ' CB ' HG11 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.409 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 157' ' ' CYS . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CE1' HD23 ' A' ' 20' ' ' LEU . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB1' ' CG2' ' A' ' 4' ' ' ILE . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . 0.4 ' HB2' ' NE2' ' B' ' 17' ' ' HIS . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.403 HG23 HG21 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.48 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.456 HG12 ' CG ' ' B' ' 34' ' ' LEU . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' B' ' 42' ' ' PHE . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' B' ' 48' ' ' SER . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.48 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t -98.8 -15.81 19.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.2 -22.53 15.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.382 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.22 125.57 5.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.12 -172.63 2.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.8 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.85 78.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 34.2 m -106.42 7.05 30.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.64 104.9 3.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.1 55.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -85.79 118.12 25.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.85 112.14 20.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.254 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -134.99 43.99 2.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.128 179.724 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.428 ' O2A' ' CD1' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.851 0.357 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -171.67 154.58 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.436 ' CG2' ' HE2' ' A' ' 5' ' ' LYS . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' HA3' ' PA ' ' A' ' 181' ' ' GCP . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' B' ' 15' ' ' PHE . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.66 173.77 13.93 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -44.09 2.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 136.9 50.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 4.9 p90 -158.05 124.35 4.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.35 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.702 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 62.6 Cg_endo -87.51 128.98 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.702 2.268 . . . . 0.0 112.251 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 36' ' ' VAL . 27.8 m -162.31 -96.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 37' ' ' PHE . 0.7 OUTLIER 65.97 -58.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.593 0.357 . . . . 0.0 111.6 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.489 ' CE2' ' CD2' ' B' ' 17' ' ' HIS . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' B' ' 12' ' ' PRO . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' CD2' ' A' ' 51' ' ' TYR . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.424 ' CG2' HG21 ' A' ' 7' ' ' VAL . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 97' ' ' TRP . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CB ' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.414 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.427 ' CB ' HG11 ' A' ' 152' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 155' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 HD12 ' CA ' ' A' ' 146' ' ' ALA . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.408 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.416 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.414 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.419 HD22 ' CG1' ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.432 ' CG2' HD11 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.432 ' N ' HD12 ' A' ' 117' ' ' ILE . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.466 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' B' ' 9' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.434 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.43 ' CB ' HG12 ' A' ' 42' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 2.6 t-160 -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . 0.468 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.401 ' CB ' HG13 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.448 ' CG1' ' HG ' ' B' ' 34' ' ' LEU . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.463 HD21 ' CE1' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.413 ' CG ' ' HB3' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.474 HD11 ' CZ ' ' B' ' 29' ' ' PHE . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p -86.46 -144.6 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -42.02 -26.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 58.28 107.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.902 0.382 . . . . 0.0 111.457 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -88.75 175.4 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -167.65 36.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.087 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.0 m -96.76 8.39 44.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -56.92 155.42 8.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.83 -83.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.64 127.3 32.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.07 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 15.2 p -105.9 29.25 6.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 151.92 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.918 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.418 ' PA ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -147.67 133.47 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.435 ' CD1' HG21 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.435 ' N ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' HA3' ' H8 ' ' A' ' 181' ' ' GCP . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.424 ' CA ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.75 157.4 48.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.38 -8.82 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.069 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 137.45 44.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.74 0.305 . . . . 0.0 110.956 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.45 98.99 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.309 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -172.66 -66.38 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.71 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 72.5 Cg_endo -73.9 -161.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.741 2.294 . . . . 0.0 111.796 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 81.72 116.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.211 0.529 . . . . 0.0 111.711 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' B' ' 23' ' ' TRP . 83.7 t -137.47 -49.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.898 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CE1' ' CD2' ' B' ' 17' ' ' HIS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 43' ' ' THR . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' B' ' 12' ' ' PRO . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 101' ' ' ILE . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.43 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.437 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.455 HG21 ' CE2' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.481 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.467 HG21 HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD2' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.441 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.484 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.47 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 HG21 ' CG1' ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 22' ' ' SER . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 175' ' ' ALA . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' B' ' 4' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.457 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.432 HG23 ' CG2' ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.575 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 4.1 t-160 -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.458 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.467 ' CD1' ' OE1' ' B' ' 51' ' ' GLN . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 37' ' ' PHE . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 81.0 p -97.96 -87.2 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . 0.433 ' N ' ' OG ' ' B' ' 48' ' ' SER . 4.1 mt-10 -97.01 -24.39 15.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 170.31 148.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.149 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.467 ' OE1' ' CD1' ' B' ' 29' ' ' PHE . 3.7 mt-30 -92.41 161.04 14.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.0 mt -50.66 167.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.35 109.45 0.99 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.36 0.6 . . . . 0.0 110.108 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 57.94 87.04 0.07 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.94 100.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.972 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -74.24 110.76 8.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 120.16 26.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -69.32 112.23 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tttp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.005 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.447 ' H8 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.25 131.52 45.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.434 HG23 ' CB ' ' A' ' 176' ' ' ALA . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 16' ' ' LYS . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 8' ' ' VAL . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD23 ' CE1' ' A' ' 169' ' ' PHE . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.465 HG23 ' CD1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.8 168.85 20.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -3.65 8.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.694 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 151.44 5.74 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -123.43 100.54 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p 178.56 125.46 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.51 152.42 40.47 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.377 2.051 . . . . 0.0 112.194 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -83.91 144.87 28.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -116.59 -46.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' CB ' ' HE2' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 43' ' ' THR . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.434 ' N ' HG11 ' A' ' 42' ' ' VAL . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' CD2' HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 75' ' ' THR . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.464 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG11 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 90' ' ' PHE . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.486 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.526 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 101' ' ' ILE . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' HG22 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.419 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 129' ' ' LEU . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' A' ' 154' ' ' TYR . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 152' ' ' VAL . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.424 ' CG2' HG11 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.48 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 53' ' ' LEU . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.441 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' B' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.426 ' CB ' HG13 ' A' ' 42' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.436 ' HE2' ' CB ' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.419 ' NE2' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . 0.419 ' HB2' ' NE2' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 37' ' ' PHE . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' B' ' 34' ' ' LEU . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.443 ' CD1' HG13 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.01 -24.97 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -101.43 -25.46 13.92 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.72 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.98 -4.76 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.096 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 49.7 -164.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.775 0.322 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 -42.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 9.0 m -101.24 9.58 41.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.081 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 51.34 86.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 118.31 3.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 66.47 121.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -81.47 119.83 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.3 91.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.4 ' H8 ' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -84.42 155.27 22.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HE2' ' PB ' ' A' ' 181' ' ' GCP . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 19' ' ' LEU . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.02 152.36 28.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.93 -10.16 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.14 171.49 0.72 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.904 0.383 . . . . 0.0 111.125 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 33' ' ' VAL . 5.1 p90 -130.58 -168.84 2.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' CB ' ' O ' ' A' ' 32' ' ' TYR . 4.8 t 84.56 131.89 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.86 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -40.35 153.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.698 2.266 . . . . 0.0 112.851 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -77.56 -27.72 51.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG13 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t 68.42 -75.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' B' ' 18' ' ' VAL . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.418 HG13 ' CG2' ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' CG2' HG13 ' A' ' 42' ' ' VAL . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 46' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 7' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CB ' HG22 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.489 ' CE1' ' CD2' ' A' ' 145' ' ' LEU . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG22 ' CB ' ' A' ' 82' ' ' PHE . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.488 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 ' CE2' ' A' ' 78' ' ' PHE . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' CB ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 126' ' ' ILE . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.48 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.422 ' CB ' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 90' ' ' PHE . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.489 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 109' ' ' PRO . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' CE ' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CE1' ' HB1' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' HD13 ' A' ' 117' ' ' ILE . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 163' ' ' LYS . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.482 HD11 ' N2 ' ' A' ' 181' ' ' GCP . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 22' ' ' SER . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' TYR . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.434 HG23 ' CD1' ' A' ' 4' ' ' ILE . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.416 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' B' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.449 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.439 ' HE3' ' CG2' ' B' ' 18' ' ' VAL . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.439 ' CG2' ' HE3' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' B' ' 34' ' ' LEU . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.436 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.487 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -100.76 5.36 43.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.57 -10.98 60.4 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 69.1 8.74 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -170.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.935 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.97 153.16 18.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' B' ' 54' ' ' ASP . 2.6 t -129.11 -125.5 0.22 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.075 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' B' ' 53' ' ' THR . 3.7 m-20 -65.88 116.33 6.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.94 127.97 34.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -71.71 154.97 40.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -30.28 6.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.61 98.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.504 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.35 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.26 143.6 31.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 24.83 110.91 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.72 110.906 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.19 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.46 109.961 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.3 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' O ' HG11 ' A' ' 7' ' ' VAL . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.3 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.17 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.27 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.64 112.404 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' O ' H5'1 ' A' ' 181' ' ' GCP . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.7 112.519 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.69 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.19 110.906 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.05 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HG ' HD22 ' A' ' 19' ' ' LEU . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.97 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.15 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.43 ' OG1' ' CD1' ' B' ' 15' ' ' PHE . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.94 111.621 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.79 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.6 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.11 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.66 167.2 27.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.51 112.459 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.61 -7.13 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 41.89 111.667 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -53.41 171.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 43.87 110.931 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' CD2' ' CG2' ' A' ' 33' ' ' VAL . 5.2 p90 -137.38 -169.39 2.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.21 -0.45 . . . . 23.27 109.87 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 12.8 t 70.94 108.33 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.928 -0.578 . . . . 21.53 111.035 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.78 142.17 19.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 15.4 112.43 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 170.99 14.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 20.14 110.894 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.448 HG13 ' CE2' ' B' ' 29' ' ' PHE . 59.5 t -109.3 -45.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 23.47 111.082 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.06 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.28 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.53 111.555 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.33 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.28 111.197 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.62 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.45 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.88 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.19 110.937 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.1 110.936 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' CD2' HD13 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.78 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.06 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.96 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.61 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.88 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.24 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.15 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.51 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.67 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.12 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.94 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.69 111.992 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.39 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.542 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.01 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.26 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.477 HG21 ' CE1' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.87 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.51 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.42 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.62 110.454 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.21 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.72 111.008 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.97 111.038 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.57 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.26 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.03 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CZ ' HD21 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.3 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.64 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.45 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.6 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.56 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.3 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.29 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.13 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.04 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.47 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.83 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.04 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.1 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.63 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.6 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.72 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.74 110.935 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 154' ' ' TYR . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.79 110.549 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.46 111.676 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.95 110.778 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.06 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.92 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.85 110.878 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.91 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.48 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.35 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.35 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.76 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.421 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.71 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.56 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.73 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.12 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.478 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.58 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.97 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.28 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.9 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.71 111.954 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.28 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.05 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.6 111.715 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.95 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.39 110.358 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.97 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.487 HD21 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.74 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.3 110.597 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.66 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.49 111.194 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.1 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.4 110.963 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.53 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.63 111.475 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.1 112.052 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.88 109.914 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.27 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.47 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.7 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.55 112.38 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 22' ' ' SER . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.55 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.12 111.476 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.45 110.921 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.21 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.451 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.7 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.54 111.139 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.467 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' OG1' ' A' ' 24' ' ' THR . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.411 HG23 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.426 HG11 ' N ' ' B' ' 22' ' ' GLY . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.426 ' N ' HG11 ' B' ' 21' ' ' VAL . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 47' ' ' ILE . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' B' ' 34' ' ' LEU . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.438 ' CG ' HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.436 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.466 HD13 ' CZ ' ' B' ' 29' ' ' PHE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t -100.42 21.71 12.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.08 -8.07 41.78 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.031 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.06 -0.97 15.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.72 -174.84 2.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.822 0.344 . . . . 0.0 111.147 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.55 135.27 34.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.64 114.03 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.309 0.576 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.12 162.62 23.6 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.034 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.7 -24.08 13.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 60.88 22.12 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.276 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -96.25 26.28 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.99 124.32 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tttt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.496 H5'1 ' O ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.793 0.33 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -108.73 150.9 26.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' HA ' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 19' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.468 ' HB ' ' CD1' ' B' ' 15' ' ' PHE . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.91 154.88 73.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -20.33 10.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -53.76 155.19 3.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 110.974 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 6.6 t80 -141.38 113.98 8.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 12.4 p -160.77 137.15 6.3 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.974 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 81.7 Cg_exo -44.63 147.76 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.445 2.097 . . . . 0.0 112.277 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 m -134.83 153.89 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG11 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p -131.61 -39.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.372 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 44' ' ' VAL . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 42' ' ' VAL . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' A' ' 42' ' ' VAL . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CA ' ' HB2' ' B' ' 45' ' ' ALA . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' CD2' ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 98' ' ' VAL . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.422 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG23 ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HB2' ' CG2' ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.472 HD21 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.463 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.485 ' OD2' ' N2 ' ' A' ' 181' ' ' GCP . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 138' ' ' THR . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.4 ' N ' HG21 ' A' ' 137' ' ' ILE . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.492 HD11 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 109' ' ' PRO . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CD1' HD21 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.447 ' CG2' HD11 ' A' ' 4' ' ' ILE . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.416 ' CB ' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' B' ' 4' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.474 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.474 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.452 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.468 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 36' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.403 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.462 HG13 ' CD1' ' B' ' 34' ' ' LEU . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.462 ' CD1' HG13 ' B' ' 31' ' ' VAL . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.463 ' CB ' ' CD2' ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.426 ' HB2' ' CA ' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t -79.18 -150.19 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -40.2 -29.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.72 10.99 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -49.25 167.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 0.0 110.972 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.47 25.63 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.895 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 43.1 p -105.05 -122.17 0.22 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.013 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.01 83.19 0.22 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.904 0.383 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.87 -82.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -74.07 133.31 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.68 -62.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p 47.48 90.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.485 ' N2 ' ' OD2' ' A' ' 118' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.54 141.96 39.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 24.83 110.68 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.72 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 ' CD1' HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.19 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.46 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.3 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.3 110.594 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG12 ' CE ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.17 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.497 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.27 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.64 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.7 112.868 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' CE ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.69 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.19 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.05 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' CD1' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 HD21 ' CZ ' ' A' ' 169' ' ' PHE . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.97 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 21' ' ' ILE . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.15 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.499 ' CG2' ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.94 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.79 111.441 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.6 110.857 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.11 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.57 163.65 37.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.51 111.736 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.53 -40.17 1.61 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.484 -0.325 . . . . 41.89 111.202 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.58 145.14 15.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 43.87 111.082 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' CD1' " H3'" ' A' ' 181' ' ' GCP . 27.5 t80 -129.41 101.72 6.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 23.27 110.439 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -172.92 -60.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 21.53 111.452 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' CD ' HG23 ' A' ' 33' ' ' VAL . 48.5 Cg_endo -69.88 120.65 7.38 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.38 2.053 . . . . 15.4 112.948 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' PHE . 18.9 m -163.5 -85.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 20.14 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 47.24 -84.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.458 0.474 . . . . 23.47 110.995 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 35' ' ' THR . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.06 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.28 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.53 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' CB ' ' HE2' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.33 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 43' ' ' THR . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.44 ' N ' HG12 ' A' ' 42' ' ' VAL . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.28 111.489 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.62 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.45 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.88 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.19 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.1 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.78 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.06 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.96 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.61 110.933 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.88 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.24 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.15 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.51 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.67 111.493 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.12 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' B' ' 47' ' ' ILE . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.94 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.69 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.39 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.01 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.26 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.454 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.87 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.51 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.42 111.152 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.62 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CB ' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.21 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.72 111.059 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.97 111.433 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.57 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.26 110.85 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.03 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.3 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.64 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 ' CG2' ' CB ' ' A' ' 82' ' ' PHE . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.45 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HA ' ' CD2' ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.6 111.672 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.497 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.56 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' CD ' ' A' ' 99' ' ' PRO . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.459 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.3 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.29 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.13 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.04 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.47 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.83 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.04 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.1 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.63 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.6 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.72 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.431 HD12 ' CG2' ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.74 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.79 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.46 111.757 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.95 110.884 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.433 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.06 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.92 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.85 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.91 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.48 110.362 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.35 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.35 111.477 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.76 110.85 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.71 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.56 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.73 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.12 112.061 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.58 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.97 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.28 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.9 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.71 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.28 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.05 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.6 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.95 110.784 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.39 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.97 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.523 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.74 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.3 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.66 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.49 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.1 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.431 ' CG2' HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.4 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.53 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.63 111.257 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.406 ' SG ' ' CD1' ' A' ' 19' ' ' LEU . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.1 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.88 110.64 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.27 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.47 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.7 111.091 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.433 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.55 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.435 HD12 ' CD1' ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.55 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 156' ' ' GLU . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.12 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.45 111.538 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.408 ' N ' HD21 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.443 HG23 ' CD1' ' A' ' 4' ' ' ILE . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.21 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.445 ' CD1' ' HG3' ' B' ' 6' ' ' LYS . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.7 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CB ' ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.54 111.592 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.458 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.441 ' HB ' HD21 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.445 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.425 ' HB3' HG11 ' A' ' 42' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' THR . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CD1' ' CG2' ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' HB1' ' A' ' 41' ' ' ALA . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.429 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.42 ' CG1' HG23 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' B' ' 47' ' ' ILE . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.439 HG12 ' CG ' ' B' ' 34' ' ' LEU . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' CD1' ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.407 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' B' ' 29' ' ' PHE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p -80.18 -153.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -42.2 -28.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.78 12.59 6.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 63.58 161.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.782 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.56 53.11 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.8 p -89.2 -118.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 172.34 0.18 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 73.03 50.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -106.64 -76.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 116.61 22.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.091 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -94.71 25.84 3.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.467 " H3'" ' CD1' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.783 0.325 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.63 135.03 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 24.83 110.855 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.72 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.19 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.46 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.3 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.3 110.759 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.17 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.27 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.64 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' HA2' ' O1A' ' A' ' 181' ' ' GCP . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.7 113.013 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.69 112.171 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' LEU . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.19 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.05 111.618 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 169' ' ' PHE . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.97 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' HB3' ' NE2' ' A' ' 162' ' ' GLN . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.15 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.94 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.79 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.6 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.11 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo -63.61 -165.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.51 112.741 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.5 t -146.87 -45.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 41.89 110.655 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 169.38 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 43.87 110.724 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -136.54 110.45 8.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 23.27 111.107 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 33' ' ' VAL . 9.5 p -167.63 135.49 1.95 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 21.53 111.096 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.29 121.44 9.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.422 2.081 . . . . 15.4 112.419 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.406 ' CB ' ' O2G' ' A' ' 181' ' ' GCP . 1.4 m -56.83 -41.84 78.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 20.14 110.472 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.71 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.728 -0.669 . . . . 23.47 110.561 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.06 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.28 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.53 110.998 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.476 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.33 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 44' ' ' VAL . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' CG2' HG13 ' A' ' 42' ' ' VAL . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.28 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' HB ' ' CD2' ' A' ' 51' ' ' TYR . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.62 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.45 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.88 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.417 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.19 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.1 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.78 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.477 ' CD1' ' CD1' ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.06 111.119 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.96 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.61 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.88 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.24 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.15 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.51 111.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.67 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.12 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' CA ' ' HB2' ' B' ' 45' ' ' ALA . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.94 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.69 110.835 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.39 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.01 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.26 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.87 109.669 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.51 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.459 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.42 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' CD2' ' CG2' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.62 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB3' HG23 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.21 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.72 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 137' ' ' ILE . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.97 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.57 111.724 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.26 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.03 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.3 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.64 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.527 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.45 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.6 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.537 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.56 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.3 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.29 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.13 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.04 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.47 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.83 110.863 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.04 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.1 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.63 111.352 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.437 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.6 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.72 111.901 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.74 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.79 110.827 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.458 ' CG2' ' CD2' ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.46 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.95 110.946 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.43 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.06 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.92 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.85 110.094 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.91 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.48 110.746 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.35 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.35 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.76 110.138 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.453 ' HA ' HD12 ' A' ' 129' ' ' LEU . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.71 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 130' ' ' ALA . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.46 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.56 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 129' ' ' LEU . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.73 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.12 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.58 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.97 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.46 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.28 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.9 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.401 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.71 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.421 ' N ' HG11 ' A' ' 84' ' ' VAL . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.28 110.843 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.05 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.6 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.95 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.39 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.97 110.378 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.74 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.3 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.66 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.416 HD21 ' CB ' ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.49 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.1 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 111' ' ' LEU . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.4 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.53 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.63 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.427 ' CA ' HD12 ' A' ' 117' ' ' ILE . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.1 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.43 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.88 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.27 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.524 ' HB2' ' N1 ' ' A' ' 181' ' ' GCP . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.47 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 22' ' ' SER . 2.6 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.7 111.262 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.55 112.567 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.55 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.12 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.45 111.043 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.21 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.439 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.7 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.449 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.54 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' B' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.439 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.462 ' CD2' ' OH ' ' A' ' 64' ' ' TYR . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' B' ' 21' ' ' VAL . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' B' ' 42' ' ' PHE . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 42' ' ' PHE . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.423 ' O ' ' CB ' ' B' ' 45' ' ' ALA . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.459 ' CD1' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.438 ' HB2' ' CA ' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -87.97 -146.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -47.65 -22.47 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 75.58 136.64 0.06 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.949 0.404 . . . . 0.0 111.289 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 65.78 153.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.286 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.76 132.73 40.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 12.2 m -120.47 8.96 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -167.8 0.05 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.81 167.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.972 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -142.28 -53.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -81.13 139.91 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.87 155.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.01 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.869 179.837 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.524 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.469 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -100.69 142.48 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CD1' HG21 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CB ' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD23 ' CE1' ' A' ' 169' ' ' PHE . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' A' ' 159' ' ' ALA . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.99 156.8 51.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.64 -17.73 14.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.437 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.54 138.16 34.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.24 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 33' ' ' VAL . 4.0 t80 -131.05 106.26 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.456 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 1.2 t 169.04 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.674 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 99.2 Cg_exo -46.52 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 112.956 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' O2G' ' A' ' 181' ' ' GCP . 2.4 m -172.44 98.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.391 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.419 ' CG1' HG13 ' B' ' 21' ' ' VAL . 57.8 t -159.59 -61.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.481 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG12 ' CG2' ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.425 ' N ' HG11 ' A' ' 42' ' ' VAL . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG2' HG12 ' A' ' 42' ' ' VAL . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.424 HD22 ' CD1' ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.43 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 101' ' ' ILE . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CD2' ' HB2' ' A' ' 90' ' ' PHE . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.407 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 82' ' ' PHE . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.417 HG22 ' CE1' ' A' ' 78' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' CG ' ' HA ' ' A' ' 176' ' ' ALA . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD21 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 114' ' ' GLY . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 115' ' ' THR . 0.9 OUTLIER 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.418 ' N ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' CG2' HD21 ' A' ' 111' ' ' LEU . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.463 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.436 HD11 ' CD1' ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 4' ' ' ILE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.446 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.434 ' HA ' ' CG ' ' A' ' 109' ' ' PRO . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.427 ' HB2' HG13 ' B' ' 4' ' ' ILE . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 179' ' ' PRO . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' B' ' 34' ' ' LEU . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.446 ' CD1' HG12 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' B' ' 35' ' ' ASP . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' B' ' 45' ' ' ALA . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.434 ' CG ' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER -101.4 -22.32 14.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.08 -22.75 15.54 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.9 -84.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.046 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 50.03 -163.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.13 63.45 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 28.5 m -109.79 6.51 23.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.109 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -106.81 27.48 8.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.776 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.46 15.97 9.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -70.63 108.11 4.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.821 0.343 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.7 m -155.73 35.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -50.99 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 mttm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.416 ' O2G' ' CG2' ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.808 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.498 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 -141.6 151.93 43.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' CG1' HG22 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' N7 ' ' A' ' 181' ' ' GCP . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.475 ' CB ' ' CD2' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 21' ' ' ILE . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.47 172.54 15.48 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -52.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 149.87 31.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 10.5 p90 -155.98 120.8 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.6 -64.85 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 69.1 Cg_endo -74.54 65.71 5.61 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.533 2.155 . . . . 0.0 112.556 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 37' ' ' PHE . 70.4 m -118.22 -79.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CB ' ' B' ' 23' ' ' TRP . 38.3 t 64.05 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.308 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 35' ' ' THR . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 43' ' ' THR . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 42' ' ' VAL . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.414 HD11 ' CB ' ' A' ' 51' ' ' TYR . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' CD2' HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' B' ' 47' ' ' ILE . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.51 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.424 HG22 ' CG1' ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.488 ' CZ ' ' CD1' ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.43 HG21 ' CB ' ' A' ' 82' ' ' PHE . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.467 ' CB ' ' CG1' ' A' ' 152' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.465 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.436 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.43 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.431 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.3 m-80 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.458 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' CD1' ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.406 ' HB2' HD21 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 109' ' ' PRO . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 113' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.43 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' HB1' ' CA ' ' A' ' 19' ' ' LEU . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD2' ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 23' ' ' TYR . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 4' ' ' ILE . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' B' ' 9' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.467 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.424 HG12 ' CG2' ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.458 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.414 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' B' ' 34' ' ' LEU . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.414 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.414 HD12 ' CB ' ' B' ' 35' ' ' ASP . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 45' ' ' ALA . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.429 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t -86.46 -144.57 0.11 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.65 -25.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.85 113.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 170.49 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mp -137.11 36.35 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 9.3 m -99.18 9.11 44.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.048 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -55.47 121.24 8.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.018 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.14 100.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -49.51 134.06 19.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -90.69 -165.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.45 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.995 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 mtmm . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.878 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . 0.464 ' N7 ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.794 0.33 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.2 147.5 49.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.118 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.435 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.517 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.46 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -35.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.549 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.24 168.24 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.647 0.261 . . . . 0.0 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.33 -168.52 1.34 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.365 0.603 . . . . 0.0 110.594 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 1.6 t 47.68 47.96 5.25 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.421 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 27.2 Cg_endo -93.7 -168.95 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.476 2.117 . . . . 0.0 112.77 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m 71.48 -137.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.543 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' B' ' 21' ' ' VAL . 14.1 t 78.03 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' CB ' ' B' ' 12' ' ' PRO . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.421 ' N ' HG11 ' A' ' 42' ' ' VAL . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 46' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' CD1' ' CD2' ' A' ' 55' ' ' LEU . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 53' ' ' LEU . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.461 HG21 ' CE1' ' A' ' 72' ' ' TYR . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB1' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 64' ' ' TYR . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 HD22 ' N ' ' B' ' 42' ' ' PHE . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.475 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' HG23 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.519 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 96' ' ' LYS . 21.6 m120 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 82' ' ' PHE . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.499 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.469 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 132' ' ' ASN . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.442 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD21 ' CG1' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 111' ' ' LEU . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 19' ' ' LEU . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.427 ' CB ' HD12 ' A' ' 117' ' ' ILE . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 23' ' ' TYR . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.447 HG12 ' CD2' ' A' ' 53' ' ' LEU . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.439 ' CB ' HG13 ' A' ' 42' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.4 HG12 ' CG1' ' A' ' 36' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.441 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.428 HG11 ' CG ' ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.428 ' CG ' HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.414 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.416 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.439 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' B' ' 29' ' ' PHE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER -100.64 0.75 39.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.8 -11.83 61.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.123 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.85 106.07 7.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.286 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -106.78 -164.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.45 110.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.9 m -102.79 9.07 39.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.051 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -52.02 103.94 0.07 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.951 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.22 136.53 50.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 52.35 178.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.2 -83.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.31 64.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.135 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.932 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 -124.92 142.45 51.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 24.83 110.926 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.72 111.024 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.19 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.46 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.3 110.239 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.3 110.774 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.17 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.27 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.64 112.634 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.7 113.259 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.69 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.19 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.05 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD12 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.97 110.251 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.15 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.94 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.79 111.438 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.6 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.11 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.62 -174.56 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.51 112.116 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 t -149.29 -46.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 41.89 111.169 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.95 134.0 51.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 43.87 111.164 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 13.4 p90 -154.5 120.46 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 23.27 110.704 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.44 -64.61 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 21.53 111.054 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 30.1 Cg_endo -66.23 -82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.514 2.143 . . . . 15.4 112.916 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 35' ' ' THR . 69.9 m 56.16 23.47 7.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.807 0.337 . . . . 20.14 110.877 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.8 t -51.68 -63.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.276 -0.42 . . . . 23.47 110.987 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE2' ' CD1' ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.06 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.28 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.53 111.633 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.33 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' B' ' 12' ' ' PRO . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.407 ' N ' HG13 ' A' ' 42' ' ' VAL . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.28 111.426 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.62 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.45 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.88 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.19 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.1 110.991 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' CD1' HD21 ' A' ' 55' ' ' LEU . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.78 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.06 111.031 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.96 110.725 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.61 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.88 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.24 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.15 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.51 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.67 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.12 111.318 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' B' ' 45' ' ' ALA . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.94 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.69 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.39 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.01 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.26 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.87 110.953 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.51 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.403 ' N ' ' CG2' ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.42 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG11 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.62 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' HB3' HG22 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.21 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.72 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.97 110.725 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.57 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.26 110.94 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.03 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.3 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.64 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.483 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.45 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.6 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.496 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.56 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.3 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.29 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.13 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.04 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.47 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.83 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.04 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.1 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.63 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' CB ' HG11 ' A' ' 152' ' ' VAL . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.6 111.729 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.72 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.74 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.528 ' CD2' ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.79 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.4 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.46 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.95 110.774 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.06 110.571 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.92 111.15 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.85 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.91 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.416 ' OD2' ' CG2' ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.48 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.35 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.35 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.76 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.71 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB2' ' CB ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.56 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.73 110.713 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.12 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.58 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.97 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.478 ' CB ' ' HB2' ' A' ' 129' ' ' LEU . 1.4 mt-30 -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.28 108.337 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.9 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.71 111.921 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.28 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.05 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.6 110.864 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.95 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.39 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.97 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.74 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.3 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.66 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.49 111.329 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.1 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG2' HD23 ' A' ' 111' ' ' LEU . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.4 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.53 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.428 HG12 ' CG ' ' A' ' 171' ' ' GLU . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.63 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.1 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.88 110.49 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.27 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.47 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.7 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.55 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.55 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.12 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.428 ' CG ' HG12 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.45 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.21 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' B' ' 4' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.7 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.54 111.072 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.446 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.46 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.457 ' HB ' ' CD1' ' A' ' 174' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 174' ' ' LEU . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.428 ' CB ' HG12 ' A' ' 42' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.415 ' CD1' HG21 ' A' ' 24' ' ' THR . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' B' ' 34' ' ' LEU . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.445 ' CD1' HG12 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' B' ' 42' ' ' PHE . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.423 ' CD1' ' HB3' ' B' ' 38' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.436 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -74.35 -150.49 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -42.57 -27.58 0.17 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.22 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 63.21 -177.9 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.81 -159.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.19 112.57 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.329 0.585 . . . . 0.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.72 119.81 7.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.027 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.49 -24.55 10.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.43 100.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 21.5 m -112.64 45.63 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.58 87.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.798 0.332 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 56' ' ' PHE . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.707 HG21 ' O ' ' A' ' 81' ' ' CYS . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.947 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.83 ' HB2' HD11 ' A' ' 165' ' ' LEU . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.525 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.894 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 44' ' ' VAL . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG11 HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.48 HG12 HG23 ' B' ' 9' ' ' ILE . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 4' ' ' ILE . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.905 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 7' ' ' VAL . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.575 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 113' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.707 ' O ' HG21 ' A' ' 14' ' ' VAL . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.484 ' CB ' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.777 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.853 ' CZ ' HG22 ' A' ' 141' ' ' THR . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.661 ' HB ' HD22 ' A' ' 149' ' ' LEU . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' VAL . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 76' ' ' ASP . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.852 ' HB2' HG23 ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG11 ' A' ' 168' ' ' VAL . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.53 ' H ' HG22 ' A' ' 115' ' ' THR . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 119' ' ' LEU . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.652 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.684 HG21 HD21 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HG3' HG23 ' A' ' 126' ' ' ILE . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.853 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 93' ' ' VAL . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.114 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CD1' HD23 ' A' ' 112' ' ' LEU . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.755 HG23 HG13 ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.512 ' C ' HD11 ' A' ' 117' ' ' ILE . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.871 ' O ' HD22 ' A' ' 165' ' ' LEU . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.947 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.622 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.746 ' O ' HD12 ' A' ' 173' ' ' ILE . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.684 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.442 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.454 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' B' ' 9' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 1.114 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 173' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.517 ' HE2' HD22 ' A' ' 177' ' ' LEU . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 177' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.798 HG22 HG11 ' A' ' 44' ' ' VAL . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.542 ' HA ' HG22 ' A' ' 44' ' ' VAL . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.894 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 33' ' ' ASN . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.701 HG13 ' CG2' ' B' ' 31' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.454 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.525 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' B' ' 21' ' ' VAL . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' B' ' 19' ' ' SER . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.796 HD12 ' HB2' ' B' ' 35' ' ' ASP . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.478 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.606 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.822 0.344 . . . . 24.829999999999998 111.016 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' THR . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.719999999999999 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.766 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.190000000000001 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.460000000000001 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.300000000000001 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.623 HG11 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.300000000000001 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG11 ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.1699999999999999 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.2699999999999996 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.6400000000000006 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 15' ' ' GLY . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.699999999999999 112.992 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HD3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.6899999999999995 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.190000000000001 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.050000000000001 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.969999999999999 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 165' ' ' LEU . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.149999999999999 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.940000000000001 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 21' ' ' ILE . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.789999999999999 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.600000000000001 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.109999999999999 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.510000000000002 112.461 -179.405 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 64' ' ' TYR . 97.5 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.736 0.303 . . . . 23.469999999999999 111.248 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.059999999999999 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.280000000000001 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' ND2' ' CD1' ' A' ' 56' ' ' PHE . 11.6 t-20 -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.530000000000001 111.787 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.329999999999998 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' B' ' 9' ' ' ILE . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.280000000000001 111.32 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.620000000000001 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.449999999999999 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.879999999999999 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.609 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.190000000000001 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 3' ' ' THR . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.100000000000001 110.749 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 173' ' ' ILE . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.780000000000001 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.555 ' CD1' ' ND2' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.059999999999999 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.960000000000001 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.6099999999999994 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.8800000000000008 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.239999999999998 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.149999999999999 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.510000000000002 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.670000000000002 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.940000000000001 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.444 HD12 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.690000000000001 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.390000000000001 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.623 ' CE2' HG11 ' A' ' 7' ' ' VAL . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.010000000000002 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.259999999999998 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.805 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.559 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.870000000000001 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.510000000000002 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.805 ' CZ ' HG21 ' A' ' 75' ' ' THR . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.420000000000002 111.281 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 9' ' ' VAL . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.6200000000000001 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 93' ' ' VAL . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.210000000000001 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD ' ' A' ' 156' ' ' GLU . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.969999999999999 110.94 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.5700000000000003 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.260000000000002 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.029999999999999 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.949 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 141' ' ' THR . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.299999999999997 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.640000000000001 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 89' ' ' SER . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.449999999999999 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.600000000000001 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.466 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.559999999999999 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.300000000000001 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.542 ' OE2' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.289999999999999 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.542 HG23 ' OE2' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.129999999999999 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.039999999999999 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.469999999999999 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.829999999999998 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.039999999999999 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.100000000000001 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.629999999999999 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.600000000000001 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 152' ' ' VAL . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.719999999999999 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.739999999999998 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.789999999999999 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 111' ' ' LEU . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.4600000000000009 111.495 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3000000000000007 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HG3' HD12 ' A' ' 119' ' ' LEU . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.949999999999999 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.815 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.060000000000002 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.428 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.920000000000002 111.015 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG3' ' A' ' 116' ' ' GLN . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.850000000000001 110.379 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' C ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.909999999999997 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.786 ' OD1' HG23 ' A' ' 125' ' ' THR . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.479999999999997 110.626 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.350000000000001 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.350000000000001 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.786 HG23 ' OD1' ' A' ' 122' ' ' ASP . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.759999999999998 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.710000000000001 111.163 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.560000000000002 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.729999999999997 112.2 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.119999999999997 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.579999999999998 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.969999999999999 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.280000000000001 112.039 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.899999999999999 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.710000000000001 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.429 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.279999999999999 111.06 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.050000000000001 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.600000000000001 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.949999999999999 110.85 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.390000000000001 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.969999999999999 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 94' ' ' LYS . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.739999999999998 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.751 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.300000000000001 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.659999999999997 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 98' ' ' VAL . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.489999999999998 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.100000000000001 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 175' ' ' ALA . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.399999999999999 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.692 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.530000000000001 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.008 HG21 HG13 ' A' ' 168' ' ' VAL . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.629999999999999 111.256 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 84' ' ' VAL . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.815 ' CA ' HD11 ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.100000000000001 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.880000000000001 110.486 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.2699999999999996 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.469999999999999 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.699999999999999 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB3' HD12 ' A' ' 117' ' ' ILE . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.550000000000001 112.296 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.550000000000001 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.008 HG13 HG21 ' A' ' 155' ' ' VAL . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.120000000000001 111.184 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.908 ' O ' HD12 ' A' ' 173' ' ' ILE . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.431 ' OE1' HD21 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.449999999999999 110.731 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.908 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.210000000000001 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.699999999999999 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.539999999999999 111.629 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' B' ' 4' ' ' ILE . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.729 ' HB ' HD12 ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.758 ' CG2' HG11 ' A' ' 44' ' ' VAL . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' VAL . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.766 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.766 HG22 HG13 ' B' ' 21' ' ' VAL . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.893 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.893 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.854 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 53' ' ' LEU . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 72' ' ' TYR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.417 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.026 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB2' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 HG21 ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 9.1 t-20 -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG21 HG22 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HG23 ' B' ' 9' ' ' ILE . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.959 HD13 HG12 ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 8' ' ' VAL . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.957 ' HB3' HD11 ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.659 HG22 ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.659 ' NH1' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.824 HD21 ' CB ' ' B' ' 41' ' ' LEU . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.719 ' HE1' HG21 ' A' ' 7' ' ' VAL . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.421 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 119' ' ' LEU . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' HD21 ' A' ' 149' ' ' LEU . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.502 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 149' ' ' LEU . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' VAL . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 146' ' ' ALA . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 79' ' ' LEU . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 116' ' ' GLN . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.834 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' HD11 ' A' ' 126' ' ' ILE . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.707 ' NE2' HD22 ' A' ' 129' ' ' LEU . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 138' ' ' THR . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' ILE . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.818 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 98' ' ' VAL . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.865 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.726 HG21 HG23 ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.877 ' HB3' HG11 ' A' ' 168' ' ' VAL . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.624 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.836 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.026 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.877 HG11 ' HB3' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.779 ' O ' HD12 ' A' ' 173' ' ' ILE . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.416 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.959 HG12 HD13 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.865 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' B' ' 2' ' ' LYS . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.516 ' CE ' HD22 ' A' ' 177' ' ' LEU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.792 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.6 HG22 HG11 ' A' ' 44' ' ' VAL . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.422 ' H ' HG13 ' A' ' 42' ' ' VAL . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.038 HG13 HG22 ' B' ' 31' ' ' VAL . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.415 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.038 HG22 HG13 ' B' ' 21' ' ' VAL . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.768 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' B' ' 35' ' ' ASP . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.824 ' CB ' HD21 ' A' ' 70' ' ' LEU . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.768 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 70' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.764 0.316 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.853 ' HA3' HG21 ' A' ' 115' ' ' THR . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.568 HG22 ' OG1' ' A' ' 25' ' ' THR . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.58 ' C ' HD21 ' A' ' 165' ' ' LEU . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.771 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 64' ' ' TYR . 13.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.299 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.601 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG12 HG23 ' A' ' 44' ' ' VAL . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' B' ' 13' ' ' SER . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.401 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.466 HG12 HG23 ' B' ' 9' ' ' ILE . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CE2' HG13 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.626 HD22 HD13 ' B' ' 41' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE1' HG21 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG21 ' OE2' ' A' ' 156' ' ' GLU . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 116' ' ' GLN . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 141' ' ' THR . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 89' ' ' SER . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 149' ' ' LEU . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 98' ' ' VAL . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.651 ' HG2' HG23 ' A' ' 77' ' ' VAL . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 152' ' ' VAL . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.718 HD22 ' HD1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.853 HG21 ' HA3' ' A' ' 15' ' ' GLY . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.637 ' CD ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.637 HD12 ' CD ' ' A' ' 116' ' ' GLN . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.647 ' O ' HD11 ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.741 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.766 HD23 HG12 ' A' ' 93' ' ' VAL . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.819 HD13 HG21 ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 175' ' ' ALA . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.718 ' HD1' HD22 ' A' ' 112' ' ' LEU . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.94 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 28' ' ' PHE . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.935 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.94 HG21 ' SG ' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 173' ' ' ILE . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.697 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.712 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.771 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.878 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.469 ' CE2' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.692 HG22 HG13 ' B' ' 21' ' ' VAL . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.74 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' B' ' 35' ' ' ASP . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 70' ' ' LEU . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.74 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.592 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.304 . . . . 24.829999999999998 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.719999999999999 111.12 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.190000000000001 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.460000000000001 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.300000000000001 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.300000000000001 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 56' ' ' PHE . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.1699999999999999 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.2699999999999996 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.6400000000000006 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.85 HG12 ' OE1' ' A' ' 116' ' ' GLN . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.699999999999999 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.6899999999999995 112.173 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.841 ' HA ' HD12 ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.190000000000001 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 159' ' ' ALA . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.050000000000001 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.969999999999999 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 165' ' ' LEU . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.149999999999999 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' HG21 ' A' ' 42' ' ' VAL . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.940000000000001 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.789999999999999 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.600000000000001 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.109999999999999 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.510000000000002 112.565 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 110.391 -0.225 . . . . 23.469999999999999 110.391 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' N ' HG22 ' A' ' 36' ' ' VAL . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.059999999999999 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.280000000000001 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.530000000000001 110.925 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.329999999999998 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 44' ' ' VAL . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' B' ' 12' ' ' PRO . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.280000000000001 111.55 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.443 ' N ' HG12 ' A' ' 44' ' ' VAL . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.620000000000001 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.449999999999999 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.879999999999999 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.190000000000001 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 3' ' ' THR . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.100000000000001 110.798 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.780000000000001 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.643 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.059999999999999 110.856 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.960000000000001 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.6099999999999994 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.8800000000000008 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.239999999999998 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.149999999999999 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.510000000000002 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.670000000000002 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.119999999999997 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.736 HD21 HD11 ' B' ' 47' ' ' ILE . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.940000000000001 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.779 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.690000000000001 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.390000000000001 111.744 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.010000000000002 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.259999999999998 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 108' ' ' THR . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.870000000000001 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.510000000000002 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' H ' HG22 ' A' ' 77' ' ' VAL . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.420000000000002 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.561 ' SG ' HG11 ' A' ' 113' ' ' VAL . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.6200000000000001 110.558 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.645 ' CG ' HG21 ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.210000000000001 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.7199999999999998 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.969999999999999 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 116' ' ' GLN . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.5700000000000003 111.208 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.260000000000002 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.029999999999999 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.299999999999997 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.640000000000001 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 89' ' ' SER . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.449999999999999 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 149' ' ' LEU . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.600000000000001 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HB2' ' CA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.559999999999999 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.062 HG11 HD22 ' A' ' 149' ' ' LEU . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.300000000000001 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.289999999999999 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 97' ' ' TRP . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.129999999999999 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.039999999999999 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.469999999999999 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.829999999999998 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.039999999999999 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.485 ' HD2' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.100000000000001 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.629999999999999 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.803 ' HB2' HG23 ' A' ' 77' ' ' VAL . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.600000000000001 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.719999999999999 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.739999999999998 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 146' ' ' ALA . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.789999999999999 110.699 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.4600000000000009 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3000000000000007 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.85 ' OE1' HG12 ' A' ' 14' ' ' VAL . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.949999999999999 110.843 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.599 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.060000000000002 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.920000000000002 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.850000000000001 110.643 178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.653 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.909999999999997 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.413 ' C ' HD12 ' A' ' 126' ' ' ILE . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.479999999999997 110.676 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.350000000000001 112.422 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.350000000000001 111.043 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.759999999999998 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.710000000000001 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.560000000000002 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.729999999999997 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.119999999999997 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.579999999999998 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.969999999999999 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.482 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.280000000000001 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.899999999999999 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HG3' HG23 ' A' ' 126' ' ' ILE . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.710000000000001 112.351 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.279999999999999 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.050000000000001 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.600000000000001 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.949999999999999 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.390000000000001 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 141' ' ' THR . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.969999999999999 109.969 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.778 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.739999999999998 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.636 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.300000000000001 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.659999999999997 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.062 HD22 HG11 ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.489999999999998 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.100000000000001 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.789 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.399999999999999 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.566 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.530000000000001 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.629999999999999 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.897 ' SG ' HG21 ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.100000000000001 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.880000000000001 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.2699999999999996 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.469999999999999 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.699999999999999 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.447 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.550000000000001 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.661 HD11 ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.550000000000001 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.897 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.120000000000001 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 19' ' ' LEU . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.591 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.449999999999999 110.573 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.446 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.210000000000001 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.699999999999999 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.789 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.539999999999999 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.474 ' HB2' HG13 ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.653 HG22 HG11 ' A' ' 44' ' ' VAL . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.807 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.085 HG13 HG22 ' B' ' 31' ' ' VAL . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.085 HG22 HG13 ' B' ' 21' ' ' VAL . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' B' ' 42' ' ' PHE . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB3' HD21 ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.736 HD11 HD21 ' A' ' 67' ' ' LEU . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.847 0.356 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 52' ' ' THR . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 81' ' ' CYS . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.073 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' LEU . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG2' HG11 ' B' ' 21' ' ' VAL . 2.5 m . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.849 0.357 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' B' ' 12' ' ' PRO . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 13' ' ' SER . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG11 HG22 ' B' ' 9' ' ' ILE . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 51' ' ' TYR . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' HB2' HD12 ' A' ' 46' ' ' ILE . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.815 ' O ' HG23 ' A' ' 3' ' ' THR . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.99 HD22 HD11 ' A' ' 173' ' ' ILE . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.48 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.85 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.748 ' CG ' HG21 ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 14' ' ' VAL . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB2' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 115' ' ' THR . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 ' HG2' ' A' ' 116' ' ' GLN . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.973 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 89' ' ' SER . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.52 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.77 ' HD3' HG23 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.748 HG21 ' CG ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.743 ' HB2' HG11 ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' H ' HG13 ' A' ' 152' ' ' VAL . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.628 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 168' ' ' VAL . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.667 ' HG3' HD12 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' A' ' 116' ' ' GLN . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.685 ' O ' HD11 ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.596 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.476 ' N ' HD12 ' A' ' 126' ' ' ILE . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.626 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 84' ' ' VAL . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 98' ' ' VAL . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD1' HD22 ' A' ' 112' ' ' LEU . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 171' ' ' GLU . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.073 HD13 HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.664 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.72 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.99 HD11 HD22 ' A' ' 53' ' ' LEU . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.85 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.498 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 44' ' ' VAL . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.454 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 36' ' ' VAL . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 24' ' ' ASP . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.917 HG13 HD23 ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.917 HD23 HG13 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.6 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD12 ' B' ' 34' ' ' LEU . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.467 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 70' ' ' LEU . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.46 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 52' ' ' THR . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 53' ' ' LEU . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 81' ' ' CYS . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 8' ' ' VAL . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 37' ' ' PHE . 2.3 p . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' HB3' HG21 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.624 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 2.4 t-20 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' B' ' 12' ' ' PRO . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 173' ' ' ILE . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 173' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.689 HD12 ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.532 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.792 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 98' ' ' VAL . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 14' ' ' VAL . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 119' ' ' LEU . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CZ ' HG22 ' A' ' 141' ' ' THR . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 89' ' ' SER . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.773 HG21 HD13 ' A' ' 149' ' ' LEU . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 77' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.598 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.565 HG13 HG21 ' A' ' 168' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.592 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.617 ' OD2' HD22 ' A' ' 119' ' ' LEU . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD22 ' OD2' ' A' ' 118' ' ' ASP . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.681 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' CD ' ' A' ' 87' ' ' PRO . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.626 ' HG3' HG23 ' A' ' 126' ' ' ILE . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.83 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.676 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 98' ' ' VAL . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.84 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 19' ' ' LEU . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 118' ' ' ASP . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.534 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.859 HG23 ' HB ' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 173' ' ' ILE . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.903 HD11 HD22 ' A' ' 53' ' ' LEU . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.543 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.84 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 173' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.789 ' HA ' HG22 ' A' ' 44' ' ' VAL . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.55 HG22 HD21 ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.993 HG13 HD23 ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.993 HD23 HG13 ' B' ' 31' ' ' VAL . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 70' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.482 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 70' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.453 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.888 0.375 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.908 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.8 HG12 HG21 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 20' ' ' LEU . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' CE ' HG12 ' A' ' 8' ' ' VAL . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' PRO . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 8' ' ' VAL . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.801 HG21 ' CD1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.451 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 22.9 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.572 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 t-20 -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.947 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.616 HD12 ' CB ' ' A' ' 51' ' ' TYR . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HD11 ' A' ' 173' ' ' ILE . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.757 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.716 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.8 HG21 HG12 ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' H ' HG22 ' A' ' 77' ' ' VAL . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.834 HD23 HG21 ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.799 ' HB3' HG21 ' A' ' 93' ' ' VAL . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.976 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 89' ' ' SER . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.773 ' HB3' HD13 ' A' ' 145' ' ' LEU . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.965 ' O ' HG23 ' A' ' 102' ' ' THR . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 98' ' ' VAL . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.965 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 108' ' ' THR . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.901 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.694 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.834 HG21 HD23 ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.613 ' OD2' HD22 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.706 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.523 ' CG ' HG23 ' A' ' 125' ' ' THR . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 122' ' ' ASP . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.739 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.658 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.663 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.58 HD13 HG21 ' A' ' 98' ' ' VAL . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' CB ' ' A' ' 175' ' ' ALA . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.694 ' CD1' HD23 ' A' ' 112' ' ' LEU . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.803 ' CG2' HG23 ' A' ' 168' ' ' VAL . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.426 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.4 ' N ' HD13 ' A' ' 160' ' ' LEU . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.803 HG23 ' CG2' ' A' ' 155' ' ' VAL . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 173' ' ' ILE . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' B' ' 9' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.735 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.523 HD13 HD11 ' B' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.484 ' HD3' HD22 ' A' ' 177' ' ' LEU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.947 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.893 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.588 ' CE1' HD12 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 21' ' ' VAL . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.585 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.757 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' B' ' 40' ' ' SER . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.79 0.328 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HG23 ' A' ' 75' ' ' THR . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.675 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.675 HD12 ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 165' ' ' LEU . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' LEU . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' B' ' 23' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 2.4 t-20 -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.928 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG23 HD11 ' A' ' 55' ' ' LEU . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.779 HG11 HG22 ' B' ' 9' ' ' ILE . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 44' ' ' VAL . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 173' ' ' ILE . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.67 HD11 HG23 ' A' ' 42' ' ' VAL . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.764 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 78' ' ' PHE . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 75' ' ' THR . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' CD ' ' A' ' 120' ' ' ARG . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.832 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 149' ' ' LEU . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.434 HG21 ' CD2' ' A' ' 78' ' ' PHE . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 98' ' ' VAL . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.599 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 105' ' ' CYS . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.565 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 145' ' ' LEU . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 155' ' ' VAL . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 115' ' ' THR . 4.0 mm-40 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.71 ' O ' HD11 ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.488 ' N ' HD12 ' A' ' 126' ' ' ILE . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.668 ' HG3' HG23 ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 84' ' ' VAL . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.544 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.761 ' CG2' HD12 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.478 ' HB3' HG11 ' A' ' 168' ' ' VAL . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 168' ' ' VAL . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 22' ' ' SER . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' O ' HD12 ' A' ' 173' ' ' ILE . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.796 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.62 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.725 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.678 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.709 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 4' ' ' ILE . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 178' ' ' GLU . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.561 ' HA ' HG22 ' A' ' 44' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 0.3 OUTLIER -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' HIS . . . . . 0.528 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.034 HG13 HG22 ' B' ' 31' ' ' VAL . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.632 ' HB2' HG11 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.034 HG22 HG13 ' B' ' 21' ' ' VAL . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.57 HD11 ' CG ' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.764 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.833 0.349 . . . . 0.0 111.014 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.813 HG12 HG23 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.401 ' SG ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 75' ' ' THR . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.745 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 16' ' ' LYS . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 20' ' ' LEU . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.512 ' OG1' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' B' ' 23' ' ' TRP . 83.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.133 0.492 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.3 t-20 -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' B' ' 16' ' ' LYS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 55' ' ' LEU . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' ILE . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.755 ' HB2' HD12 ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 3' ' ' THR . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 42' ' ' VAL . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.474 HG22 ' OG ' ' A' ' 71' ' ' SER . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' HG22 ' A' ' 58' ' ' THR . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.734 HG21 ' CE1' ' A' ' 78' ' ' PHE . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.798 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' A' ' 75' ' ' THR . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 97' ' ' TRP . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG11 ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' HD22 ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.015 HG21 HD13 ' A' ' 149' ' ' LEU . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' VAL . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.575 HG23 ' HD3' ' A' ' 107' ' ' LYS . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.794 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.726 HD12 HG23 ' A' ' 152' ' ' VAL . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.51 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.512 ' CG ' HD23 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.643 HD12 HG21 ' A' ' 125' ' ' THR . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.797 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' C ' HD12 ' A' ' 126' ' ' ILE . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.643 HG21 HD12 ' A' ' 119' ' ' LEU . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.845 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 141' ' ' THR . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.757 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.62 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.015 HD13 HG21 ' A' ' 98' ' ' VAL . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 175' ' ' ALA . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.773 HG21 HG13 ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.512 HD23 ' CG ' ' A' ' 118' ' ' ASP . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.773 HG13 HG21 ' A' ' 155' ' ' VAL . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.758 ' O ' HD12 ' A' ' 173' ' ' ILE . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.465 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.688 ' HB3' HD11 ' A' ' 111' ' ' LEU . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.482 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.813 HG23 HG12 ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 173' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 42' ' ' VAL . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.645 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.618 HG22 HD21 ' B' ' 34' ' ' LEU . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.809 ' HB2' HG21 ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.721 HG13 HD23 ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.721 HD23 HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' B' ' 34' ' ' LEU . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 43' ' ' SER . 81.0 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.876 HG13 HD21 ' A' ' 177' ' ' LEU . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG11 ' CE1' ' A' ' 72' ' ' TYR . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 20' ' ' LEU . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.722 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.725 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.781 HD11 HG21 ' A' ' 8' ' ' VAL . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.463 HG22 ' OG1' ' A' ' 25' ' ' THR . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.463 ' OG1' HG22 ' A' ' 21' ' ' ILE . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 5.8 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.707 0.289 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' CG2' HD11 ' A' ' 55' ' ' LEU . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 ' CG2' ' A' ' 42' ' ' VAL . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.474 ' HD2' HD21 ' A' ' 67' ' ' LEU . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.766 ' O ' HD21 ' B' ' 38' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' H ' HG22 ' A' ' 77' ' ' VAL . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.832 HG13 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.564 ' SG ' HG11 ' A' ' 113' ' ' VAL . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CB ' HG21 ' A' ' 93' ' ' VAL . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 137' ' ' ILE . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 119' ' ' LEU . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 89' ' ' SER . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HB3' HD13 ' A' ' 145' ' ' LEU . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.832 ' CE3' HG13 ' A' ' 80' ' ' VAL . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 102' ' ' THR . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.857 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.96 HG21 HD23 ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.639 ' CD2' HG21 ' A' ' 85' ' ' VAL . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.7 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.634 ' OD2' HG23 ' A' ' 125' ' ' THR . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' N ' HD12 ' A' ' 126' ' ' ILE . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.634 HG23 ' OD2' ' A' ' 122' ' ' ASP . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.902 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 98' ' ' VAL . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.825 HG21 HG13 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.892 ' SG ' HG21 ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.557 HD23 ' OD2' ' A' ' 118' ' ' ASP . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.892 HG21 ' SG ' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.795 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.795 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.604 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.876 HD21 HG13 ' A' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.483 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.762 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.619 HG22 ' CE ' ' B' ' 16' ' ' LYS . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.811 HG13 HG22 ' B' ' 31' ' ' VAL . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.811 HG22 HG13 ' B' ' 21' ' ' VAL . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.67 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 70' ' ' LEU . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.297 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.865 HG12 HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.606 HG12 ' HD2' ' A' ' 16' ' ' LYS . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 HH21 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 81' ' ' CYS . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.617 ' O ' HD23 ' A' ' 19' ' ' LEU . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' LYS . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' C ' HD21 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 21' ' ' ILE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo . . . . . 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.698 0.285 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' HG23 ' B' ' 21' ' ' VAL . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 2.5 t-20 -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.746 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.655 HD13 HG21 ' A' ' 173' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.874 HD13 ' CG1' ' A' ' 173' ' ' ILE . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD21 HD21 ' A' ' 53' ' ' LEU . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.599 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB1' HE21 ' A' ' 61' ' ' GLN . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.422 HE21 ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.64 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' H ' HG22 ' A' ' 77' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CD2' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.727 HG11 ' HB2' ' A' ' 119' ' ' LEU . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.811 ' CZ ' HG22 ' A' ' 141' ' ' THR . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' SER . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' HD11 ' A' ' 149' ' ' LEU . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 102' ' ' THR . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 98' ' ' VAL . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.882 ' HB2' HG23 ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.622 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.754 HD12 HG23 ' A' ' 152' ' ' VAL . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 146' ' ' ALA . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.754 ' HB3' HD23 ' A' ' 119' ' ' LEU . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.48 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 116' ' ' GLN . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.728 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.547 ' C ' HD12 ' A' ' 126' ' ' ILE . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 124' ' ' SER . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.425 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.744 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.811 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.668 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 94' ' ' LYS . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.864 HG11 ' HB1' ' A' ' 175' ' ' ALA . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 168' ' ' VAL . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.915 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.428 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 19' ' ' LEU . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HE2' ' CD ' ' B' ' 12' ' ' PRO . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.915 HG21 ' SG ' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.783 ' O ' HD12 ' A' ' 173' ' ' ILE . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.646 ' HB3' HD11 ' A' ' 111' ' ' LEU . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.874 ' CG1' HD13 ' A' ' 53' ' ' LEU . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.746 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 44' ' ' VAL . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.663 HG22 ' NZ ' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.002 HG13 HG22 ' B' ' 31' ' ' VAL . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.403 ' CB ' HG21 ' A' ' 36' ' ' VAL . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.002 HG22 HG13 ' B' ' 21' ' ' VAL . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.654 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.912 HD12 ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 43' ' ' SER . 1.3 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 24.829999999999998 110.91 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' THR . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.719999999999999 110.906 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.549 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.190000000000001 110.994 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.460000000000001 109.961 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.300000000000001 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 72' ' ' TYR . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.300000000000001 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.1699999999999999 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.2699999999999996 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.6400000000000006 112.404 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' CD ' ' A' ' 16' ' ' LYS . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' H ' HG21 ' A' ' 115' ' ' THR . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.699999999999999 112.519 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.6899999999999995 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' HD12 ' A' ' 20' ' ' LEU . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.190000000000001 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.050000000000001 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 17' ' ' THR . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.969999999999999 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.149999999999999 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.940000000000001 111.621 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.789999999999999 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.600000000000001 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.109999999999999 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.510000000000002 112.459 -179.622 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' B' ' 23' ' ' TRP . 59.5 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.777 0.322 . . . . 23.469999999999999 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.059999999999999 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.280000000000001 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 7.3 t-20 -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.530000000000001 111.555 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.329999999999998 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' B' ' 12' ' ' PRO . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 9' ' ' ILE . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.280000000000001 111.197 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 ' CB ' ' A' ' 51' ' ' TYR . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.620000000000001 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.449999999999999 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.879999999999999 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.190000000000001 110.937 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' THR . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.100000000000001 110.936 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.780000000000001 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.059999999999999 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.960000000000001 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.6099999999999994 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.8800000000000008 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.239999999999998 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.149999999999999 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.510000000000002 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.670000000000002 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.119999999999997 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.940000000000001 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' B' ' 41' ' ' LEU . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.690000000000001 111.992 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.390000000000001 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.766 ' HE1' HG21 ' A' ' 7' ' ' VAL . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.010000000000002 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.259999999999998 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.89 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.851 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.870000000000001 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.510000000000002 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.89 ' CZ ' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.420000000000002 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 93' ' ' VAL . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 113' ' ' VAL . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.6200000000000001 110.454 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 93' ' ' VAL . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.210000000000001 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.7199999999999998 111.008 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 115' ' ' THR . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.969999999999999 111.038 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.5700000000000003 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.260000000000002 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.029999999999999 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 93' ' ' VAL . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.299999999999997 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.640000000000001 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 89' ' ' SER . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.449999999999999 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.600000000000001 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.559999999999999 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 102' ' ' THR . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.300000000000001 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.289999999999999 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.129999999999999 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.039999999999999 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.469999999999999 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.829999999999998 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.039999999999999 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.100000000000001 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.629999999999999 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 77' ' ' VAL . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.600000000000001 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.777 ' CD1' HD12 ' A' ' 101' ' ' ILE . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.719999999999999 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.792 HD12 ' CG2' ' A' ' 152' ' ' VAL . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.739999999999998 110.935 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.789999999999999 110.549 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 81' ' ' CYS . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.4600000000000009 111.676 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3000000000000007 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.797 ' CG ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.949999999999999 110.778 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.060000000000002 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.920000000000002 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.797 HD12 ' CG ' ' A' ' 116' ' ' GLN . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.850000000000001 110.878 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.856 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.909999999999997 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.479999999999997 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.350000000000001 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.350000000000001 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.723 HG21 HD22 ' A' ' 119' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.759999999999998 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.856 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.710000000000001 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.560000000000002 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.729999999999997 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.119999999999997 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.579999999999998 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.969999999999999 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.856 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.280000000000001 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.899999999999999 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.710000000000001 111.954 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.279999999999999 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.050000000000001 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.5 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.600000000000001 111.715 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.949999999999999 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.390000000000001 110.358 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.969999999999999 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.739999999999998 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.300000000000001 110.597 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.659999999999997 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 98' ' ' VAL . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.489999999999998 111.194 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.100000000000001 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.962 HG11 ' HB1' ' A' ' 175' ' ' ALA . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.399999999999999 110.963 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.530000000000001 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 168' ' ' VAL . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.629999999999999 111.475 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.954 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.100000000000001 112.052 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.880000000000001 109.914 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.2699999999999996 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.469999999999999 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.699999999999999 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.550000000000001 112.38 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 19' ' ' LEU . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.550000000000001 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.954 HG21 ' SG ' ' A' ' 157' ' ' CYS . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.120000000000001 111.476 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.449999999999999 110.921 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.892 HD11 HD22 ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.210000000000001 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.699999999999999 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.962 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.539999999999999 111.139 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.823 HG22 HG11 ' A' ' 44' ' ' VAL . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 31' ' ' VAL . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.569 ' HB2' HG21 ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 21' ' ' VAL . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.627 HD12 HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.882 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.525 ' HB3' HD21 ' A' ' 70' ' ' LEU . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.625 ' N ' HD13 ' B' ' 47' ' ' ILE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.843 0.354 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 53' ' ' LEU . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 75' ' ' THR . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' HG22 ' A' ' 14' ' ' VAL . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 12' ' ' GLY . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 20' ' ' LEU . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 16' ' ' LYS . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.439 ' C ' HD21 ' A' ' 165' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 42' ' ' VAL . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.443 0.163 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HE2' ' HG ' ' A' ' 71' ' ' SER . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 24' ' ' THR . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 13' ' ' SER . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.823 ' HB2' HD12 ' A' ' 46' ' ' ILE . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 173' ' ' ILE . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 42' ' ' VAL . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.714 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' HE2' ' A' ' 37' ' ' PHE . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 7' ' ' VAL . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' H ' HG22 ' A' ' 77' ' ' VAL . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.88 ' CD2' HG21 ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 93' ' ' VAL . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.836 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' THR . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.923 HG11 HD12 ' A' ' 119' ' ' LEU . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.966 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.71 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 89' ' ' SER . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 145' ' ' LEU . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.899 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.711 ' HD3' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' THR . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.838 ' HB2' HG23 ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.821 HD12 HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 115' ' ' THR . 51.8 mm-40 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.588 HD11 ' CA ' ' A' ' 157' ' ' CYS . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.923 HD12 HG11 ' A' ' 85' ' ' VAL . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.574 ' O ' HD11 ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.606 HG21 HD21 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.622 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.71 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 98' ' ' VAL . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.923 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.607 ' CD1' HD23 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 84' ' ' VAL . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.817 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.647 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 19' ' ' LEU . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.817 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' HD13 ' B' ' 9' ' ' ILE . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.701 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 53' ' ' LEU . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.923 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 173' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.485 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.57 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.83 HG13 HG22 ' B' ' 31' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.83 HG22 HG13 ' B' ' 21' ' ' VAL . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.787 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.787 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.558 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.745 0.307 . . . . 24.829999999999998 110.68 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.719999999999999 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.190000000000001 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.460000000000001 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.300000000000001 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG23 HG23 ' A' ' 75' ' ' THR . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.300000000000001 110.594 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' CD ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.1699999999999999 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.2699999999999996 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.6400000000000006 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 15' ' ' GLY . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.699999999999999 112.868 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' CD ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.6899999999999995 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 20' ' ' LEU . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.190000000000001 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.050000000000001 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 19' ' ' LEU . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.969999999999999 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' THR . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.484 ' OG ' HD21 ' A' ' 165' ' ' LEU . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.149999999999999 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.836 HG21 ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.940000000000001 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ILE . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.789999999999999 111.441 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' SER . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.600000000000001 110.857 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.109999999999999 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.510000000000002 111.736 178.764 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 120.543 0.211 . . . . 23.469999999999999 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.704 ' N ' HG22 ' A' ' 36' ' ' VAL . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.059999999999999 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.280000000000001 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.530000000000001 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.329999999999998 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' B' ' 12' ' ' PRO . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.912 HG11 HG22 ' B' ' 9' ' ' ILE . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.280000000000001 111.489 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 HG23 ' B' ' 9' ' ' ILE . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.620000000000001 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.449999999999999 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.879999999999999 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.190000000000001 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.100000000000001 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 173' ' ' ILE . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.780000000000001 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.059999999999999 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.960000000000001 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' TYR . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.6099999999999994 110.933 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.8800000000000008 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.239999999999998 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.149999999999999 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.510000000000002 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.670000000000002 111.493 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 67' ' ' LEU . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.940000000000001 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.690000000000001 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.390000000000001 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.010000000000002 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.259999999999998 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.870000000000001 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.510000000000002 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 75' ' ' THR . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.420000000000002 111.152 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 113' ' ' VAL . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.439 HG13 ' HE3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.6200000000000001 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.210000000000001 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 14' ' ' VAL . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.7199999999999998 111.059 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 137' ' ' ILE . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.969999999999999 111.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.5700000000000003 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.260000000000002 110.85 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.029999999999999 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.756 ' CZ ' HG22 ' A' ' 141' ' ' THR . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.299999999999997 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.640000000000001 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 89' ' ' SER . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.449999999999999 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.600000000000001 111.672 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.523 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.559999999999999 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.907 HG11 ' HB3' ' A' ' 149' ' ' LEU . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.300000000000001 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.289999999999999 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.129999999999999 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.039999999999999 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.469999999999999 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.829999999999998 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.039999999999999 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.100000000000001 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.629999999999999 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HG2' HG23 ' A' ' 77' ' ' VAL . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.600000000000001 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.719999999999999 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.777 HD12 HG23 ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.739999999999998 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.592 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.789999999999999 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 79' ' ' LEU . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.4600000000000009 111.757 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3000000000000007 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.576 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.576 ' H ' HG22 ' A' ' 115' ' ' THR . 6.7 mm100 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.949999999999999 110.884 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.060000000000002 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.920000000000002 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.850000000000001 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.687 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.909999999999997 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 125' ' ' THR . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.479999999999997 110.362 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.350000000000001 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.350000000000001 111.477 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.427 HG23 ' OD2' ' A' ' 122' ' ' ASP . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.759999999999998 110.85 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 136' ' ' PRO . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.710000000000001 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.560000000000002 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.816 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.729999999999997 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.119999999999997 112.061 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.579999999999998 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.969999999999999 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.493 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.280000000000001 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.899999999999999 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.710000000000001 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 84' ' ' VAL . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.279999999999999 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.050000000000001 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.756 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.600000000000001 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.949999999999999 110.784 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.390000000000001 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.969999999999999 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.739999999999998 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.300000000000001 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.659999999999997 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG11 ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.489999999999998 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.100000000000001 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.777 HG23 HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.399999999999999 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.592 ' CD1' HD23 ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.530000000000001 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.629999999999999 111.257 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.100000000000001 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.880000000000001 110.64 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.2699999999999996 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.469999999999999 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.699999999999999 111.091 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.550000000000001 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.550000000000001 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 155' ' ' VAL . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.120000000000001 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 173' ' ' ILE . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 9' ' ' ILE . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.41 ' HB3' HD11 ' A' ' 111' ' ' LEU . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.449999999999999 111.538 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.733 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 1.059 HD11 HD22 ' A' ' 53' ' ' LEU . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.210000000000001 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.669 HD23 ' HB ' ' B' ' 4' ' ' ILE . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.699999999999999 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.539999999999999 111.592 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.45 ' HD3' HD22 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.669 ' HB ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.912 HG22 HG11 ' A' ' 44' ' ' VAL . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.707 ' HA ' HG22 ' A' ' 44' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.836 ' CD1' HG21 ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.855 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.432 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.976 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.976 HG22 HG13 ' B' ' 21' ' ' VAL . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.939 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.939 HD12 ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.723 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.512 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.825 0.345 . . . . 24.829999999999998 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.719999999999999 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.907 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.190000000000001 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' HG22 ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.460000000000001 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.300000000000001 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.300000000000001 110.759 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.1699999999999999 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.2699999999999996 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.6400000000000006 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.699999999999999 113.013 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.553 ' O ' HD23 ' A' ' 19' ' ' LEU . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.6899999999999995 112.171 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 20' ' ' LEU . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.190000000000001 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.050000000000001 111.618 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.127 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 17' ' ' THR . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.969999999999999 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.149999999999999 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.484 HG21 ' CE1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.940000000000001 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.789999999999999 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.600000000000001 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.109999999999999 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo . . . . . 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.510000000000002 112.741 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG21 ' H ' ' B' ' 23' ' ' TRP . 2.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.018 0.437 . . . . 23.469999999999999 110.561 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.059999999999999 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.280000000000001 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.530000000000001 110.998 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.329999999999998 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.864 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.280000000000001 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 4' ' ' ILE . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.620000000000001 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.449999999999999 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.879999999999999 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.190000000000001 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.100000000000001 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.886 HD13 HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.780000000000001 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD11 HD13 ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.059999999999999 111.119 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.960000000000001 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.6099999999999994 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.8800000000000008 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.239999999999998 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.149999999999999 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 61' ' ' GLN . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.510000000000002 111.731 -178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.670000000000002 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.119999999999997 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 67' ' ' LEU . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.940000000000001 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' B' ' 41' ' ' LEU . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.690000000000001 110.835 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.390000000000001 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.010000000000002 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.259999999999998 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 108' ' ' THR . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.870000000000001 109.669 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.510000000000002 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.420000000000002 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD23 HG21 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.788 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.6200000000000001 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CB ' HG21 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.210000000000001 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.7199999999999998 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' THR . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.969999999999999 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 119' ' ' LEU . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.5700000000000003 111.724 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.260000000000002 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.029999999999999 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.299999999999997 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.640000000000001 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 89' ' ' SER . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.449999999999999 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.806 ' HB3' HD13 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.600000000000001 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.788 ' CE3' HG13 ' A' ' 80' ' ' VAL . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.559999999999999 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.935 HG11 HD22 ' A' ' 149' ' ' LEU . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.300000000000001 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.289999999999999 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.651 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.129999999999999 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.039999999999999 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.469999999999999 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.474 ' HB2' HG23 ' A' ' 108' ' ' THR . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.829999999999998 110.863 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.039999999999999 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.100000000000001 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 105' ' ' CYS . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.629999999999999 111.352 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.600000000000001 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.632 ' H ' HG13 ' A' ' 152' ' ' VAL . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.719999999999999 111.901 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.739999999999998 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 154' ' ' TYR . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.789999999999999 110.827 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.86 HG21 HD23 ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.4600000000000009 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3000000000000007 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.749 ' HG3' HD22 ' A' ' 119' ' ' LEU . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.949999999999999 110.946 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.551 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.060000000000002 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.920000000000002 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 116' ' ' GLN . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.850000000000001 110.094 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.713 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.909999999999997 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.479999999999997 110.746 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.350000000000001 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.350000000000001 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.45 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.759999999999998 110.138 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.710000000000001 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.560000000000002 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.729999999999997 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.119999999999997 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.579999999999998 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.513 ' CD ' ' N ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.969999999999999 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.935 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.280000000000001 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.899999999999999 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.710000000000001 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.279999999999999 110.843 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.050000000000001 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.600000000000001 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.949999999999999 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.390000000000001 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.969999999999999 110.378 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.739999999999998 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.711 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.300000000000001 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.659999999999997 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 HG11 ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.489999999999998 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.100000000000001 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.399999999999999 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 112' ' ' LEU . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.530000000000001 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.006 HG21 HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.629999999999999 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.878 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.100000000000001 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.880000000000001 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.2699999999999996 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.611 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.469999999999999 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.699999999999999 111.262 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.550000000000001 112.567 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.127 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.550000000000001 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.006 HG13 HG21 ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.120000000000001 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.449999999999999 111.043 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.907 HG23 HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.210000000000001 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.699999999999999 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.539999999999999 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.456 HD21 HG13 ' A' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.541 HG22 HG22 ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.608 ' H ' HG21 ' A' ' 36' ' ' VAL . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.534 ' CE1' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.607 HG11 HD12 ' B' ' 34' ' ' LEU . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.607 HD12 HG11 ' B' ' 31' ' ' VAL . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.85 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' B' ' 35' ' ' ASP . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.565 ' CB ' HD13 ' A' ' 70' ' ' LEU . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.534 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.583 HG11 ' HE1' ' A' ' 72' ' ' TYR . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 81' ' ' CYS . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.893 ' HB2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 24' ' ' THR . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 20' ' ' LEU . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.562 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.1 t-20 -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' B' ' 12' ' ' PRO . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.458 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.841 HD13 HG12 ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 20' ' ' LEU . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.562 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.461 HG23 HG12 ' A' ' 7' ' ' VAL . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' B' ' 41' ' ' LEU . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HE1' HG11 ' A' ' 7' ' ' VAL . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.674 HG21 ' CE1' ' A' ' 78' ' ' PHE . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 75' ' ' THR . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.49 HD23 HG21 ' A' ' 113' ' ' VAL . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 93' ' ' VAL . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB2' HG21 ' A' ' 14' ' ' VAL . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' HG21 ' A' ' 93' ' ' VAL . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.41 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HD2' ' A' ' 120' ' ' ARG . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.92 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.002 ' O ' HG23 ' A' ' 102' ' ' THR . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 110' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.661 ' H ' HG13 ' A' ' 152' ' ' VAL . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 154' ' ' TYR . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 79' ' ' LEU . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mm-40 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 158' ' ' SER . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.748 ' HD2' HG11 ' A' ' 84' ' ' VAL . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' N ' HD12 ' A' ' 126' ' ' ILE . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 124' ' ' SER . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.845 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.508 ' CG ' HD23 ' A' ' 145' ' ' LEU . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.83 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.772 HG11 ' HB1' ' A' ' 175' ' ' ALA . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.644 ' HD1' HD22 ' A' ' 112' ' ' LEU . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 168' ' ' VAL . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.589 ' HB3' HG21 ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' ILE . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 155' ' ' VAL . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.898 ' O ' HD12 ' A' ' 173' ' ' ILE . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.772 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' B' ' 2' ' ' LYS . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.737 ' HE2' HD22 ' A' ' 177' ' ' LEU . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.639 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.826 ' HA ' HG22 ' A' ' 44' ' ' VAL . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 24' ' ' THR . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.091 HG13 HG22 ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.091 HG22 HG13 ' B' ' 21' ' ' VAL . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.674 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.565 ' CB ' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD13 ' A' ' 70' ' ' LEU . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.96 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 53' ' ' LEU . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.842 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' LEU . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' B' ' 23' ' ' TRP . 38.3 t . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.752 ' O ' HG23 ' B' ' 21' ' ' VAL . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 44' ' ' VAL . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HG22 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.585 ' CD1' HG21 ' A' ' 173' ' ' ILE . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 67' ' ' LEU . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.759 HD22 HD13 ' B' ' 41' ' ' LEU . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 108' ' ' THR . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.877 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' H ' HG22 ' A' ' 77' ' ' VAL . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' OE2' ' A' ' 156' ' ' GLU . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.857 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 89' ' ' SER . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HA ' HD11 ' A' ' 149' ' ' LEU . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.837 HG11 ' HB3' ' A' ' 149' ' ' LEU . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 98' ' ' VAL . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.877 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 101' ' ' ILE . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 172' ' ' ALA . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 145' ' ' LEU . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.514 ' H ' HG22 ' A' ' 115' ' ' THR . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.742 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.559 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.742 HD11 ' O ' ' A' ' 120' ' ' ARG . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 123' ' ' PRO . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 124' ' ' SER . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.716 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.3 m120 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.555 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.648 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.495 ' HB2' HD23 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.837 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 112' ' ' LEU . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 168' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.485 ' SG ' HG11 ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 155' ' ' VAL . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 19' ' ' LEU . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.455 ' O ' HD13 ' B' ' 9' ' ' ILE . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 53' ' ' LEU . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' B' ' 4' ' ' ILE . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.505 ' HE3' HD23 ' A' ' 177' ' ' LEU . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.623 ' HB ' HD12 ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.855 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.0 HG13 HG22 ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.648 ' HB2' HG21 ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 1.0 HG22 HG13 ' B' ' 21' ' ' VAL . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.63 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 70' ' ' LEU . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.759 HD13 HD22 ' A' ' 70' ' ' LEU . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 56' ' ' PHE . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 16' ' ' LYS . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.684 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.095 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 165' ' ' LEU . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 28' ' ' PHE . 20.2 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.76 HG12 ' OH ' ' A' ' 64' ' ' TYR . 14.1 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG23 HD11 ' A' ' 55' ' ' LEU . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' HG12 ' A' ' 44' ' ' VAL . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG12 HG23 ' B' ' 9' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 173' ' ' ILE . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 42' ' ' VAL . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HB2' HG22 ' A' ' 7' ' ' VAL . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 71' ' ' SER . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.76 ' OH ' HG12 ' A' ' 36' ' ' VAL . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 58' ' ' THR . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.588 ' H ' HG22 ' A' ' 77' ' ' VAL . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 113' ' ' VAL . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 119' ' ' LEU . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.8 m-20 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 89' ' ' SER . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.557 ' HA ' HD21 ' A' ' 149' ' ' LEU . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 ' CB ' HD22 ' A' ' 149' ' ' LEU . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 97' ' ' TRP . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.512 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HG23 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.51 HD23 ' CD1' ' A' ' 154' ' ' TYR . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD23 ' A' ' 79' ' ' LEU . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.549 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' HD22 ' A' ' 119' ' ' LEU . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.636 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 125' ' ' THR . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.766 HG23 ' HG3' ' A' ' 136' ' ' PRO . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.766 ' HG3' HG23 ' A' ' 126' ' ' ILE . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.656 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 110' ' ' PHE . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.51 ' CD1' HD23 ' A' ' 112' ' ' LEU . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' C ' HD11 ' A' ' 117' ' ' ILE . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 163' ' ' LYS . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 165' ' ' LEU . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.858 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.095 HD13 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.904 ' O ' HD12 ' A' ' 173' ' ' ILE . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' HD21 ' A' ' 111' ' ' LEU . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.954 HG23 HG12 ' A' ' 4' ' ' ILE . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.668 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.677 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.566 HD12 HG13 ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.668 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.451 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.952 HG11 HD12 ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.952 HD12 HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.516 ' H ' HD23 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 39' ' ' ARG . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' B' ' 36' ' ' PRO . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.449 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' C ' HD13 ' B' ' 47' ' ' ILE . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.601 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 24.829999999999998 110.926 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 52' ' ' THR . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.719999999999999 111.024 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.72 ' CG1' HD21 ' A' ' 177' ' ' LEU . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.190000000000001 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.460000000000001 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG22 ' A' ' 4' ' ' ILE . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.300000000000001 110.239 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.619 HG23 HG23 ' A' ' 75' ' ' THR . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.300000000000001 110.774 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.2699999999999996 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.6400000000000006 112.634 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.636 ' H ' HG21 ' A' ' 115' ' ' THR . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.699999999999999 113.259 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.6899999999999995 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.752 ' HA ' HD12 ' A' ' 20' ' ' LEU . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.190000000000001 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.050000000000001 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 17' ' ' THR . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.969999999999999 110.251 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 25' ' ' THR . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 165' ' ' LEU . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.149999999999999 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.940000000000001 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 21' ' ' ILE . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.789999999999999 111.438 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.600000000000001 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.109999999999999 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.510000000000002 112.116 179.828 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' B' ' 29' ' ' PHE . 20.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.376 . . . . 23.469999999999999 110.987 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.059999999999999 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.280000000000001 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.530000000000001 111.633 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.329999999999998 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' H ' ' B' ' 13' ' ' SER . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.861 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.280000000000001 111.426 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.412 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 51' ' ' TYR . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.620000000000001 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.449999999999999 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.879999999999999 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.565 ' CB ' HD12 ' A' ' 46' ' ' ILE . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.190000000000001 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 3' ' ' THR . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.100000000000001 110.991 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 173' ' ' ILE . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.780000000000001 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 8' ' ' VAL . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.059999999999999 111.031 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.415 ' CG ' HD11 ' A' ' 20' ' ' LEU . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.960000000000001 110.725 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.6099999999999994 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.8800000000000008 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.239999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.149999999999999 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.510000000000002 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.670000000000002 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.119999999999997 111.318 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.940000000000001 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.831 HD21 ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.690000000000001 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.390000000000001 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.010000000000002 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.259999999999998 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.619 HG23 HG23 ' A' ' 7' ' ' VAL . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.742 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.870000000000001 110.953 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.510000000000002 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' HG22 ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.420000000000002 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 113' ' ' VAL . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.76 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.6200000000000001 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CG ' HG21 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.210000000000001 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.7199999999999998 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.969999999999999 110.725 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.5700000000000003 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.260000000000002 110.94 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.029999999999999 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.299999999999997 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.640000000000001 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 89' ' ' SER . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.449999999999999 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB3' HD13 ' A' ' 145' ' ' LEU . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.600000000000001 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.76 ' CE3' HG13 ' A' ' 80' ' ' VAL . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.559999999999999 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 102' ' ' THR . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.300000000000001 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.289999999999999 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.129999999999999 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.039999999999999 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.469999999999999 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.829999999999998 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.039999999999999 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.100000000000001 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.629999999999999 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.600000000000001 111.729 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.719999999999999 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.739999999999998 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.979 HD23 ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.789999999999999 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 HD23 ' A' ' 79' ' ' LEU . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.4600000000000009 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3000000000000007 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.636 HG21 ' H ' ' A' ' 15' ' ' GLY . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.949999999999999 110.774 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.060000000000002 110.571 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.644 ' OD1' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.920000000000002 111.15 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.771 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.850000000000001 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.695 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.909999999999997 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.936 ' OD2' HG23 ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.479999999999997 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.350000000000001 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.350000000000001 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.936 HG23 ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.759999999999998 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.695 HD11 ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.710000000000001 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.560000000000002 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.729999999999997 110.713 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.119999999999997 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.579999999999998 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.969999999999999 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.814 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.280000000000001 108.337 174.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.899999999999999 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.710000000000001 111.921 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.279999999999999 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.050000000000001 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.600000000000001 110.864 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.949999999999999 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.390000000000001 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.969999999999999 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.739999999999998 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.300000000000001 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.659999999999997 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.489999999999998 111.329 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.100000000000001 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.399999999999999 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.979 ' CD1' HD23 ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.530000000000001 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.833 ' CG2' HG13 ' A' ' 168' ' ' VAL . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.629999999999999 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 168' ' ' VAL . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.100000000000001 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' HD13 ' A' ' 165' ' ' LEU . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.880000000000001 110.49 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.2699999999999996 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.469999999999999 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.699999999999999 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.684 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.550000000000001 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.550000000000001 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 ' CG2' ' A' ' 155' ' ' VAL . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.120000000000001 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' A' ' 19' ' ' LEU . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' HD13 ' B' ' 9' ' ' ILE . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CG ' HG11 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.449999999999999 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.210000000000001 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' B' ' 9' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.699999999999999 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.539999999999999 111.072 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.72 HD21 ' CG1' ' A' ' 4' ' ' ILE . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.47 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.47 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 177' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 174' ' ' LEU . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.861 HG22 HG11 ' A' ' 44' ' ' VAL . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.66 ' HA ' HG22 ' A' ' 44' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 42' ' ' VAL . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.907 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.929 HG22 HG13 ' B' ' 21' ' ' VAL . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.641 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' B' ' 35' ' ' ASP . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD21 ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 67' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.465 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.32 147.8 22.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 56' ' ' PHE . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' H3B1 ' A' ' 181' ' ' GCP . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.707 HG21 ' O ' ' A' ' 81' ' ' CYS . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.858 HG21 ' HG2' ' A' ' 34' ' ' PRO . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' N7 ' ' A' ' 181' ' ' GCP . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.947 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.83 ' HB2' HD11 ' A' ' 165' ' ' LEU . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.01 -167.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.04 -47.5 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.17 159.71 22.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.794 ' O ' HG13 ' A' ' 33' ' ' VAL . 40.3 t80 -129.25 98.15 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.795 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 170.22 60.7 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.409 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.858 ' HG2' HG21 ' A' ' 17' ' ' THR . 48.9 Cg_endo -115.21 3.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.167 2.578 . . . . 0.0 114.105 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 36' ' ' VAL . 21.5 m -91.58 90.47 7.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.955 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.525 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t -159.82 -70.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.514 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.894 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 44' ' ' VAL . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG11 HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.48 HG12 HG23 ' B' ' 9' ' ' ILE . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 4' ' ' ILE . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.905 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 7' ' ' VAL . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 113' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.707 ' O ' HG21 ' A' ' 14' ' ' VAL . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.484 ' CB ' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.777 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.853 ' CZ ' HG22 ' A' ' 141' ' ' THR . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.661 ' HB ' HD22 ' A' ' 149' ' ' LEU . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' VAL . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 76' ' ' ASP . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.852 ' HB2' HG23 ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG11 ' A' ' 168' ' ' VAL . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.53 ' H ' HG22 ' A' ' 115' ' ' THR . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 119' ' ' LEU . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.652 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.684 HG21 HD21 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HG3' HG23 ' A' ' 126' ' ' ILE . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.853 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 93' ' ' VAL . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.114 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CD1' HD23 ' A' ' 112' ' ' LEU . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.755 HG23 HG13 ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.512 ' C ' HD11 ' A' ' 117' ' ' ILE . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.871 ' O ' HD22 ' A' ' 165' ' ' LEU . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.947 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.622 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.746 ' O ' HD12 ' A' ' 173' ' ' ILE . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.684 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.442 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.454 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' B' ' 9' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 1.114 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 173' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.517 ' HE2' HD22 ' A' ' 177' ' ' LEU . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 177' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.798 HG22 HG11 ' A' ' 44' ' ' VAL . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.542 ' HA ' HG22 ' A' ' 44' ' ' VAL . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.894 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 33' ' ' ASN . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.701 HG13 ' CG2' ' B' ' 31' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.454 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.525 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' B' ' 21' ' ' VAL . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' B' ' 19' ' ' SER . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.796 HD12 ' HB2' ' B' ' 35' ' ' ASP . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.478 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.606 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -99.7 14.04 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 1.6 mt-10 -73.63 -12.16 60.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.648 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' B' ' 49' ' ' GLU . . . 172.18 137.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.781 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -52.19 166.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 16.8 mt -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -131.35 9.47 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.07 99.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.89 126.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -65.59 153.01 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 44.8 p -66.92 134.25 51.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -75.53 117.95 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.432 ' N7 ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -88.19 140.24 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 24.829999999999998 111.016 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' THR . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.719999999999999 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.766 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.190000000000001 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.460000000000001 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.300000000000001 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG11 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.300000000000001 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG11 ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.1699999999999999 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.2699999999999996 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.6400000000000006 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 15' ' ' GLY . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.699999999999999 112.992 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HD3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.6899999999999995 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.190000000000001 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.050000000000001 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.969999999999999 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 165' ' ' LEU . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.149999999999999 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.940000000000001 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 21' ' ' ILE . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.789999999999999 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.600000000000001 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.109999999999999 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.84 157.59 58.25 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.510000000000002 112.461 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.94 -18.23 11.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.935 -0.575 . . . . 41.890000000000001 111.17 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.21 162.04 0.78 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.829 0.347 . . . . 43.869999999999997 110.855 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -142.19 109.15 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 23.27 110.902 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 13.3 p -169.81 138.72 1.55 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 21.530000000000001 110.914 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 76.7 Cg_exo -48.17 149.73 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.613 2.209 . . . . 15.4 112.482 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -123.48 81.89 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 20.140000000000001 110.804 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 64' ' ' TYR . 97.5 t -50.16 -78.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 23.469999999999999 111.248 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.059999999999999 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.280000000000001 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' ND2' ' CD1' ' A' ' 56' ' ' PHE . 11.6 t-20 -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.530000000000001 111.787 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.329999999999998 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' B' ' 9' ' ' ILE . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.280000000000001 111.32 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.620000000000001 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.449999999999999 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.879999999999999 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.609 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.190000000000001 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 3' ' ' THR . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.100000000000001 110.749 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 173' ' ' ILE . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.780000000000001 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.555 ' CD1' ' ND2' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.059999999999999 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.960000000000001 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.6099999999999994 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.8800000000000008 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.239999999999998 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.149999999999999 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.510000000000002 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.670000000000002 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.940000000000001 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.444 HD12 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.690000000000001 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.390000000000001 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' CE2' HG11 ' A' ' 7' ' ' VAL . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.010000000000002 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.259999999999998 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.805 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.559 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.870000000000001 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.510000000000002 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.805 ' CZ ' HG21 ' A' ' 75' ' ' THR . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.420000000000002 111.281 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 9' ' ' VAL . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.6200000000000001 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 93' ' ' VAL . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.210000000000001 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD ' ' A' ' 156' ' ' GLU . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.969999999999999 110.94 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.5700000000000003 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.260000000000002 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.029999999999999 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.949 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 141' ' ' THR . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.299999999999997 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.640000000000001 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 89' ' ' SER . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.449999999999999 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.600000000000001 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.466 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.559999999999999 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.300000000000001 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.542 ' OE2' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.289999999999999 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.542 HG23 ' OE2' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.129999999999999 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.039999999999999 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.469999999999999 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.829999999999998 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.039999999999999 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.100000000000001 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.629999999999999 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.600000000000001 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 152' ' ' VAL . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.719999999999999 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.739999999999998 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.789999999999999 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 111' ' ' LEU . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.4600000000000009 111.495 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3000000000000007 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HG3' HD12 ' A' ' 119' ' ' LEU . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.949999999999999 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.815 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.060000000000002 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.428 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.920000000000002 111.015 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG3' ' A' ' 116' ' ' GLN . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.850000000000001 110.379 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' C ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.909999999999997 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.786 ' OD1' HG23 ' A' ' 125' ' ' THR . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.479999999999997 110.626 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.350000000000001 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.350000000000001 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.786 HG23 ' OD1' ' A' ' 122' ' ' ASP . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.759999999999998 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.710000000000001 111.163 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.560000000000002 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.729999999999997 112.2 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.119999999999997 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.579999999999998 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.969999999999999 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.280000000000001 112.039 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.899999999999999 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.710000000000001 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.429 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.279999999999999 111.06 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.050000000000001 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.600000000000001 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.949999999999999 110.85 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.390000000000001 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.969999999999999 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 94' ' ' LYS . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.739999999999998 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.751 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.300000000000001 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.659999999999997 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 98' ' ' VAL . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.489999999999998 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.100000000000001 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 175' ' ' ALA . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.399999999999999 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.692 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.530000000000001 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.008 HG21 HG13 ' A' ' 168' ' ' VAL . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.629999999999999 111.256 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 84' ' ' VAL . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.815 ' CA ' HD11 ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.100000000000001 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.880000000000001 110.486 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.2699999999999996 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.469999999999999 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.699999999999999 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB3' HD12 ' A' ' 117' ' ' ILE . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.550000000000001 112.296 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.550000000000001 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.008 HG13 HG21 ' A' ' 155' ' ' VAL . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.120000000000001 111.184 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.908 ' O ' HD12 ' A' ' 173' ' ' ILE . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.431 ' OE1' HD21 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.449999999999999 110.731 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.908 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.210000000000001 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.699999999999999 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.539999999999999 111.629 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' B' ' 4' ' ' ILE . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.729 ' HB ' HD12 ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.758 ' CG2' HG11 ' A' ' 44' ' ' VAL . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' VAL . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.766 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.766 HG22 HG13 ' B' ' 21' ' ' VAL . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.893 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.893 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p -77.77 -151.48 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 1.5 mt-10 -47.36 -22.64 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 74.18 125.03 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -71.36 169.79 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' B' ' 52' ' ' LEU . 16.4 mt -74.17 117.51 16.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.532 HG22 ' O ' ' B' ' 53' ' ' THR . 25.8 m -115.25 8.91 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.05 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.95 93.5 1.16 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.33 123.47 19.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.95 111.97 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 38.4 p -88.19 93.89 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.33 87.85 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.918 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.415 ' H8 ' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -81.29 144.77 31.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.217 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 53' ' ' LEU . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 72' ' ' TYR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' HA2' ' O3A' ' A' ' 181' ' ' GCP . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.723 ' OG1' HG21 ' A' ' 35' ' ' THR . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.026 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB2' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 HG21 ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo -54.34 -164.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -147.02 -45.73 0.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.736 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.24 163.51 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.075 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 8.6 t80 -143.35 116.44 8.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 111.177 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.1 p -177.67 139.98 0.42 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.29 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' HD2' HG23 ' A' ' 33' ' ' VAL . 67.7 Cg_exo -28.28 145.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.031 3.154 . . . . 0.0 113.828 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.723 HG21 ' OG1' ' A' ' 17' ' ' THR . 1.5 m -155.7 82.76 1.03 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.348 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -75.31 -43.04 43.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.804 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 9.1 t-20 -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG21 HG22 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HG23 ' B' ' 9' ' ' ILE . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.959 HD13 HG12 ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 8' ' ' VAL . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.957 ' HB3' HD11 ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.659 HG22 ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.659 ' NH1' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.824 HD21 ' CB ' ' B' ' 41' ' ' LEU . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.719 ' HE1' HG21 ' A' ' 7' ' ' VAL . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.421 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 119' ' ' LEU . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' HD21 ' A' ' 149' ' ' LEU . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.502 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 149' ' ' LEU . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' VAL . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 146' ' ' ALA . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 79' ' ' LEU . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 116' ' ' GLN . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.834 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' HD11 ' A' ' 126' ' ' ILE . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.707 ' NE2' HD22 ' A' ' 129' ' ' LEU . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 138' ' ' THR . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' ILE . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.818 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 98' ' ' VAL . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.865 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.726 HG21 HG23 ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.877 ' HB3' HG11 ' A' ' 168' ' ' VAL . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.624 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.836 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.026 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.877 HG11 ' HB3' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.779 ' O ' HD12 ' A' ' 173' ' ' ILE . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.416 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.959 HG12 HD13 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.865 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' B' ' 2' ' ' LYS . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.516 ' CE ' HD22 ' A' ' 177' ' ' LEU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.792 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.6 HG22 HG11 ' A' ' 44' ' ' VAL . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.422 ' H ' HG13 ' A' ' 42' ' ' VAL . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.038 HG13 HG22 ' B' ' 31' ' ' VAL . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.415 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.038 HG22 HG13 ' B' ' 21' ' ' VAL . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.768 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' B' ' 35' ' ' ASP . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.824 ' CB ' HD21 ' A' ' 70' ' ' LEU . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.768 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 70' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -89.55 -141.17 0.14 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 3.8 mt-10 -42.02 -25.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 76.33 -70.64 0.13 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 65.23 -175.84 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.01 130.31 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.04 116.05 0.16 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.906 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -77.33 99.97 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.853 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.72 105.54 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.93 121.65 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.5 66.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -104.07 22.21 15.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.008 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.204 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.412 ' O3A' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.88 0.372 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.73 158.5 15.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.812 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.871 HG12 " O4'" ' A' ' 181' ' ' GCP . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.853 ' HA3' HG21 ' A' ' 115' ' ' THR . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HD2' ' PG ' ' A' ' 181' ' ' GCP . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.568 HG22 ' OG1' ' A' ' 25' ' ' THR . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.58 ' C ' HD21 ' A' ' 165' ' ' LEU . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.771 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo -73.39 158.68 47.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.73 -4.49 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.589 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.19 167.97 1.57 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.49 -168.35 1.9 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.37 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 32' ' ' TYR . 6.2 m 54.82 159.08 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.896 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 77.2 Cg_exo -48.42 163.12 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.554 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' PHE . 7.5 m -85.16 -26.88 26.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.644 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 64' ' ' TYR . 13.1 t 65.8 -70.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.833 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.601 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG12 HG23 ' A' ' 44' ' ' VAL . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' B' ' 13' ' ' SER . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.401 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.466 HG12 HG23 ' B' ' 9' ' ' ILE . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CE2' HG13 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.626 HD22 HD13 ' B' ' 41' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE1' HG21 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG21 ' OE2' ' A' ' 156' ' ' GLU . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 116' ' ' GLN . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 141' ' ' THR . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 89' ' ' SER . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 149' ' ' LEU . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 98' ' ' VAL . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.651 ' HG2' HG23 ' A' ' 77' ' ' VAL . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 152' ' ' VAL . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.718 HD22 ' HD1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.853 HG21 ' HA3' ' A' ' 15' ' ' GLY . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.637 ' CD ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.637 HD12 ' CD ' ' A' ' 116' ' ' GLN . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.647 ' O ' HD11 ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.741 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.766 HD23 HG12 ' A' ' 93' ' ' VAL . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.819 HD13 HG21 ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 175' ' ' ALA . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.718 ' HD1' HD22 ' A' ' 112' ' ' LEU . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.94 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD12 ' HN1' ' A' ' 181' ' ' GCP . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.935 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.94 HG21 ' SG ' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 173' ' ' ILE . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.697 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.712 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.771 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.878 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.469 ' CE2' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.692 HG22 HG13 ' B' ' 21' ' ' VAL . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.74 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' B' ' 35' ' ' ASP . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 70' ' ' LEU . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.74 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.592 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -75.84 -153.16 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.52 -27.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.26 -161.46 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.692 0.282 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -68.55 149.83 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.93 142.44 32.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.543 HG22 ' O ' ' B' ' 53' ' ' THR . 30.6 m -101.92 8.36 41.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.15 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t0 58.13 33.49 23.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.968 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 31.91 21.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 68.68 118.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.718 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.42 106.26 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.95 -165.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.671 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.871 " O4'" HG12 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.87 0.367 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 -160.33 159.25 31.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 24.829999999999998 110.857 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.719999999999999 111.12 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.190000000000001 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.460000000000001 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.300000000000001 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.300000000000001 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 56' ' ' PHE . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.1699999999999999 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.2699999999999996 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.6400000000000006 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.85 HG12 ' OE1' ' A' ' 116' ' ' GLN . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.699999999999999 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.6899999999999995 112.173 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.841 ' HA ' HD12 ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.190000000000001 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.050000000000001 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.969999999999999 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 165' ' ' LEU . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.149999999999999 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' HG21 ' A' ' 42' ' ' VAL . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.940000000000001 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.789999999999999 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.600000000000001 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.109999999999999 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo -62.35 -168.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.510000000000002 112.565 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.77 -48.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 41.890000000000001 110.576 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.38 168.21 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 43.869999999999997 110.688 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.5 p90 -134.16 115.73 14.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.13 0.491 . . . . 23.27 110.73 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -172.14 124.14 0.5 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.66 -0.7 . . . . 21.530000000000001 110.397 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 36' ' ' VAL . 50.1 Cg_exo -54.71 123.62 14.16 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.509 2.139 . . . . 15.4 112.81 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 38' ' ' ASP . 1.1 m -61.43 -29.58 70.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 20.140000000000001 111.214 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 51.72 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.905 -0.589 . . . . 23.469999999999999 110.391 -176.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' N ' HG22 ' A' ' 36' ' ' VAL . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.059999999999999 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 35' ' ' THR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.280000000000001 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.530000000000001 110.925 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.329999999999998 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 44' ' ' VAL . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' B' ' 12' ' ' PRO . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.280000000000001 111.55 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.443 ' N ' HG12 ' A' ' 44' ' ' VAL . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.620000000000001 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.449999999999999 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.879999999999999 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.190000000000001 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 3' ' ' THR . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.100000000000001 110.798 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.780000000000001 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.643 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.059999999999999 110.856 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.960000000000001 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.6099999999999994 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.8800000000000008 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.239999999999998 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.149999999999999 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.510000000000002 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.670000000000002 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.119999999999997 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.736 HD21 HD11 ' B' ' 47' ' ' ILE . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.940000000000001 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.779 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.690000000000001 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.390000000000001 111.744 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.010000000000002 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.259999999999998 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 108' ' ' THR . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.870000000000001 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.510000000000002 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' H ' HG22 ' A' ' 77' ' ' VAL . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.420000000000002 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.561 ' SG ' HG11 ' A' ' 113' ' ' VAL . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.6200000000000001 110.558 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.645 ' CG ' HG21 ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.210000000000001 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.7199999999999998 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.969999999999999 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 116' ' ' GLN . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.5700000000000003 111.208 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.260000000000002 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.029999999999999 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.299999999999997 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.640000000000001 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 89' ' ' SER . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.449999999999999 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 149' ' ' LEU . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.600000000000001 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HB2' ' CA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.559999999999999 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.062 HG11 HD22 ' A' ' 149' ' ' LEU . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.300000000000001 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.289999999999999 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 97' ' ' TRP . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.129999999999999 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.039999999999999 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.469999999999999 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.829999999999998 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.039999999999999 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.485 ' HD2' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.100000000000001 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.629999999999999 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.803 ' HB2' HG23 ' A' ' 77' ' ' VAL . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.600000000000001 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.719999999999999 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.739999999999998 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 146' ' ' ALA . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.789999999999999 110.699 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.4600000000000009 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3000000000000007 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.85 ' OE1' HG12 ' A' ' 14' ' ' VAL . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.949999999999999 110.843 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.599 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.060000000000002 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.920000000000002 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.850000000000001 110.643 178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.653 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.909999999999997 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.413 ' C ' HD12 ' A' ' 126' ' ' ILE . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.479999999999997 110.676 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.350000000000001 112.422 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.350000000000001 111.043 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.759999999999998 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.710000000000001 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.560000000000002 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.729999999999997 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.119999999999997 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.579999999999998 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.969999999999999 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.482 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.280000000000001 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.899999999999999 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HG3' HG23 ' A' ' 126' ' ' ILE . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.710000000000001 112.351 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.279999999999999 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.050000000000001 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.600000000000001 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.949999999999999 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.390000000000001 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 141' ' ' THR . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.969999999999999 109.969 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.778 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.739999999999998 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.636 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.300000000000001 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.659999999999997 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.062 HD22 HG11 ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.489999999999998 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.100000000000001 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.789 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.399999999999999 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.566 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.530000000000001 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.629999999999999 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.897 ' SG ' HG21 ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.100000000000001 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.880000000000001 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.2699999999999996 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.469999999999999 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.699999999999999 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.447 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.550000000000001 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.661 HD11 ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.550000000000001 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.897 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.120000000000001 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 19' ' ' LEU . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.591 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.449999999999999 110.573 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.446 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.210000000000001 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.699999999999999 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.789 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.539999999999999 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.474 ' HB2' HG13 ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.653 HG22 HG11 ' A' ' 44' ' ' VAL . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.807 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.085 HG13 HG22 ' B' ' 31' ' ' VAL . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.085 HG22 HG13 ' B' ' 21' ' ' VAL . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' B' ' 42' ' ' PHE . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB3' HD21 ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.736 HD11 HD21 ' A' ' 67' ' ' LEU . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 4.4 p -82.6 -145.35 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 0.2 OUTLIER -45.19 -23.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 70.88 103.76 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 111.09 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.98 169.07 10.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.481 ' C ' HG23 ' B' ' 53' ' ' THR . 0.9 OUTLIER -105.32 -9.29 17.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.599 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.481 HG23 ' C ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER 60.38 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.576 0.703 . . . . 0.0 111.137 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.94 114.15 15.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.099 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.16 18.42 17.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.04 172.04 13.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.442 ' O ' HG22 ' B' ' 57' ' ' THR . 7.2 m 72.01 17.54 5.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 10.8 m -79.37 63.92 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.962 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.488 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -84.48 131.64 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.775 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 52' ' ' THR . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 81' ' ' CYS . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.073 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' LEU . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 167.1 25.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -116.37 -23.76 8.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.242 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.35 159.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p90 -155.29 127.37 7.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.8 p -170.4 138.6 1.37 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 71.4 Cg_exo -49.08 101.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.51 2.14 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -94.21 117.4 30.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.702 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG2' HG11 ' B' ' 21' ' ' VAL . 2.5 m -88.11 -42.48 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' B' ' 12' ' ' PRO . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 13' ' ' SER . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG11 HG22 ' B' ' 9' ' ' ILE . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 51' ' ' TYR . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' HB2' HD12 ' A' ' 46' ' ' ILE . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.815 ' O ' HG23 ' A' ' 3' ' ' THR . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.99 HD22 HD11 ' A' ' 173' ' ' ILE . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.48 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.85 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.748 ' CG ' HG21 ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 14' ' ' VAL . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB2' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 115' ' ' THR . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 ' HG2' ' A' ' 116' ' ' GLN . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.973 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 89' ' ' SER . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.52 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.77 ' HD3' HG23 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.748 HG21 ' CG ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.743 ' HB2' HG11 ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' H ' HG13 ' A' ' 152' ' ' VAL . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.628 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 168' ' ' VAL . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.667 ' HG3' HD12 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' A' ' 116' ' ' GLN . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.685 ' O ' HD11 ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.596 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.476 ' N ' HD12 ' A' ' 126' ' ' ILE . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.626 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 84' ' ' VAL . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 98' ' ' VAL . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD1' HD22 ' A' ' 112' ' ' LEU . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 171' ' ' GLU . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.073 HD13 HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.664 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.72 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.99 HD11 HD22 ' A' ' 53' ' ' LEU . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.85 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.498 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 44' ' ' VAL . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.454 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 36' ' ' VAL . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 24' ' ' ASP . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.917 HG13 HD23 ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.917 HD23 HG13 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.6 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD12 ' B' ' 34' ' ' LEU . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.467 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 70' ' ' LEU . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.46 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER -101.03 33.39 2.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.9 -23.49 0.45 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.906 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 111.98 23.43 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -87.17 143.03 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 110.935 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 59.7 tp -91.37 103.22 15.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.937 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.8 m -107.41 7.83 29.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.043 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.68 130.85 44.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.815 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -123.02 67.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 p -123.56 -45.61 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -144.44 47.1 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.421 ' N7 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 -138.89 147.07 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 52' ' ' THR . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 53' ' ' LEU . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 81' ' ' CYS . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 8' ' ' VAL . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.46 -164.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 t -147.42 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.79 152.04 45.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.324 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 6.3 p90 -150.57 122.15 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 6.5 p 149.03 -31.8 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 124.182 0.926 . . . . 0.0 111.638 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 23.8 Cg_exo -66.43 -14.32 43.64 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.785 1.657 . . . . 0.0 112.701 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -51.0 121.01 5.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' PRO . 2.3 p -155.41 -49.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.565 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' HB3' HG21 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.624 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 2.4 t-20 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' B' ' 12' ' ' PRO . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 173' ' ' ILE . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 173' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.689 HD12 ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.532 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.792 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 98' ' ' VAL . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 14' ' ' VAL . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 119' ' ' LEU . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CZ ' HG22 ' A' ' 141' ' ' THR . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 89' ' ' SER . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.773 HG21 HD13 ' A' ' 149' ' ' LEU . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 77' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.598 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.565 HG13 HG21 ' A' ' 168' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.592 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.617 ' OD2' HD22 ' A' ' 119' ' ' LEU . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD22 ' OD2' ' A' ' 118' ' ' ASP . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.681 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' CD ' ' A' ' 87' ' ' PRO . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.626 ' HG3' HG23 ' A' ' 126' ' ' ILE . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.83 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.676 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 98' ' ' VAL . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.84 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 19' ' ' LEU . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 118' ' ' ASP . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.534 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.859 HG23 ' HB ' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 173' ' ' ILE . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.903 HD11 HD22 ' A' ' 53' ' ' LEU . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.543 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.84 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 173' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.789 ' HA ' HG22 ' A' ' 44' ' ' VAL . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.55 HG22 HD21 ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.993 HG13 HD23 ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.993 HD23 HG13 ' B' ' 31' ' ' VAL . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 70' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.482 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 70' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.453 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -74.85 -151.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.41 -28.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.7 0.286 . . . . 0.0 111.685 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 61.0 118.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' B' ' 54' ' ' ASP . 4.7 mm-40 56.08 176.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' B' ' 53' ' ' THR . 0.6 OUTLIER -91.12 103.05 15.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.319 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.641 HG22 ' O ' ' B' ' 53' ' ' THR . 63.3 m 64.46 10.96 6.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.456 ' CB ' ' HB2' ' B' ' 51' ' ' GLN . 12.0 t0 -71.96 120.06 17.03 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -163.06 -69.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.63 100.48 3.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -61.58 103.59 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.78 50.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.448 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.807 0.336 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.65 144.23 27.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.908 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.8 HG12 HG21 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 20' ' ' LEU . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB1' H5'2 ' A' ' 181' ' ' GCP . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' CE ' HG12 ' A' ' 8' ' ' VAL . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' PRO . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 8' ' ' VAL . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.801 HG21 ' CD1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.451 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 22.9 Cg_endo -62.9 164.13 20.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.57 -38.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.522 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 33' ' ' VAL . 1.8 tt0 -52.82 138.91 28.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' C ' HG22 ' A' ' 33' ' ' VAL . 1.4 t80 -133.93 98.69 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -174.0 -61.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.065 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.65 ' CD ' HG23 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -68.31 82.37 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.637 2.225 . . . . 0.0 112.728 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 35' ' ' THR . 13.9 m -138.78 17.25 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.324 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.36 -70.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.572 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 5.4 t-20 -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.947 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.616 HD12 ' CB ' ' A' ' 51' ' ' TYR . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HD11 ' A' ' 173' ' ' ILE . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.757 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.716 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.8 HG21 HG12 ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' H ' HG22 ' A' ' 77' ' ' VAL . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.834 HD23 HG21 ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.799 ' HB3' HG21 ' A' ' 93' ' ' VAL . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.976 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 89' ' ' SER . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.773 ' HB3' HD13 ' A' ' 145' ' ' LEU . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.965 ' O ' HG23 ' A' ' 102' ' ' THR . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 98' ' ' VAL . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.965 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 108' ' ' THR . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.901 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.694 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.834 HG21 HD23 ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.613 ' OD2' HD22 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.706 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.523 ' CG ' HG23 ' A' ' 125' ' ' THR . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 122' ' ' ASP . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.739 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.658 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.663 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.58 HD13 HG21 ' A' ' 98' ' ' VAL . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' CB ' ' A' ' 175' ' ' ALA . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.694 ' CD1' HD23 ' A' ' 112' ' ' LEU . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.803 ' CG2' HG23 ' A' ' 168' ' ' VAL . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.426 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.4 ' N ' HD13 ' A' ' 160' ' ' LEU . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.803 HG23 ' CG2' ' A' ' 155' ' ' VAL . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 173' ' ' ILE . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' B' ' 9' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.735 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.523 HD13 HD11 ' B' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.484 ' HD3' HD22 ' A' ' 177' ' ' LEU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.947 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.893 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.588 ' CE1' HD12 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 21' ' ' VAL . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.585 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.757 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' B' ' 40' ' ' SER . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t -98.8 -15.81 19.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.2 -22.53 15.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.382 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.22 125.57 5.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.12 -172.63 2.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.8 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.85 78.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 53' ' ' THR . 34.2 m -106.42 7.05 30.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.64 104.9 3.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.1 55.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -85.79 118.12 25.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.85 112.14 20.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.254 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -134.99 43.99 2.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.128 179.724 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.86 H5'2 ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.851 0.357 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -171.67 154.58 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HG23 ' A' ' 75' ' ' THR . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' PA ' ' A' ' 181' ' ' GCP . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.675 HD12 ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 165' ' ' LEU . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' LEU . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.66 173.77 13.93 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -44.09 2.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 136.9 50.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 4.9 p90 -158.05 124.35 4.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.35 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.702 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 33' ' ' VAL . 62.6 Cg_endo -87.51 128.98 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.702 2.268 . . . . 0.0 112.251 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 36' ' ' VAL . 27.8 m -162.31 -96.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' B' ' 23' ' ' TRP . 0.7 OUTLIER 65.97 -58.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.593 0.357 . . . . 0.0 111.6 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' ND2' ' CD2' ' A' ' 56' ' ' PHE . 2.4 t-20 -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.928 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG23 HD11 ' A' ' 55' ' ' LEU . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.779 HG11 HG22 ' B' ' 9' ' ' ILE . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 44' ' ' VAL . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 173' ' ' ILE . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.67 HD11 HG23 ' A' ' 42' ' ' VAL . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CD2' ' ND2' ' A' ' 39' ' ' ASN . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.764 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 78' ' ' PHE . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 75' ' ' THR . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' CD ' ' A' ' 120' ' ' ARG . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.832 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 149' ' ' LEU . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.434 HG21 ' CD2' ' A' ' 78' ' ' PHE . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 98' ' ' VAL . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.599 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 105' ' ' CYS . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.565 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 145' ' ' LEU . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 155' ' ' VAL . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 115' ' ' THR . 4.0 mm-40 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.71 ' O ' HD11 ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.488 ' N ' HD12 ' A' ' 126' ' ' ILE . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.668 ' HG3' HG23 ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 84' ' ' VAL . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.544 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.761 ' CG2' HD12 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.478 ' HB3' HG11 ' A' ' 168' ' ' VAL . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 168' ' ' VAL . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 22' ' ' SER . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' O ' HD12 ' A' ' 173' ' ' ILE . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.796 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.62 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.725 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.678 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.709 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 4' ' ' ILE . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 178' ' ' GLU . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.561 ' HA ' HG22 ' A' ' 44' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 0.3 OUTLIER -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' HIS . . . . . 0.528 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.034 HG13 HG22 ' B' ' 31' ' ' VAL . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.632 ' HB2' HG11 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.034 HG22 HG13 ' B' ' 21' ' ' VAL . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.57 HD11 ' CG ' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.764 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p -86.46 -144.6 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -42.02 -26.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 58.28 107.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.902 0.382 . . . . 0.0 111.457 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -88.75 175.4 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -167.65 36.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.087 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.508 HG22 ' O ' ' B' ' 53' ' ' THR . 21.0 m -96.76 8.39 44.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -56.92 155.42 8.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.83 -83.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.64 127.3 32.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.07 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 15.2 p -105.9 29.25 6.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 151.92 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.918 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.425 ' PA ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -147.67 133.47 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.813 HG12 HG23 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.401 ' SG ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 75' ' ' THR . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' HA3' ' H8 ' ' A' ' 181' ' ' GCP . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.745 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 35' ' ' THR . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 16' ' ' LYS . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 20' ' ' LEU . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.512 ' OG1' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.75 157.4 48.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.38 -8.82 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.069 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 137.45 44.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.74 0.305 . . . . 0.0 110.956 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 33' ' ' VAL . 1.2 t80 -138.45 98.99 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.309 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -172.66 -66.38 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.71 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.617 ' CD ' HG23 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -73.9 -161.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.741 2.294 . . . . 0.0 111.796 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 81.72 116.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.211 0.529 . . . . 0.0 111.711 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' B' ' 23' ' ' TRP . 83.7 t -137.47 -49.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.898 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.3 t-20 -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' B' ' 16' ' ' LYS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 55' ' ' LEU . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' ILE . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.755 ' HB2' HD12 ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 3' ' ' THR . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 42' ' ' VAL . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 HG22 ' OG ' ' A' ' 71' ' ' SER . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' HG22 ' A' ' 58' ' ' THR . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.734 HG21 ' CE1' ' A' ' 78' ' ' PHE . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.798 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' A' ' 75' ' ' THR . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 97' ' ' TRP . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG11 ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' HD22 ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.015 HG21 HD13 ' A' ' 149' ' ' LEU . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' VAL . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.575 HG23 ' HD3' ' A' ' 107' ' ' LYS . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.794 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.726 HD12 HG23 ' A' ' 152' ' ' VAL . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.51 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.512 ' CG ' HD23 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.643 HD12 HG21 ' A' ' 125' ' ' THR . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.797 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' C ' HD12 ' A' ' 126' ' ' ILE . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.643 HG21 HD12 ' A' ' 119' ' ' LEU . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.845 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 141' ' ' THR . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.757 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.62 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.015 HD13 HG21 ' A' ' 98' ' ' VAL . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 175' ' ' ALA . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.773 HG21 HG13 ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.512 HD23 ' CG ' ' A' ' 118' ' ' ASP . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.773 HG13 HG21 ' A' ' 155' ' ' VAL . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.758 ' O ' HD12 ' A' ' 173' ' ' ILE . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.465 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.688 ' HB3' HD11 ' A' ' 111' ' ' LEU . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.482 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.813 HG23 HG12 ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 173' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 42' ' ' VAL . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.645 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.618 HG22 HD21 ' B' ' 34' ' ' LEU . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.809 ' HB2' HG21 ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.721 HG13 HD23 ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.721 HD23 HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' B' ' 34' ' ' LEU . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.596 HD12 ' OE1' ' B' ' 51' ' ' GLN . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 81.0 p -97.96 -87.2 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 4.1 mt-10 -97.01 -24.39 15.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 49' ' ' GLU . . . 170.31 148.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.149 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.596 ' OE1' HD12 ' B' ' 47' ' ' ILE . 3.7 mt-30 -92.41 161.04 14.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.0 mt -50.66 167.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.35 109.45 0.99 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.36 0.6 . . . . 0.0 110.108 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 57.94 87.04 0.07 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.94 100.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.972 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -74.24 110.76 8.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 120.16 26.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -69.32 112.23 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tttp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.005 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.463 ' H8 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -55.25 131.52 45.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.876 HG13 HD21 ' A' ' 177' ' ' LEU . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG11 ' CE1' ' A' ' 72' ' ' TYR . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 20' ' ' LEU . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.722 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.725 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD11 HG21 ' A' ' 8' ' ' VAL . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.463 HG22 ' OG1' ' A' ' 25' ' ' THR . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.463 ' OG1' HG22 ' A' ' 21' ' ' ILE . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.8 168.85 20.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -3.65 8.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.694 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 151.44 5.74 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -123.43 100.54 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 33' ' ' VAL . 14.8 p 178.56 125.46 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.51 152.42 40.47 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.377 2.051 . . . . 0.0 112.194 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -83.91 144.87 28.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 5.8 p -116.59 -46.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' CG2' HD11 ' A' ' 55' ' ' LEU . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 ' CG2' ' A' ' 42' ' ' VAL . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.474 ' HD2' HD21 ' A' ' 67' ' ' LEU . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.766 ' O ' HD21 ' B' ' 38' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' H ' HG22 ' A' ' 77' ' ' VAL . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.832 HG13 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.564 ' SG ' HG11 ' A' ' 113' ' ' VAL . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CB ' HG21 ' A' ' 93' ' ' VAL . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 137' ' ' ILE . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 119' ' ' LEU . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 89' ' ' SER . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HB3' HD13 ' A' ' 145' ' ' LEU . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.832 ' CE3' HG13 ' A' ' 80' ' ' VAL . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 102' ' ' THR . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.857 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.96 HG21 HD23 ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.639 ' CD2' HG21 ' A' ' 85' ' ' VAL . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.7 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.634 ' OD2' HG23 ' A' ' 125' ' ' THR . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' N ' HD12 ' A' ' 126' ' ' ILE . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.634 HG23 ' OD2' ' A' ' 122' ' ' ASP . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.902 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 98' ' ' VAL . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.825 HG21 HG13 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.892 ' SG ' HG21 ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.557 HD23 ' OD2' ' A' ' 118' ' ' ASP . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.892 HG21 ' SG ' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.795 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.795 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.604 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.876 HD21 HG13 ' A' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.483 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.762 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.619 HG22 ' CE ' ' B' ' 16' ' ' LYS . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.811 HG13 HG22 ' B' ' 31' ' ' VAL . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.811 HG22 HG13 ' B' ' 21' ' ' VAL . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.67 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 70' ' ' LEU . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER -102.01 -24.97 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -101.43 -25.46 13.92 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.72 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.98 -4.76 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.096 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 49.7 -164.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.775 0.322 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 -42.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 53' ' ' THR . 9.0 m -101.24 9.58 41.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 51.34 86.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 118.31 3.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 66.47 121.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -81.47 119.83 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.3 91.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.424 ' H8 ' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -84.42 155.27 22.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.865 HG12 HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.606 HG12 ' HD2' ' A' ' 16' ' ' LYS . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 HH21 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 81' ' ' CYS . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.44 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' O ' HD23 ' A' ' 19' ' ' LEU . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' LYS . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' C ' HD21 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 21' ' ' ILE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.02 152.36 28.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.93 -10.16 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.14 171.49 0.72 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.904 0.383 . . . . 0.0 111.125 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.567 ' C ' HG23 ' A' ' 33' ' ' VAL . 5.1 p90 -130.58 -168.84 2.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 32' ' ' TYR . 4.8 t 84.56 131.89 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.86 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -40.35 153.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.698 2.266 . . . . 0.0 112.851 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -77.56 -27.72 51.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t 68.42 -75.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' HG23 ' B' ' 21' ' ' VAL . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 2.5 t-20 -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.746 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.655 HD13 HG21 ' A' ' 173' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.874 HD13 ' CG1' ' A' ' 173' ' ' ILE . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD21 HD21 ' A' ' 53' ' ' LEU . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.599 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB1' HE21 ' A' ' 61' ' ' GLN . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.422 HE21 ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.64 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' H ' HG22 ' A' ' 77' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CD2' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.727 HG11 ' HB2' ' A' ' 119' ' ' LEU . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.811 ' CZ ' HG22 ' A' ' 141' ' ' THR . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' SER . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' HD11 ' A' ' 149' ' ' LEU . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 102' ' ' THR . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 98' ' ' VAL . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.882 ' HB2' HG23 ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.622 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.754 HD12 HG23 ' A' ' 152' ' ' VAL . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 146' ' ' ALA . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.754 ' HB3' HD23 ' A' ' 119' ' ' LEU . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.48 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 116' ' ' GLN . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.728 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.547 ' C ' HD12 ' A' ' 126' ' ' ILE . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 124' ' ' SER . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.425 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.744 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.811 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.668 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 94' ' ' LYS . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.864 HG11 ' HB1' ' A' ' 175' ' ' ALA . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 168' ' ' VAL . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.915 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.428 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.458 HD12 ' HN1' ' A' ' 181' ' ' GCP . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 19' ' ' LEU . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HE2' ' CD ' ' B' ' 12' ' ' PRO . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.915 HG21 ' SG ' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.783 ' O ' HD12 ' A' ' 173' ' ' ILE . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.646 ' HB3' HD11 ' A' ' 111' ' ' LEU . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.874 ' CG1' HD13 ' A' ' 53' ' ' LEU . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.746 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 44' ' ' VAL . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.663 HG22 ' NZ ' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.002 HG13 HG22 ' B' ' 31' ' ' VAL . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.403 ' CB ' HG21 ' A' ' 36' ' ' VAL . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.002 HG22 HG13 ' B' ' 21' ' ' VAL . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.654 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.912 HD12 ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 43' ' ' SER . 1.3 t -100.76 5.36 43.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 2.2 mt-10 -69.57 -10.98 60.4 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 69.1 8.74 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.71 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -170.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.935 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.97 153.16 18.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' B' ' 54' ' ' ASP . 2.6 t -129.11 -125.5 0.22 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.075 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' B' ' 53' ' ' THR . 3.7 m-20 -65.88 116.33 6.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.94 127.97 34.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -71.71 154.97 40.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -30.28 6.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.61 98.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.875 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.507 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.35 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.26 143.6 31.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 24.829999999999998 110.91 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' THR . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.719999999999999 110.906 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.190000000000001 110.994 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.460000000000001 109.961 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.300000000000001 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 72' ' ' TYR . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.300000000000001 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.1699999999999999 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.2699999999999996 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.6400000000000006 112.404 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' O ' H5'2 ' A' ' 181' ' ' GCP . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' CD ' ' A' ' 16' ' ' LYS . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' H ' HG21 ' A' ' 115' ' ' THR . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.699999999999999 112.519 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.6899999999999995 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' HD12 ' A' ' 20' ' ' LEU . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.190000000000001 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.050000000000001 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 17' ' ' THR . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.969999999999999 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.149999999999999 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.940000000000001 111.621 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.789999999999999 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.600000000000001 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.109999999999999 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.66 167.2 27.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.510000000000002 112.459 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.61 -7.13 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 41.890000000000001 111.667 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -53.41 171.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 43.869999999999997 110.931 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CD2' HG23 ' A' ' 33' ' ' VAL . 5.2 p90 -137.38 -169.39 2.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.21 -0.45 . . . . 23.27 109.87 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.685 HG23 ' CD2' ' A' ' 32' ' ' TYR . 12.8 t 70.94 108.33 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.928 -0.578 . . . . 21.530000000000001 111.035 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.78 142.17 19.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 15.4 112.43 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 36' ' ' VAL . 2.0 m -83.09 170.99 14.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 20.140000000000001 110.894 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' B' ' 23' ' ' TRP . 59.5 t -109.3 -45.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 23.469999999999999 111.082 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.059999999999999 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.280000000000001 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 7.3 t-20 -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.530000000000001 111.555 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.329999999999998 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' B' ' 12' ' ' PRO . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 9' ' ' ILE . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.280000000000001 111.197 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 ' CB ' ' A' ' 51' ' ' TYR . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.620000000000001 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.449999999999999 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.879999999999999 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.190000000000001 110.937 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' THR . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.100000000000001 110.936 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.780000000000001 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.621 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.059999999999999 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.960000000000001 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.6099999999999994 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.8800000000000008 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.239999999999998 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.149999999999999 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.510000000000002 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.670000000000002 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.119999999999997 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.940000000000001 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' B' ' 41' ' ' LEU . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.690000000000001 111.992 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.390000000000001 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.766 ' HE1' HG21 ' A' ' 7' ' ' VAL . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.010000000000002 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.259999999999998 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.89 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.851 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.870000000000001 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.510000000000002 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.89 ' CZ ' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.420000000000002 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 93' ' ' VAL . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 113' ' ' VAL . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.6200000000000001 110.454 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 93' ' ' VAL . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.210000000000001 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.7199999999999998 111.008 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 115' ' ' THR . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.969999999999999 111.038 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.5700000000000003 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.260000000000002 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.029999999999999 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 93' ' ' VAL . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.299999999999997 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.640000000000001 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 89' ' ' SER . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.449999999999999 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.600000000000001 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.559999999999999 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 102' ' ' THR . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.300000000000001 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.289999999999999 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.129999999999999 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.039999999999999 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.469999999999999 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.829999999999998 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.039999999999999 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.100000000000001 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.629999999999999 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 77' ' ' VAL . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.600000000000001 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.777 ' CD1' HD12 ' A' ' 101' ' ' ILE . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.719999999999999 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.792 HD12 ' CG2' ' A' ' 152' ' ' VAL . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.739999999999998 110.935 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.789999999999999 110.549 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 81' ' ' CYS . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.4600000000000009 111.676 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3000000000000007 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.797 ' CG ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.949999999999999 110.778 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.060000000000002 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.920000000000002 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.797 HD12 ' CG ' ' A' ' 116' ' ' GLN . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.850000000000001 110.878 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.856 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.909999999999997 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.479999999999997 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.350000000000001 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.350000000000001 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.723 HG21 HD22 ' A' ' 119' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.759999999999998 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.856 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.710000000000001 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.560000000000002 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.729999999999997 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.119999999999997 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.579999999999998 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.969999999999999 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.856 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.280000000000001 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.899999999999999 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.710000000000001 111.954 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.279999999999999 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.050000000000001 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.5 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.600000000000001 111.715 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.949999999999999 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.390000000000001 110.358 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.969999999999999 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.739999999999998 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.300000000000001 110.597 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.659999999999997 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 98' ' ' VAL . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.489999999999998 111.194 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.100000000000001 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.962 HG11 ' HB1' ' A' ' 175' ' ' ALA . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.399999999999999 110.963 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.530000000000001 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 168' ' ' VAL . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.629999999999999 111.475 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.954 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.100000000000001 112.052 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.880000000000001 109.914 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.2699999999999996 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.469999999999999 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.699999999999999 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.550000000000001 112.38 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 19' ' ' LEU . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.550000000000001 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.954 HG21 ' SG ' ' A' ' 157' ' ' CYS . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.120000000000001 111.476 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.449999999999999 110.921 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.892 HD11 HD22 ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.210000000000001 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.699999999999999 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.962 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.539999999999999 111.139 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.823 HG22 HG11 ' A' ' 44' ' ' VAL . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 31' ' ' VAL . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.569 ' HB2' HG21 ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 21' ' ' VAL . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.627 HD12 HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.882 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.525 ' HB3' HD21 ' A' ' 70' ' ' LEU . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.625 ' N ' HD13 ' B' ' 47' ' ' ILE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t -100.42 21.71 12.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.08 -8.07 41.78 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.031 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.06 -0.97 15.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.72 -174.84 2.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.822 0.344 . . . . 0.0 111.147 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.55 135.27 34.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.64 114.03 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.309 0.576 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.12 162.62 23.6 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.034 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.7 -24.08 13.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 60.88 22.12 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.276 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -96.25 26.28 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.99 124.32 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tttt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.473 H5'2 ' O ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.793 0.33 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -108.73 150.9 26.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 53' ' ' LEU . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 75' ' ' THR . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' HG22 ' A' ' 14' ' ' VAL . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 12' ' ' GLY . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 20' ' ' LEU . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 16' ' ' LYS . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.439 ' C ' HD21 ' A' ' 165' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 42' ' ' VAL . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.91 154.88 73.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -20.33 10.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -53.76 155.19 3.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 110.974 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 6.6 t80 -141.38 113.98 8.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 12.4 p -160.77 137.15 6.3 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.974 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 81.7 Cg_exo -44.63 147.76 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.445 2.097 . . . . 0.0 112.277 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 m -134.83 153.89 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p -131.61 -39.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.372 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HE2' ' HG ' ' A' ' 71' ' ' SER . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 24' ' ' THR . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 13' ' ' SER . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.823 ' HB2' HD12 ' A' ' 46' ' ' ILE . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 173' ' ' ILE . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 42' ' ' VAL . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.714 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' HE2' ' A' ' 37' ' ' PHE . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 7' ' ' VAL . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' H ' HG22 ' A' ' 77' ' ' VAL . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.88 ' CD2' HG21 ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 93' ' ' VAL . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.836 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' THR . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.923 HG11 HD12 ' A' ' 119' ' ' LEU . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.966 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.71 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 89' ' ' SER . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 145' ' ' LEU . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.899 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.711 ' HD3' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' THR . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.838 ' HB2' HG23 ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.821 HD12 HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 115' ' ' THR . 51.8 mm-40 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.588 HD11 ' CA ' ' A' ' 157' ' ' CYS . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.485 ' OD2' ' N2 ' ' A' ' 181' ' ' GCP . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.923 HD12 HG11 ' A' ' 85' ' ' VAL . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.574 ' O ' HD11 ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.606 HG21 HD21 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.622 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.71 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 98' ' ' VAL . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.923 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.607 ' CD1' HD23 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 84' ' ' VAL . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.817 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.647 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 19' ' ' LEU . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.817 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' HD13 ' B' ' 9' ' ' ILE . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.701 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 53' ' ' LEU . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.923 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 173' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.485 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.57 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.83 HG13 HG22 ' B' ' 31' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.83 HG22 HG13 ' B' ' 21' ' ' VAL . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.787 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.787 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.558 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t -79.18 -150.19 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 4.2 mt-10 -40.2 -29.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 68.72 10.99 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -49.25 167.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 0.0 110.972 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.47 25.63 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.895 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 43.1 p -105.05 -122.17 0.22 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.013 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.01 83.19 0.22 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.904 0.383 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.87 -82.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -74.07 133.31 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.68 -62.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p 47.48 90.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.485 ' N2 ' ' OD2' ' A' ' 118' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.54 141.96 39.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 24.829999999999998 110.68 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.719999999999999 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.190000000000001 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.460000000000001 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.300000000000001 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG23 HG23 ' A' ' 75' ' ' THR . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.300000000000001 110.594 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' CD ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.1699999999999999 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.2699999999999996 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.6400000000000006 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 15' ' ' GLY . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.699999999999999 112.868 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' CD ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.6899999999999995 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 20' ' ' LEU . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.190000000000001 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.050000000000001 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 19' ' ' LEU . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.969999999999999 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' THR . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.484 ' OG ' HD21 ' A' ' 165' ' ' LEU . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.149999999999999 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.836 HG21 ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.940000000000001 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ILE . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.789999999999999 111.441 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' SER . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.600000000000001 110.857 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.109999999999999 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.57 163.65 37.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.510000000000002 111.736 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.53 -40.17 1.61 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.484 -0.325 . . . . 41.890000000000001 111.202 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.58 145.14 15.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 43.869999999999997 111.082 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' C ' HG22 ' A' ' 33' ' ' VAL . 27.5 t80 -129.41 101.72 6.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 23.27 110.439 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -172.92 -60.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 21.530000000000001 111.452 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.628 ' CD ' HG23 ' A' ' 33' ' ' VAL . 48.5 Cg_endo -69.88 120.65 7.38 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.38 2.053 . . . . 15.4 112.948 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' PHE . 18.9 m -163.5 -85.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 20.140000000000001 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 47.24 -84.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.458 0.474 . . . . 23.469999999999999 110.995 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.704 ' N ' HG22 ' A' ' 36' ' ' VAL . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.059999999999999 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.280000000000001 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.530000000000001 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.329999999999998 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' B' ' 12' ' ' PRO . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.912 HG11 HG22 ' B' ' 9' ' ' ILE . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.280000000000001 111.489 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 HG23 ' B' ' 9' ' ' ILE . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.620000000000001 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.449999999999999 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.879999999999999 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.190000000000001 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.100000000000001 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 173' ' ' ILE . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.780000000000001 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.059999999999999 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.960000000000001 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' TYR . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.6099999999999994 110.933 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.8800000000000008 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.239999999999998 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.149999999999999 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.510000000000002 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.670000000000002 111.493 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 67' ' ' LEU . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.940000000000001 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.690000000000001 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.390000000000001 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.010000000000002 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.259999999999998 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.870000000000001 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.510000000000002 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 75' ' ' THR . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.420000000000002 111.152 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 113' ' ' VAL . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.439 HG13 ' HE3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.6200000000000001 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.210000000000001 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 14' ' ' VAL . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.7199999999999998 111.059 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 137' ' ' ILE . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.969999999999999 111.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.5700000000000003 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.260000000000002 110.85 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.029999999999999 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.756 ' CZ ' HG22 ' A' ' 141' ' ' THR . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.299999999999997 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.640000000000001 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 89' ' ' SER . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.449999999999999 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.600000000000001 111.672 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.523 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.559999999999999 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.907 HG11 ' HB3' ' A' ' 149' ' ' LEU . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.300000000000001 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.289999999999999 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.129999999999999 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.039999999999999 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.469999999999999 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.829999999999998 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.039999999999999 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.100000000000001 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.629999999999999 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HG2' HG23 ' A' ' 77' ' ' VAL . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.600000000000001 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.719999999999999 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.777 HD12 HG23 ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.739999999999998 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.592 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.789999999999999 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 79' ' ' LEU . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.4600000000000009 111.757 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3000000000000007 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.576 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.576 ' H ' HG22 ' A' ' 115' ' ' THR . 6.7 mm100 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.949999999999999 110.884 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.060000000000002 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.920000000000002 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.850000000000001 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.687 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.909999999999997 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 125' ' ' THR . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.479999999999997 110.362 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.350000000000001 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.350000000000001 111.477 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.427 HG23 ' OD2' ' A' ' 122' ' ' ASP . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.759999999999998 110.85 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 136' ' ' PRO . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.710000000000001 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.560000000000002 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.816 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.729999999999997 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.119999999999997 112.061 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.579999999999998 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.969999999999999 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.493 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.280000000000001 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.899999999999999 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.710000000000001 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 84' ' ' VAL . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.279999999999999 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.050000000000001 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.756 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.600000000000001 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.949999999999999 110.784 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.390000000000001 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.969999999999999 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.739999999999998 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.300000000000001 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.659999999999997 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG11 ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.489999999999998 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.100000000000001 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.777 HG23 HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.399999999999999 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.592 ' CD1' HD23 ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.530000000000001 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.629999999999999 111.257 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.100000000000001 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.880000000000001 110.64 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.2699999999999996 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.469999999999999 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.699999999999999 111.091 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.550000000000001 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.550000000000001 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 155' ' ' VAL . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.120000000000001 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 173' ' ' ILE . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 9' ' ' ILE . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.41 ' HB3' HD11 ' A' ' 111' ' ' LEU . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.449999999999999 111.538 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.733 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 1.059 HD11 HD22 ' A' ' 53' ' ' LEU . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.210000000000001 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.669 HD23 ' HB ' ' B' ' 4' ' ' ILE . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.699999999999999 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.539999999999999 111.592 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.45 ' HD3' HD22 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.669 ' HB ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.912 HG22 HG11 ' A' ' 44' ' ' VAL . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.707 ' HA ' HG22 ' A' ' 44' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.836 ' CD1' HG21 ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.855 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.432 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.976 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.976 HG22 HG13 ' B' ' 21' ' ' VAL . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.939 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.939 HD12 ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.723 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.512 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p -80.18 -153.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -42.2 -28.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.78 12.59 6.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 63.58 161.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.782 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.56 53.11 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.8 p -89.2 -118.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' B' ' 55' ' ' ALA . 0.4 OUTLIER 63.96 172.34 0.18 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 54' ' ' ASP . . . 73.03 50.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -106.64 -76.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 116.61 22.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.091 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -94.71 25.84 3.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.461 " H3'" ' CG ' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.783 0.325 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.63 135.03 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 24.829999999999998 110.855 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.719999999999999 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.907 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.190000000000001 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' HG22 ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.460000000000001 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.300000000000001 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.300000000000001 110.759 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.1699999999999999 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.2699999999999996 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.6400000000000006 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' HA2' ' O1A' ' A' ' 181' ' ' GCP . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.699999999999999 113.013 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.553 ' O ' HD23 ' A' ' 19' ' ' LEU . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.6899999999999995 112.171 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.586 ' OG1' HG21 ' A' ' 35' ' ' THR . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.190000000000001 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.050000000000001 111.618 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.127 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 17' ' ' THR . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.969999999999999 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.149999999999999 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.484 HG21 ' CE1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.940000000000001 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.789999999999999 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.600000000000001 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.109999999999999 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo -63.61 -165.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.510000000000002 112.741 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.5 t -146.87 -45.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 41.890000000000001 110.655 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 169.38 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 43.869999999999997 110.724 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -136.54 110.45 8.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 23.27 111.107 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.63 135.49 1.95 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 21.530000000000001 111.096 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' VAL . 36.6 Cg_exo -59.29 121.44 9.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.422 2.081 . . . . 15.4 112.419 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.586 HG21 ' OG1' ' A' ' 17' ' ' THR . 1.4 m -56.83 -41.84 78.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 20.140000000000001 110.472 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 34' ' ' PRO . 2.5 t 69.71 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.728 -0.669 . . . . 23.469999999999999 110.561 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.059999999999999 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.280000000000001 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.530000000000001 110.998 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.329999999999998 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.864 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.280000000000001 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 4' ' ' ILE . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.620000000000001 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.449999999999999 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.879999999999999 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.190000000000001 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.100000000000001 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.886 HD13 HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.780000000000001 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD11 HD13 ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.059999999999999 111.119 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.960000000000001 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.6099999999999994 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.8800000000000008 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.239999999999998 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.149999999999999 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 61' ' ' GLN . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.510000000000002 111.731 -178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.670000000000002 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.119999999999997 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.940000000000001 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' B' ' 41' ' ' LEU . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.690000000000001 110.835 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.390000000000001 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.010000000000002 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.259999999999998 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 108' ' ' THR . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.870000000000001 109.669 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.510000000000002 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.420000000000002 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD23 HG21 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.788 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.6200000000000001 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CB ' HG21 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.210000000000001 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.7199999999999998 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' THR . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.969999999999999 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 119' ' ' LEU . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.5700000000000003 111.724 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.260000000000002 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.029999999999999 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.299999999999997 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.640000000000001 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 89' ' ' SER . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.449999999999999 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.806 ' HB3' HD13 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.600000000000001 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.788 ' CE3' HG13 ' A' ' 80' ' ' VAL . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.559999999999999 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.935 HG11 HD22 ' A' ' 149' ' ' LEU . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.300000000000001 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.289999999999999 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.651 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.129999999999999 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.039999999999999 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.469999999999999 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.474 ' HB2' HG23 ' A' ' 108' ' ' THR . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.829999999999998 110.863 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.039999999999999 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.100000000000001 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 105' ' ' CYS . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.629999999999999 111.352 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.600000000000001 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.632 ' H ' HG13 ' A' ' 152' ' ' VAL . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.719999999999999 111.901 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.739999999999998 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 154' ' ' TYR . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.789999999999999 110.827 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.86 HG21 HD23 ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.4600000000000009 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3000000000000007 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.749 ' HG3' HD22 ' A' ' 119' ' ' LEU . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.949999999999999 110.946 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.551 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.060000000000002 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.920000000000002 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 116' ' ' GLN . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.850000000000001 110.094 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.713 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.909999999999997 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.479999999999997 110.746 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.350000000000001 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.350000000000001 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.45 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.759999999999998 110.138 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.710000000000001 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.560000000000002 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.729999999999997 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.119999999999997 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.579999999999998 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.969999999999999 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.935 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.280000000000001 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.899999999999999 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.710000000000001 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.279999999999999 110.843 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.050000000000001 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.600000000000001 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.949999999999999 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.390000000000001 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.969999999999999 110.378 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.739999999999998 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.711 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.300000000000001 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.659999999999997 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 HG11 ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.489999999999998 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.100000000000001 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.399999999999999 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 112' ' ' LEU . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.530000000000001 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.006 HG21 HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.629999999999999 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.878 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.100000000000001 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.880000000000001 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.2699999999999996 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.469999999999999 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.699999999999999 111.262 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.550000000000001 112.567 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.127 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.550000000000001 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.006 HG13 HG21 ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.120000000000001 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.449999999999999 111.043 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.907 HG23 HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.210000000000001 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.699999999999999 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.539999999999999 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.456 HD21 HG13 ' A' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.541 HG22 HG22 ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.608 ' H ' HG21 ' A' ' 36' ' ' VAL . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.534 ' CE1' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.607 HG11 HD12 ' B' ' 34' ' ' LEU . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.607 HD12 HG11 ' B' ' 31' ' ' VAL . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.85 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' B' ' 35' ' ' ASP . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.565 ' CB ' HD13 ' A' ' 70' ' ' LEU . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.534 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -87.97 -146.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 3.7 mt-10 -47.65 -22.47 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 75.58 136.64 0.06 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.949 0.404 . . . . 0.0 111.289 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 65.78 153.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.286 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.76 132.73 40.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.483 HG22 ' O ' ' B' ' 53' ' ' THR . 12.2 m -120.47 8.96 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -167.8 0.05 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.81 167.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.972 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -142.28 -53.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -81.13 139.91 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.87 155.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.01 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.869 179.837 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.542 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -100.69 142.48 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.583 HG11 ' HE1' ' A' ' 72' ' ' TYR . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB1' H5'2 ' A' ' 181' ' ' GCP . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 81' ' ' CYS . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.893 ' HB2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 24' ' ' THR . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 20' ' ' LEU . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.99 156.8 51.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.64 -17.73 14.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.437 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.54 138.16 34.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.24 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.0 t80 -131.05 106.26 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.456 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG12 ' HD3' ' A' ' 34' ' ' PRO . 1.2 t 169.04 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.674 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD3' HG12 ' A' ' 33' ' ' VAL . 99.2 Cg_exo -46.52 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 112.956 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' O2G' ' A' ' 181' ' ' GCP . 2.4 m -172.44 98.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.391 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 35' ' ' THR . 57.8 t -159.59 -61.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.481 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.562 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.1 t-20 -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' B' ' 12' ' ' PRO . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.458 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.841 HD13 HG12 ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 20' ' ' LEU . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.562 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.461 HG23 HG12 ' A' ' 7' ' ' VAL . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' B' ' 41' ' ' LEU . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HE1' HG11 ' A' ' 7' ' ' VAL . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.674 HG21 ' CE1' ' A' ' 78' ' ' PHE . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 75' ' ' THR . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.49 HD23 HG21 ' A' ' 113' ' ' VAL . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 93' ' ' VAL . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB2' HG21 ' A' ' 14' ' ' VAL . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' HG21 ' A' ' 93' ' ' VAL . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.41 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HD2' ' A' ' 120' ' ' ARG . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.92 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.002 ' O ' HG23 ' A' ' 102' ' ' THR . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 110' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.661 ' H ' HG13 ' A' ' 152' ' ' VAL . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 154' ' ' TYR . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 79' ' ' LEU . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mm-40 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 158' ' ' SER . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.748 ' HD2' HG11 ' A' ' 84' ' ' VAL . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' N ' HD12 ' A' ' 126' ' ' ILE . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 124' ' ' SER . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.845 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' CG ' HD23 ' A' ' 145' ' ' LEU . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.83 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.772 HG11 ' HB1' ' A' ' 175' ' ' ALA . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.644 ' HD1' HD22 ' A' ' 112' ' ' LEU . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 168' ' ' VAL . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.589 ' HB3' HG21 ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' ILE . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 155' ' ' VAL . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.898 ' O ' HD12 ' A' ' 173' ' ' ILE . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.772 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' B' ' 2' ' ' LYS . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.737 ' HE2' HD22 ' A' ' 177' ' ' LEU . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.639 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.826 ' HA ' HG22 ' A' ' 44' ' ' VAL . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 24' ' ' THR . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.091 HG13 HG22 ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.091 HG22 HG13 ' B' ' 21' ' ' VAL . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.674 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.565 ' CB ' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD13 ' A' ' 70' ' ' LEU . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER -101.4 -22.32 14.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.08 -22.75 15.54 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.9 -84.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.046 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 50.03 -163.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.13 63.45 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.536 HG22 ' O ' ' B' ' 53' ' ' THR . 28.5 m -109.79 6.51 23.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.109 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -106.81 27.48 8.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.776 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.46 15.97 9.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -70.63 108.11 4.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.821 0.343 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.431 ' O ' HG22 ' B' ' 57' ' ' THR . 10.7 m -155.73 35.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -50.99 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 mttm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.907 H5'2 ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.808 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 -141.6 151.93 43.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.96 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 53' ' ' LEU . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.842 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' LEU . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.47 172.54 15.48 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -52.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 149.87 31.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' C ' HG22 ' A' ' 33' ' ' VAL . 10.5 p90 -155.98 120.8 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.6 -64.85 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.603 ' CD ' HG23 ' A' ' 33' ' ' VAL . 69.1 Cg_endo -74.54 65.71 5.61 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.533 2.155 . . . . 0.0 112.556 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 37' ' ' PHE . 70.4 m -118.22 -79.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' B' ' 23' ' ' TRP . 38.3 t 64.05 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.308 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.752 ' O ' HG23 ' B' ' 21' ' ' VAL . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 44' ' ' VAL . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HG22 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.585 ' CD1' HG21 ' A' ' 173' ' ' ILE . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.759 HD22 HD13 ' B' ' 41' ' ' LEU . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 108' ' ' THR . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.877 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' H ' HG22 ' A' ' 77' ' ' VAL . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' OE2' ' A' ' 156' ' ' GLU . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.857 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 89' ' ' SER . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HA ' HD11 ' A' ' 149' ' ' LEU . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.837 HG11 ' HB3' ' A' ' 149' ' ' LEU . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 98' ' ' VAL . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.877 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 101' ' ' ILE . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 172' ' ' ALA . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 145' ' ' LEU . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.514 ' H ' HG22 ' A' ' 115' ' ' THR . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.742 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.559 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.742 HD11 ' O ' ' A' ' 120' ' ' ARG . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 123' ' ' PRO . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 124' ' ' SER . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.716 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.3 m120 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.555 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.648 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.495 ' HB2' HD23 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.837 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 112' ' ' LEU . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 168' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.485 ' SG ' HG11 ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 155' ' ' VAL . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 19' ' ' LEU . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.455 ' O ' HD13 ' B' ' 9' ' ' ILE . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 53' ' ' LEU . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' B' ' 4' ' ' ILE . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.505 ' HE3' HD23 ' A' ' 177' ' ' LEU . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.623 ' HB ' HD12 ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.855 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.0 HG13 HG22 ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.648 ' HB2' HG21 ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 1.0 HG22 HG13 ' B' ' 21' ' ' VAL . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.63 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 70' ' ' LEU . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.759 HD13 HD22 ' A' ' 70' ' ' LEU . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t -86.46 -144.57 0.11 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.65 -25.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.85 113.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 170.49 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mp -137.11 36.35 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.449 HG22 ' O ' ' B' ' 53' ' ' THR . 9.3 m -99.18 9.11 44.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.048 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -55.47 121.24 8.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.018 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.14 100.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -49.51 134.06 19.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' B' ' 58' ' ' SER . 9.7 t -90.69 -165.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.412 ' N ' ' OG1' ' B' ' 57' ' ' THR . 0.5 OUTLIER 58.45 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.995 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 mtmm . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.878 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.464 ' N7 ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.794 0.33 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.2 147.5 49.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.118 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 56' ' ' PHE . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 16' ' ' LYS . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.684 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.095 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 165' ' ' LEU . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 28' ' ' PHE . 20.2 Cg_endo -60.46 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -35.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.549 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.24 168.24 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.647 0.261 . . . . 0.0 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.33 -168.52 1.34 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.365 0.603 . . . . 0.0 110.594 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 1.6 t 47.68 47.96 5.25 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.421 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 27.2 Cg_endo -93.7 -168.95 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.476 2.117 . . . . 0.0 112.77 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m 71.48 -137.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.543 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.76 HG12 ' OH ' ' A' ' 64' ' ' TYR . 14.1 t 78.03 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG23 HD11 ' A' ' 55' ' ' LEU . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' HG12 ' A' ' 44' ' ' VAL . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG12 HG23 ' B' ' 9' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 173' ' ' ILE . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 42' ' ' VAL . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HB2' HG22 ' A' ' 7' ' ' VAL . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 71' ' ' SER . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.76 ' OH ' HG12 ' A' ' 36' ' ' VAL . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 58' ' ' THR . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.588 ' H ' HG22 ' A' ' 77' ' ' VAL . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 113' ' ' VAL . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 119' ' ' LEU . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.8 m-20 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 89' ' ' SER . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.557 ' HA ' HD21 ' A' ' 149' ' ' LEU . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 ' CB ' HD22 ' A' ' 149' ' ' LEU . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 97' ' ' TRP . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.512 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HG23 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.51 HD23 ' CD1' ' A' ' 154' ' ' TYR . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD23 ' A' ' 79' ' ' LEU . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.549 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' HD22 ' A' ' 119' ' ' LEU . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.636 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 125' ' ' THR . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.766 HG23 ' HG3' ' A' ' 136' ' ' PRO . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.766 ' HG3' HG23 ' A' ' 126' ' ' ILE . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.656 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 110' ' ' PHE . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.51 ' CD1' HD23 ' A' ' 112' ' ' LEU . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' C ' HD11 ' A' ' 117' ' ' ILE . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 163' ' ' LYS . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 165' ' ' LEU . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.858 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.095 HD13 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.904 ' O ' HD12 ' A' ' 173' ' ' ILE . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' HD21 ' A' ' 111' ' ' LEU . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.954 HG23 HG12 ' A' ' 4' ' ' ILE . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.668 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.677 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.566 HD12 HG13 ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.668 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.451 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.952 HG11 HD12 ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.952 HD12 HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.516 ' H ' HD23 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 39' ' ' ARG . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' B' ' 36' ' ' PRO . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.449 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' C ' HD13 ' B' ' 47' ' ' ILE . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.601 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER -100.64 0.75 39.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.8 -11.83 61.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.123 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.85 106.07 7.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.286 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -106.78 -164.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.45 110.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.422 HG22 ' O ' ' B' ' 53' ' ' THR . 5.9 m -102.79 9.07 39.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.051 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -52.02 103.94 0.07 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.951 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.22 136.53 50.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 52.35 178.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.2 -83.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.31 64.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.135 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.932 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GCP . . . . . 0.669 ' O1B' HG23 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 -124.92 142.45 51.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 24.829999999999998 110.926 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 52' ' ' THR . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.719999999999999 111.024 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.72 ' CG1' HD21 ' A' ' 177' ' ' LEU . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.190000000000001 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.460000000000001 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG22 ' A' ' 4' ' ' ILE . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.300000000000001 110.239 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 HG23 HG23 ' A' ' 75' ' ' THR . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.300000000000001 110.774 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.2699999999999996 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.6400000000000006 112.634 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.636 ' H ' HG21 ' A' ' 115' ' ' THR . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.699999999999999 113.259 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.6899999999999995 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.752 ' HA ' HD12 ' A' ' 20' ' ' LEU . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.190000000000001 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.050000000000001 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 17' ' ' THR . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.969999999999999 110.251 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 25' ' ' THR . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 165' ' ' LEU . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.149999999999999 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.940000000000001 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 21' ' ' ILE . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.789999999999999 111.438 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.600000000000001 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.109999999999999 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.62 -174.56 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.510000000000002 112.116 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 t -149.29 -46.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 41.890000000000001 111.169 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.95 134.0 51.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 43.869999999999997 111.164 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' C ' HG22 ' A' ' 33' ' ' VAL . 13.4 p90 -154.5 120.46 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 23.27 110.704 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.44 -64.61 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 21.530000000000001 111.054 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.532 ' CD ' HG23 ' A' ' 33' ' ' VAL . 30.1 Cg_endo -66.23 -82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.514 2.143 . . . . 15.4 112.916 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 35' ' ' THR . 69.9 m 56.16 23.47 7.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.807 0.337 . . . . 20.140000000000001 110.877 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' B' ' 29' ' ' PHE . 20.8 t -51.68 -63.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.276 -0.42 . . . . 23.469999999999999 110.987 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.059999999999999 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.280000000000001 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.530000000000001 111.633 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.329999999999998 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' H ' ' B' ' 13' ' ' SER . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.280000000000001 111.426 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.412 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 51' ' ' TYR . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.620000000000001 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.449999999999999 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.879999999999999 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.565 ' CB ' HD12 ' A' ' 46' ' ' ILE . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.190000000000001 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 3' ' ' THR . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.100000000000001 110.991 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 173' ' ' ILE . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.780000000000001 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 8' ' ' VAL . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.059999999999999 111.031 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' CG ' HD11 ' A' ' 20' ' ' LEU . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.960000000000001 110.725 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.6099999999999994 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.8800000000000008 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.239999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.149999999999999 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.510000000000002 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.670000000000002 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.119999999999997 111.318 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.940000000000001 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.831 HD21 ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.690000000000001 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.390000000000001 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.010000000000002 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.259999999999998 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.619 HG23 HG23 ' A' ' 7' ' ' VAL . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.742 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.870000000000001 110.953 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.510000000000002 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' HG22 ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.420000000000002 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 113' ' ' VAL . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.76 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.6200000000000001 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CG ' HG21 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.210000000000001 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.7199999999999998 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.969999999999999 110.725 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.5700000000000003 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.260000000000002 110.94 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.029999999999999 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.299999999999997 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.640000000000001 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 89' ' ' SER . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.449999999999999 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB3' HD13 ' A' ' 145' ' ' LEU . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.600000000000001 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.76 ' CE3' HG13 ' A' ' 80' ' ' VAL . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.559999999999999 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 102' ' ' THR . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.300000000000001 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.289999999999999 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.129999999999999 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.039999999999999 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.469999999999999 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.829999999999998 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.039999999999999 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.100000000000001 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.629999999999999 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.600000000000001 111.729 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.719999999999999 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.739999999999998 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.979 HD23 ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.789999999999999 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 HD23 ' A' ' 79' ' ' LEU . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.4600000000000009 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3000000000000007 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.636 HG21 ' H ' ' A' ' 15' ' ' GLY . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.949999999999999 110.774 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.060000000000002 110.571 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.644 ' OD1' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.920000000000002 111.15 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.771 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.850000000000001 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.695 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.909999999999997 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.936 ' OD2' HG23 ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.479999999999997 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.350000000000001 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.350000000000001 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.936 HG23 ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.759999999999998 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.695 HD11 ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.710000000000001 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.560000000000002 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.729999999999997 110.713 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.119999999999997 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.579999999999998 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.969999999999999 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.814 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.280000000000001 108.337 174.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.899999999999999 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.710000000000001 111.921 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.279999999999999 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.050000000000001 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.600000000000001 110.864 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.949999999999999 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.390000000000001 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.969999999999999 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.739999999999998 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.300000000000001 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.659999999999997 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.489999999999998 111.329 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.100000000000001 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.399999999999999 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.979 ' CD1' HD23 ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.530000000000001 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.833 ' CG2' HG13 ' A' ' 168' ' ' VAL . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.629999999999999 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 168' ' ' VAL . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.100000000000001 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' HD13 ' A' ' 165' ' ' LEU . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.880000000000001 110.49 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.2699999999999996 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.469999999999999 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.699999999999999 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.684 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.550000000000001 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.550000000000001 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 ' CG2' ' A' ' 155' ' ' VAL . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.120000000000001 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' A' ' 19' ' ' LEU . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' HD13 ' B' ' 9' ' ' ILE . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CG ' HG11 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.449999999999999 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.210000000000001 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' B' ' 9' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.699999999999999 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.539999999999999 111.072 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.72 HD21 ' CG1' ' A' ' 4' ' ' ILE . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.47 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.47 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 177' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 174' ' ' LEU . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.861 HG22 HG11 ' A' ' 44' ' ' VAL . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.66 ' HA ' HG22 ' A' ' 44' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 42' ' ' VAL . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.907 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.929 HG22 HG13 ' B' ' 21' ' ' VAL . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.641 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' B' ' 35' ' ' ASP . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD21 ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 67' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.465 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -74.35 -150.49 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 2.0 mt-10 -42.57 -27.58 0.17 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 68.22 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 63.21 -177.9 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.81 -159.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.19 112.57 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.329 0.585 . . . . 0.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.72 119.81 7.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.027 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.49 -24.55 10.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.43 100.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 57' ' ' THR . 21.5 m -112.64 45.63 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.58 87.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.798 0.332 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 56' ' ' PHE . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.707 HG21 ' O ' ' A' ' 81' ' ' CYS . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.947 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.83 ' HB2' HD11 ' A' ' 165' ' ' LEU . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.525 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.894 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 44' ' ' VAL . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG11 HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.48 HG12 HG23 ' B' ' 9' ' ' ILE . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 4' ' ' ILE . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.905 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 7' ' ' VAL . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.575 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 113' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.707 ' O ' HG21 ' A' ' 14' ' ' VAL . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.484 ' CB ' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.777 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.853 ' CZ ' HG22 ' A' ' 141' ' ' THR . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.661 ' HB ' HD22 ' A' ' 149' ' ' LEU . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' VAL . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 76' ' ' ASP . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.852 ' HB2' HG23 ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG11 ' A' ' 168' ' ' VAL . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.53 ' H ' HG22 ' A' ' 115' ' ' THR . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 119' ' ' LEU . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.652 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.684 HG21 HD21 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HG3' HG23 ' A' ' 126' ' ' ILE . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.853 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 93' ' ' VAL . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.114 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CD1' HD23 ' A' ' 112' ' ' LEU . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.755 HG23 HG13 ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.512 ' C ' HD11 ' A' ' 117' ' ' ILE . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.871 ' O ' HD22 ' A' ' 165' ' ' LEU . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.947 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.622 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.746 ' O ' HD12 ' A' ' 173' ' ' ILE . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.684 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.442 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.454 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' B' ' 9' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 1.114 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 173' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.517 ' HE2' HD22 ' A' ' 177' ' ' LEU . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 177' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.798 HG22 HG11 ' A' ' 44' ' ' VAL . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.542 ' HA ' HG22 ' A' ' 44' ' ' VAL . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.894 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 33' ' ' ASN . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.701 HG13 ' CG2' ' B' ' 31' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.454 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.525 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' B' ' 21' ' ' VAL . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' B' ' 19' ' ' SER . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.796 HD12 ' HB2' ' B' ' 35' ' ' ASP . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.478 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.606 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.822 0.344 . . . . 24.829999999999998 111.016 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' THR . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.719999999999999 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.766 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.190000000000001 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.460000000000001 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.300000000000001 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.623 HG11 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.300000000000001 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG11 ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.1699999999999999 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.2699999999999996 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.6400000000000006 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 15' ' ' GLY . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.699999999999999 112.992 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HD3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.6899999999999995 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.190000000000001 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.050000000000001 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.969999999999999 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 165' ' ' LEU . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.149999999999999 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.940000000000001 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 21' ' ' ILE . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.789999999999999 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.600000000000001 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.109999999999999 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.510000000000002 112.461 -179.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 64' ' ' TYR . 97.5 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.736 0.303 . . . . 23.469999999999999 111.248 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.059999999999999 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.280000000000001 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.530000000000001 111.787 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.329999999999998 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' B' ' 9' ' ' ILE . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.280000000000001 111.32 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.620000000000001 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.449999999999999 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.879999999999999 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.609 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.190000000000001 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 3' ' ' THR . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.100000000000001 110.749 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 173' ' ' ILE . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.780000000000001 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.059999999999999 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.960000000000001 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.6099999999999994 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.8800000000000008 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.239999999999998 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.149999999999999 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.510000000000002 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.670000000000002 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.940000000000001 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.444 HD12 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.690000000000001 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.390000000000001 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.623 ' CE2' HG11 ' A' ' 7' ' ' VAL . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.010000000000002 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.259999999999998 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.805 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.559 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.870000000000001 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.510000000000002 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.805 ' CZ ' HG21 ' A' ' 75' ' ' THR . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.420000000000002 111.281 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 9' ' ' VAL . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.6200000000000001 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 93' ' ' VAL . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.210000000000001 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD ' ' A' ' 156' ' ' GLU . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.969999999999999 110.94 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.5700000000000003 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.260000000000002 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.029999999999999 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.949 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 141' ' ' THR . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.299999999999997 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.640000000000001 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 89' ' ' SER . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.449999999999999 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.600000000000001 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.466 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.559999999999999 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.300000000000001 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.542 ' OE2' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.289999999999999 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.542 HG23 ' OE2' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.129999999999999 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.039999999999999 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.469999999999999 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.829999999999998 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.039999999999999 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.100000000000001 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.629999999999999 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.600000000000001 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 152' ' ' VAL . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.719999999999999 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.739999999999998 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.789999999999999 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 111' ' ' LEU . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.4600000000000009 111.495 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3000000000000007 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HG3' HD12 ' A' ' 119' ' ' LEU . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.949999999999999 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.815 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.060000000000002 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.428 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.920000000000002 111.015 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG3' ' A' ' 116' ' ' GLN . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.850000000000001 110.379 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' C ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.909999999999997 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.786 ' OD1' HG23 ' A' ' 125' ' ' THR . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.479999999999997 110.626 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.350000000000001 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.350000000000001 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.786 HG23 ' OD1' ' A' ' 122' ' ' ASP . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.759999999999998 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.710000000000001 111.163 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.560000000000002 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.729999999999997 112.2 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.119999999999997 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.579999999999998 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.969999999999999 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.280000000000001 112.039 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.899999999999999 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.710000000000001 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.429 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.279999999999999 111.06 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.050000000000001 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.600000000000001 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.949999999999999 110.85 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.390000000000001 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.969999999999999 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 94' ' ' LYS . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.739999999999998 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.751 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.300000000000001 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.659999999999997 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 98' ' ' VAL . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.489999999999998 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.100000000000001 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 175' ' ' ALA . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.399999999999999 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.692 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.530000000000001 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.008 HG21 HG13 ' A' ' 168' ' ' VAL . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.629999999999999 111.256 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 84' ' ' VAL . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.815 ' CA ' HD11 ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.100000000000001 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.880000000000001 110.486 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.2699999999999996 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.469999999999999 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.699999999999999 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB3' HD12 ' A' ' 117' ' ' ILE . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.550000000000001 112.296 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.550000000000001 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.008 HG13 HG21 ' A' ' 155' ' ' VAL . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.120000000000001 111.184 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.908 ' O ' HD12 ' A' ' 173' ' ' ILE . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.431 ' OE1' HD21 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.449999999999999 110.731 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.908 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.210000000000001 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.699999999999999 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.539999999999999 111.629 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' B' ' 4' ' ' ILE . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.729 ' HB ' HD12 ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.758 ' CG2' HG11 ' A' ' 44' ' ' VAL . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' VAL . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.766 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.766 HG22 HG13 ' B' ' 21' ' ' VAL . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.893 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.893 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.854 0.359 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 53' ' ' LEU . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 72' ' ' TYR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.417 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.026 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB2' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 HG21 ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo . . . . . 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.848 0.356 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG21 HG22 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HG23 ' B' ' 9' ' ' ILE . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.959 HD13 HG12 ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 8' ' ' VAL . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.957 ' HB3' HD11 ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.659 HG22 ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.659 ' NH1' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.824 HD21 ' CB ' ' B' ' 41' ' ' LEU . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.719 ' HE1' HG21 ' A' ' 7' ' ' VAL . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.421 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 119' ' ' LEU . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' HD21 ' A' ' 149' ' ' LEU . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.502 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 149' ' ' LEU . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' VAL . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 146' ' ' ALA . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 79' ' ' LEU . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 116' ' ' GLN . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.834 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' HD11 ' A' ' 126' ' ' ILE . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.707 ' NE2' HD22 ' A' ' 129' ' ' LEU . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 138' ' ' THR . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' ILE . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.818 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 98' ' ' VAL . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.865 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.726 HG21 HG23 ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.877 ' HB3' HG11 ' A' ' 168' ' ' VAL . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.624 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.836 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.026 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.877 HG11 ' HB3' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.779 ' O ' HD12 ' A' ' 173' ' ' ILE . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.416 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.959 HG12 HD13 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.865 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' B' ' 2' ' ' LYS . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.516 ' CE ' HD22 ' A' ' 177' ' ' LEU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.792 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.6 HG22 HG11 ' A' ' 44' ' ' VAL . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.422 ' H ' HG13 ' A' ' 42' ' ' VAL . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.038 HG13 HG22 ' B' ' 31' ' ' VAL . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.415 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.038 HG22 HG13 ' B' ' 21' ' ' VAL . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.768 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' B' ' 35' ' ' ASP . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.824 ' CB ' HD21 ' A' ' 70' ' ' LEU . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.768 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 70' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.764 0.316 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.853 ' HA3' HG21 ' A' ' 115' ' ' THR . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.568 HG22 ' OG1' ' A' ' 25' ' ' THR . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.58 ' C ' HD21 ' A' ' 165' ' ' LEU . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.771 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 64' ' ' TYR . 13.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.299 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG12 HG23 ' A' ' 44' ' ' VAL . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' B' ' 13' ' ' SER . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.401 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.466 HG12 HG23 ' B' ' 9' ' ' ILE . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CE2' HG13 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.626 HD22 HD13 ' B' ' 41' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE1' HG21 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG21 ' OE2' ' A' ' 156' ' ' GLU . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 116' ' ' GLN . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 141' ' ' THR . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 89' ' ' SER . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 149' ' ' LEU . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 98' ' ' VAL . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.651 ' HG2' HG23 ' A' ' 77' ' ' VAL . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 152' ' ' VAL . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.718 HD22 ' HD1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.853 HG21 ' HA3' ' A' ' 15' ' ' GLY . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.637 ' CD ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.637 HD12 ' CD ' ' A' ' 116' ' ' GLN . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.647 ' O ' HD11 ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.741 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.766 HD23 HG12 ' A' ' 93' ' ' VAL . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.819 HD13 HG21 ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 175' ' ' ALA . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.718 ' HD1' HD22 ' A' ' 112' ' ' LEU . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.94 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.448 ' HG ' ' CE2' ' A' ' 28' ' ' PHE . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.935 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.94 HG21 ' SG ' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 173' ' ' ILE . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.697 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.712 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.771 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.878 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.469 ' CE2' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.692 HG22 HG13 ' B' ' 21' ' ' VAL . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.74 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' B' ' 35' ' ' ASP . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 70' ' ' LEU . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.74 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.592 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.304 . . . . 24.829999999999998 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.719999999999999 111.12 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.190000000000001 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.460000000000001 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.300000000000001 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.300000000000001 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 56' ' ' PHE . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.1699999999999999 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.2699999999999996 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.6400000000000006 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.85 HG12 ' OE1' ' A' ' 116' ' ' GLN . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.699999999999999 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.6899999999999995 112.173 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.841 ' HA ' HD12 ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.190000000000001 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 159' ' ' ALA . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.050000000000001 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.969999999999999 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 165' ' ' LEU . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.149999999999999 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' HG21 ' A' ' 42' ' ' VAL . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.940000000000001 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.789999999999999 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.600000000000001 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.109999999999999 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.510000000000002 112.565 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 110.391 -0.225 . . . . 23.469999999999999 110.391 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' N ' HG22 ' A' ' 36' ' ' VAL . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.059999999999999 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.280000000000001 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.530000000000001 110.925 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.329999999999998 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 44' ' ' VAL . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' B' ' 12' ' ' PRO . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.280000000000001 111.55 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.443 ' N ' HG12 ' A' ' 44' ' ' VAL . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.620000000000001 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.449999999999999 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.879999999999999 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.190000000000001 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 3' ' ' THR . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.100000000000001 110.798 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.780000000000001 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.643 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.059999999999999 110.856 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.960000000000001 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.6099999999999994 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.8800000000000008 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.239999999999998 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.149999999999999 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.510000000000002 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.670000000000002 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.119999999999997 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.736 HD21 HD11 ' B' ' 47' ' ' ILE . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.940000000000001 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.779 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.690000000000001 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.390000000000001 111.744 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.010000000000002 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.259999999999998 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 108' ' ' THR . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.870000000000001 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.510000000000002 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' H ' HG22 ' A' ' 77' ' ' VAL . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.420000000000002 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.561 ' SG ' HG11 ' A' ' 113' ' ' VAL . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.6200000000000001 110.558 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.645 ' CG ' HG21 ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.210000000000001 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.7199999999999998 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.969999999999999 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 116' ' ' GLN . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.5700000000000003 111.208 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.260000000000002 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.029999999999999 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.299999999999997 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.437 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.640000000000001 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 89' ' ' SER . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.449999999999999 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 149' ' ' LEU . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.600000000000001 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HB2' ' CA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.559999999999999 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.062 HG11 HD22 ' A' ' 149' ' ' LEU . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.300000000000001 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.289999999999999 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 97' ' ' TRP . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.129999999999999 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.039999999999999 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.469999999999999 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.829999999999998 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.039999999999999 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.485 ' HD2' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.100000000000001 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.629999999999999 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.803 ' HB2' HG23 ' A' ' 77' ' ' VAL . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.600000000000001 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.719999999999999 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.739999999999998 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 146' ' ' ALA . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.789999999999999 110.699 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.4600000000000009 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3000000000000007 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.85 ' OE1' HG12 ' A' ' 14' ' ' VAL . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.949999999999999 110.843 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.599 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.060000000000002 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.920000000000002 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.850000000000001 110.643 178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.653 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.909999999999997 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.413 ' C ' HD12 ' A' ' 126' ' ' ILE . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.479999999999997 110.676 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.350000000000001 112.422 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.350000000000001 111.043 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.759999999999998 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.710000000000001 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.560000000000002 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.729999999999997 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.119999999999997 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.579999999999998 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.969999999999999 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.482 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.280000000000001 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.899999999999999 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HG3' HG23 ' A' ' 126' ' ' ILE . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.710000000000001 112.351 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.279999999999999 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.050000000000001 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.600000000000001 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.949999999999999 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.390000000000001 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 141' ' ' THR . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.969999999999999 109.969 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.778 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.739999999999998 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.636 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.300000000000001 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.659999999999997 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.062 HD22 HG11 ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.489999999999998 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.100000000000001 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.789 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.399999999999999 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.566 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.530000000000001 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.629999999999999 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.897 ' SG ' HG21 ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.100000000000001 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.880000000000001 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.2699999999999996 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.469999999999999 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.699999999999999 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.447 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.550000000000001 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.661 HD11 ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.550000000000001 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.897 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.120000000000001 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 19' ' ' LEU . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.591 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.449999999999999 110.573 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.446 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.210000000000001 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.699999999999999 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.789 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.539999999999999 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.474 ' HB2' HG13 ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.653 HG22 HG11 ' A' ' 44' ' ' VAL . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.807 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.085 HG13 HG22 ' B' ' 31' ' ' VAL . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.085 HG22 HG13 ' B' ' 21' ' ' VAL . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' B' ' 42' ' ' PHE . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB3' HD21 ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.736 HD11 HD21 ' A' ' 67' ' ' LEU . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.847 0.356 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 52' ' ' THR . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 81' ' ' CYS . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.073 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' LEU . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG2' HG11 ' B' ' 21' ' ' VAL . 2.5 m . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.849 0.357 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' B' ' 12' ' ' PRO . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 13' ' ' SER . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG11 HG22 ' B' ' 9' ' ' ILE . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 51' ' ' TYR . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' HB2' HD12 ' A' ' 46' ' ' ILE . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.815 ' O ' HG23 ' A' ' 3' ' ' THR . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.99 HD22 HD11 ' A' ' 173' ' ' ILE . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.48 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.85 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.748 ' CG ' HG21 ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 14' ' ' VAL . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB2' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 115' ' ' THR . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 ' HG2' ' A' ' 116' ' ' GLN . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.973 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 89' ' ' SER . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.52 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.77 ' HD3' HG23 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.748 HG21 ' CG ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.743 ' HB2' HG11 ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' H ' HG13 ' A' ' 152' ' ' VAL . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.628 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 168' ' ' VAL . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.667 ' HG3' HD12 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' A' ' 116' ' ' GLN . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.685 ' O ' HD11 ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.596 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.476 ' N ' HD12 ' A' ' 126' ' ' ILE . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.626 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 84' ' ' VAL . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 98' ' ' VAL . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD1' HD22 ' A' ' 112' ' ' LEU . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 171' ' ' GLU . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.073 HD13 HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.664 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.72 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.99 HD11 HD22 ' A' ' 53' ' ' LEU . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.85 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.498 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 44' ' ' VAL . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.454 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 36' ' ' VAL . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 24' ' ' ASP . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.917 HG13 HD23 ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.917 HD23 HG13 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.6 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD12 ' B' ' 34' ' ' LEU . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.467 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 70' ' ' LEU . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.46 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 52' ' ' THR . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 53' ' ' LEU . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 81' ' ' CYS . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 8' ' ' VAL . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 37' ' ' PHE . 2.3 p . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' HB3' HG21 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 3.0 t30 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' B' ' 12' ' ' PRO . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 173' ' ' ILE . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 173' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.689 HD12 ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.532 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.792 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 98' ' ' VAL . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 14' ' ' VAL . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 119' ' ' LEU . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CZ ' HG22 ' A' ' 141' ' ' THR . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 89' ' ' SER . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.773 HG21 HD13 ' A' ' 149' ' ' LEU . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 77' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.598 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.565 HG13 HG21 ' A' ' 168' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.592 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.617 ' OD2' HD22 ' A' ' 119' ' ' LEU . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD22 ' OD2' ' A' ' 118' ' ' ASP . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.681 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' CD ' ' A' ' 87' ' ' PRO . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.626 ' HG3' HG23 ' A' ' 126' ' ' ILE . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.83 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.676 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 98' ' ' VAL . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.84 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 19' ' ' LEU . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 118' ' ' ASP . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.3 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.534 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.859 HG23 ' HB ' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 173' ' ' ILE . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.903 HD11 HD22 ' A' ' 53' ' ' LEU . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.543 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.84 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 173' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.789 ' HA ' HG22 ' A' ' 44' ' ' VAL . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 7.2 t-160 -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.55 HG22 HD21 ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.993 HG13 HD23 ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.993 HD23 HG13 ' B' ' 31' ' ' VAL . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 70' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.482 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 70' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.453 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.888 0.375 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.908 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.8 HG12 HG21 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 20' ' ' LEU . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' CE ' HG12 ' A' ' 8' ' ' VAL . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' PRO . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 8' ' ' VAL . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.801 HG21 ' CD1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.451 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 22.9 Cg_endo . . . . . 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' CB ' ' HB3' ' B' ' 19' ' ' SER . 0.2 OUTLIER -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.947 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.616 HD12 ' CB ' ' A' ' 51' ' ' TYR . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HD11 ' A' ' 173' ' ' ILE . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.757 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.716 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.8 HG21 HG12 ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' H ' HG22 ' A' ' 77' ' ' VAL . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.834 HD23 HG21 ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.799 ' HB3' HG21 ' A' ' 93' ' ' VAL . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.976 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 89' ' ' SER . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.773 ' HB3' HD13 ' A' ' 145' ' ' LEU . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.965 ' O ' HG23 ' A' ' 102' ' ' THR . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 98' ' ' VAL . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.965 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 108' ' ' THR . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.901 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.694 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.834 HG21 HD23 ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.613 ' OD2' HD22 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.706 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.523 ' CG ' HG23 ' A' ' 125' ' ' THR . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 122' ' ' ASP . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.739 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.658 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.663 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.58 HD13 HG21 ' A' ' 98' ' ' VAL . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' CB ' ' A' ' 175' ' ' ALA . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.694 ' CD1' HD23 ' A' ' 112' ' ' LEU . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.803 ' CG2' HG23 ' A' ' 168' ' ' VAL . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.426 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.4 ' N ' HD13 ' A' ' 160' ' ' LEU . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.803 HG23 ' CG2' ' A' ' 155' ' ' VAL . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 173' ' ' ILE . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' B' ' 9' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.735 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.523 HD13 HD11 ' B' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.484 ' HD3' HD22 ' A' ' 177' ' ' LEU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.947 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.893 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.588 ' CE1' HD12 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 21' ' ' VAL . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.585 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.757 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' B' ' 40' ' ' SER . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.79 0.328 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HG23 ' A' ' 75' ' ' THR . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.675 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.675 HD12 ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 165' ' ' LEU . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' LEU . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' B' ' 23' ' ' TRP . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.928 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG23 HD11 ' A' ' 55' ' ' LEU . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.779 HG11 HG22 ' B' ' 9' ' ' ILE . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 44' ' ' VAL . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 173' ' ' ILE . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.67 HD11 HG23 ' A' ' 42' ' ' VAL . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.764 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 78' ' ' PHE . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 75' ' ' THR . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' CD ' ' A' ' 120' ' ' ARG . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.832 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 149' ' ' LEU . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.434 HG21 ' CD2' ' A' ' 78' ' ' PHE . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 98' ' ' VAL . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.599 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 105' ' ' CYS . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.565 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 145' ' ' LEU . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 155' ' ' VAL . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 115' ' ' THR . 0.4 OUTLIER 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.71 ' O ' HD11 ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.488 ' N ' HD12 ' A' ' 126' ' ' ILE . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.668 ' HG3' HG23 ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 84' ' ' VAL . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.544 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.761 ' CG2' HD12 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.478 ' HB3' HG11 ' A' ' 168' ' ' VAL . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 168' ' ' VAL . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 22' ' ' SER . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' O ' HD12 ' A' ' 173' ' ' ILE . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.796 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.62 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.725 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.678 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.709 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 4' ' ' ILE . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 178' ' ' GLU . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.561 ' HA ' HG22 ' A' ' 44' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 2.6 t-160 -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . 0.468 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.034 HG13 HG22 ' B' ' 31' ' ' VAL . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.632 ' HB2' HG11 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.034 HG22 HG13 ' B' ' 21' ' ' VAL . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.57 HD11 ' CG ' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.764 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.833 0.349 . . . . 0.0 111.014 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.813 HG12 HG23 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.401 ' SG ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 75' ' ' THR . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.745 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 16' ' ' LYS . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 20' ' ' LEU . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 ' OG1' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' B' ' 23' ' ' TRP . 83.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.133 0.492 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CE1' ' CD2' ' B' ' 17' ' ' HIS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 55' ' ' LEU . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' ILE . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.755 ' HB2' HD12 ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 3' ' ' THR . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 42' ' ' VAL . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.474 HG22 ' OG ' ' A' ' 71' ' ' SER . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' HG22 ' A' ' 58' ' ' THR . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.734 HG21 ' CE1' ' A' ' 78' ' ' PHE . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.798 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' A' ' 75' ' ' THR . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 97' ' ' TRP . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG11 ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' HD22 ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.015 HG21 HD13 ' A' ' 149' ' ' LEU . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' VAL . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.575 HG23 ' HD3' ' A' ' 107' ' ' LYS . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.794 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.726 HD12 HG23 ' A' ' 152' ' ' VAL . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.51 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.512 ' CG ' HD23 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.643 HD12 HG21 ' A' ' 125' ' ' THR . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.797 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' C ' HD12 ' A' ' 126' ' ' ILE . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.643 HG21 HD12 ' A' ' 119' ' ' LEU . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.845 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 141' ' ' THR . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.757 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.62 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.015 HD13 HG21 ' A' ' 98' ' ' VAL . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 175' ' ' ALA . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.773 HG21 HG13 ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.512 HD23 ' CG ' ' A' ' 118' ' ' ASP . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.773 HG13 HG21 ' A' ' 155' ' ' VAL . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.758 ' O ' HD12 ' A' ' 173' ' ' ILE . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.465 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.688 ' HB3' HD11 ' A' ' 111' ' ' LEU . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.482 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.813 HG23 HG12 ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 173' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 42' ' ' VAL . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.575 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 4.1 t-160 -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.645 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.618 HG22 HD21 ' B' ' 34' ' ' LEU . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.809 ' HB2' HG21 ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.721 HG13 HD23 ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.721 HD23 HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' B' ' 34' ' ' LEU . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' B' ' 43' ' ' SER . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 43' ' ' SER . 81.0 p . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.819 0.342 . . . . 0.0 110.81 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.876 HG13 HD21 ' A' ' 177' ' ' LEU . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG11 ' CE1' ' A' ' 72' ' ' TYR . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 20' ' ' LEU . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.722 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.725 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.781 HD11 HG21 ' A' ' 8' ' ' VAL . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.463 HG22 ' OG1' ' A' ' 25' ' ' THR . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.463 ' OG1' HG22 ' A' ' 21' ' ' ILE . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 5.8 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.707 0.289 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' CG2' HD11 ' A' ' 55' ' ' LEU . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 ' CG2' ' A' ' 42' ' ' VAL . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.474 ' HD2' HD21 ' A' ' 67' ' ' LEU . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.766 ' O ' HD21 ' B' ' 38' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' H ' HG22 ' A' ' 77' ' ' VAL . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.832 HG13 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.564 ' SG ' HG11 ' A' ' 113' ' ' VAL . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CB ' HG21 ' A' ' 93' ' ' VAL . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 137' ' ' ILE . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 119' ' ' LEU . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 89' ' ' SER . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HB3' HD13 ' A' ' 145' ' ' LEU . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.832 ' CE3' HG13 ' A' ' 80' ' ' VAL . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 102' ' ' THR . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.857 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.96 HG21 HD23 ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.639 ' CD2' HG21 ' A' ' 85' ' ' VAL . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.7 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.634 ' OD2' HG23 ' A' ' 125' ' ' THR . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' N ' HD12 ' A' ' 126' ' ' ILE . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.634 HG23 ' OD2' ' A' ' 122' ' ' ASP . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.902 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 98' ' ' VAL . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.825 HG21 HG13 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.892 ' SG ' HG21 ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.557 HD23 ' OD2' ' A' ' 118' ' ' ASP . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.892 HG21 ' SG ' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.795 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.795 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.604 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.876 HD21 HG13 ' A' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.483 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.762 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.619 HG22 ' CE ' ' B' ' 16' ' ' LYS . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.811 HG13 HG22 ' B' ' 31' ' ' VAL . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.811 HG22 HG13 ' B' ' 21' ' ' VAL . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.67 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 70' ' ' LEU . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.297 . . . . 0.0 110.877 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.865 HG12 HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.606 HG12 ' HD2' ' A' ' 16' ' ' LYS . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 HH21 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 81' ' ' CYS . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.617 ' O ' HD23 ' A' ' 19' ' ' LEU . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' LYS . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' C ' HD21 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 21' ' ' ILE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo . . . . . 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.698 0.285 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' HG23 ' B' ' 21' ' ' VAL . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.746 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.655 HD13 HG21 ' A' ' 173' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.874 HD13 ' CG1' ' A' ' 173' ' ' ILE . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD21 HD21 ' A' ' 53' ' ' LEU . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB1' HE21 ' A' ' 61' ' ' GLN . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.422 HE21 ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.64 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' H ' HG22 ' A' ' 77' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CD2' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.727 HG11 ' HB2' ' A' ' 119' ' ' LEU . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.811 ' CZ ' HG22 ' A' ' 141' ' ' THR . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' SER . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' HD11 ' A' ' 149' ' ' LEU . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 102' ' ' THR . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 98' ' ' VAL . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.882 ' HB2' HG23 ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.622 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.754 HD12 HG23 ' A' ' 152' ' ' VAL . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 146' ' ' ALA . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.754 ' HB3' HD23 ' A' ' 119' ' ' LEU . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.48 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 116' ' ' GLN . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.728 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.547 ' C ' HD12 ' A' ' 126' ' ' ILE . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 124' ' ' SER . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.425 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.744 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.811 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.668 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 94' ' ' LYS . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.864 HG11 ' HB1' ' A' ' 175' ' ' ALA . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 168' ' ' VAL . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.915 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.428 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 19' ' ' LEU . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HE2' ' CD ' ' B' ' 12' ' ' PRO . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.915 HG21 ' SG ' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.783 ' O ' HD12 ' A' ' 173' ' ' ILE . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.646 ' HB3' HD11 ' A' ' 111' ' ' LEU . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.874 ' CG1' HD13 ' A' ' 53' ' ' LEU . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.746 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 44' ' ' VAL . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.663 HG22 ' NZ ' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.002 HG13 HG22 ' B' ' 31' ' ' VAL . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.403 ' CB ' HG21 ' A' ' 36' ' ' VAL . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.002 HG22 HG13 ' B' ' 21' ' ' VAL . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.654 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.912 HD12 ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 43' ' ' SER . 1.3 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 24.829999999999998 110.91 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' THR . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.719999999999999 110.906 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.549 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.190000000000001 110.994 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.460000000000001 109.961 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.300000000000001 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 72' ' ' TYR . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.300000000000001 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.1699999999999999 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.2699999999999996 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.6400000000000006 112.404 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' CD ' ' A' ' 16' ' ' LYS . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' H ' HG21 ' A' ' 115' ' ' THR . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.699999999999999 112.519 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.6899999999999995 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' HD12 ' A' ' 20' ' ' LEU . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.190000000000001 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.050000000000001 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 17' ' ' THR . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.969999999999999 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.149999999999999 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.940000000000001 111.621 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.789999999999999 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.600000000000001 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.109999999999999 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.510000000000002 112.459 -179.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' B' ' 23' ' ' TRP . 59.5 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.777 0.322 . . . . 23.469999999999999 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.059999999999999 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.280000000000001 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.530000000000001 111.555 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.329999999999998 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' B' ' 12' ' ' PRO . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 9' ' ' ILE . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.280000000000001 111.197 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 ' CB ' ' A' ' 51' ' ' TYR . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.620000000000001 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.449999999999999 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.879999999999999 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.190000000000001 110.937 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' THR . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.100000000000001 110.936 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.780000000000001 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.059999999999999 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.960000000000001 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.6099999999999994 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.8800000000000008 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.239999999999998 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.149999999999999 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.510000000000002 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.670000000000002 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.119999999999997 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.940000000000001 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' B' ' 41' ' ' LEU . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.690000000000001 111.992 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.390000000000001 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.766 ' HE1' HG21 ' A' ' 7' ' ' VAL . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.010000000000002 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.259999999999998 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.89 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.851 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.870000000000001 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.510000000000002 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.89 ' CZ ' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.420000000000002 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 93' ' ' VAL . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 113' ' ' VAL . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.6200000000000001 110.454 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 93' ' ' VAL . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.210000000000001 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.7199999999999998 111.008 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 115' ' ' THR . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.969999999999999 111.038 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.5700000000000003 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.260000000000002 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.029999999999999 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 93' ' ' VAL . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.299999999999997 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.640000000000001 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 89' ' ' SER . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.449999999999999 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.600000000000001 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.559999999999999 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 102' ' ' THR . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.300000000000001 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.289999999999999 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.129999999999999 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.039999999999999 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.469999999999999 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.829999999999998 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.039999999999999 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.100000000000001 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.629999999999999 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 77' ' ' VAL . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.600000000000001 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.777 ' CD1' HD12 ' A' ' 101' ' ' ILE . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.719999999999999 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.792 HD12 ' CG2' ' A' ' 152' ' ' VAL . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.739999999999998 110.935 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.789999999999999 110.549 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 81' ' ' CYS . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.4600000000000009 111.676 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3000000000000007 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.797 ' CG ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.949999999999999 110.778 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.060000000000002 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.920000000000002 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.797 HD12 ' CG ' ' A' ' 116' ' ' GLN . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.850000000000001 110.878 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.856 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.909999999999997 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.479999999999997 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.350000000000001 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.350000000000001 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.723 HG21 HD22 ' A' ' 119' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.759999999999998 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.856 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.710000000000001 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.560000000000002 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.729999999999997 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.119999999999997 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.579999999999998 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.969999999999999 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.856 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.280000000000001 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.899999999999999 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.710000000000001 111.954 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.279999999999999 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.050000000000001 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.5 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.600000000000001 111.715 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.949999999999999 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.390000000000001 110.358 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.969999999999999 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.739999999999998 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.300000000000001 110.597 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.659999999999997 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 98' ' ' VAL . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.489999999999998 111.194 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.100000000000001 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.962 HG11 ' HB1' ' A' ' 175' ' ' ALA . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.399999999999999 110.963 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.530000000000001 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 168' ' ' VAL . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.629999999999999 111.475 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.954 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.100000000000001 112.052 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.880000000000001 109.914 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.2699999999999996 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.469999999999999 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.699999999999999 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.550000000000001 112.38 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 19' ' ' LEU . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.550000000000001 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.954 HG21 ' SG ' ' A' ' 157' ' ' CYS . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.120000000000001 111.476 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.449999999999999 110.921 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.892 HD11 HD22 ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.210000000000001 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.699999999999999 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.962 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.539999999999999 111.139 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.823 HG22 HG11 ' A' ' 44' ' ' VAL . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 31' ' ' VAL . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.569 ' HB2' HG21 ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 21' ' ' VAL . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.627 HD12 HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.882 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.525 ' HB3' HD21 ' A' ' 70' ' ' LEU . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.625 ' N ' HD13 ' B' ' 47' ' ' ILE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.843 0.354 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 53' ' ' LEU . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 75' ' ' THR . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' HG22 ' A' ' 14' ' ' VAL . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 12' ' ' GLY . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 20' ' ' LEU . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 16' ' ' LYS . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.439 ' C ' HD21 ' A' ' 165' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 42' ' ' VAL . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 120.443 0.163 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HE2' ' HG ' ' A' ' 71' ' ' SER . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 24' ' ' THR . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 13' ' ' SER . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.823 ' HB2' HD12 ' A' ' 46' ' ' ILE . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 173' ' ' ILE . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 42' ' ' VAL . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.714 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' HE2' ' A' ' 37' ' ' PHE . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 7' ' ' VAL . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' H ' HG22 ' A' ' 77' ' ' VAL . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.88 ' CD2' HG21 ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 93' ' ' VAL . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.836 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' THR . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.923 HG11 HD12 ' A' ' 119' ' ' LEU . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.966 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.71 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 89' ' ' SER . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 145' ' ' LEU . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.899 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.711 ' HD3' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' THR . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.838 ' HB2' HG23 ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.821 HD12 HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 115' ' ' THR . 13.2 mm100 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.588 HD11 ' CA ' ' A' ' 157' ' ' CYS . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.923 HD12 HG11 ' A' ' 85' ' ' VAL . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.574 ' O ' HD11 ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.606 HG21 HD21 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.622 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.71 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 98' ' ' VAL . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.923 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.607 ' CD1' HD23 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 84' ' ' VAL . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.817 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.647 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 19' ' ' LEU . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.817 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' HD13 ' B' ' 9' ' ' ILE . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.701 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 53' ' ' LEU . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.923 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 173' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.485 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.57 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.83 HG13 HG22 ' B' ' 31' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.83 HG22 HG13 ' B' ' 21' ' ' VAL . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.787 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.714 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.787 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.558 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.745 0.307 . . . . 24.829999999999998 110.68 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.719999999999999 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.190000000000001 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.460000000000001 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.300000000000001 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.526 HG23 HG23 ' A' ' 75' ' ' THR . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.300000000000001 110.594 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' CD ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.1699999999999999 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.2699999999999996 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.6400000000000006 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 15' ' ' GLY . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.699999999999999 112.868 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' CD ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.6899999999999995 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 20' ' ' LEU . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.190000000000001 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.050000000000001 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 19' ' ' LEU . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.969999999999999 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' THR . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.484 ' OG ' HD21 ' A' ' 165' ' ' LEU . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.149999999999999 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.836 HG21 ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.940000000000001 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ILE . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.789999999999999 111.441 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' SER . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.600000000000001 110.857 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.109999999999999 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.510000000000002 111.736 178.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 120.543 0.211 . . . . 23.469999999999999 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.704 ' N ' HG22 ' A' ' 36' ' ' VAL . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.059999999999999 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.280000000000001 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.530000000000001 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.329999999999998 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' B' ' 12' ' ' PRO . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.912 HG11 HG22 ' B' ' 9' ' ' ILE . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.280000000000001 111.489 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 HG23 ' B' ' 9' ' ' ILE . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.620000000000001 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.449999999999999 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.879999999999999 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.190000000000001 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.100000000000001 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 173' ' ' ILE . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.780000000000001 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.059999999999999 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.960000000000001 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' TYR . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.6099999999999994 110.933 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.8800000000000008 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.239999999999998 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.149999999999999 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.510000000000002 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.670000000000002 111.493 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 67' ' ' LEU . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.940000000000001 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.690000000000001 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.390000000000001 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.010000000000002 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.259999999999998 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.870000000000001 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.510000000000002 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 75' ' ' THR . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.420000000000002 111.152 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 113' ' ' VAL . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.439 HG13 ' HE3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.6200000000000001 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.210000000000001 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 14' ' ' VAL . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.7199999999999998 111.059 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 137' ' ' ILE . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.969999999999999 111.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.5700000000000003 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.260000000000002 110.85 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.029999999999999 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.756 ' CZ ' HG22 ' A' ' 141' ' ' THR . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.299999999999997 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.640000000000001 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 89' ' ' SER . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.449999999999999 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.600000000000001 111.672 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.523 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.559999999999999 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.907 HG11 ' HB3' ' A' ' 149' ' ' LEU . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.300000000000001 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.289999999999999 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.129999999999999 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.039999999999999 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.469999999999999 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.829999999999998 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.039999999999999 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.100000000000001 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.629999999999999 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HG2' HG23 ' A' ' 77' ' ' VAL . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.600000000000001 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.719999999999999 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.777 HD12 HG23 ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.739999999999998 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.592 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.789999999999999 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 79' ' ' LEU . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.4600000000000009 111.757 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3000000000000007 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.576 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.576 ' H ' HG22 ' A' ' 115' ' ' THR . 4.5 mm-40 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.949999999999999 110.884 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.060000000000002 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.920000000000002 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.850000000000001 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.687 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.909999999999997 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 125' ' ' THR . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.479999999999997 110.362 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.350000000000001 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.350000000000001 111.477 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.427 HG23 ' OD2' ' A' ' 122' ' ' ASP . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.759999999999998 110.85 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 136' ' ' PRO . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.710000000000001 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.560000000000002 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.816 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.729999999999997 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.119999999999997 112.061 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.579999999999998 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.969999999999999 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.493 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.280000000000001 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.899999999999999 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.710000000000001 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 84' ' ' VAL . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.279999999999999 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.050000000000001 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.756 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.600000000000001 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.949999999999999 110.784 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.390000000000001 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.969999999999999 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.739999999999998 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.300000000000001 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.659999999999997 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG11 ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.489999999999998 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.100000000000001 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.777 HG23 HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.399999999999999 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.592 ' CD1' HD23 ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.530000000000001 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.629999999999999 111.257 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.100000000000001 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.880000000000001 110.64 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.2699999999999996 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.469999999999999 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.699999999999999 111.091 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.550000000000001 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.550000000000001 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 155' ' ' VAL . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.120000000000001 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 173' ' ' ILE . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 9' ' ' ILE . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.41 ' HB3' HD11 ' A' ' 111' ' ' LEU . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.449999999999999 111.538 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.733 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 1.059 HD11 HD22 ' A' ' 53' ' ' LEU . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.210000000000001 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.669 HD23 ' HB ' ' B' ' 4' ' ' ILE . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.699999999999999 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.539999999999999 111.592 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.45 ' HD3' HD22 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.669 ' HB ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.912 HG22 HG11 ' A' ' 44' ' ' VAL . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.707 ' HA ' HG22 ' A' ' 44' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.836 ' CD1' HG21 ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.855 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.432 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.976 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.976 HG22 HG13 ' B' ' 21' ' ' VAL . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.939 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.939 HD12 ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.723 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.512 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.825 0.345 . . . . 24.829999999999998 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.719999999999999 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.907 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.190000000000001 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' HG22 ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.460000000000001 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.300000000000001 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.300000000000001 110.759 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.1699999999999999 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.2699999999999996 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.6400000000000006 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.699999999999999 113.013 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.553 ' O ' HD23 ' A' ' 19' ' ' LEU . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.6899999999999995 112.171 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.544 ' HA ' HD12 ' A' ' 20' ' ' LEU . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.190000000000001 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.050000000000001 111.618 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.127 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 17' ' ' THR . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.969999999999999 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 162' ' ' GLN . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.149999999999999 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.484 HG21 ' CE1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.940000000000001 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.789999999999999 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.600000000000001 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.109999999999999 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo . . . . . 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.510000000000002 112.741 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG21 ' H ' ' B' ' 23' ' ' TRP . 2.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.018 0.437 . . . . 23.469999999999999 110.561 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.059999999999999 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.280000000000001 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.530000000000001 110.998 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.329999999999998 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.864 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.280000000000001 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 4' ' ' ILE . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.620000000000001 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.449999999999999 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.879999999999999 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.190000000000001 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.100000000000001 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.886 HD13 HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.780000000000001 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD11 HD13 ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.059999999999999 111.119 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.960000000000001 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.6099999999999994 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.8800000000000008 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.239999999999998 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.149999999999999 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 61' ' ' GLN . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.510000000000002 111.731 -178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.670000000000002 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.119999999999997 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.940000000000001 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' B' ' 41' ' ' LEU . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.690000000000001 110.835 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.390000000000001 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.010000000000002 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.259999999999998 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 108' ' ' THR . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.870000000000001 109.669 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.510000000000002 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.420000000000002 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD23 HG21 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.788 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.6200000000000001 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CB ' HG21 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.210000000000001 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.7199999999999998 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' THR . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.969999999999999 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 119' ' ' LEU . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.5700000000000003 111.724 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.260000000000002 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.029999999999999 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.299999999999997 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.640000000000001 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 89' ' ' SER . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.449999999999999 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.806 ' HB3' HD13 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.600000000000001 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.788 ' CE3' HG13 ' A' ' 80' ' ' VAL . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.559999999999999 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.935 HG11 HD22 ' A' ' 149' ' ' LEU . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.300000000000001 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.289999999999999 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.651 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.129999999999999 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.039999999999999 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.469999999999999 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.474 ' HB2' HG23 ' A' ' 108' ' ' THR . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.829999999999998 110.863 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.039999999999999 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.100000000000001 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 105' ' ' CYS . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.629999999999999 111.352 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.600000000000001 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.632 ' H ' HG13 ' A' ' 152' ' ' VAL . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.719999999999999 111.901 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.739999999999998 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 154' ' ' TYR . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.789999999999999 110.827 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.86 HG21 HD23 ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.4600000000000009 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3000000000000007 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.749 ' HG3' HD22 ' A' ' 119' ' ' LEU . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.949999999999999 110.946 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.551 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.060000000000002 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.920000000000002 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 116' ' ' GLN . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.850000000000001 110.094 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.713 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.909999999999997 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.479999999999997 110.746 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.350000000000001 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.350000000000001 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.45 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.759999999999998 110.138 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.710000000000001 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.560000000000002 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.729999999999997 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.119999999999997 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.579999999999998 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.969999999999999 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.935 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.280000000000001 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.899999999999999 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.710000000000001 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.279999999999999 110.843 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.050000000000001 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.600000000000001 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.949999999999999 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.390000000000001 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.969999999999999 110.378 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.739999999999998 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.711 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.300000000000001 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.659999999999997 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 HG11 ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.489999999999998 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.100000000000001 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.399999999999999 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 112' ' ' LEU . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.530000000000001 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.006 HG21 HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.629999999999999 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.878 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.100000000000001 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.880000000000001 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.2699999999999996 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.469999999999999 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 22' ' ' SER . 2.6 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.699999999999999 111.262 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.550000000000001 112.567 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.127 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.550000000000001 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.006 HG13 HG21 ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.120000000000001 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.449999999999999 111.043 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.907 HG23 HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.210000000000001 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.699999999999999 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.539999999999999 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.456 HD21 HG13 ' A' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.541 HG22 HG22 ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.608 ' H ' HG21 ' A' ' 36' ' ' VAL . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.534 ' CE1' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.607 HG11 HD12 ' B' ' 34' ' ' LEU . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.607 HD12 HG11 ' B' ' 31' ' ' VAL . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.85 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' B' ' 35' ' ' ASP . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.565 ' CB ' HD13 ' A' ' 70' ' ' LEU . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.534 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.583 HG11 ' HE1' ' A' ' 72' ' ' TYR . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 81' ' ' CYS . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.893 ' HB2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 24' ' ' THR . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 20' ' ' LEU . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' B' ' 12' ' ' PRO . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.458 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.841 HD13 HG12 ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 20' ' ' LEU . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.461 HG23 HG12 ' A' ' 7' ' ' VAL . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' B' ' 41' ' ' LEU . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HE1' HG11 ' A' ' 7' ' ' VAL . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.674 HG21 ' CE1' ' A' ' 78' ' ' PHE . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 75' ' ' THR . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.49 HD23 HG21 ' A' ' 113' ' ' VAL . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 93' ' ' VAL . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB2' HG21 ' A' ' 14' ' ' VAL . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' HG21 ' A' ' 93' ' ' VAL . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.41 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HD2' ' A' ' 120' ' ' ARG . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.92 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.002 ' O ' HG23 ' A' ' 102' ' ' THR . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 110' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.661 ' H ' HG13 ' A' ' 152' ' ' VAL . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 154' ' ' TYR . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 79' ' ' LEU . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 158' ' ' SER . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.748 ' HD2' HG11 ' A' ' 84' ' ' VAL . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' N ' HD12 ' A' ' 126' ' ' ILE . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 124' ' ' SER . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.845 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.508 ' CG ' HD23 ' A' ' 145' ' ' LEU . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.83 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.772 HG11 ' HB1' ' A' ' 175' ' ' ALA . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.644 ' HD1' HD22 ' A' ' 112' ' ' LEU . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 168' ' ' VAL . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.589 ' HB3' HG21 ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' ILE . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 155' ' ' VAL . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.898 ' O ' HD12 ' A' ' 173' ' ' ILE . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.772 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' B' ' 2' ' ' LYS . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.737 ' HE2' HD22 ' A' ' 177' ' ' LEU . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.639 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.826 ' HA ' HG22 ' A' ' 44' ' ' VAL . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 24' ' ' THR . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.091 HG13 HG22 ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.091 HG22 HG13 ' B' ' 21' ' ' VAL . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.674 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.565 ' CB ' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD13 ' A' ' 70' ' ' LEU . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.828 0.347 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.96 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 53' ' ' LEU . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.842 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' LEU . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' B' ' 23' ' ' TRP . 38.3 t . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.782 0.325 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.752 ' O ' HG23 ' B' ' 21' ' ' VAL . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 44' ' ' VAL . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HG22 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.585 ' CD1' HG21 ' A' ' 173' ' ' ILE . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 67' ' ' LEU . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.759 HD22 HD13 ' B' ' 41' ' ' LEU . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 108' ' ' THR . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.877 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' H ' HG22 ' A' ' 77' ' ' VAL . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' OE2' ' A' ' 156' ' ' GLU . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.857 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 89' ' ' SER . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HA ' HD11 ' A' ' 149' ' ' LEU . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.837 HG11 ' HB3' ' A' ' 149' ' ' LEU . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 98' ' ' VAL . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.877 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 101' ' ' ILE . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 172' ' ' ALA . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 145' ' ' LEU . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.514 ' H ' HG22 ' A' ' 115' ' ' THR . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.742 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.559 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.742 HD11 ' O ' ' A' ' 120' ' ' ARG . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 123' ' ' PRO . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 124' ' ' SER . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.716 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.3 m-80 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.555 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.648 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.495 ' HB2' HD23 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.837 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 112' ' ' LEU . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 168' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.485 ' SG ' HG11 ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 155' ' ' VAL . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 19' ' ' LEU . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.455 ' O ' HD13 ' B' ' 9' ' ' ILE . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 53' ' ' LEU . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' B' ' 4' ' ' ILE . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.505 ' HE3' HD23 ' A' ' 177' ' ' LEU . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.623 ' HB ' HD12 ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.855 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.0 HG13 HG22 ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.648 ' HB2' HG21 ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 1.0 HG22 HG13 ' B' ' 21' ' ' VAL . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.63 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 70' ' ' LEU . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.759 HD13 HD22 ' A' ' 70' ' ' LEU . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 56' ' ' PHE . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 16' ' ' LYS . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.684 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.095 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 165' ' ' LEU . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 28' ' ' PHE . 20.2 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.76 HG12 ' OH ' ' A' ' 64' ' ' TYR . 14.1 t . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG23 HD11 ' A' ' 55' ' ' LEU . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' HG12 ' A' ' 44' ' ' VAL . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG12 HG23 ' B' ' 9' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 173' ' ' ILE . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 42' ' ' VAL . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HB2' HG22 ' A' ' 7' ' ' VAL . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 71' ' ' SER . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.76 ' OH ' HG12 ' A' ' 36' ' ' VAL . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 58' ' ' THR . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.588 ' H ' HG22 ' A' ' 77' ' ' VAL . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 113' ' ' VAL . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 119' ' ' LEU . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 96' ' ' LYS . 21.6 m120 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 89' ' ' SER . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.557 ' HA ' HD21 ' A' ' 149' ' ' LEU . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 ' CB ' HD22 ' A' ' 149' ' ' LEU . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 97' ' ' TRP . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.512 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HG23 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.51 HD23 ' CD1' ' A' ' 154' ' ' TYR . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD23 ' A' ' 79' ' ' LEU . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.549 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' HD22 ' A' ' 119' ' ' LEU . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.636 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 125' ' ' THR . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.766 HG23 ' HG3' ' A' ' 136' ' ' PRO . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.766 ' HG3' HG23 ' A' ' 126' ' ' ILE . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.656 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 110' ' ' PHE . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.51 ' CD1' HD23 ' A' ' 112' ' ' LEU . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' C ' HD11 ' A' ' 117' ' ' ILE . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 163' ' ' LYS . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 165' ' ' LEU . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.858 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.095 HD13 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.904 ' O ' HD12 ' A' ' 173' ' ' ILE . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' HD21 ' A' ' 111' ' ' LEU . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.954 HG23 HG12 ' A' ' 4' ' ' ILE . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.668 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.677 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.566 HD12 HG13 ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.668 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.451 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.952 HG11 HD12 ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.952 HD12 HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.516 ' H ' HD23 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 39' ' ' ARG . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' B' ' 36' ' ' PRO . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.449 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' C ' HD13 ' B' ' 47' ' ' ILE . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.601 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.806 0.336 . . . . 24.829999999999998 110.926 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 52' ' ' THR . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.719999999999999 111.024 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.72 ' CG1' HD21 ' A' ' 177' ' ' LEU . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.190000000000001 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.460000000000001 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG22 ' A' ' 4' ' ' ILE . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.300000000000001 110.239 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.619 HG23 HG23 ' A' ' 75' ' ' THR . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.300000000000001 110.774 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.2699999999999996 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.6400000000000006 112.634 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.636 ' H ' HG21 ' A' ' 115' ' ' THR . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.699999999999999 113.259 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.6899999999999995 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.752 ' HA ' HD12 ' A' ' 20' ' ' LEU . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.190000000000001 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.050000000000001 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 17' ' ' THR . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.969999999999999 110.251 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 25' ' ' THR . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 165' ' ' LEU . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.149999999999999 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.940000000000001 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 21' ' ' ILE . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.789999999999999 111.438 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.600000000000001 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.109999999999999 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.510000000000002 112.116 179.828 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' B' ' 29' ' ' PHE . 20.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.891 0.376 . . . . 23.469999999999999 110.987 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.059999999999999 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.280000000000001 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.530000000000001 111.633 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.329999999999998 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' H ' ' B' ' 13' ' ' SER . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.861 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.280000000000001 111.426 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.412 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 51' ' ' TYR . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.620000000000001 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.449999999999999 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.879999999999999 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.565 ' CB ' HD12 ' A' ' 46' ' ' ILE . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.190000000000001 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 3' ' ' THR . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.100000000000001 110.991 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 173' ' ' ILE . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.780000000000001 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 8' ' ' VAL . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.059999999999999 111.031 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.415 ' CG ' HD11 ' A' ' 20' ' ' LEU . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.960000000000001 110.725 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.6099999999999994 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.8800000000000008 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.239999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.149999999999999 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.510000000000002 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.670000000000002 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.119999999999997 111.318 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.940000000000001 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.831 HD21 ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.690000000000001 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.390000000000001 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.010000000000002 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.259999999999998 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.619 HG23 HG23 ' A' ' 7' ' ' VAL . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.742 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.870000000000001 110.953 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.510000000000002 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' HG22 ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.420000000000002 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 113' ' ' VAL . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.76 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.6200000000000001 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CG ' HG21 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.210000000000001 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.7199999999999998 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.969999999999999 110.725 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.5700000000000003 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.260000000000002 110.94 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.029999999999999 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.299999999999997 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.640000000000001 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 89' ' ' SER . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.449999999999999 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB3' HD13 ' A' ' 145' ' ' LEU . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.600000000000001 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.76 ' CE3' HG13 ' A' ' 80' ' ' VAL . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.559999999999999 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 102' ' ' THR . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.300000000000001 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.289999999999999 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.129999999999999 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.039999999999999 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.469999999999999 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.829999999999998 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.039999999999999 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.100000000000001 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.629999999999999 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.600000000000001 111.729 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.719999999999999 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.739999999999998 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.979 HD23 ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.789999999999999 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 HD23 ' A' ' 79' ' ' LEU . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.4600000000000009 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3000000000000007 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.636 HG21 ' H ' ' A' ' 15' ' ' GLY . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.949999999999999 110.774 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.060000000000002 110.571 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.644 ' OD1' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.920000000000002 111.15 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.771 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.850000000000001 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.695 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.909999999999997 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.936 ' OD2' HG23 ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.479999999999997 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.350000000000001 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.350000000000001 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.936 HG23 ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.759999999999998 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.695 HD11 ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.710000000000001 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.560000000000002 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.729999999999997 110.713 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.119999999999997 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.579999999999998 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.969999999999999 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.814 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.4 mt-30 -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.280000000000001 108.337 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.899999999999999 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.710000000000001 111.921 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.279999999999999 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.050000000000001 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.600000000000001 110.864 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.949999999999999 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.390000000000001 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.969999999999999 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.739999999999998 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.300000000000001 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.659999999999997 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.489999999999998 111.329 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.100000000000001 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.399999999999999 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.979 ' CD1' HD23 ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.530000000000001 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.833 ' CG2' HG13 ' A' ' 168' ' ' VAL . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.629999999999999 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 168' ' ' VAL . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.100000000000001 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' HD13 ' A' ' 165' ' ' LEU . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.880000000000001 110.49 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.2699999999999996 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.469999999999999 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.699999999999999 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.684 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.550000000000001 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.550000000000001 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 ' CG2' ' A' ' 155' ' ' VAL . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.120000000000001 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' A' ' 19' ' ' LEU . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' HD13 ' B' ' 9' ' ' ILE . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CG ' HG11 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.449999999999999 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.210000000000001 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' B' ' 9' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.699999999999999 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.539999999999999 111.072 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.72 HD21 ' CG1' ' A' ' 4' ' ' ILE . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.47 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.47 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 177' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 174' ' ' LEU . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.861 HG22 HG11 ' A' ' 44' ' ' VAL . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.66 ' HA ' HG22 ' A' ' 44' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 42' ' ' VAL . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.907 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.929 HG22 HG13 ' B' ' 21' ' ' VAL . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.641 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' B' ' 35' ' ' ASP . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD21 ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 67' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.465 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.76 0.314 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.32 147.8 22.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.6 m -142.56 136.7 29.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.917 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.32 154.39 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.776 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.9 mttp -112.48 70.46 0.71 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.45 0.643 . . . . 0.0 110.467 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.31 107.84 18.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.978 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 56' ' ' PHE . 15.4 t -112.81 133.78 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.767 HG21 HD11 ' A' ' 20' ' ' LEU . 12.2 t -86.55 115.84 28.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.107 0.48 . . . . 0.0 111.087 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.0 145.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.127 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 154.54 148.79 5.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.707 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.01 100.0 6.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.88 0.372 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.61 -166.24 32.24 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.321 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' H3B1 ' A' ' 181' ' ' GCP . . . -111.49 84.86 2.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.452 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.707 HG21 ' O ' ' A' ' 81' ' ' CYS . 17.2 m -115.77 34.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.971 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 43.97 42.78 6.66 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.385 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -76.76 -24.73 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.858 HG21 ' HG2' ' A' ' 34' ' ' PRO . 42.8 m -77.85 -48.13 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.244 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' N7 ' ' A' ' 181' ' ' GCP . 1.8 t -66.91 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 0.0 111.69 -177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -69.68 -32.62 71.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.071 0.462 . . . . 0.0 109.803 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.986 ' N ' HD13 ' A' ' 19' ' ' LEU . 52.7 mt -65.98 -42.35 89.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.743 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.0 mm -67.37 -67.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.611 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.947 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -44.97 -28.69 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.83 ' HB2' HD11 ' A' ' 165' ' ' LEU . 14.0 t80 -64.35 -47.81 77.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' CE1' ' B' ' 15' ' ' PHE . 38.6 p -89.88 -31.24 17.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.972 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.0 p -97.6 -8.17 29.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.79 23.7 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 110.858 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -91.26 125.33 58.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.01 -167.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.56 2.174 . . . . 0.0 112.584 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.04 -47.5 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.17 159.71 22.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.543 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.794 ' O ' HG13 ' A' ' 33' ' ' VAL . 40.3 t80 -129.25 98.15 4.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.795 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER 170.22 60.7 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.409 177.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.858 ' HG2' HG21 ' A' ' 17' ' ' THR . 48.9 Cg_endo -115.21 3.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.167 2.578 . . . . 0.0 114.105 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 36' ' ' VAL . 21.5 m -91.58 90.47 7.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.955 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.525 HG11 ' CE2' ' B' ' 29' ' ' PHE . 3.1 t -159.82 -70.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.514 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CE1' HD13 ' B' ' 38' ' ' LEU . 34.6 t80 -173.93 125.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.707 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 23.9 m-20 -147.38 114.69 6.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.485 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.72 117.44 34.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.563 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 12.9 m-85 -114.21 140.76 48.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.7 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.894 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -122.29 118.77 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.993 0.425 . . . . 0.0 110.422 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 HG23 ' A' ' 44' ' ' VAL . 6.3 t -102.86 157.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.8 m -118.96 94.35 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.11 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG11 HG22 ' B' ' 9' ' ' ILE . 3.8 t -104.4 155.94 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.329 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -87.67 89.02 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.622 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.48 HG12 HG23 ' B' ' 9' ' ' ILE . 28.6 mt -106.77 132.3 54.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.486 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.69 62.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.785 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.47 23.82 57.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.631 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -149.53 147.85 24.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 110.939 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.4 89.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.607 2.204 . . . . 0.0 112.168 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -81.9 170.61 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HD12 ' A' ' 4' ' ' ILE . 40.5 m -116.2 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.423 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.905 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -112.87 106.78 15.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.996 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.09 100.41 1.49 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.424 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' A' ' 53' ' ' LEU . 5.1 mt -95.0 120.74 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 7' ' ' VAL . 90.3 m-85 -119.76 119.87 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.743 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -97.86 129.27 44.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.012 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 8' ' ' VAL . 31.1 p -93.05 -174.37 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.663 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.75 -22.7 15.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.472 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.58 40.52 97.98 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.505 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -144.01 -174.42 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.22 -27.77 9.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -22.81 66.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -104.43 28.6 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.145 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -66.58 -21.18 66.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.074 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -65.44 -61.92 1.83 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.223 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.2 pp -92.43 21.2 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -79.04 -64.62 0.34 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 9.7 Cg_endo -54.11 -17.6 11.77 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.961 2.441 . . . . 0.0 113.138 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' B' ' 41' ' ' LEU . 21.8 mt -47.02 -26.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 111.6 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.46 10.4 41.45 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 10.2 m-30 -91.78 -48.63 0.33 Allowed Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 72' ' ' TYR . 70.6 Cg_exo -41.5 -61.08 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.553 2.169 . . . . 0.0 113.136 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -88.56 65.28 7.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.183 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 12.4 m -127.97 151.99 48.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.226 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -121.47 -55.61 1.93 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.622 178.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.9 p -117.09 171.58 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.066 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.9 m-85 -134.68 135.09 41.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 111.467 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 113' ' ' VAL . 1.7 mp -100.29 98.26 8.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.886 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 97' ' ' TRP . 13.5 t -91.79 86.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.707 ' O ' HG21 ' A' ' 14' ' ' VAL . 30.7 m -81.99 111.04 17.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CB ' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -115.52 141.05 48.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.604 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.484 ' CB ' HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -69.69 120.37 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.065 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.22 -31.58 52.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.699 HG11 HD12 ' A' ' 119' ' ' LEU . 18.6 m -93.7 34.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -155.09 94.78 2.62 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.022 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' CG ' ' HG2' ' A' ' 135' ' ' LYS . 71.5 Cg_exo -50.47 -33.25 37.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.525 2.15 . . . . 0.0 112.319 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.5 m -49.6 -54.96 15.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.076 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.777 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -57.67 -45.99 84.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.853 ' CZ ' HG22 ' A' ' 141' ' ' THR . 66.8 t80 -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.714 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.0 -51.7 68.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' LYS . 25.4 m-20 -69.59 -38.32 77.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -39.82 -45.38 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.963 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.934 ' HA ' HD21 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -86.99 -26.4 23.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -132.93 62.11 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 111.723 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.99 -51.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.846 179.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.514 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 15.7 m95 -73.02 -55.83 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.661 ' HB ' HD22 ' A' ' 149' ' ' LEU . 41.5 t -73.13 -46.37 8.14 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 75.1 Cg_exo -49.07 -43.04 37.62 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.373 2.049 . . . . 0.0 112.071 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -53.77 -27.61 29.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.392 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.41 -41.99 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.986 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 98' ' ' VAL . 18.3 p -51.86 -36.74 49.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -62.21 -20.61 64.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -45.42 4.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 m -146.16 88.65 6.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.05 9.15 4.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.762 2.308 . . . . 0.0 113.085 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -33.59 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.156 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 76' ' ' ASP . 6.5 p -57.75 146.91 64.48 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.219 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.852 ' HB2' HG23 ' A' ' 77' ' ' VAL . 19.0 Cg_endo -55.56 155.87 19.92 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 112.07 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -136.51 101.4 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.385 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -76.02 135.74 39.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.515 178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 154' ' ' TYR . 18.0 tp -107.73 91.83 3.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.422 . . . . 0.0 110.486 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.632 HG13 HG11 ' A' ' 168' ' ' VAL . 12.0 t -86.35 131.39 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.035 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -110.31 111.1 2.99 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.4 m -113.34 173.66 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.374 . . . . 0.0 111.475 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.53 ' H ' HG22 ' A' ' 115' ' ' THR . 1.1 tp-100 79.27 50.66 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -80.06 -46.73 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.573 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.15 -43.51 3.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.759 HD13 ' O ' ' A' ' 119' ' ' LEU . 2.8 tm? -78.57 -39.66 37.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.339 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.652 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.51 -26.2 41.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.699 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -99.06 15.38 26.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -110.88 77.31 1.36 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-O 120.737 0.303 . . . . 0.0 111.004 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 93.1 Cg_exo -43.31 -28.82 1.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.667 2.245 . . . . 0.0 112.643 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.7 -40.16 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.176 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.684 HG21 HD21 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -93.66 -42.84 8.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.064 0.459 . . . . 0.0 109.999 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.713 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.4 mt -50.74 -50.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.57 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -72.66 -27.69 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -62.54 -46.36 88.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.673 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.09 -21.08 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.0 111.651 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.66 -25.49 0.73 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.707 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -123.64 16.25 9.54 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -112.23 -31.41 6.87 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.561 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 170.11 -29.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 112.069 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -102.42 171.98 7.14 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.337 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG2' ' CG ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -172.77 143.4 1.16 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.856 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HG3' HG23 ' A' ' 126' ' ' ILE . 53.8 Cg_endo -69.12 160.72 48.74 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.53 2.153 . . . . 0.0 112.331 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.01 134.33 46.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.024 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.1 p -83.71 149.75 57.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -35.96 71.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.524 2.149 . . . . 0.0 112.103 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.37 -33.35 74.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.715 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.853 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.6 m -73.31 -38.14 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.428 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.72 -41.68 71.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.393 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.9 OUTLIER -52.42 -58.34 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.334 178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -41.36 -51.22 3.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 93' ' ' VAL . 8.3 mp -59.6 -42.09 91.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.833 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.27 -28.41 27.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.165 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -96.87 -29.51 13.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.577 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.39 -29.98 68.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.742 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -106.14 20.88 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.263 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mttp 55.32 25.04 7.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.944 0.402 . . . . 0.0 110.712 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.29 132.62 54.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.265 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.114 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.4 m -52.28 -37.82 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.62 160.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 111.423 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.536 ' CD1' HD23 ' A' ' 112' ' ' LEU . 33.7 t80 -109.65 122.0 46.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.702 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.755 HG23 HG13 ' A' ' 168' ' ' VAL . 27.8 m -147.46 131.54 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.588 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 14.7 mt-10 -92.3 164.84 13.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.738 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.512 ' C ' HD11 ' A' ' 117' ' ' ILE . 1.6 p -160.2 164.52 32.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.315 0.579 . . . . 0.0 112.033 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.871 ' O ' HD22 ' A' ' 165' ' ' LEU . 34.3 t -135.44 -169.73 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.759 177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.947 ' HB1' ' OG ' ' A' ' 22' ' ' SER . . . -139.44 -49.21 0.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.622 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -53.75 -50.86 65.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 m -100.65 -22.54 14.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.427 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 19.7 mt-30 77.45 24.53 0.79 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.52 101.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.55 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.8 24.67 54.31 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.005 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.74 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.928 0.394 . . . . 0.0 111.579 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.9 -39.34 68.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.189 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -43.77 -31.56 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.452 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 155' ' ' VAL . 53.4 t -71.68 -49.19 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.631 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.746 ' O ' HD12 ' A' ' 173' ' ' ILE . 54.0 m-85 -60.64 -28.58 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.376 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.684 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.3 m-20 -63.76 -29.69 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.911 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.442 ' HB3' HD21 ' A' ' 111' ' ' LEU . 2.5 tp10 -81.75 -35.19 29.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.397 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.454 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.8 -68.64 0.27 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.597 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.917 HG23 HG12 ' A' ' 4' ' ' ILE . 3.2 mt -47.14 -53.75 3.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.0 110.719 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' B' ' 9' ' ' ILE . 11.2 tp -46.58 -29.38 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.547 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 1.114 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.26 -49.63 7.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.999 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -50.94 -38.06 48.19 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.941 0.4 . . . . 0.0 110.764 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 173' ' ' ILE . 21.0 mt -80.62 -172.91 3.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.83 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.7 pt-20 -166.78 161.14 11.52 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.122 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.003 2.468 . . . . 0.0 111.996 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.749 0.309 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.517 ' HE2' HD22 ' A' ' 177' ' ' LEU . 18.8 tttt -118.81 26.5 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 111.008 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 10.6 mmmt -72.85 118.87 16.32 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.769 0.795 . . . . 0.0 111.786 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 177' ' ' LEU . 1.3 mm -87.84 145.37 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.024 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 85.8 p -127.27 151.56 48.57 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.839 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -46.8 -27.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.649 0.262 . . . . 0.0 111.648 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.05 -2.71 55.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.73 -67.47 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.157 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.798 HG22 HG11 ' A' ' 44' ' ' VAL . 1.2 mp -53.61 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.487 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.66 -161.61 1.17 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.319 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.79 133.0 62.89 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.527 0.203 . . . . 0.0 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.542 ' HA ' HG22 ' A' ' 44' ' ' VAL . 8.7 Cg_endo -49.42 163.96 0.37 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.553 2.169 . . . . 0.0 111.984 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.19 79.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.27 40.43 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.258 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' OG1' ' A' ' 24' ' ' THR . 5.6 t80 -48.43 111.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.0 110.928 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.894 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 18.7 tptt -116.85 100.86 8.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.197 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.28 85.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.83 -28.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.22 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' B' ' 33' ' ' ASN . 2.2 t -162.6 140.16 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -128.82 116.48 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.282 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.701 HG13 ' CG2' ' B' ' 31' ' ' VAL . 57.9 t -115.61 110.55 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -110.73 98.48 1.06 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.682 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.454 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.2 t90 -69.11 159.9 32.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.73 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -161.21 122.66 1.66 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.377 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.41 -5.66 14.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.322 2.015 . . . . 0.0 113.017 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -111.97 -26.98 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.626 0.25 . . . . 0.0 111.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -111.13 -33.83 6.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.702 0.287 . . . . 0.0 111.502 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.687 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.525 ' CE2' HG11 ' A' ' 36' ' ' VAL . 27.4 m-85 60.6 126.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.019 0.438 . . . . 0.0 111.352 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER -124.39 39.75 3.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.524 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' B' ' 21' ' ' VAL . 64.2 t -66.35 125.03 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.243 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.13 23.0 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.935 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' B' ' 19' ' ' SER . 1.6 t30 -173.73 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.1 mt -60.11 167.48 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.242 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.796 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -70.99 155.8 92.88 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.096 -179.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 23.4 Cg_exo -63.6 -54.05 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.27 . . . . 0.0 111.826 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.32 77.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.424 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.796 HD12 ' HB2' ' B' ' 35' ' ' ASP . 59.3 mt -70.48 -26.13 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.519 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 5.7 mtt-85 -56.97 -35.1 68.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.511 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.4 m -83.16 -31.83 26.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.947 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.555 ' HB3' HD22 ' A' ' 70' ' ' LEU . 21.6 mt -80.05 -33.69 38.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.344 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -68.52 -57.42 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.0 t -59.68 -22.26 61.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -91.85 -22.03 20.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.405 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -90.7 -99.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.478 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -94.09 -15.04 49.95 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.455 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.606 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -98.52 34.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.269 0.557 . . . . 0.0 110.51 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -99.7 14.04 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.857 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 1.6 mt-10 -73.63 -12.16 60.65 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.648 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' B' ' 49' ' ' GLU . . . 172.18 137.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.781 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -52.19 166.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 16.8 mt -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -131.35 9.47 4.75 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.07 99.02 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.034 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.89 126.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -65.59 153.01 42.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 44.8 p -66.92 134.25 51.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -75.53 117.95 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.432 ' N7 ' ' HB3' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -88.19 140.24 29.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 24.829999999999998 111.016 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' THR . 53.7 m -143.02 141.51 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 25.719999999999999 110.65 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.766 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -94.49 121.48 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 24.190000000000001 111.159 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 73.11 0.8 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.018 -0.537 . . . . 25.460000000000001 110.038 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 115.99 24.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.967 -0.56 . . . . 14.300000000000001 110.867 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG11 ' CE2' ' A' ' 72' ' ' TYR . 17.6 t -126.51 127.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 16.300000000000001 110.628 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG11 ' HD3' ' A' ' 16' ' ' LYS . 2.5 t -87.97 148.27 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.046 0.451 . . . . 6.1699999999999999 111.285 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -137.94 128.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 5.79 110.92 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 97' ' ' TRP . . . 160.86 159.97 10.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 7.2699999999999996 112.472 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' N ' ' CH2' ' A' ' 97' ' ' TRP . 10.5 t0 -49.61 142.63 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 21.84 110.939 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.01 62.75 2.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 8.6400000000000006 112.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.67 35.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.313 . . . . 12.93 111.069 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 15' ' ' GLY . 32.3 m -100.11 -46.21 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 12.76 110.998 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 119.87 19.78 3.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.5 -0.857 . . . . 13.699999999999999 112.992 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' HD3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.54 -55.76 30.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.571 0.211 . . . . 9.6899999999999995 111.571 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.406 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 23.5 m -47.68 -35.92 10.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.729 0.3 . . . . 18.190000000000001 111.102 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -26.11 65.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.383 . . . . 17.050000000000001 110.778 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -90.65 -45.67 8.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 13.42 110.678 -178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 19' ' ' LEU . 10.3 mp -49.06 -43.75 41.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.964 0.411 . . . . 16.969999999999999 111.08 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.5 mm -67.12 -69.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 17.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 p -51.25 -24.78 4.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 16.43 110.823 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.676 ' HB2' HD11 ' A' ' 165' ' ' LEU . 1.2 t80 -59.72 -43.54 94.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 21.149999999999999 110.661 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' CD1' ' B' ' 15' ' ' PHE . 0.0 OUTLIER -109.36 -17.68 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 18.940000000000001 111.662 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 21' ' ' ILE . 57.3 p -96.98 -22.44 16.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.747 0.308 . . . . 30.5 111.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.53 14.34 7.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.36 -0.382 . . . . 34.789999999999999 111.495 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.9 150.22 49.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.92 0.39 . . . . 24.600000000000001 111.181 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -105.69 108.72 62.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 23.109999999999999 110.552 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.84 157.59 58.25 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.448 2.099 . . . . 29.510000000000002 112.461 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.94 -18.23 11.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.935 -0.575 . . . . 41.890000000000001 111.17 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.21 162.04 0.78 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.829 0.347 . . . . 43.869999999999997 110.855 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -142.19 109.15 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 23.27 110.902 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 13.3 p -169.81 138.72 1.55 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 21.530000000000001 110.914 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 76.7 Cg_exo -48.17 149.73 5.84 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.613 2.209 . . . . 15.4 112.482 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 m -123.48 81.89 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 20.140000000000001 110.804 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.531 HG13 ' CE2' ' A' ' 64' ' ' TYR . 97.5 t -50.16 -78.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 23.469999999999999 111.248 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -138.5 91.22 2.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 31.059999999999999 111.429 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -106.83 105.35 15.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 36.280000000000001 110.229 178.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -102.23 121.62 42.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 41.530000000000001 111.787 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 2.6 m-85 -117.67 161.02 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.883 -0.599 . . . . 31.02 110.079 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.891 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.77 119.91 24.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 24.329999999999998 111.281 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.5 146.31 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.441 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -106.33 122.48 46.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.531 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.758 HG11 ' CG2' ' B' ' 9' ' ' ILE . 5.2 t -137.19 156.88 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.372 -0.376 . . . . 27.280000000000001 111.32 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.63 88.49 5.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 35.5 110.358 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' A' ' 51' ' ' TYR . 27.1 mt -98.14 122.19 49.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.272 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.47 43.75 97.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 24.620000000000001 112.591 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.61 25.94 64.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.674 -0.774 . . . . 28.449999999999999 112.459 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -142.63 140.37 18.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.0 110.961 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.56 119.98 6.94 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.455 2.103 . . . . 25.879999999999999 112.004 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.609 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.5 m-85 -114.07 179.81 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 26.190000000000001 111.054 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 3' ' ' THR . 1.9 m -142.62 85.91 1.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 29.100000000000001 110.749 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 173' ' ' ILE . 23.2 tp -52.64 127.75 24.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 19.32 111.054 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.14 100.65 2.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.826 -0.702 . . . . 16.780000000000001 112.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.9 mt -87.26 127.88 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.812 0.339 . . . . 20.41 111.105 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 10.3 m-85 -128.53 124.17 35.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 19.059999999999999 111.216 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.57 128.8 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 14.960000000000001 110.387 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -124.43 152.88 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 11.77 111.435 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . . . -67.83 -176.99 0.72 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 9.6099999999999994 110.603 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.28 50.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.283 -0.961 . . . . 9.8800000000000008 113.234 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -141.41 9.21 2.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.739 0.274 . . . . 24.239999999999998 111.739 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.4 -1.74 0.92 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.935 1.087 . . . . 32.149999999999999 113.935 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -69.79 -48.28 59.79 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.177 -0.327 . . . . 27.510000000000002 111.096 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.775 ' CE1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -99.0 27.09 5.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 14.69 110.546 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -20.75 28.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 24.670000000000002 111.123 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -48.85 -38.86 23.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.281 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -128.04 19.25 6.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.583 -0.28 . . . . 18.940000000000001 111.719 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 5.0 ttm180 -70.79 -44.65 15.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 111.832 0.308 . . . . 19.91 111.832 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 16.7 Cg_exo -67.74 -18.09 47.63 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.429 2.086 . . . . 19.93 112.741 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.444 HD12 ' CB ' ' A' ' 67' ' ' LEU . 61.6 mt -65.49 -10.7 36.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.057 0.392 . . . . 22.690000000000001 112.057 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.5 m -90.01 17.43 6.88 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.039 0.385 . . . . 20.390000000000001 112.039 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' CE2' HG11 ' A' ' 7' ' ' VAL . 1.5 m-85 -132.96 41.07 0.65 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.434 0.531 . . . . 25.010000000000002 112.434 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.7 Cg_exo -38.74 -59.37 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.545 2.164 . . . . 18.16 112.677 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.05 64.15 1.49 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 45.259999999999998 110.159 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.805 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.8 m -39.67 132.59 1.62 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.857 -0.61 . . . . 20.66 112.208 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.559 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 42.1 t0 -106.12 -24.29 12.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.838 -0.619 . . . . 22.870000000000001 110.351 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.8 p -162.9 172.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 16.510000000000002 110.21 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.805 ' CZ ' HG21 ' A' ' 75' ' ' THR . 42.6 m-85 -133.32 117.21 17.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.939 0.399 . . . . 16.420000000000002 111.281 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp -94.48 99.41 11.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 14.58 110.554 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 9' ' ' VAL . 14.5 t -99.38 90.57 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.404 . . . . 13.09 111.315 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.3 m -86.26 111.31 20.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 7.6200000000000001 110.412 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 93' ' ' VAL . 28.4 p90 -117.43 134.02 55.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 13.210000000000001 110.852 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 p -56.7 120.23 7.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 7.7199999999999998 111.046 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG21 ' CD ' ' A' ' 156' ' ' GLU . 90.7 t -65.22 -29.01 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 16.969999999999999 110.94 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 m -92.58 23.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 8.5700000000000003 111.327 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.85 105.04 5.76 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 16.260000000000002 110.619 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 -21.89 54.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.522 2.148 . . . . 14.83 112.422 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -64.39 -59.41 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.287 -0.415 . . . . 13.029999999999999 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.949 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 p -53.36 -45.48 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 16.82 110.759 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 141' ' ' THR . 12.5 t80 -64.61 -46.72 81.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 14.56 110.402 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.44 -23.33 57.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.381 . . . . 32.299999999999997 110.391 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' LYS . 3.2 m-20 -91.41 -33.14 15.36 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.4 0.619 . . . . 17.640000000000001 109.805 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 89' ' ' SER . 69.5 t -57.13 -43.29 81.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.703 . . . . 13.449999999999999 110.366 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.39 -20.35 44.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.451 -0.795 . . . . 21.16 111.02 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 19.3 mt-10 -146.57 62.7 1.21 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.971 -0.292 . . . . 24.600000000000001 111.764 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 178.64 -59.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.439 -0.346 . . . . 21.09 111.582 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.466 ' CH2' ' HA2' ' A' ' 10' ' ' GLY . 74.3 m95 -80.45 -37.42 32.0 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.607 0.241 . . . . 17.559999999999999 111.516 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 96.0 t -73.6 -59.47 1.93 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.665 -0.243 . . . . 22.34 111.557 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 10.4 Cg_endo -54.2 -29.86 58.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.481 2.121 . . . . 18.300000000000001 112.675 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.542 ' OE2' HG23 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -65.74 -30.06 70.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.671 0.272 . . . . 19.289999999999999 111.026 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.542 HG23 ' OE2' ' A' ' 100' ' ' GLU . 6.1 pt -96.03 -36.81 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 22.129999999999999 110.836 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 15.5 p -52.29 -26.82 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 31.07 110.384 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -31.44 62.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 45.039999999999999 110.602 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -45.18 8.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 27.469999999999999 110.788 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.2 m -150.08 83.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 24.829999999999998 110.895 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.74 7.78 4.66 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.74 2.293 . . . . 25.039999999999999 112.991 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 -34.55 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 46.100000000000001 110.857 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 p -55.17 154.14 11.35 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 26.629999999999999 111.179 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.453 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 59.6 Cg_endo -68.1 149.62 76.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.808 2.338 . . . . 18.600000000000001 111.58 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' H ' HG13 ' A' ' 152' ' ' VAL . 26.4 m-85 -133.47 97.75 4.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 40.719999999999999 111.478 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -75.52 120.52 21.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.003 -0.544 . . . . 19.739999999999998 110.893 179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 154' ' ' TYR . 9.1 tp -93.12 98.27 11.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 10.789999999999999 110.894 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 111' ' ' LEU . 3.9 t -91.11 144.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 9.4600000000000009 111.495 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.35 108.65 1.04 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.945 -0.645 . . . . 9.3000000000000007 112.08 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -107.71 174.51 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 15.23 111.106 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HG3' HD12 ' A' ' 119' ' ' LEU . 1.2 tp-100 80.17 44.75 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.189 -0.46 . . . . 21.949999999999999 111.329 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.815 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -79.98 -36.73 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 32.060000000000002 110.067 178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.428 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -45.51 -40.89 9.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.671 -0.695 . . . . 23.920000000000002 111.015 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG3' ' A' ' 116' ' ' GLN . 28.4 mt -79.31 -40.06 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 26.850000000000001 110.379 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' C ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.53 -23.69 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 30.25 110.768 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.96 15.03 24.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.412 . . . . 41.909999999999997 111.129 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.786 ' OD1' HG23 ' A' ' 125' ' ' THR . 12.2 t70 -111.27 82.91 3.66 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.709 0.29 . . . . 44.479999999999997 110.626 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -42.25 -45.61 7.62 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.863 2.375 . . . . 38.350000000000001 112.822 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 38.5 t -45.96 -35.17 4.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 39.350000000000001 111.497 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.786 HG23 ' OD1' ' A' ' 122' ' ' ASP . 5.2 p -93.17 -44.21 8.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 38.759999999999998 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.648 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.4 mt -59.47 -41.51 84.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.821 -0.627 . . . . 32.710000000000001 111.163 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.71 -27.98 45.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.286 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -79.38 -26.5 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 110.858 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.3 pp -98.14 -32.72 11.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.072 -0.513 . . . . 37.560000000000002 111.088 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -39.76 -29.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.331 -0.85 . . . . 32.729999999999997 112.2 -177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -123.32 24.08 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.64 -0.254 . . . . 38.119999999999997 111.46 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -119.3 -32.07 4.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.692 -0.403 . . . . 42.579999999999998 111.87 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.4 ptmt 165.94 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.154 0.798 . . . . 40.969999999999999 113.154 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -100.73 175.09 5.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.047 0.451 . . . . 33.280000000000001 112.039 -176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.96 144.18 0.58 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.664 . . . . 24.899999999999999 110.654 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.22 138.85 23.04 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.63 2.22 . . . . 17.710000000000001 112.455 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.59 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 15.6 111.004 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.429 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 29.5 p -74.1 154.2 88.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 15.279999999999999 111.06 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 50.7 Cg_endo -68.9 -12.51 34.62 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.578 2.185 . . . . 16.66 112.617 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.3 -48.17 6.56 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.764 -0.458 . . . . 26.050000000000001 109.764 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 98.9 m -49.79 -48.82 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 24.600000000000001 110.894 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.73 -54.27 38.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 24.949999999999999 110.85 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -55.79 8.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.15 0.5 . . . . 28.390000000000001 110.958 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -43.25 -49.46 6.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.525 -0.761 . . . . 38.969999999999999 111.492 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 94' ' ' LYS . 2.8 mp -64.66 -43.88 92.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 21.739999999999998 110.556 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.751 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -47.89 -27.89 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 25.300000000000001 110.726 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -34.69 11.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.919 -0.582 . . . . 31.18 110.622 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.0 -35.69 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 32.659999999999997 111.189 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 98' ' ' VAL . 5.9 mt -91.83 19.81 6.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 18.489999999999998 111.427 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 60.99 21.41 11.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.563 -0.29 . . . . 24.100000000000001 111.149 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -71.05 142.57 50.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 15.08 110.83 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 175' ' ' ALA . 21.5 m -57.0 -31.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 21.399999999999999 111.229 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 177.44 -163.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.11 0.481 . . . . 18.59 111.548 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.692 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.4 t80 -136.29 124.05 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 24.530000000000001 110.637 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.008 HG21 HG13 ' A' ' 168' ' ' VAL . 27.7 m -133.77 152.65 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 21.629999999999999 111.256 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.461 ' CD ' HG21 ' A' ' 84' ' ' VAL . 34.1 tt0 -144.01 131.32 20.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.006 -0.543 . . . . 22.43 110.61 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.815 ' CA ' HD11 ' A' ' 117' ' ' ILE . 20.1 p -161.67 168.63 23.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 17.100000000000001 111.479 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.418 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.5 t -135.96 165.56 25.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.858 -0.61 . . . . 13.880000000000001 110.486 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -102.68 -6.33 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.473 -0.33 . . . . 8.2699999999999996 111.726 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.7 tp -90.65 -34.41 15.44 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.783 0.325 . . . . 13.52 110.943 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.8 m -110.66 -23.47 11.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 16.469999999999999 111.116 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 73.98 30.96 1.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 22.699999999999999 111.179 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB3' HD12 ' A' ' 117' ' ' ILE . 7.0 tmtt? -68.55 102.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.646 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 58.13 21.45 46.47 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.703 -0.76 . . . . 14.550000000000001 112.296 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -47.34 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 14.75 111.641 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -38.22 65.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.921 -0.581 . . . . 24.77 111.09 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.87 -25.46 11.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.827 -0.624 . . . . 26.550000000000001 111.188 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.008 HG13 HG21 ' A' ' 155' ' ' VAL . 97.6 t -74.36 -57.89 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 22.120000000000001 111.184 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.908 ' O ' HD12 ' A' ' 173' ' ' ILE . 81.3 m-85 -52.25 -31.04 30.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 19.68 110.495 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -29.18 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.856 -0.611 . . . . 32.18 110.446 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.431 ' OE1' HD21 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -78.44 -36.05 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 21.449999999999999 110.731 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 175' ' ' ALA . . . -63.26 -63.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.77 110.865 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.908 HD12 ' O ' ' A' ' 169' ' ' PHE . 3.1 mt -47.34 -55.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.058 0.456 . . . . 20.210000000000001 110.559 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.1 tp -48.0 -27.63 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 19.699999999999999 110.475 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.53 -45.66 9.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.746 -0.661 . . . . 13.52 111.184 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -47.35 -61.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 10.539999999999999 111.629 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.487 HD22 ' CD1' ' B' ' 4' ' ' ILE . 8.6 mp -53.36 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.272 -0.422 . . . . 15.24 111.531 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.1 pt-20 101.59 159.23 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 124.688 1.195 . . . . 0.0 110.007 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.102 2.535 . . . . 0.0 112.323 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 179' ' ' PRO . 8.7 tttp -146.15 28.41 1.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.757 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 16.3 mmmt -71.09 117.6 12.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.919 0.866 . . . . 0.0 111.913 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.729 ' HB ' HD12 ' A' ' 174' ' ' LEU . 4.2 mm -95.83 150.28 4.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.28 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.77 152.21 50.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.365 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -48.38 -26.14 1.93 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.777 0.323 . . . . 0.0 111.32 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 -2.95 45.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 86.3 m-20 -81.03 -65.28 1.03 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.582 0.23 . . . . 0.0 111.311 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.758 ' CG2' HG11 ' A' ' 44' ' ' VAL . 3.1 mt -48.14 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.49 -165.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.686 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.93 124.54 86.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.489 0.185 . . . . 0.0 110.824 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.705 ' HA ' HG22 ' A' ' 44' ' ' VAL . 30.1 Cg_endo -62.82 161.66 28.16 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.431 2.087 . . . . 0.0 112.063 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.07 165.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.699 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.71 42.26 9.17 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.469 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 3.0 t80 -45.15 118.88 1.82 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.794 0.33 . . . . 0.0 110.846 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.891 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 27.0 tptt -116.18 109.84 17.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -72.25 85.61 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.872 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -72.7 -22.1 20.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.655 -177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -169.01 163.08 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.817 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -163.52 117.16 1.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 111.622 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.766 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -111.11 140.97 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.443 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.0 93.24 0.36 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.373 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 76.4 t90 -91.52 93.07 8.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -79.02 143.49 61.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.602 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.08 -9.23 20.57 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.298 1.999 . . . . 0.0 112.549 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -112.86 -29.39 7.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.834 0.35 . . . . 0.0 111.173 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.44 -28.01 8.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.335 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.31 -154.13 20.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 30.8 m-85 -57.36 146.37 29.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.03 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 9.6 t70 -145.6 53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.766 HG22 HG13 ' B' ' 21' ' ' VAL . 87.7 t -65.59 111.94 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.982 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.52 -26.99 13.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.3 83.45 1.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.893 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -90.6 -175.7 4.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -88.11 150.13 46.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.663 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 38.7 Cg_exo -57.2 -52.59 6.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.536 2.158 . . . . 0.0 112.239 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.05 -41.31 64.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' B' ' 35' ' ' ASP . 26.5 mt -64.23 -33.2 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 16.0 mtt-85 -50.47 -44.61 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.27 -44.78 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.214 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.39 -28.86 64.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.48 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.893 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.6 OUTLIER -62.56 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.984 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -64.06 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.071 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -90.47 -15.55 30.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -98.55 -91.76 0.27 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.08 -18.01 16.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.646 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.652 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.7 mm -92.98 39.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.976 0.417 . . . . 0.0 111.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.9 p -77.77 -151.48 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.424 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 1.5 mt-10 -47.36 -22.64 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 74.18 125.03 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -71.36 169.79 14.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' B' ' 52' ' ' LEU . 16.4 mt -74.17 117.51 16.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.532 HG22 ' O ' ' B' ' 53' ' ' THR . 25.8 m -115.25 8.91 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.05 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.95 93.5 1.16 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.33 123.47 19.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.95 111.97 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 38.4 p -88.19 93.89 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.33 87.85 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.918 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.415 ' H8 ' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -81.29 144.77 31.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.217 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 83.3 m -142.93 124.1 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.552 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 173' ' ' ILE . 4.4 mp -94.33 158.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.6 178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -121.12 79.58 1.53 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.454 0.645 . . . . 0.0 111.328 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 53' ' ' LEU . 6.9 m -89.44 107.49 19.1 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.167 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 72' ' ' TYR . 7.7 p -109.7 138.02 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.797 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 t -87.32 116.76 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 111.264 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.401 HG21 ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -116.08 146.39 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.825 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 152.46 150.39 5.37 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.747 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.71 100.33 12.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.92 0.39 . . . . 0.0 110.545 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.0 177.31 29.08 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.138 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -82.78 -66.65 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.595 0.236 . . . . 0.0 111.453 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 34.3 m 43.49 27.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.493 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' HA2' ' O3A' ' A' ' 181' ' ' GCP . . . 38.28 91.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.453 0 CA-C-N 116.133 -0.485 . . . . 0.0 114.179 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.543 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.77 -38.66 83.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.723 ' OG1' HG21 ' A' ' 35' ' ' THR . 29.8 m -78.92 -13.66 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.06 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.07 -62.82 1.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.026 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.49 -37.13 82.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.444 -176.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 57' ' ' ASP . 28.0 mt -52.52 -46.0 66.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.952 0.406 . . . . 0.0 110.604 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 mm -79.67 -36.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.608 ' HB2' HD21 ' A' ' 165' ' ' LEU . 35.0 m -66.16 -11.44 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.661 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 9.7 t80 -96.7 -66.08 0.93 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.009 0.433 . . . . 0.0 110.999 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 HG21 ' A' ' 42' ' ' VAL . 21.2 p -54.6 -44.34 72.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.67 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -93.41 -22.41 18.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.358 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.5 25.47 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.48 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -142.8 126.18 16.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 15.7 t80 -67.4 122.55 83.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.638 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 11.9 Cg_endo -54.34 -164.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.679 2.253 . . . . 0.0 112.44 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -147.02 -45.73 0.18 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.736 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.24 163.51 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.075 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 8.6 t80 -143.35 116.44 8.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 111.177 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 34' ' ' PRO . 7.1 p -177.67 139.98 0.42 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.29 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' HD2' HG23 ' A' ' 33' ' ' VAL . 67.7 Cg_exo -28.28 145.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.031 3.154 . . . . 0.0 113.828 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.723 HG21 ' OG1' ' A' ' 17' ' ' THR . 1.5 m -155.7 82.76 1.03 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.348 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -75.31 -43.04 43.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.804 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -145.36 111.16 5.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.46 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.34 110.84 13.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.63 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.88 123.15 49.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.783 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.499 ' CD2' ' CZ ' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -121.53 159.21 26.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.024 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.88 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -118.9 118.39 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.442 . . . . 0.0 110.472 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG21 HG22 ' A' ' 24' ' ' THR . 11.2 t -103.45 142.43 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.826 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -110.44 112.8 24.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.51 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -123.56 157.8 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.448 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.1 mmt -90.02 88.09 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.023 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG12 HG23 ' B' ' 9' ' ' ILE . 9.1 mt -104.39 127.02 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.189 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.66 34.4 89.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.201 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.3 32.74 76.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.584 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.28 152.1 21.04 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.04 108.62 2.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.895 2.396 . . . . 0.0 112.398 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.34 -175.14 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.383 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -141.57 90.03 2.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 0.0 110.96 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.959 HD13 HG12 ' A' ' 173' ' ' ILE . 26.8 tp -65.78 135.12 54.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.998 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.93 106.93 3.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.088 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 42' ' ' VAL . 2.7 mm? -87.3 114.13 23.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.183 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 8' ' ' VAL . 35.4 m-85 -126.84 143.16 51.35 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.22 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.957 ' HB3' HD11 ' A' ' 20' ' ' LEU . 34.3 p-10 -142.03 126.55 17.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.659 HG22 ' NH1' ' A' ' 68' ' ' ARG . 45.6 p -107.25 139.15 42.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.127 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.36 -160.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.32 -120.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.287 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.01 69.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.456 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 179.29 -52.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.228 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.84 65.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -103.55 23.08 13.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.542 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.64 -32.89 31.07 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.805 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -45.47 90.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' B' ' 47' ' ' ILE . 4.0 pp -104.64 21.23 17.21 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.659 ' NH1' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -74.34 -63.78 0.79 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.186 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.6 Cg_endo -62.73 -16.57 54.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.282 1.988 . . . . 0.0 111.836 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.824 HD21 ' CB ' ' B' ' 41' ' ' LEU . 5.4 tp -59.7 -15.91 23.05 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.055 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.0 p -96.98 14.73 24.52 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.719 ' HE1' HG21 ' A' ' 7' ' ' VAL . 7.0 m-85 -120.1 37.55 0.28 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.4 Cg_exo -37.47 -34.98 0.27 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.655 2.237 . . . . 0.0 112.598 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -172.45 54.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.947 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.421 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 78.3 m -55.12 151.13 9.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.65 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -109.09 -67.22 0.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.093 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -112.04 149.14 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.538 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.473 ' CD1' HG21 ' A' ' 101' ' ' ILE . 49.3 m-85 -117.48 141.82 47.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.217 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 113' ' ' VAL . 1.5 mp -106.65 99.88 9.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -90.93 92.5 3.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.677 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.9 m -88.77 111.19 21.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -113.74 170.27 8.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 27.5 t -93.87 117.52 30.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 111.24 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.96 -33.97 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.69 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.834 HG11 ' HB2' ' A' ' 119' ' ' LEU . 35.6 m -91.6 39.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.918 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.64 102.72 2.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.657 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.12 -26.33 82.23 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.982 1.788 . . . . 0.0 111.752 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -55.54 30.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.6 m -51.66 -45.23 63.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.653 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 145' ' ' LEU . 38.2 t80 -54.99 -36.37 65.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.476 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -67.56 -51.04 55.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.766 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' LYS . 77.3 m-20 -71.33 -29.42 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.145 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 89' ' ' SER . 2.7 t -49.12 -39.28 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.598 178.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' HD21 ' A' ' 149' ' ' LEU . 4.6 pttp -96.7 -23.3 16.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.519 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -129.62 48.6 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.791 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 179.36 -53.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.502 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 17.3 m95 -73.56 -42.78 61.21 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 149' ' ' LEU . 83.0 t -81.37 -45.17 1.14 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.599 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 76.9 Cg_exo -53.4 -33.38 66.53 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.535 2.157 . . . . 0.0 112.449 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -29.78 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.33 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 78' ' ' PHE . 1.5 mt -87.33 -42.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.639 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' VAL . 3.1 p -60.25 -27.22 67.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -30.54 68.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.989 0.423 . . . . 0.0 110.425 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -93.35 -42.05 9.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.863 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.8 m -150.22 90.04 4.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.963 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.95 4.93 6.08 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.571 2.181 . . . . 0.0 112.755 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -27.25 9.02 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.792 0.329 . . . . 0.0 111.24 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.447 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 21.2 p -67.82 148.36 98.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 27.0 Cg_endo -60.85 152.72 68.24 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.064 2.509 . . . . 0.0 112.521 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' A' ' 108' ' ' THR . 15.3 m-85 -131.26 93.52 3.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.87 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -67.7 120.18 13.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.052 177.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 146' ' ' ALA . 24.9 tp -88.86 96.99 10.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 79' ' ' LEU . 33.1 t -87.83 135.11 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.43 111.96 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.222 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 116' ' ' GLN . 4.2 m -104.63 169.1 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.638 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' SER . 2.2 mm100 77.21 45.52 0.08 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.657 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -81.34 -28.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 109.576 177.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -40.47 -52.97 2.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.164 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.834 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.1 mm? -76.47 -35.3 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' HD11 ' A' ' 126' ' ' ILE . 1.5 tmm_? -53.24 -21.1 4.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.499 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.64 16.38 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.918 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.88 80.41 14.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.794 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 80.0 Cg_exo -42.88 -42.21 8.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.758 2.305 . . . . 0.0 112.472 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -47.94 -38.5 16.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.508 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -91.96 -43.15 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.401 . . . . 0.0 110.139 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.694 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 49.7 mt -49.96 -47.46 23.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.34 -27.73 56.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.833 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 0.1 OUTLIER -61.44 -45.78 92.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.345 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.6 pp -95.36 -24.48 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.297 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.66 -26.27 0.6 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.848 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -129.46 25.13 5.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -115.41 -33.32 5.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.382 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.51 -30.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.707 ' NE2' HD22 ' A' ' 129' ' ' LEU . 1.8 tt0 -116.52 168.81 9.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.308 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -166.16 143.88 4.54 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.781 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.34 171.37 18.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.525 2.15 . . . . 0.0 111.969 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 138' ' ' THR . 16.7 mm -102.12 160.15 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.019 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' ILE . 3.0 p -106.07 156.44 36.76 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.969 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.81 -31.23 87.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.538 2.159 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.01 -38.1 53.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.487 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' CE2' ' A' ' 90' ' ' PHE . 63.2 m -68.36 -38.65 81.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.754 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.49 -34.96 63.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -57.69 -49.91 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 109.793 177.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -43.12 -53.0 5.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.934 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.818 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.8 mt -58.0 -46.97 84.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.03 -28.61 17.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.907 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.47 -36.13 10.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.66 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.03 67.23 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.309 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 98' ' ' VAL . 5.9 mt -99.44 16.92 21.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.464 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 58.8 19.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.291 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.15 130.1 43.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.008 0.432 . . . . 0.0 111.567 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.865 HG11 ' HB1' ' A' ' 175' ' ' ALA . 15.5 m -48.29 -43.3 12.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.009 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.54 155.16 3.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.711 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 112' ' ' LEU . 21.6 t80 -96.21 125.77 40.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.953 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.726 HG21 HG23 ' A' ' 168' ' ' VAL . 32.7 m -142.18 142.41 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 117' ' ' ILE . 14.0 pm0 -106.1 159.2 16.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.714 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.877 ' HB3' HG11 ' A' ' 168' ' ' VAL . 30.5 p -158.41 139.1 12.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.497 0.665 . . . . 0.0 112.211 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.5 t -136.89 117.91 14.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.31 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -76.36 -22.08 55.31 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.624 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -70.68 -50.31 37.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.085 0.469 . . . . 0.0 110.481 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -101.08 -20.41 15.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.933 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' SER . 37.9 mt-30 76.37 21.58 1.38 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.232 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HB3' HD12 ' A' ' 117' ' ' ILE . 5.8 tptt -70.41 99.61 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.495 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.836 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 79.63 -6.59 57.73 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.501 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.026 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 tp -43.16 -47.13 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -81.42 -34.58 31.47 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.33 -56.74 17.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 110.218 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.877 HG11 ' HB3' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -41.18 -68.28 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.742 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.779 ' O ' HD12 ' A' ' 173' ' ' ILE . 35.8 m-85 -44.57 -33.95 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.148 0.499 . . . . 0.0 111.029 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.16 -28.53 69.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -83.46 -31.1 26.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.677 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.416 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -58.42 -67.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.959 HG12 HD13 ' A' ' 53' ' ' LEU . 2.7 mp -48.62 -51.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.914 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' B' ' 4' ' ' ILE . 10.7 tp -53.84 -28.67 37.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.663 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.865 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.04 -51.36 7.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.07 -56.02 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.031 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' B' ' 2' ' ' LYS . 12.4 mt -58.25 -172.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.657 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 11.6 pt-20 -170.75 163.48 5.59 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.933 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.5 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.942 2.428 . . . . 0.0 112.538 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.1 mttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.755 0.312 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.516 ' CE ' HD22 ' A' ' 177' ' ' LEU . 4.2 tttp -130.82 27.79 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmm -73.09 116.42 13.59 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.008 0.909 . . . . 0.0 111.799 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.792 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.33 149.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.264 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 20.3 p -130.4 -176.8 4.08 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -72.38 -29.24 63.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.77 -2.57 44.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.9 -65.39 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.543 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.6 HG22 HG11 ' A' ' 44' ' ' VAL . 2.3 mt -51.73 98.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.729 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.61 -151.41 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.673 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.68 28.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.647 0.261 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.7 Cg_endo -59.4 160.13 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.161 1.907 . . . . 0.0 112.301 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.422 ' H ' HG13 ' A' ' 42' ' ' VAL . 34.2 p -176.19 -173.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.434 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.5 33.11 39.83 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.579 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 4.7 t80 -44.74 112.46 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.927 0.394 . . . . 0.0 110.152 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.88 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 22.9 tptt -115.03 113.95 24.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.238 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -73.18 86.06 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 109.712 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.1 -28.92 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.158 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -165.72 163.89 18.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.635 0.255 . . . . 0.0 110.993 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -165.33 114.05 1.02 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.893 0.378 . . . . 0.0 111.417 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.038 HG13 HG22 ' B' ' 31' ' ' VAL . 25.4 t -101.84 145.47 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.127 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -131.39 93.23 0.29 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.206 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.415 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 44.3 t90 -75.2 96.08 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.716 -0.285 . . . . 0.0 110.63 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -75.52 135.16 72.26 Favored Pre-proline 0 C--N 1.335 -0.043 0 CA-C-O 120.611 0.243 . . . . 0.0 110.754 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.21 -6.32 17.77 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.093 1.862 . . . . 0.0 112.41 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -113.21 -29.41 7.29 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.691 0.282 . . . . 0.0 111.054 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.96 -30.31 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.573 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 108.41 0.12 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.42 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.648 ' CZ ' HD12 ' B' ' 47' ' ' ILE . 24.6 m-85 59.86 123.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.154 0.502 . . . . 0.0 111.772 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.8 t0 -138.01 52.56 1.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.204 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.038 HG22 HG13 ' B' ' 21' ' ' VAL . 87.8 t -65.37 124.81 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -114.88 -23.86 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.52 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -148.33 69.63 1.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.698 0.285 . . . . 0.0 111.558 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.768 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.5 mt -83.74 176.66 8.79 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.255 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -77.04 144.2 71.6 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.3 -49.1 18.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.275 1.983 . . . . 0.0 112.265 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -47.32 47.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.933 0.396 . . . . 0.0 110.375 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' B' ' 35' ' ' ASP . 21.5 mt -59.12 -35.12 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.678 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -48.79 -35.96 15.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.063 0.458 . . . . 0.0 110.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.9 t -78.34 -46.31 20.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.438 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.824 ' CB ' HD21 ' A' ' 70' ' ' LEU . 12.3 mt -73.97 -26.62 60.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.309 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.768 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -66.57 -59.35 3.71 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 11.1 t -54.66 -25.98 30.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.192 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -23.81 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.741 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 70' ' ' LEU . . . -102.44 70.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.45 -30.51 7.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.917 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.648 HD12 ' CZ ' ' B' ' 29' ' ' PHE . 1.4 mm -94.35 37.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.372 0.606 . . . . 0.0 110.898 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -89.55 -141.17 0.14 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.975 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 3.8 mt-10 -42.02 -25.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 76.33 -70.64 0.13 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 65.23 -175.84 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mt -169.01 130.31 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.04 116.05 0.16 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.906 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -77.33 99.97 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.853 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.72 105.54 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.102 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.93 121.65 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.138 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.5 66.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 81.0 p -104.07 22.21 15.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.008 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.204 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.412 ' O3A' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.88 0.372 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.73 158.5 15.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.812 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.9 m -143.18 136.29 28.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.354 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 173' ' ' ILE . 2.5 mp -103.43 125.14 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -87.25 97.2 10.65 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.151 0.501 . . . . 0.0 109.67 178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.47 121.39 43.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.702 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.08 127.2 67.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.084 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 20' ' ' LEU . 6.3 t -85.91 123.95 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.161 0.505 . . . . 0.0 110.496 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.12 161.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.433 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 151.11 138.14 2.78 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.671 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.93 56.71 3.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.11 -130.23 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -172.63 -168.37 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.871 HG12 " O4'" ' A' ' 181' ' ' GCP . 15.7 m 48.85 116.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.231 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.853 ' HA3' HG21 ' A' ' 115' ' ' THR . . . 114.58 -54.16 0.58 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 114.281 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HD2' ' PG ' ' A' ' 181' ' ' GCP . 0.0 OUTLIER -41.56 -56.1 2.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -176.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 84.5 m -95.18 -14.09 24.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.32 -26.81 47.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 110.393 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -92.03 -36.92 13.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.487 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 8' ' ' VAL . 29.9 mt -49.81 -45.25 49.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 0.0 110.71 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.568 HG22 ' OG1' ' A' ' 25' ' ' THR . 10.1 mm -76.05 -51.65 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.069 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.58 ' C ' HD21 ' A' ' 165' ' ' LEU . 39.0 m -58.92 -16.85 19.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 14.8 t80 -81.53 -37.93 27.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.603 0.24 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.771 HG21 ' CD1' ' B' ' 15' ' ' PHE . 20.7 m -98.16 -29.15 13.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -109.13 -20.57 12.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER 68.88 18.47 8.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.649 0.261 . . . . 0.0 110.928 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 116.79 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 29.4 t80 -62.73 125.53 86.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.664 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 65.2 Cg_endo -73.39 158.68 47.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.524 2.149 . . . . 0.0 112.645 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.73 -4.49 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.589 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -59.19 167.97 1.57 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.49 -168.35 1.9 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.37 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 32' ' ' TYR . 6.2 m 54.82 159.08 0.06 OUTLIER Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.896 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 77.2 Cg_exo -48.42 163.12 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.554 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' PHE . 7.5 m -85.16 -26.88 26.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.644 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG13 ' CE2' ' A' ' 64' ' ' TYR . 13.1 t 65.8 -70.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.833 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' B' ' 38' ' ' LEU . 88.9 t80 -171.55 109.29 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -124.91 130.3 52.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -116.67 138.48 51.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 111.663 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.1 m-85 -143.29 158.6 43.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.352 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.4 119.64 19.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 111.039 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG12 HG23 ' A' ' 44' ' ' VAL . 14.6 t -105.02 141.81 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' B' ' 13' ' ' SER . 23.0 m -106.65 106.97 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.629 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.4 t -118.63 156.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.343 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.401 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.4 mmt -88.78 88.79 7.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.466 HG12 HG23 ' B' ' 9' ' ' ILE . 19.9 mt -104.46 127.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.183 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.11 27.84 71.28 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.383 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.34 27.15 73.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -150.58 158.69 35.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.673 0.273 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 118.27 5.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.491 2.128 . . . . 0.0 112.031 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 2' ' ' GLN . 4.1 m-85 -118.63 -177.51 3.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.4 m -141.07 138.32 33.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.63 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 173' ' ' ILE . 44.4 tp -111.68 102.52 10.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.24 98.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.154 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mt -88.78 132.45 34.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.38 . . . . 0.0 111.165 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 6.8 m-85 -133.08 151.14 52.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.74 141.78 50.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -147.27 133.25 19.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.61 -169.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.68 -103.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.16 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -178.7 83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.845 0.355 . . . . 0.0 111.426 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.38 -56.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.68 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.45 -59.73 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CE2' HG13 ' A' ' 36' ' ' VAL . 2.6 m-85 -94.86 25.36 4.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.665 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -50.33 -30.42 12.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 6.7 mmt180 -68.03 -55.01 14.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.362 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.653 ' HB3' ' HB3' ' B' ' 45' ' ' ALA . 4.6 pp -97.89 17.41 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.559 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 7.1 ttt85 -81.53 -58.87 0.47 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 38.6 Cg_endo -66.92 -6.72 16.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.498 2.132 . . . . 0.0 113.299 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.626 HD22 HD13 ' B' ' 41' ' ' LEU . 81.5 mt -57.17 -20.51 26.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.47 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.0 17.8 13.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.5 m-30 -92.05 -38.38 0.36 Allowed Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 50.1 Cg_exo -40.17 105.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.031 1.821 . . . . 0.0 113.004 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 75.86 61.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.741 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 m -90.15 135.83 33.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.849 0.356 . . . . 0.0 110.667 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 19.2 m-20 -97.53 -27.52 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.53 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.7 p -159.2 173.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.784 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE1' HG21 ' A' ' 75' ' ' THR . 43.2 m-85 -138.31 118.05 13.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.681 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 113' ' ' VAL . 3.8 mt -88.16 104.14 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.0 t -96.62 86.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.446 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.6 m -86.61 111.54 20.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.115 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -105.12 169.04 8.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.038 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -92.36 110.54 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG21 ' OE2' ' A' ' 156' ' ' GLU . 90.8 t -62.36 -31.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 116' ' ' GLN . 24.8 m -97.07 35.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.89 0.376 . . . . 0.0 110.838 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.29 83.29 5.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.35 -34.42 3.05 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.534 2.156 . . . . 0.0 112.326 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -52.77 59.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.683 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.9 m -53.36 -49.43 67.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.341 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 141' ' ' THR . 51.3 t80 -54.03 -46.22 71.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.748 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.62 80.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.943 0.401 . . . . 0.0 110.956 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 75.1 m-20 -84.06 -25.81 29.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.435 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 89' ' ' SER . 8.7 t -52.28 -42.89 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.303 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -91.69 -16.3 27.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -138.64 56.68 1.7 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.64 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER 171.67 -53.56 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 13.3 m95 -71.92 -55.16 7.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.238 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 149' ' ' LEU . 84.5 t -70.23 -58.73 4.74 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.809 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.7 Cg_endo -48.79 -38.69 38.11 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.281 1.987 . . . . 0.0 112.175 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 1.9 mm-40 -54.07 -35.53 62.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.376 . . . . 0.0 110.234 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.04 -45.81 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 98' ' ' VAL . 8.6 p -56.89 -27.41 60.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -68.33 -29.42 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.168 0.508 . . . . 0.0 110.064 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -91.63 -43.28 9.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.292 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.2 p -155.04 90.08 3.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.57 1.51 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.0 113.064 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -37.32 10.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 p -52.67 148.63 12.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.651 ' HG2' HG23 ' A' ' 77' ' ' VAL . 59.1 Cg_endo -68.88 161.04 47.28 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.721 2.281 . . . . 0.0 111.573 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 152' ' ' VAL . 45.6 m-85 -138.78 112.3 8.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.898 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -87.41 122.34 31.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.519 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.718 HD22 ' HD1' ' A' ' 154' ' ' TYR . 0.9 OUTLIER -91.78 114.28 26.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.666 0.269 . . . . 0.0 110.501 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG21 ' CD2' ' A' ' 79' ' ' LEU . 45.1 t -118.47 117.19 53.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 112.01 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -96.61 110.43 4.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.689 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.853 HG21 ' HA3' ' A' ' 15' ' ' GLY . 1.6 m -103.02 173.1 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.637 ' CD ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER 75.93 58.08 0.05 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.047 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -87.53 -36.66 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.531 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -45.05 -32.55 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.272 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.637 HD12 ' CD ' ' A' ' 116' ' ' GLN . 27.5 mt -90.9 -36.92 13.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.27 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.647 ' O ' HD11 ' A' ' 126' ' ' ILE . 2.7 ttp85 -57.73 -25.14 59.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.38 9.06 40.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.614 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -112.38 93.19 21.61 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 120.73 0.3 . . . . 0.0 110.968 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 87.2 Cg_exo -47.47 -38.69 27.95 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.783 2.322 . . . . 0.0 112.507 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.77 -40.11 40.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 3.6 p -91.01 -44.92 9.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.046 0.45 . . . . 0.0 109.992 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.703 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 34.9 mt -51.31 -50.64 26.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.52 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -72.48 -24.94 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.21 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -66.92 -45.76 76.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.741 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -98.01 -20.91 17.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.6 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -46.06 -25.72 0.62 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.663 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.05 25.66 5.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.4 m-80 -119.78 -32.46 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.92 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 170.33 -21.65 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 69.3 mt-30 -120.31 169.33 10.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.903 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -163.16 148.39 9.45 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.531 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.1 Cg_endo -74.43 150.47 41.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.316 2.011 . . . . 0.0 111.853 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.29 143.82 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.2 p -96.73 160.84 28.41 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.519 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 35.4 Cg_exo -58.73 -37.78 92.34 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.862 2.375 . . . . 0.0 112.375 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.11 -43.12 83.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 5.8 m -66.32 -40.14 89.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -75.25 -47.8 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 21.9 tt0 -50.87 -37.56 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.0 110.179 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 6.2 ttpt -55.41 -51.99 65.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.83 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.766 HD23 HG12 ' A' ' 93' ' ' VAL . 8.1 mp -54.26 -43.18 70.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -52.67 -29.99 29.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.682 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -96.63 -31.13 12.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.749 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 4.5 t0 -74.77 -31.88 61.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.819 HD13 HG21 ' A' ' 98' ' ' VAL . 5.3 mt -99.14 18.88 16.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 56.24 24.09 7.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.503 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.75 147.21 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.958 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 175' ' ' ALA . 18.1 m -63.44 -30.66 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HD2' ' CG ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER 175.38 162.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.055 0.455 . . . . 0.0 110.703 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.718 ' HD1' HD22 ' A' ' 112' ' ' LEU . 36.8 t80 -107.73 134.18 51.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.154 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 168' ' ' VAL . 28.6 m -146.4 151.86 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.033 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 mt-10 -125.87 142.72 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.297 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.94 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.1 p -165.44 157.33 14.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.381 0.61 . . . . 0.0 112.53 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.444 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.4 t -135.69 176.46 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.811 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -103.74 -34.01 8.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.724 0.297 . . . . 0.0 111.303 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD12 ' HN1' ' A' ' 181' ' ' GCP . 6.9 mt -68.14 -50.53 54.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.663 0.744 . . . . 0.0 110.282 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -87.91 -32.02 19.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.157 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.409 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 56.4 mt-30 69.79 24.72 5.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.03 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.06 110.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.576 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.935 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 52.03 23.52 11.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.106 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.835 HD12 HD12 ' A' ' 19' ' ' LEU . 64.7 tp -48.4 -35.68 13.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.356 . . . . 0.0 111.252 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -84.46 -51.93 6.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.479 -179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -47.04 -32.22 3.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.487 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.94 HG21 ' SG ' ' A' ' 157' ' ' CYS . 18.4 t -60.53 -58.55 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.475 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 173' ' ' ILE . 87.3 m-85 -60.4 -37.53 81.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.021 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -28.85 48.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.621 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -82.65 -43.05 17.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.502 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -53.22 -63.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.8 mp -47.48 -58.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.116 0.484 . . . . 0.0 110.35 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.697 HD12 ' HB ' ' B' ' 4' ' ' ILE . 11.8 tp -51.67 -30.8 23.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.07 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -77.21 -54.12 6.89 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -51.68 -50.93 59.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 110.692 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' B' ' 4' ' ' ILE . 23.9 mt -66.86 -178.0 0.69 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 pt-20 -169.64 165.75 6.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.595 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.6 Cg_endo . . . . . 0 C--O 1.249 1.058 0 C-N-CA 123.06 2.507 . . . . 0.0 112.252 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 9.4 tttt -131.25 25.31 4.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.559 . . . . 0.0 110.933 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -71.42 114.25 9.29 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.77 0.795 . . . . 0.0 111.596 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.5 mm -91.67 146.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.421 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.4 p -130.33 157.77 41.64 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.842 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -52.03 -26.95 12.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.04 -2.92 45.8 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 78.9 m-20 -81.06 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.63 0.252 . . . . 0.0 111.206 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.712 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mt -50.35 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 110.849 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.6 -152.36 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.399 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.11 139.0 28.73 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.651 0.262 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.79 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -59.52 163.47 12.83 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.091 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 172.9 153.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.84 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 36.58 17.81 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.681 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.771 ' CD1' HG21 ' A' ' 24' ' ' THR . 23.5 t80 -41.8 111.72 0.26 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.878 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.1 tptm -113.41 104.31 12.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.818 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -70.22 85.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -71.05 -21.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.716 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 27.3 t -179.72 159.62 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 111.331 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . 0.437 ' CG ' ' OD1' ' A' ' 38' ' ' ASP . 3.1 t-160 -160.74 129.11 4.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 68.7 t -116.85 125.43 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -122.69 98.07 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.634 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 73.5 t90 -93.82 102.67 14.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.346 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.84 144.1 44.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.338 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.46 -8.75 17.33 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.471 2.114 . . . . 0.0 112.852 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -112.59 -27.27 8.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -110.2 -32.25 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.249 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 -153.66 19.21 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.959 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.469 ' CE2' HD12 ' B' ' 47' ' ' ILE . 14.6 m-85 -64.66 126.91 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.6 m-20 -117.01 40.46 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.199 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.692 HG22 HG13 ' B' ' 21' ' ' VAL . 91.3 t -65.01 119.63 9.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.169 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.91 -31.37 8.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.937 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -143.35 79.68 1.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.208 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.74 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.0 OUTLIER -87.84 162.19 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.469 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.606 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -69.01 147.79 97.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.823 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.11 -58.2 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.489 2.126 . . . . 0.0 112.041 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 8.6 m-20 -63.92 -34.8 78.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.823 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' B' ' 35' ' ' ASP . 29.3 mt -76.0 -21.18 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.152 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 1.6 mtt-85 -64.0 -37.8 88.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.968 0.413 . . . . 0.0 110.641 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.8 OUTLIER -76.23 -30.81 58.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.623 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 70' ' ' LEU . 31.2 mt -82.61 -34.24 27.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.881 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.74 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -57.33 -59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.419 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -58.69 -24.48 61.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.011 0.434 . . . . 0.0 110.34 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -88.71 -13.06 40.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.73 -94.51 0.26 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.04 -17.93 21.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.476 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.592 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.4 mm -92.96 40.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.162 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -75.84 -153.16 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.632 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.52 -27.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 62.26 -161.46 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.692 0.282 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -68.55 149.83 48.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.93 142.44 32.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.543 HG22 ' O ' ' B' ' 53' ' ' THR . 30.6 m -101.92 8.36 41.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.15 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t0 58.13 33.49 23.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.968 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 31.91 21.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 68.68 118.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.718 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.42 106.26 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.95 -165.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.671 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.874 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.871 " O4'" HG12 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.87 0.367 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' CB ' ' CE2' ' A' ' 51' ' ' TYR . 7.5 mm100 -160.33 159.25 31.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 24.829999999999998 110.857 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 52' ' ' THR . 61.4 m -143.15 134.42 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 25.719999999999999 111.12 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 173' ' ' ILE . 1.9 mp -99.7 145.48 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 24.190000000000001 110.773 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.58 90.77 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.038 0.446 . . . . 25.460000000000001 111.102 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -105.65 142.2 35.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.712 -0.676 . . . . 14.300000000000001 110.535 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.46 129.54 75.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 16.300000000000001 110.746 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 56' ' ' PHE . 3.7 t -86.7 111.94 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.443 . . . . 6.1699999999999999 111.212 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.72 124.51 73.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 5.79 110.892 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -161.55 155.06 26.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.587 -0.816 . . . . 7.2699999999999996 112.672 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -69.36 146.42 52.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 21.84 110.986 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.53 -136.51 27.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 8.6400000000000006 112.6 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -102.9 -53.99 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.079 -0.071 . . . . 12.93 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.85 HG12 ' OE1' ' A' ' 116' ' ' GLN . 2.2 m 54.91 -60.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.147 0.979 . . . . 12.76 113.171 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . 154.8 43.34 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.566 -0.826 . . . . 13.699999999999999 112.629 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.2 0.524 . . . . 9.6899999999999995 112.173 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.841 ' HA ' HD12 ' A' ' 20' ' ' LEU . 67.6 m -60.32 -13.02 10.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.545 0.572 . . . . 18.190000000000001 112.545 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 1.8 t -61.33 -59.91 4.55 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 121.144 -0.223 . . . . 17.050000000000001 110.884 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.9 OUTLIER -67.96 -25.51 65.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.421 -0.912 . . . . 13.42 110.117 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 17' ' ' THR . 28.6 mt -57.37 -35.95 70.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.04 0.447 . . . . 16.969999999999999 109.808 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.7 mm -88.71 -39.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 17.0 110.58 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 165' ' ' LEU . 11.9 m -74.67 -6.13 47.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 16.43 111.344 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.2 t80 -97.28 -54.8 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.805 0.336 . . . . 21.149999999999999 110.737 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.437 ' CG2' HG21 ' A' ' 42' ' ' VAL . 31.6 p -66.99 -42.9 84.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 18.940000000000001 111.649 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 p -96.44 -18.54 19.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.479 -0.328 . . . . 30.5 111.549 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.4 t30 71.1 21.01 4.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.608 0.242 . . . . 34.789999999999999 111.32 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.05 146.68 52.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.42 . . . . 24.600000000000001 111.14 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 54.2 t80 -81.38 136.43 49.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 23.109999999999999 110.582 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 27.7 Cg_endo -62.35 -168.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 29.510000000000002 112.565 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.77 -48.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 41.890000000000001 110.576 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.38 168.21 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.038 -0.528 . . . . 43.869999999999997 110.688 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.5 p90 -134.16 115.73 14.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.13 0.491 . . . . 23.27 110.73 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -172.14 124.14 0.5 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.66 -0.7 . . . . 21.530000000000001 110.397 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 36' ' ' VAL . 50.1 Cg_exo -54.71 123.62 14.16 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.509 2.139 . . . . 15.4 112.81 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 38' ' ' ASP . 1.1 m -61.43 -29.58 70.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 20.140000000000001 111.214 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 51.72 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.905 -0.589 . . . . 23.469999999999999 110.391 -176.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' N ' HG22 ' A' ' 36' ' ' VAL . 47.5 t80 -145.83 91.35 2.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.896 0.379 . . . . 31.059999999999999 110.932 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 35' ' ' THR . 72.4 m-20 -118.63 120.44 37.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.089 -0.505 . . . . 36.280000000000001 110.677 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 118.13 36.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 41.530000000000001 110.925 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 0.7 OUTLIER -115.93 165.57 12.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 31.02 110.58 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.3 119.43 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 24.329999999999998 110.955 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 44' ' ' VAL . 12.4 t -105.12 139.88 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.2 m -107.06 110.51 22.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.807 HG22 ' HA ' ' B' ' 12' ' ' PRO . 6.2 t -121.12 159.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 27.280000000000001 111.55 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.443 ' N ' HG12 ' A' ' 44' ' ' VAL . 15.9 mmt -87.36 88.42 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.534 . . . . 35.5 110.213 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 51' ' ' TYR . 21.9 mt -108.49 124.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.345 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.28 35.45 90.94 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.828 -0.701 . . . . 24.620000000000001 112.829 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.05 25.45 74.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 28.449999999999999 112.544 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -148.5 141.5 15.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.809 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 96.0 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.498 2.132 . . . . 25.879999999999999 112.254 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CB ' HD12 ' A' ' 46' ' ' ILE . 4.0 m-85 -81.74 -177.69 6.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 26.190000000000001 110.953 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 3' ' ' THR . 5.3 m -142.42 91.56 2.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 29.100000000000001 110.798 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD13 HG12 ' A' ' 173' ' ' ILE . 38.1 tp -65.64 136.51 56.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 19.32 111.064 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -95.21 102.15 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 16.780000000000001 112.083 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -84.85 110.83 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.864 0.364 . . . . 20.41 111.195 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.643 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.3 m-85 -119.45 129.5 54.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 19.059999999999999 110.856 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -120.27 140.23 51.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 14.960000000000001 110.972 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -123.61 163.71 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 11.77 110.916 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.94 150.03 20.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 9.6099999999999994 111.023 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.4 -40.84 14.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 9.8800000000000008 112.668 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.84 164.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.34 . . . . 24.239999999999998 111.121 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -91.45 -24.95 19.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 32.149999999999999 111.132 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.91 -25.57 30.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 27.510000000000002 110.898 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -94.38 15.23 18.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 14.69 111.329 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -72.11 -25.67 61.83 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 24.670000000000002 111.088 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -62.41 -40.19 95.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 46.119999999999997 111.15 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.736 HD21 HD11 ' B' ' 47' ' ' ILE . 4.4 pp -116.85 24.65 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 18.940000000000001 111.315 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 12.9 ttt-85 -79.24 -44.16 1.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.33 . . . . 19.91 111.564 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 15.6 Cg_exo -67.7 -25.54 40.0 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.407 2.071 . . . . 19.93 111.533 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.779 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.9 mp -56.83 -22.14 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 22.690000000000001 111.05 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.7 m -89.54 17.85 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.333 -0.394 . . . . 20.390000000000001 111.744 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 4.4 m-85 -118.35 47.21 0.78 Allowed Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 111.673 0.249 . . . . 25.010000000000002 111.673 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 37.2 Cg_endo -64.8 90.76 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.431 2.087 . . . . 18.16 111.988 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 54.39 39.52 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 45.259999999999998 110.667 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -47.5 145.31 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.071 -0.513 . . . . 20.66 111.246 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 108' ' ' THR . 53.9 m-20 -94.65 -74.75 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.531 . . . . 22.870000000000001 110.641 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.803 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -103.43 175.77 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.364 -0.38 . . . . 16.510000000000002 110.585 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' H ' HG22 ' A' ' 77' ' ' VAL . 88.2 m-85 -136.82 125.74 24.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.527 -0.306 . . . . 16.420000000000002 111.206 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 113' ' ' VAL . 1.6 mt -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 14.58 110.789 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.89 86.44 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 13.09 111.218 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.561 ' SG ' HG11 ' A' ' 113' ' ' VAL . 79.1 m -82.9 111.4 18.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 7.6200000000000001 110.558 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.645 ' CG ' HG21 ' A' ' 93' ' ' VAL . 11.5 p90 -121.59 137.48 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 13.210000000000001 110.682 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.72 119.12 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.34 -0.391 . . . . 7.7199999999999998 111.05 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.62 -28.99 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 16.969999999999999 110.735 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 116' ' ' GLN . 16.4 m -91.72 38.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 8.5700000000000003 111.208 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.65 110.44 0.48 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 16.260000000000002 110.711 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.18 -19.41 66.54 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.466 2.111 . . . . 14.83 112.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.1 p -51.96 -64.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.379 -0.373 . . . . 13.029999999999999 110.786 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -54.98 -43.62 73.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 16.82 110.568 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 145' ' ' LEU . 59.6 t80 -58.83 -38.7 79.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 14.56 111.202 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.76 -51.19 65.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 32.299999999999997 110.592 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.437 ' CA ' ' HB2' ' A' ' 96' ' ' LYS . 67.3 m-20 -71.81 -29.1 64.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 17.640000000000001 110.245 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 89' ' ' SER . 2.2 t -49.79 -47.58 22.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 13.449999999999999 110.405 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 149' ' ' LEU . 24.9 pttt -89.61 -20.38 23.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.957 -0.565 . . . . 21.16 111.326 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.27 56.29 1.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.035 -0.266 . . . . 24.600000000000001 111.624 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HB2' ' CA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -179.34 -71.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.8 0.296 . . . . 21.09 111.8 179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.413 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 67.0 m95 -65.87 -47.17 75.8 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.874 0.324 . . . . 17.559999999999999 111.874 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.062 HG11 HD22 ' A' ' 149' ' ' LEU . 81.8 t -70.03 -59.68 4.15 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 111.747 0.277 . . . . 22.34 111.747 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 9.5 Cg_endo -53.2 -22.54 20.11 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.393 2.062 . . . . 18.300000000000001 112.616 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.54 -31.53 62.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.442 -0.344 . . . . 19.289999999999999 111.065 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 97' ' ' TRP . 5.6 pt -95.68 -39.95 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.347 -0.388 . . . . 22.129999999999999 111.166 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' VAL . 13.8 p -52.85 -28.08 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 31.07 110.503 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -77.25 -38.4 51.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 45.039999999999999 110.672 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.23 -29.4 38.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 27.469999999999999 110.457 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 55.5 m -153.91 92.9 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.8 -0.637 . . . . 24.829999999999998 110.786 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.59 10.87 3.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.837 2.358 . . . . 25.039999999999999 112.867 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.485 ' HD2' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -117.11 -35.64 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.093 0.473 . . . . 46.100000000000001 110.719 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 107' ' ' LYS . 5.4 p -55.17 139.54 64.68 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 26.629999999999999 111.315 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.803 ' HB2' HG23 ' A' ' 77' ' ' VAL . 28.7 Cg_endo -61.73 154.33 61.3 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.637 2.225 . . . . 18.600000000000001 111.883 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.37 93.53 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 40.719999999999999 111.559 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -72.64 121.1 19.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.562 . . . . 19.739999999999998 110.544 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 146' ' ' ALA . 31.1 tp -91.67 120.38 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 10.789999999999999 110.699 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 79' ' ' LEU . 59.9 t -119.76 125.81 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.077 0.465 . . . . 9.4600000000000009 111.866 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.41 99.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.727 -0.67 . . . . 9.3000000000000007 111.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -91.77 177.32 6.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.804 0.335 . . . . 15.23 111.292 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.85 ' OE1' HG12 ' A' ' 14' ' ' VAL . 1.1 mp0 75.58 54.03 0.06 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.165 -0.47 . . . . 21.949999999999999 110.843 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.599 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.5 OUTLIER -91.73 -31.94 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 32.060000000000002 110.634 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -50.39 -24.69 3.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 23.920000000000002 111.041 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.572 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -97.39 -33.49 11.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 26.850000000000001 110.643 178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.653 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.24 -23.56 36.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 30.25 110.975 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.74 3.19 44.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 41.909999999999997 111.594 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.413 ' C ' HD12 ' A' ' 126' ' ' ILE . 28.8 t0 -106.37 103.59 46.45 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-O 120.495 0.188 . . . . 44.479999999999997 110.676 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 Cg_endo -61.55 -38.33 63.35 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.331 2.02 . . . . 38.350000000000001 112.422 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 32.7 m -50.04 -36.7 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 39.350000000000001 111.043 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 1.4 p -92.6 -46.21 7.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.168 -0.469 . . . . 38.759999999999998 110.09 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 48.2 mt -51.55 -48.52 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 32.710000000000001 110.514 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.1 -27.05 61.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 24.5 ttmt -65.8 -45.62 81.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.393 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -97.14 -20.42 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 37.560000000000002 111.596 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -40.29 -29.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.248 0.462 . . . . 32.729999999999997 112.248 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.62 30.27 3.48 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.962 0.356 . . . . 38.119999999999997 111.962 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.8 m-80 -117.03 -31.17 5.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 42.579999999999998 111.523 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER 172.57 -22.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.886 0.698 . . . . 40.969999999999999 112.886 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.482 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 2.5 mt-30 -121.63 178.73 4.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.118 0.485 . . . . 33.280000000000001 111.609 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.24 147.18 1.78 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.683 -0.689 . . . . 24.899999999999999 110.622 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.47 ' HG3' HG23 ' A' ' 126' ' ' ILE . 73.4 Cg_endo -76.02 145.59 28.23 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.613 2.208 . . . . 17.710000000000001 112.351 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.73 136.96 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 15.6 110.936 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -83.02 148.63 57.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 15.279999999999999 110.933 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 73.9 Cg_exo -49.04 -37.7 38.23 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.573 2.182 . . . . 16.66 112.24 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -68.89 -48.74 62.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 26.050000000000001 110.946 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 99.2 m -53.62 -41.78 67.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 24.600000000000001 110.791 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -70.61 -46.88 62.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 24.949999999999999 110.745 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.49 -31.67 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.079 0.466 . . . . 28.390000000000001 110.005 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 141' ' ' THR . 31.8 tttt -56.81 -50.85 71.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.749 -0.66 . . . . 38.969999999999999 109.969 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.778 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -59.93 -45.74 91.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.591 -0.522 . . . . 21.739999999999998 109.591 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.636 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -57.78 -26.48 61.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.544 -0.753 . . . . 25.300000000000001 110.951 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -96.5 -32.08 12.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 31.18 111.092 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.63 -25.57 53.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 32.659999999999997 110.689 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.062 HD22 HG11 ' A' ' 98' ' ' VAL . 6.4 mt -102.87 13.67 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 18.489999999999998 111.461 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt 61.07 21.23 11.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.603 0.239 . . . . 24.100000000000001 111.387 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -53.64 141.4 26.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.345 . . . . 15.08 110.934 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.789 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.2 m -58.43 -31.8 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 21.399999999999999 111.314 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.95 149.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 18.59 111.262 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.566 ' CD1' HD23 ' A' ' 112' ' ' LEU . 4.5 t80 -98.45 129.31 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 24.530000000000001 110.593 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' A' ' 168' ' ' VAL . 32.7 m -147.55 126.42 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 21.629999999999999 111.342 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.61 144.8 28.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.947 -0.57 . . . . 22.43 110.174 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.897 ' SG ' HG21 ' A' ' 168' ' ' VAL . 23.3 p -166.03 152.71 9.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.551 0.691 . . . . 17.100000000000001 112.688 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 159' ' ' ALA . 1.4 t -136.23 178.53 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.145 . . . . 13.880000000000001 108.742 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' OG ' ' A' ' 158' ' ' SER . . . -109.56 -24.93 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.296 -0.562 . . . . 8.2699999999999996 110.998 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.8 tm? -65.91 -51.73 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 13.52 110.235 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.1 m -93.52 -29.58 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.619 -0.718 . . . . 16.469999999999999 111.199 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 70.42 28.12 3.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.3 -0.409 . . . . 22.699999999999999 111.179 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.447 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -66.31 121.96 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 49.39 32.23 14.53 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.507 -0.854 . . . . 14.550000000000001 111.868 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.661 HD11 ' CB ' ' A' ' 19' ' ' LEU . 60.4 tp -65.25 -39.95 93.36 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.878 0.325 . . . . 14.75 111.878 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -78.47 -44.04 25.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.452 -0.34 . . . . 24.77 111.615 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.38 -46.95 62.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.261 -0.427 . . . . 26.550000000000001 111.618 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.897 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.9 t -46.17 -71.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 22.120000000000001 111.993 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 19' ' ' LEU . 43.2 m-85 -52.06 -45.65 64.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 19.68 110.573 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -30.61 50.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.913 -0.585 . . . . 32.18 110.533 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.591 ' HB3' HD21 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -82.44 -30.09 30.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 21.449999999999999 110.573 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.446 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -66.17 -68.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 10.77 110.614 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 4' ' ' ILE . 2.9 mt -44.75 -54.86 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.209 0.528 . . . . 20.210000000000001 110.82 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -49.7 -29.57 7.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.498 -0.774 . . . . 19.699999999999999 110.527 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.789 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.77 -47.77 7.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 13.52 111.134 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -49.22 -35.51 17.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 10.539999999999999 111.038 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.474 ' HB2' HG13 ' B' ' 4' ' ' ILE . 22.4 mt -83.28 -172.34 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 15.24 110.657 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.6 OUTLIER -162.08 160.73 21.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.069 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.929 2.42 . . . . 0.0 112.115 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.3 tttp -133.76 25.6 4.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 111.175 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 13.4 mmmt -73.58 117.77 15.75 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.837 0.827 . . . . 0.0 111.687 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -85.98 149.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.012 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.413 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.31 171.52 12.83 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -63.07 -28.31 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.756 0.312 . . . . 0.0 111.197 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 -2.19 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' B' ' 5' ' ' SER . 76.4 m-20 -79.47 -67.52 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.617 0.246 . . . . 0.0 111.408 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.653 HG22 HG11 ' A' ' 44' ' ' VAL . 1.7 mt -52.09 99.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 0.0 110.837 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.62 -145.23 0.1 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.604 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.84 137.92 29.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.591 0.234 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.807 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.4 Cg_endo -62.91 160.89 31.47 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.403 2.069 . . . . 0.0 112.156 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -175.64 -167.7 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.59 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.41 29.1 10.41 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.683 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -42.34 108.07 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.972 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.8 ttpp -114.73 140.85 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.048 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -101.25 84.65 2.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.07 -38.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.919 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -146.68 124.3 11.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.908 0.385 . . . . 0.0 110.791 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -121.95 115.68 22.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.164 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.085 HG13 HG22 ' B' ' 31' ' ' VAL . 62.1 t -109.7 123.09 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.56 100.21 1.49 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.16 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -96.65 94.93 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.798 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' B' ' 28' ' ' GLY . 32.2 m-20 -68.91 137.74 90.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.226 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.92 -8.3 22.71 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.127 1.885 . . . . 0.0 112.375 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -113.46 -45.27 3.14 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.96 0.41 . . . . 0.0 110.798 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.35 19.02 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.447 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 61.73 -130.06 45.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.448 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -82.8 152.15 25.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.93 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -155.6 63.18 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.085 HG22 HG13 ' B' ' 21' ' ' VAL . 53.1 t -65.32 126.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.928 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.7 -35.49 6.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.082 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -143.56 81.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.528 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' B' ' 42' ' ' PHE . 2.4 mt -93.5 -176.84 4.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.44 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.583 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -94.09 153.41 40.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.791 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.28 -55.31 2.28 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.6 2.2 . . . . 0.0 111.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 -40.43 76.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.611 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' B' ' 35' ' ' ASP . 18.7 mt -68.28 -26.66 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.607 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -57.01 -39.24 74.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.006 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.1 -28.12 42.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.779 ' HB3' HD21 ' A' ' 70' ' ' LEU . 29.1 mt -86.5 -30.31 22.07 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -67.16 -54.87 17.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 19.1 t -61.26 -27.0 68.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.443 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -90.97 -21.31 21.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.29 70.8 1.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.33 12.84 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.843 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.736 HD11 HD21 ' A' ' 67' ' ' LEU . 2.1 mm -96.33 30.93 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 110.859 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 4.4 p -82.6 -145.35 0.07 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.71 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 0.2 OUTLIER -45.19 -23.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 70.88 103.76 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 111.09 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.98 169.07 10.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.097 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.481 ' C ' HG23 ' B' ' 53' ' ' THR . 0.9 OUTLIER -105.32 -9.29 17.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.599 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.481 HG23 ' C ' ' B' ' 52' ' ' LEU . 0.1 OUTLIER 60.38 112.45 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.576 0.703 . . . . 0.0 111.137 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.94 114.15 15.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.099 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.16 18.42 17.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.285 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.04 172.04 13.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.442 ' O ' HG22 ' B' ' 57' ' ' THR . 7.2 m 72.01 17.54 5.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 10.8 m -79.37 63.92 4.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.962 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.488 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -84.48 131.64 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.775 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 52' ' ' THR . 97.4 m -140.46 138.05 34.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.971 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 173' ' ' ILE . 5.0 mp -94.65 129.47 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.761 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 6.6 tptm -87.81 87.18 7.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 113.03 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.03 125.63 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 16.7 t -86.47 111.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.631 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.55 148.07 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.402 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 153.0 153.64 6.41 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.644 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.41 128.22 35.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.756 0.312 . . . . 0.0 110.991 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.69 -178.74 48.78 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.687 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.05 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.818 0.342 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 81' ' ' CYS . 27.7 m -148.55 31.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 73.69 64.78 2.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.32 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 20' ' ' LEU . 20.8 mtmm -68.09 -74.23 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 111.469 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -69.33 -15.08 63.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.203 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.13 -67.07 0.64 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.073 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.54 -35.71 63.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.733 -177.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 59.6 mt -52.02 -45.88 64.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 110.342 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.63 -46.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.649 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.0 m -58.73 -24.57 61.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.753 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CE2' ' CG ' ' A' ' 169' ' ' PHE . 9.6 t80 -79.45 -25.22 42.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' LEU . 7.5 p -104.27 -31.18 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.699 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 p -104.42 -22.6 13.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.529 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.68 19.78 9.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.699 0.285 . . . . 0.0 111.115 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 115.38 13.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -57.6 110.26 2.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 167.1 25.78 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.439 2.093 . . . . 0.0 112.608 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -116.37 -23.76 8.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.242 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.35 159.05 1.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 p90 -155.29 127.37 7.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 7.8 p -170.4 138.6 1.37 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.036 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 71.4 Cg_exo -49.08 101.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.51 2.14 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -94.21 117.4 30.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.702 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG2' HG11 ' B' ' 21' ' ' VAL . 2.5 m -88.11 -42.48 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' B' ' 38' ' ' LEU . 50.6 t80 -166.94 142.36 4.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -154.81 130.53 9.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.731 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 4.0 t-20 -109.1 119.03 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.392 . . . . 0.0 111.282 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -115.55 161.83 18.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.232 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -132.64 119.64 20.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' B' ' 12' ' ' PRO . 6.8 t -102.71 146.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.157 0.503 . . . . 0.0 110.789 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' B' ' 13' ' ' SER . 90.7 m -110.33 119.78 40.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.332 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG11 HG22 ' B' ' 9' ' ' ILE . 4.1 t -133.71 156.87 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.6 mmt -91.9 88.19 6.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.395 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 51' ' ' TYR . 8.4 mt -104.26 125.81 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.343 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.78 45.51 94.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.402 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.46 29.98 61.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.376 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -153.78 143.33 15.1 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.53 121.89 8.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.535 2.156 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' HB2' HD12 ' A' ' 46' ' ' ILE . 5.7 m-85 -111.14 -177.01 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.815 ' O ' HG23 ' A' ' 3' ' ' THR . 5.0 m -137.3 86.09 2.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.677 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.99 HD22 HD11 ' A' ' 173' ' ' ILE . 27.6 tp -60.64 125.93 25.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.28 115.75 5.0 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.148 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.1 134.51 45.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 88.2 m-85 -141.28 129.27 21.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.104 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.48 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 p30 -113.26 119.92 39.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 p -92.17 152.37 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.096 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.27 146.27 49.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.048 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.47 57.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.66 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.26 160.97 41.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.0 111.032 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.46 -36.53 38.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -64.51 -24.58 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.79 17.39 22.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.46 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 75.7 m-20 -66.96 -15.11 63.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.265 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -67.87 -61.42 1.88 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.65 0.262 . . . . 0.0 111.274 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -89.57 15.59 9.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.637 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -72.1 -55.31 5.18 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.728 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 30.9 Cg_endo -65.9 -7.61 17.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.239 1.959 . . . . 0.0 113.138 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' B' ' 41' ' ' LEU . 0.6 OUTLIER -49.9 -25.6 3.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.723 0.296 . . . . 0.0 110.993 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -97.78 15.57 23.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.491 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 14.4 m-30 -91.29 -44.39 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 81.0 Cg_exo -45.77 120.09 3.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.256 1.971 . . . . 0.0 112.718 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 63.27 51.54 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.648 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 25.1 m -86.64 127.06 34.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.85 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 8.0 m-20 -88.43 -27.09 21.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.39 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 2.5 p -157.12 173.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.708 0.289 . . . . 0.0 111.092 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.748 ' CG ' HG21 ' A' ' 101' ' ' ILE . 38.1 m-85 -136.73 118.18 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.36 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 3.9 mp -88.83 107.95 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.867 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.86 85.73 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 14' ' ' VAL . 80.2 m -81.17 111.97 18.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.152 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB2' HG21 ' A' ' 93' ' ' VAL . 7.5 p90 -120.61 150.56 40.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.589 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.75 129.09 37.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 0.0 111.13 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 115' ' ' THR . 97.5 t -76.75 -28.55 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.11 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 ' HG2' ' A' ' 116' ' ' GLN . 34.8 m -92.71 22.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.348 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 t -140.79 109.09 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.67 -30.73 5.98 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.468 2.112 . . . . 0.0 112.498 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -64.11 -33.1 74.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.997 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.973 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -77.63 -44.08 29.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 145' ' ' LEU . 45.3 t80 -61.93 -40.77 96.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.935 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -58.57 -27.34 64.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.047 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' LYS . 31.8 m-20 -89.36 -40.38 12.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 89' ' ' SER . 51.2 t -56.53 -28.97 28.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.854 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.723 ' HB3' HD21 ' A' ' 145' ' ' LEU . 10.6 ptpt -82.55 -26.62 32.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.076 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -149.66 71.92 1.12 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 169.07 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.829 -178.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.52 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 5.0 m95 -83.46 -33.41 25.64 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.69 -57.86 23.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.666 -178.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.77 ' HD3' HG23 ' A' ' 98' ' ' VAL . 37.9 Cg_endo -68.26 -31.94 27.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.937 2.425 . . . . 0.0 112.992 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' HG12 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -47.97 -32.03 5.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.321 . . . . 0.0 110.895 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.748 HG21 ' CG ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -96.58 -38.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.166 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 98' ' ' VAL . 2.6 p -60.91 -27.18 68.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.889 0.376 . . . . 0.0 110.644 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -27.74 66.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.683 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -93.29 -33.13 14.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.592 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 40.9 m -158.29 92.09 2.1 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.51 2.85 7.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.592 2.194 . . . . 0.0 113.01 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -27.8 10.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -63.76 148.82 93.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.376 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.743 ' HB2' HG11 ' A' ' 152' ' ' VAL . 53.3 Cg_endo -66.41 151.47 83.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.923 2.415 . . . . 0.0 111.76 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' H ' HG13 ' A' ' 152' ' ' VAL . 16.5 m-85 -125.44 105.96 9.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 0.0 111.501 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -81.46 120.05 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.995 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.628 HD13 ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -87.87 99.21 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 110.812 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 168' ' ' VAL . 75.1 t -97.33 120.45 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.401 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.85 113.52 4.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.794 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 m -108.48 168.26 9.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 111.265 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.667 ' HG3' HD12 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 82.55 39.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.544 HD12 ' HE2' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -82.34 -31.22 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.73 -25.29 7.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.452 -179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.667 HD12 ' HG3' ' A' ' 116' ' ' GLN . 20.3 mt -99.15 -34.66 10.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.542 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.685 ' O ' HD11 ' A' ' 126' ' ' ILE . 5.3 ttt-85 -56.72 -28.26 60.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.023 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -96.46 9.18 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.163 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.596 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -111.14 92.56 15.69 Favored Pre-proline 0 C--O 1.231 0.1 0 CA-C-O 120.754 0.312 . . . . 0.0 110.703 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.476 ' N ' HD12 ' A' ' 126' ' ' ILE . 87.8 Cg_exo -46.57 -40.72 23.79 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.815 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.9 t -53.15 -32.72 49.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.384 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 p -95.54 -43.41 7.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.774 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.3 mt -55.32 -45.84 78.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.171 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -73.72 -27.72 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.826 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.6 ttpp -62.55 -47.41 84.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.497 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.74 -21.83 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 111.401 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -44.65 -26.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.856 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -127.85 21.91 6.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.8 m-80 -113.64 -32.87 6.03 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.244 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 165.07 -27.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.938 179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.626 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -100.11 152.61 20.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.932 -177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.98 146.56 31.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.187 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.26 151.75 26.73 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.543 2.162 . . . . 0.0 112.511 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 84' ' ' VAL . 27.0 mm -99.97 137.07 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -88.15 154.14 51.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.164 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.68 -32.89 92.26 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.605 2.204 . . . . 0.0 111.93 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -70.19 -34.6 73.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.512 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.4 m -65.44 -55.23 19.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -61.67 -51.71 67.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -49.22 -42.94 42.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.78 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -52.18 -46.51 65.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.09 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.785 HD22 ' CE1' ' A' ' 90' ' ' PHE . 9.6 mp -63.89 -44.84 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.02 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -48.22 -31.92 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.68 -34.26 11.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.62 -21.49 62.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 98' ' ' VAL . 2.3 mt -112.78 19.41 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.47 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt 60.53 21.82 11.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.643 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.5 139.46 58.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.783 0.325 . . . . 0.0 110.766 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 109' ' ' PRO . 28.4 m -53.03 -35.23 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 mttp 174.43 166.5 0.24 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD1' HD22 ' A' ' 112' ' ' LEU . 22.1 t80 -106.37 127.62 53.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.828 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 171' ' ' GLU . 32.8 m -133.13 -176.69 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.075 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' N ' HG23 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -153.8 164.4 38.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.124 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 4.4 p -163.09 141.88 8.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.302 0.573 . . . . 0.0 112.368 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HB3' ' CB ' ' A' ' 163' ' ' LYS . 1.4 t -135.68 115.56 13.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.923 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.48 -20.01 55.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.668 0.271 . . . . 0.0 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 118' ' ' ASP . 28.5 tp -73.03 -46.39 52.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 111.146 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.8 m -118.56 4.53 11.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.5 mt-30 65.26 22.29 12.11 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.04 110.27 1.32 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 163' ' ' LYS . . . 47.39 23.05 1.79 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.073 HD13 HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -54.84 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.976 0.417 . . . . 0.0 111.235 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -54.95 -42.79 72.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.51 -25.9 18.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.531 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -70.07 -35.97 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.545 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.664 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.8 m-85 -79.36 -37.52 37.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.469 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -53.5 -34.06 56.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 110.11 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.72 ' CB ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -74.91 -34.52 62.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.825 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -65.98 -59.57 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.99 HD11 HD22 ' A' ' 53' ' ' LEU . 2.7 mp -50.06 -53.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.079 0.466 . . . . 0.0 110.189 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.547 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -50.71 -31.77 17.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.219 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -82.77 -47.31 12.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.85 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.59 -54.1 45.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.034 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' B' ' 4' ' ' ILE . 83.0 mt -62.78 -172.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.84 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 8.8 pt-20 -162.26 162.05 20.09 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.146 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.498 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.25 1.082 0 C-N-CA 123.009 2.473 . . . . 0.0 112.143 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 179' ' ' PRO . 2.2 tttp -134.81 24.98 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.384 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 4.2 mmmt -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.751 0.786 . . . . 0.0 111.564 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.4 mm -81.31 147.93 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.176 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.5 p -130.31 150.07 51.71 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.826 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -46.51 -26.79 0.94 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.731 0.301 . . . . 0.0 111.623 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.71 -2.89 47.0 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 88.8 m-20 -80.43 -67.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.278 . . . . 0.0 111.052 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 1.9 mp -49.35 96.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.5 -149.2 0.01 OUTLIER Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.15 118.08 68.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.47 0.176 . . . . 0.0 111.203 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.74 ' HA ' HG22 ' A' ' 44' ' ' VAL . 68.8 Cg_exo -51.29 152.03 12.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.331 2.02 . . . . 0.0 112.277 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.9 p 177.65 169.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.59 31.05 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.516 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' A' ' 24' ' ' THR . 9.7 t80 -39.33 115.43 0.5 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.96 0.41 . . . . 0.0 111.366 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -115.14 105.12 12.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -177.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 85.3 1.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.454 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -69.72 -46.95 73.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.785 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.8 t -144.4 136.48 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.926 0.393 . . . . 0.0 111.16 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -130.55 129.11 42.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.614 HG11 ' CG2' ' A' ' 36' ' ' VAL . 52.4 t -102.25 149.14 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -126.91 93.29 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.693 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 46.5 t90 -105.81 92.39 4.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.214 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' B' ' 25' ' ' PRO . 5.1 m-20 -79.79 130.17 68.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.292 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 24' ' ' ASP . 34.7 Cg_exo -60.92 -15.13 36.6 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.045 1.83 . . . . 0.0 112.387 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -113.28 -35.51 5.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.833 0.349 . . . . 0.0 111.284 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.56 -10.52 29.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.839 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 81.16 -160.1 42.03 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.253 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 6.0 m-85 -58.31 -178.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 1.7 t70 -178.08 53.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.917 HG13 HD23 ' B' ' 34' ' ' LEU . 23.0 t -65.81 103.41 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.54 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -36.9 6.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -124.9 73.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.976 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.917 HD23 HG13 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -92.98 152.38 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.596 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.6 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -62.05 156.52 57.79 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -54.81 -44.8 46.16 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.125 1.884 . . . . 0.0 111.976 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.82 -53.86 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.322 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.616 ' C ' HD12 ' B' ' 34' ' ' LEU . 97.4 mt -52.16 -28.43 18.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.089 0.471 . . . . 0.0 110.165 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.467 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 2.0 mtp180 -48.56 -56.13 9.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.208 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.91 -49.2 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.283 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 70' ' ' LEU . 15.9 mt -52.57 -32.68 42.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.403 ' CD1' HD11 ' B' ' 34' ' ' LEU . 1.0 OUTLIER -66.67 -62.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.166 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 13.7 m -53.9 -24.65 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.563 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -24.68 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.854 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.88 70.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.22 -31.13 6.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.808 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.46 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.0 mm -93.06 36.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.195 0.522 . . . . 0.0 110.744 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.428 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.9 OUTLIER -101.03 33.39 2.86 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.102 -179.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.9 -23.49 0.45 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.906 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 111.98 23.43 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -87.17 143.03 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 110.935 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 59.7 tp -91.37 103.22 15.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.937 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.8 m -107.41 7.83 29.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.043 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.68 130.85 44.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.815 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.44 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -123.02 67.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 p -123.56 -45.61 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -144.44 47.1 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.421 ' N7 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' NE2' ' CE ' ' B' ' 2' ' ' LYS . 1.5 mm-40 -138.89 147.07 41.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 52' ' ' THR . 63.1 m -141.19 137.04 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 53' ' ' LEU . 4.4 mp -98.27 124.72 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.219 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -82.99 77.24 9.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.335 0.588 . . . . 0.0 109.532 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.33 140.13 29.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.572 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 1.4 p -149.39 136.24 12.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.176 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' LEU . 2.7 t -87.65 133.83 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -127.78 144.62 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.344 -178.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 160.97 150.89 6.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.565 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -114.82 112.66 23.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.72 0.295 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.25 -134.54 7.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.054 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.13 103.39 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.317 . . . . 0.0 111.106 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 81' ' ' CYS . 18.1 m -114.51 -30.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.9 18.96 7.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.63 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -57.85 -47.94 81.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 111.13 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.2 m -58.14 -37.89 75.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.54 -27.12 67.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.21 -42.19 19.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.603 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 8' ' ' VAL . 23.0 mt -51.27 -38.6 53.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 110.729 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.54 -42.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -79.49 -8.8 59.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.8 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.544 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 39.0 t80 -89.27 -25.14 21.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.71 0.29 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 24.1 p -110.24 -29.42 8.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.1 p -106.32 -19.02 13.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.559 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.09 18.88 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.072 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 120.84 35.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -74.31 110.91 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.46 -164.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.495 2.13 . . . . 0.0 112.265 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 t -147.42 -43.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.79 152.04 45.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.324 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 6.3 p90 -150.57 122.15 7.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 6.5 p 149.03 -31.8 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 124.182 0.926 . . . . 0.0 111.638 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 23.8 Cg_exo -66.43 -14.32 43.64 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.785 1.657 . . . . 0.0 112.701 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.4 m -51.0 121.01 5.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.109 0.48 . . . . 0.0 110.751 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' PRO . 2.3 p -155.41 -49.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.565 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' HB3' HG21 ' B' ' 21' ' ' VAL . 30.0 t80 -171.62 91.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -120.76 115.07 22.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.356 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' OD1' ' CD2' ' A' ' 56' ' ' PHE . 3.0 t30 -105.99 135.41 47.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.05 0.452 . . . . 0.0 111.639 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' CD1' ' CZ ' ' B' ' 15' ' ' PHE . 18.9 m-85 -134.03 160.4 37.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.352 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -129.06 119.13 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' B' ' 12' ' ' PRO . 10.3 t -103.78 142.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.762 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 93.3 m -105.05 113.48 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.684 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' B' ' 12' ' ' PRO . 4.0 t -125.58 155.94 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 mmt -90.87 88.5 7.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.042 0.449 . . . . 0.0 110.397 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 173' ' ' ILE . 35.8 mt -102.51 129.36 54.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.298 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.07 20.97 60.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.88 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.97 13.54 77.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -133.51 129.41 20.53 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.13 92.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.334 2.023 . . . . 0.0 112.017 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.59 179.58 7.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.067 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 3.6 m -139.87 99.59 3.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.928 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 173' ' ' ILE . 51.2 tp -70.41 134.96 48.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.49 113.02 4.57 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.292 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.92 133.36 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.39 . . . . 0.0 111.382 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CD2' ' OD1' ' A' ' 39' ' ' ASN . 29.8 m-85 -137.95 133.89 34.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.897 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -118.04 124.03 47.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.704 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.8 p -95.07 174.79 6.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.32 128.12 55.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.24 -146.27 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.285 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 51.19 -173.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 0.0 110.957 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.03 -22.3 11.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.234 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -30.0 59.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.321 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -93.15 21.94 5.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -67.8 -29.18 68.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.091 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 0.1 OUTLIER -65.93 -53.69 36.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.564 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.2 pp -98.59 21.75 10.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.735 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -78.99 -52.64 1.2 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.601 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.4 Cg_exo -59.47 -24.69 75.89 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.56 2.174 . . . . 0.0 112.222 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.689 HD12 ' HB2' ' A' ' 67' ' ' LEU . 25.1 mt -50.65 -26.26 5.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.356 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 3.22 55.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 21.5 m-85 -105.06 7.72 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -46.64 106.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 CA-C-N 121.049 1.41 . . . . 0.0 112.429 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.43 68.74 0.5 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.092 0.472 . . . . 0.0 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 5' ' ' LYS . 52.3 m -80.89 146.91 30.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.325 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.532 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -91.61 -70.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.676 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.792 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.7 p -114.47 172.92 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.939 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.7 m-85 -137.25 116.76 12.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.673 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.6 mp -88.08 101.08 13.45 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.074 0.464 . . . . 0.0 111.019 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG21 HG22 ' A' ' 98' ' ' VAL . 41.6 t -93.7 85.95 2.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.303 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HB2' HG21 ' A' ' 14' ' ' VAL . 3.9 m -85.76 111.31 20.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.127 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.9 p90 -109.3 172.36 6.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.732 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -92.83 107.63 19.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 0.0 111.099 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.22 -30.96 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.944 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 119' ' ' LEU . 6.0 m -96.05 36.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.37 93.93 3.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.752 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 74.6 Cg_exo -49.62 -28.21 16.37 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.519 2.146 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -56.02 23.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.849 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -47.92 -49.05 31.35 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.565 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CZ ' HG22 ' A' ' 141' ' ' THR . 49.5 t80 -52.11 -41.28 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.544 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -46.72 86.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' LYS . 86.5 m-20 -76.25 -33.02 59.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 89' ' ' SER . 11.4 t -44.58 -44.83 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.848 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -17.79 23.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -133.17 50.02 2.26 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 174.87 -55.19 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.511 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 24.7 m95 -65.53 -51.08 62.52 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.773 HG21 HD13 ' A' ' 149' ' ' LEU . 90.1 t -84.13 -46.38 0.74 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 83.7 Cg_exo -47.05 -27.12 5.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.511 2.141 . . . . 0.0 112.679 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.59 -34.85 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -89.77 -30.29 5.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.802 0.334 . . . . 0.0 111.032 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.1 p -56.13 -28.22 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.409 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -35.81 64.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.33 -41.48 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 10.7 m -156.71 83.5 3.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.54 4.65 6.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.758 2.305 . . . . 0.0 112.956 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -32.79 10.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.893 0.378 . . . . 0.0 110.583 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.479 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.0 p -62.67 149.21 89.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.541 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 77' ' ' VAL . 15.3 Cg_endo -54.77 152.76 27.02 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.919 2.412 . . . . 0.0 111.94 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.598 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.4 m-85 -138.8 104.52 5.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.664 0.269 . . . . 0.0 111.476 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.8 tp -78.92 126.12 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.092 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 146' ' ' ALA . 44.9 tp -95.36 92.6 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.565 HG13 HG21 ' A' ' 168' ' ' VAL . 17.3 t -92.85 146.31 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 111.803 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.48 113.0 1.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.592 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -105.23 177.09 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.076 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.592 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 78.77 45.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.973 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -78.47 -27.69 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.343 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.617 ' OD2' HD22 ' A' ' 119' ' ' LEU . 0.9 OUTLIER -48.49 -31.27 6.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.61 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD22 ' OD2' ' A' ' 118' ' ' ASP . 1.8 mm? -88.95 -37.19 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.47 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.681 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 3.3 t0 -100.85 14.03 33.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.192 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.3 OUTLIER -111.55 89.03 10.07 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-O 120.682 0.277 . . . . 0.0 110.989 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 76.6 Cg_exo -50.62 -45.4 35.26 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.442 2.095 . . . . 0.0 111.958 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -51.47 -33.87 33.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.729 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.6 p -93.26 -44.7 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.736 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 28.3 mt -53.64 -48.06 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.493 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.58 -26.69 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 29.1 ttpt -64.1 -45.88 86.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.419 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.4 pp -98.14 -21.23 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.717 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.25 -27.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.945 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.39 26.67 5.37 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 2.3 m-80 -118.35 -31.85 4.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.24 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 112.058 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' ' CD ' ' A' ' 87' ' ' PRO . 1.7 mt-30 -104.11 171.45 7.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.577 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.458 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -173.21 127.22 0.49 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.758 179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.626 ' HG3' HG23 ' A' ' 126' ' ' ILE . 24.1 Cg_endo -64.12 138.38 61.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.356 2.038 . . . . 0.0 112.473 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.3 mm -83.93 130.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -88.15 161.98 41.84 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 -43.53 31.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.502 2.135 . . . . 0.0 111.979 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.56 -71.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.2 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.83 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 m -47.79 -43.72 27.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.17 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.25 91.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 110.67 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -51.65 -55.88 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.132 0.491 . . . . 0.0 110.38 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.38 -44.08 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.012 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.676 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.0 mt -65.55 -45.83 81.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.086 0.469 . . . . 0.0 109.776 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.19 -26.99 42.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.6 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -37.72 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.691 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.08 -33.27 74.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.081 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 98' ' ' VAL . 3.3 mt -104.29 18.84 21.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.314 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 150' ' ' LYS . 0.7 OUTLIER 55.12 25.55 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.129 179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -56.03 137.34 51.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.84 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -51.21 -36.4 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.91 144.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 111.227 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -80.32 125.14 29.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 168' ' ' VAL . 3.4 m -123.76 -179.2 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 0.4 OUTLIER -152.94 151.02 29.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 19' ' ' LEU . 4.7 p -166.71 146.38 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.977 0.418 . . . . 0.0 111.708 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 1.6 t -135.62 140.36 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.308 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.65 -26.27 21.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 118' ' ' ASP . 18.0 tp -89.4 -29.57 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -106.55 -28.63 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.62 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 158' ' ' SER . 1.3 mt-30 71.07 21.22 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 110.776 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.534 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.6 tttt -71.4 101.01 2.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.719 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.45 22.72 75.03 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.084 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.983 HD12 HD12 ' A' ' 19' ' ' LEU . 32.0 tp -57.35 -37.8 73.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 0.0 111.195 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -87.47 -48.51 7.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.405 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 3.7 t-20 -50.94 -44.46 60.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.436 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.859 HG23 ' HB ' ' A' ' 155' ' ' VAL . 8.0 p -49.3 -40.06 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 173' ' ' ILE . 31.4 m-85 -73.52 -38.95 65.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.991 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -57.58 -26.34 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.211 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.7 tp10 -80.88 -31.22 35.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.508 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.15 -67.52 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.597 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.903 HD11 HD22 ' A' ' 53' ' ' LEU . 3.0 mp -45.71 -57.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.14 0.495 . . . . 0.0 110.507 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.543 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.3 tp -49.91 -35.19 22.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.397 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.84 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -76.31 -54.53 6.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.626 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -48.7 -54.42 14.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.847 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 173' ' ' ILE . 15.4 mt -60.66 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.097 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 14.7 pt-20 -170.47 162.89 6.04 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.542 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 C-N-CA 122.826 2.351 . . . . 0.0 112.202 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.721 0.296 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CE ' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -120.49 25.52 9.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 111.117 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 11.8 mmmt -72.22 113.26 9.06 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.821 0.82 . . . . 0.0 110.967 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.6 mm -85.58 146.1 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.372 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.4 p -127.55 156.4 42.27 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.841 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -53.47 -25.87 18.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.7 0.286 . . . . 0.0 111.291 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.12 -2.63 52.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.95 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.55 0.214 . . . . 0.0 111.156 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.722 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mt -52.19 96.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 110.515 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.26 -152.24 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.528 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.55 129.3 66.33 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.423 0.154 . . . . 0.0 110.779 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.789 ' HA ' HG22 ' A' ' 44' ' ' VAL . 2.7 Cg_exo -72.3 154.6 56.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.257 1.972 . . . . 0.0 111.994 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.1 t -179.72 -161.38 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.72 34.8 78.72 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.316 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 40' ' ' TYR . 11.7 t80 -40.02 111.33 0.19 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.33 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.0 tptm -112.85 100.99 9.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.515 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.5 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 7.2 t-160 -67.14 85.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.5 t -67.06 -59.7 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.716 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -129.82 151.32 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -146.23 127.19 14.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.355 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.55 HG22 HD21 ' B' ' 34' ' ' LEU . 98.2 t -110.71 142.49 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.686 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -114.32 92.89 0.62 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.649 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -97.97 106.97 19.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' B' ' 28' ' ' GLY . 13.5 m-20 -100.97 135.89 19.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.21 -6.38 18.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.336 2.024 . . . . 0.0 112.672 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -112.23 -29.99 7.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -109.42 -34.39 6.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.275 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 108.81 -156.69 15.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' B' ' 47' ' ' ILE . 26.3 m-85 -61.56 167.52 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' B' ' 22' ' ' GLY . 4.8 t0 -164.32 62.07 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.993 HG13 HD23 ' B' ' 34' ' ' LEU . 34.2 t -66.03 107.5 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.66 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.67 -30.5 9.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -139.85 75.71 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.464 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.993 HD23 HG13 ' B' ' 31' ' ' VAL . 0.4 OUTLIER -93.46 -174.95 3.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.787 0.327 . . . . 0.0 110.193 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.82 138.16 35.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.39 -33.27 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.214 1.942 . . . . 0.0 112.229 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -93.24 -60.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.631 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 70' ' ' LEU . 18.0 mt -47.47 -37.81 12.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.736 0.303 . . . . 0.0 110.84 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.482 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 46.5 mtt180 -39.41 -48.91 2.0 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.54 0.686 . . . . 0.0 110.505 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -40.47 64.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.861 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.469 HD23 HD22 ' A' ' 70' ' ' LEU . 8.1 mp -60.49 -40.97 93.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -56.37 -52.31 65.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.148 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -66.56 -17.36 64.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.436 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -89.67 -18.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.55 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -100.67 -95.4 0.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.01 -14.23 34.44 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.811 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.453 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.1 mm -93.01 36.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.095 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -74.85 -151.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.252 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -41.41 -28.75 0.13 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.7 0.286 . . . . 0.0 111.685 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 61.0 118.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.456 ' HB2' ' CB ' ' B' ' 54' ' ' ASP . 4.7 mm-40 56.08 176.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' B' ' 53' ' ' THR . 0.6 OUTLIER -91.12 103.05 15.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.319 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.641 HG22 ' O ' ' B' ' 53' ' ' THR . 63.3 m 64.46 10.96 6.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.456 ' CB ' ' HB2' ' B' ' 51' ' ' GLN . 12.0 t0 -71.96 120.06 17.03 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -163.06 -69.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.63 100.48 3.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -61.58 103.59 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.78 50.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.893 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.027 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.448 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.807 0.336 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.65 144.23 27.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -140.88 139.87 34.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.489 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.908 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.2 mp -93.85 147.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.642 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -117.15 124.65 49.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -139.27 148.01 42.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.356 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.8 HG12 HG21 ' A' ' 75' ' ' THR . 7.2 p -125.89 125.56 68.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 20' ' ' LEU . 2.4 t -85.97 112.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 0.0 111.052 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -113.54 128.18 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.315 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.58 164.26 28.77 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.843 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -99.81 134.07 43.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.035 0.445 . . . . 0.0 111.058 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.13 -103.28 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.711 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.86 ' HB1' H5'2 ' A' ' 181' ' ' GCP . . . -136.15 107.06 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.955 0.407 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 m -114.24 -24.63 3.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.643 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 107.41 51.96 0.74 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.269 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' CE ' HG12 ' A' ' 8' ' ' VAL . 1.2 mtpt -90.36 -65.61 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.843 0.354 . . . . 0.0 111.218 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 88.7 m -47.75 -26.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.112 0.482 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' PRO . 86.0 m -81.89 -30.62 31.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.855 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -76.67 -33.88 58.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.306 -178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 8' ' ' VAL . 8.9 mt -68.79 -37.28 79.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 17' ' ' THR . 11.6 mm -63.79 -55.55 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.239 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.444 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -67.68 -9.89 47.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.457 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 4.3 t80 -77.94 -33.07 51.83 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.641 0.258 . . . . 0.0 111.415 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.801 HG21 ' CD1' ' B' ' 15' ' ' PHE . 9.9 t -121.41 -19.11 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.0 p -109.4 -20.94 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.727 0.299 . . . . 0.0 110.995 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.04 20.94 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.311 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 28' ' ' PHE . 6.6 tptt -104.02 155.99 18.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.189 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.451 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 9.3 t80 -106.06 86.27 1.93 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.839 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 22.9 Cg_endo -62.9 164.13 20.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.71 2.274 . . . . 0.0 112.029 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.57 -38.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.522 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 33' ' ' VAL . 1.8 tt0 -52.82 138.91 28.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' C ' HG22 ' A' ' 33' ' ' VAL . 1.4 t80 -133.93 98.69 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -174.0 -61.68 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.065 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.65 ' CD ' HG23 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -68.31 82.37 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.637 2.225 . . . . 0.0 112.728 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 35' ' ' THR . 13.9 m -138.78 17.25 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.324 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.36 -70.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.011 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' B' ' 38' ' ' LEU . 70.9 t80 -155.28 90.8 1.29 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.823 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 52.6 m-20 -104.47 125.14 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.848 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' CB ' ' HB3' ' B' ' 19' ' ' SER . 0.2 OUTLIER -107.53 118.31 36.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.977 0.417 . . . . 0.0 111.491 -178.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 3.5 m-85 -123.48 152.44 41.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.119 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.893 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.61 121.25 25.28 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 111.374 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 t -102.89 149.75 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.568 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.4 m -116.4 102.32 9.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.767 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.947 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -108.58 154.4 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.079 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.9 mmt -86.6 88.28 7.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.616 HD12 ' CB ' ' A' ' 51' ' ' TYR . 8.6 mt -104.19 139.02 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.142 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.26 20.56 36.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.62 20.85 57.57 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.503 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -147.29 151.29 40.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.99 93.06 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.345 2.03 . . . . 0.0 111.954 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CB ' HD12 ' A' ' 46' ' ' ILE . 2.6 m-85 -84.16 179.78 7.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.541 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -132.45 131.82 42.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.833 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.821 HD22 HD11 ' A' ' 173' ' ' ILE . 44.9 tp -102.19 130.23 48.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.603 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -87.62 100.12 2.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.936 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 20' ' ' LEU . 1.8 mp -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.7 m-85 -130.34 117.86 20.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 38' ' ' ASP . 1.0 OUTLIER -107.02 131.65 53.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.589 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -113.93 170.3 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.0 177.26 5.77 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.423 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.27 26.01 4.76 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.056 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -122.37 176.52 5.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.748 0.308 . . . . 0.0 110.514 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -92.45 -32.25 14.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.983 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -25.29 57.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.744 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.8 18.77 11.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.279 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -69.93 -30.64 68.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.988 0.423 . . . . 0.0 110.747 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -55.1 -43.62 74.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.404 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -111.98 14.63 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.94 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 7.2 ttp85 -70.29 -58.17 5.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.323 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 9.6 Cg_endo -54.83 -18.01 15.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.28 1.987 . . . . 0.0 112.934 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.757 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.4 mp -59.87 -16.35 28.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.448 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.4 t -94.23 10.75 32.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.716 ' CE2' HG21 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -130.67 41.7 0.78 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 79.8 Cg_exo -40.17 -29.05 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.453 2.102 . . . . 0.0 112.394 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' TYR . 15.9 pt20 179.63 38.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.101 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.8 HG21 HG12 ' A' ' 7' ' ' VAL . 89.0 m -43.41 144.42 0.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -64.54 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.409 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -107.08 173.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.552 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' H ' HG22 ' A' ' 77' ' ' VAL . 46.0 m-85 -139.01 135.37 34.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.718 0.294 . . . . 0.0 111.713 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.834 HD23 HG21 ' A' ' 113' ' ' VAL . 1.9 mt -102.55 97.6 7.78 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.925 0.393 . . . . 0.0 111.251 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 20.9 t -98.16 86.09 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.642 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 115' ' ' THR . 5.2 m -82.86 112.09 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.645 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.799 ' HB3' HG21 ' A' ' 93' ' ' VAL . 36.0 p90 -115.06 139.88 49.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.614 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 112.85 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.36 -32.26 44.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.375 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 m -93.37 28.99 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.013 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.51 93.18 3.33 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.815 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.65 -24.27 44.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.634 2.223 . . . . 0.0 112.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -59.77 4.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.048 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.976 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -56.8 -43.54 81.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.682 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 145' ' ' LEU . 1.7 t80 -64.03 -44.55 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.384 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.6 -28.9 61.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.405 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' LYS . 11.4 m-20 -88.75 -26.53 21.7 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.354 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.976 HG23 ' O ' ' A' ' 89' ' ' SER . 74.0 t -67.29 -38.82 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.773 ' HB3' HD13 ' A' ' 145' ' ' LEU . 7.0 ptmt -86.71 -12.83 47.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.409 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.52 44.55 0.77 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.468 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -168.37 -52.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.707 0.289 . . . . 0.0 111.234 178.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.01 -66.65 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.403 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.965 ' O ' HG23 ' A' ' 102' ' ' THR . 50.9 t -55.86 -45.41 99.89 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.697 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -58.51 -37.24 95.55 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.153 1.902 . . . . 0.0 111.926 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.35 -30.57 71.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.366 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 98' ' ' VAL . 11.8 pt -95.35 -30.01 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.773 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.965 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.1 p -53.82 -24.36 15.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.425 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -80.21 -36.69 34.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.18 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.65 -31.24 21.2 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 108' ' ' THR . 9.2 m -163.04 81.81 1.57 Allowed Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.089 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.08 -1.49 10.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.559 2.172 . . . . 0.0 113.075 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -34.27 9.0 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.4 p -50.39 138.36 21.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.901 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.7 Cg_endo -52.73 146.85 33.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.017 2.478 . . . . 0.0 111.891 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 26.0 m-85 -131.34 101.97 5.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.317 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.482 HD22 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -79.24 114.88 18.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.825 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.694 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.2 tp -90.0 114.69 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.01 0.433 . . . . 0.0 111.228 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.834 HG21 HD23 ' A' ' 79' ' ' LEU . 22.0 t -117.15 148.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.855 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.62 105.56 0.62 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.736 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 116' ' ' GLN . 2.6 m -91.53 170.24 10.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.444 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.723 ' HG2' HD23 ' A' ' 119' ' ' LEU . 3.6 tt0 77.77 55.34 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.521 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' A' ' 158' ' ' SER . 0.4 OUTLIER -85.67 -24.6 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.731 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.613 ' OD2' HD22 ' A' ' 119' ' ' LEU . 6.6 p-10 -51.12 -32.16 21.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.403 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.723 HD23 ' HG2' ' A' ' 116' ' ' GLN . 1.2 mm? -87.65 -36.13 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.905 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.706 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -56.51 -28.81 60.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.55 19.13 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.675 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.523 ' CG ' HG23 ' A' ' 125' ' ' THR . 33.6 t0 -119.46 83.46 26.9 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.4 -46.57 11.72 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.536 2.157 . . . . 0.0 111.863 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 p -48.78 -32.77 9.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.129 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 122' ' ' ASP . 11.7 p -93.51 -42.84 9.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.37 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.739 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 18.9 mt -57.26 -45.41 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.455 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -73.35 -26.32 60.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 0.0 110.529 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -63.84 -48.72 75.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.385 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -95.0 -22.98 17.58 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.618 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -43.07 -31.35 0.54 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -123.16 20.61 9.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 5.2 m-80 -112.84 -30.57 7.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.506 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 162.6 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.031 0.443 . . . . 0.0 111.643 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.658 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -103.01 149.84 24.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.048 -179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -144.79 146.41 31.55 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.806 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -82.53 134.88 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.502 2.134 . . . . 0.0 112.02 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.3 mm -79.3 128.52 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 111.427 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -78.93 148.4 72.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.23 -37.78 88.07 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.669 2.246 . . . . 0.0 112.532 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.42 -26.69 65.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 90' ' ' PHE . 89.5 m -73.8 -47.78 36.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.913 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.49 -37.11 65.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.273 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 37.0 tt0 -64.59 -40.14 94.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.064 0.459 . . . . 0.0 110.242 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 -51.53 61.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.379 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.5 mt -57.73 -47.71 81.66 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.663 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -46.31 -29.01 1.47 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.611 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -92.32 -38.3 12.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.854 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -67.49 -33.31 74.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.366 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.58 HD13 HG21 ' A' ' 98' ' ' VAL . 3.6 mt -98.82 18.71 16.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.502 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.75 23.45 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.7 0.286 . . . . 0.0 111.174 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -57.65 143.1 42.66 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' CB ' ' A' ' 175' ' ' ALA . 30.5 m -62.22 -32.06 53.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.19 157.88 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.029 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.694 ' CD1' HD23 ' A' ' 112' ' ' LEU . 11.1 t80 -99.74 128.42 45.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.536 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.803 ' CG2' HG23 ' A' ' 168' ' ' VAL . 6.5 m -124.96 -179.78 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.156 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -153.12 146.54 24.91 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.7 p -166.95 140.9 3.82 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.426 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -136.99 141.56 42.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.147 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.96 -18.41 32.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.282 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.637 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -83.07 -45.26 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.4 ' N ' HD13 ' A' ' 160' ' ' LEU . 3.5 m -94.43 -28.78 15.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 75.08 13.44 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 3.3 tptm -67.25 112.87 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.023 0.44 . . . . 0.0 110.447 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 52.28 29.42 29.86 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.443 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 1.0 OUTLIER -61.91 -32.2 72.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 110.416 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.416 ' HD2' ' CD ' ' B' ' 12' ' ' PRO . 1.3 ttpm? -87.81 -54.8 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.541 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -43.61 -49.12 7.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.089 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.803 HG23 ' CG2' ' A' ' 155' ' ' VAL . 4.2 p -39.82 -45.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.05 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 173' ' ' ILE . 45.2 m-85 -75.97 -29.32 58.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.275 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.8 OUTLIER -60.89 -33.18 72.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 111' ' ' LEU . 1.2 tp10 -75.01 -32.23 61.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.836 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -66.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.178 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.1 mt -45.47 -56.39 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' B' ' 9' ' ' ILE . 13.0 tp -54.7 -32.37 59.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.246 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.735 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.12 -51.66 10.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.17 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -57.27 -43.88 83.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 110.927 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.523 HD13 HD11 ' B' ' 4' ' ' ILE . 21.1 mt -70.55 -174.86 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.41 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -172.02 164.01 4.31 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.256 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.2 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.865 2.376 . . . . 0.0 112.365 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.655 0.264 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.484 ' HD3' HD22 ' A' ' 177' ' ' LEU . 5.8 ttmt -125.48 27.37 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.774 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.1 mmmt -72.54 112.71 8.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.986 0.898 . . . . 0.0 111.666 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -89.46 147.75 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.127 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.1 p -128.4 -178.12 4.44 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.929 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.86 -27.09 61.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.2 -1.5 44.83 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -79.84 -65.17 1.04 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.947 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -52.04 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.338 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.58 -145.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.862 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.93 134.79 26.86 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.47 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.463 ' HB3' HG22 ' A' ' 44' ' ' VAL . 55.9 Cg_endo -72.09 163.59 38.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.84 1.693 . . . . 0.0 111.747 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 p 172.78 176.42 0.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 40.51 84.17 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.525 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 24' ' ' THR . 5.1 t80 -39.3 121.79 1.2 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.893 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.0 tptm -117.2 108.7 15.98 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' B' ' 19' ' ' SER . 1.9 t-160 -72.05 86.06 1.02 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.052 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.1 t -71.68 -20.05 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.413 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 39' ' ' ASN . 2.1 t -173.06 170.48 4.4 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.796 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -162.75 132.2 4.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 31' ' ' VAL . 60.7 t -122.95 118.24 54.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -108.13 95.84 0.98 Allowed Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.6 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -80.3 163.78 23.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.481 -0.423 . . . . 0.0 110.607 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.52 125.0 1.52 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.5 -6.78 18.1 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.956 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -110.46 -31.11 7.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 110.912 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -111.4 -26.23 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.411 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.83 -173.27 29.23 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.022 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.588 ' CE1' HD12 ' B' ' 47' ' ' ILE . 8.8 m-85 -52.38 147.19 8.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.152 0.476 . . . . 0.0 110.601 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 2.1 t0 -140.83 48.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.619 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 21' ' ' VAL . 25.1 t -65.96 116.39 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -100.73 -33.19 10.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -143.0 82.55 1.76 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.585 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -99.94 156.97 16.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.935 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.681 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -59.36 142.29 86.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.233 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' B' ' 39' ' ' ARG . 60.3 Cg_exo -51.21 -46.81 29.01 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.342 2.028 . . . . 0.0 112.148 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -74.85 -52.49 11.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.767 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 37' ' ' PHE . 55.4 mt -55.45 -22.82 22.18 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' B' ' 36' ' ' PRO . 0.0 OUTLIER -60.02 -52.18 66.5 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.085 0.469 . . . . 0.0 110.426 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -67.57 -43.9 79.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.084 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.757 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.0 mt -67.73 -29.41 68.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.385 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.4 OUTLIER -60.79 -57.27 13.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.664 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.4 OUTLIER -64.66 -21.19 66.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 178.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' B' ' 40' ' ' SER . 1.1 ttt85 -90.64 -14.83 31.57 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.579 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -96.25 -94.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.0 -13.35 37.11 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.97 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.3 mm -97.61 30.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.285 0.564 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' B' ' 43' ' ' SER . 18.9 t -98.8 -15.81 19.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.892 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.2 -22.53 15.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.382 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.22 125.57 5.53 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.016 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.12 -172.63 2.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.8 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.85 78.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 53' ' ' THR . 34.2 m -106.42 7.05 30.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -71.64 104.9 3.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -171.1 55.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -85.79 118.12 25.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.85 112.14 20.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.254 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -134.99 43.99 2.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.128 179.724 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.86 H5'2 ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.851 0.357 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -171.67 154.58 3.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.799 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.5 m -142.4 128.69 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.167 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.6 mp -94.34 150.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.601 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 7' ' ' VAL . 8.3 tptm -110.26 86.52 2.32 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.0 110.382 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.56 135.05 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.654 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HG23 ' A' ' 75' ' ' THR . 14.0 t -132.33 130.51 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.854 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 19.7 t -86.39 118.56 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 110.779 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.03 142.44 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.273 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' CZ3' ' A' ' 97' ' ' TRP . . . 147.13 154.16 6.12 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.651 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.05 115.29 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.25 -164.32 31.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.399 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -101.03 -82.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.312 . . . . 0.0 111.076 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 13' ' ' ALA . 26.1 m 45.69 26.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.391 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' PA ' ' A' ' 181' ' ' GCP . . . 33.22 92.17 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.981 -0.554 . . . . 0.0 114.179 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.65 -23.4 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 0.0 110.953 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 66.7 m -86.55 -12.91 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.791 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 t -82.07 -53.69 5.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.712 0.292 . . . . 0.0 111.343 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -74.61 -38.91 62.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.254 -178.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.675 HD12 ' O ' ' A' ' 16' ' ' LYS . 46.4 mt -57.82 -39.7 78.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.887 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 17' ' ' THR . 17.2 mm -80.65 -36.0 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.219 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 165' ' ' LEU . 24.1 m -68.65 -12.51 61.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.461 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 5.8 t80 -97.79 -39.15 9.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.759 0.314 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' LEU . 56.3 p -77.66 -42.58 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.42 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p -105.04 2.71 29.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 t30 51.88 24.23 2.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -132.81 146.77 52.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.995 0.426 . . . . 0.0 111.239 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -94.39 113.05 59.94 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.66 173.77 13.93 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.335 2.023 . . . . 0.0 112.252 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.93 -44.09 2.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.086 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 136.9 50.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.09 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 4.9 p90 -158.05 124.35 4.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.35 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.702 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 33' ' ' VAL . 62.6 Cg_endo -87.51 128.98 2.61 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.702 2.268 . . . . 0.0 112.251 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 36' ' ' VAL . 27.8 m -162.31 -96.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' B' ' 23' ' ' TRP . 0.7 OUTLIER 65.97 -58.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.593 0.357 . . . . 0.0 111.6 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CG2' ' A' ' 36' ' ' VAL . 27.4 t80 -157.3 125.09 5.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.785 0.326 . . . . 0.0 110.588 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 67.4 m-20 -143.58 131.41 21.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.991 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.23 118.29 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.902 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.5 m-85 -118.81 161.58 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.928 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -130.73 119.4 22.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.914 0.387 . . . . 0.0 110.787 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG23 HD11 ' A' ' 55' ' ' LEU . 11.4 t -104.77 142.97 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.763 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.8 m -108.64 112.05 24.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.297 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.779 HG11 HG22 ' B' ' 9' ' ' ILE . 9.1 t -118.14 155.91 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.573 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 44' ' ' VAL . 10.1 mmt -92.29 88.52 6.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.045 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 173' ' ' ILE . 49.7 mt -95.05 130.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.346 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 49.05 36.01 19.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.465 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.53 21.97 79.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.593 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -137.44 143.36 40.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.698 0.285 . . . . 0.0 110.978 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.24 117.64 5.26 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.525 2.15 . . . . 0.0 112.338 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 46' ' ' ILE . 5.5 m-85 -115.16 178.96 4.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 m -137.66 103.29 4.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.844 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -77.87 114.18 16.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.209 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.09 109.87 2.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.179 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.67 HD11 HG23 ' A' ' 42' ' ' VAL . 53.3 mt -92.77 123.34 35.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 111.271 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 5.0 m-85 -128.62 115.93 18.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.676 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.74 126.34 50.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 p -108.52 145.75 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -77.98 141.25 39.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.32 -163.76 20.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.437 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 59.69 164.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -83.56 -21.26 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.999 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.32 -27.93 64.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.973 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 32.4 m-85 -105.66 15.16 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -13.0 61.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.317 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -72.05 -50.58 27.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.789 0.328 . . . . 0.0 111.312 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.764 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 2.5 pp -103.86 12.3 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.913 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -84.19 -46.55 0.73 Allowed Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.259 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 43.5 Cg_exo -55.36 -19.48 22.27 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.298 1.998 . . . . 0.0 112.325 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' B' ' 41' ' ' LEU . 87.0 mt -50.64 -23.33 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.62 14.48 28.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.683 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.481 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.5 m-30 -92.17 -46.48 0.34 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 56.7 Cg_exo -51.41 127.62 22.96 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.375 2.05 . . . . 0.0 112.604 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 62.81 38.76 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 78' ' ' PHE . 55.0 m -94.29 130.3 40.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.606 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.74 -76.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.6 p -99.1 175.69 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.912 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 75' ' ' THR . 36.0 m-85 -145.25 117.14 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.17 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 8.1 mp -85.6 100.7 12.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.035 0.445 . . . . 0.0 111.542 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.81 86.19 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.541 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.5 m -84.11 111.32 19.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -108.2 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 86' ' ' SER . 1.6 m -94.91 100.23 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 0.0 111.296 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' CD ' ' A' ' 120' ' ' ARG . 95.3 t -55.32 -30.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.72 29.26 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 83' ' ' SER . 8.6 t -144.56 96.85 5.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.83 -30.37 38.15 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 t -60.46 -50.74 72.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.923 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.832 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.1 t -51.58 -51.01 58.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.387 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 29.6 t80 -53.79 -31.36 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.422 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.07 -46.59 64.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' CB ' ' HB2' ' A' ' 96' ' ' LYS . 14.7 m-20 -80.99 -29.09 35.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.378 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' SER . 10.6 t -47.23 -36.64 4.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.704 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -100.96 -16.6 17.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.27 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -132.94 47.69 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.516 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 177.09 -53.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CZ3' ' HA3' ' A' ' 10' ' ' GLY . 17.9 m95 -71.68 -48.4 47.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG21 HD13 ' A' ' 149' ' ' LEU . 96.9 t -81.21 -46.0 1.15 Allowed Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 67.6 Cg_exo -49.93 -38.57 48.7 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.33 2.02 . . . . 0.0 112.241 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -59.53 -31.87 69.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.434 HG21 ' CD2' ' A' ' 78' ' ' PHE . 3.9 mt -85.88 -43.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 98' ' ' VAL . 9.6 p -54.34 -25.33 23.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.206 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -70.28 -35.8 73.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -91.38 -38.7 12.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.841 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.599 ' HB3' HG23 ' A' ' 108' ' ' THR . 85.7 m -154.55 93.28 2.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.48 -2.48 11.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.684 2.256 . . . . 0.0 113.0 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -32.92 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.776 0.322 . . . . 0.0 110.882 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 105' ' ' CYS . 23.9 p -50.51 138.17 22.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.234 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.9 Cg_endo -53.9 141.85 65.59 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.75 2.3 . . . . 0.0 111.813 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.565 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.9 m-85 -129.17 100.92 5.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.678 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 ' CG2' ' A' ' 152' ' ' VAL . 4.4 tp -78.92 106.76 11.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.798 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 145' ' ' LEU . 3.4 tt -70.02 93.91 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.882 0.372 . . . . 0.0 110.674 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 155' ' ' VAL . 53.3 t -89.45 131.11 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.756 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.39 121.37 5.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -102.08 172.33 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 111.523 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.517 ' H ' HG22 ' A' ' 115' ' ' THR . 0.4 OUTLIER 74.13 50.58 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -87.58 -37.69 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.031 0.443 . . . . 0.0 110.284 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.6 OUTLIER -49.17 -46.26 45.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.673 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.3 mt -75.8 -40.31 55.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.71 ' O ' HD11 ' A' ' 126' ' ' ILE . 12.5 ttp85 -52.93 -28.62 24.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.77 9.53 38.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -115.72 95.69 44.42 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-O 120.698 0.285 . . . . 0.0 111.015 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.488 ' N ' HD12 ' A' ' 126' ' ' ILE . 72.2 Cg_exo -49.13 -41.14 41.74 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.626 2.218 . . . . 0.0 112.489 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.4 p -52.53 -31.86 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.237 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 122' ' ' ASP . 4.8 p -95.2 -44.37 7.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.757 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.7 mt -54.61 -42.77 62.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.624 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.33 -28.21 47.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -63.01 -45.76 90.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.57 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.2 pp -95.08 -22.81 17.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.372 . . . . 0.0 111.624 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.27 -24.52 1.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.537 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -125.87 13.02 7.92 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 1.7 m-80 -108.75 -32.24 7.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.37 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 167.33 -20.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -110.58 156.1 21.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.101 0.477 . . . . 0.0 111.786 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.98 145.35 29.93 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.375 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.668 ' HG3' HG23 ' A' ' 126' ' ' ILE . 94.2 Cg_endo -84.56 148.84 11.34 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.744 2.296 . . . . 0.0 112.746 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 84' ' ' VAL . 21.0 mm -104.54 136.11 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.51 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.9 p -87.47 155.01 54.18 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.28 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.71 -37.96 91.54 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.171 . . . . 0.0 111.866 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -67.87 -34.05 75.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.442 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -68.66 -48.04 65.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.409 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' CB ' ' CE1' ' A' ' 154' ' ' TYR . . . -64.55 -34.96 79.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.403 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.03 -50.75 63.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.391 0.615 . . . . 0.0 109.831 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -44.35 -51.91 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.883 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.585 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.9 mt -58.46 -45.98 87.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 109.75 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.544 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.69 -24.28 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -90.64 -33.25 15.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -35.86 62.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.622 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -93.37 19.13 8.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 52.34 24.95 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -54.3 141.75 28.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.96 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.761 ' CG2' HD12 ' A' ' 111' ' ' LEU . 24.4 m -55.42 -33.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.91 150.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.691 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.514 ' CE1' ' CB ' ' A' ' 142' ' ' ALA . 50.7 t80 -79.57 131.14 35.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 168' ' ' VAL . 28.0 m -132.57 171.7 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 1.9 pm0 -152.19 151.8 31.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.385 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.478 ' HB3' HG11 ' A' ' 168' ' ' VAL . 4.9 p -166.73 130.74 1.99 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 111.872 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 t -136.46 114.55 11.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.984 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.79 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.54 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -61.0 -54.46 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.9 m -106.38 -13.28 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.672 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 15.2 mt-30 77.03 18.01 1.55 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.634 0.254 . . . . 0.0 111.039 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.426 ' HG2' HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -67.41 112.53 4.67 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.705 0.288 . . . . 0.0 110.626 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 168' ' ' VAL . . . 60.45 16.42 43.51 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.454 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 22' ' ' SER . 2.1 tm? -59.08 -41.38 87.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 111.291 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.38 -54.94 4.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.459 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -47.53 -44.44 25.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.61 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 155' ' ' VAL . 6.2 p -46.88 -42.37 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.073 0.463 . . . . 0.0 111.485 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' O ' HD12 ' A' ' 173' ' ' ILE . 53.5 m-85 -76.14 -32.26 59.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.59 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.796 ' O ' HD13 ' B' ' 9' ' ' ILE . 1.7 m-20 -60.68 -27.81 68.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.074 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.62 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.4 mt-10 -79.82 -38.19 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.626 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.725 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -56.14 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 4' ' ' ILE . 3.2 mt -46.19 -51.71 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 110.432 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.678 HD12 ' HB ' ' B' ' 4' ' ' ILE . 14.5 tp -51.08 -31.12 17.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.342 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.709 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -88.7 -48.8 7.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.026 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.474 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -51.46 -44.97 62.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 4' ' ' ILE . 29.4 mt -70.13 -172.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -158.29 162.99 25.83 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.055 -177.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 4.2 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.604 2.203 . . . . 0.0 111.849 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.897 0.379 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 178' ' ' GLU . 17.6 tttt -137.23 22.67 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.258 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -68.55 114.7 7.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.091 0.948 . . . . 0.0 111.871 178.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.678 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.7 mm -85.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.091 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 97.6 p -130.41 -166.53 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.888 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.55 -27.02 41.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.32 -0.83 48.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.285 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -77.96 -68.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.522 0.201 . . . . 0.0 111.516 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 170' ' ' ASP . 1.9 mt -57.6 101.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.803 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.32 -147.09 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 134.54 33.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.606 0.241 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.561 ' HA ' HG22 ' A' ' 44' ' ' VAL . 35.5 Cg_endo -64.68 168.17 13.84 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.421 2.081 . . . . 0.0 112.311 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.29 -170.88 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.653 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.4 30.89 50.3 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.565 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 9.2 t80 -40.67 120.27 1.25 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 111.13 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.2 tptt -120.07 109.12 15.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.758 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 2.6 t-160 -72.95 85.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -68.96 -42.64 82.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.762 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.6 t -151.83 131.81 13.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 111.207 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . 0.468 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 86.4 t60 -129.05 124.09 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.034 HG13 HG22 ' B' ' 31' ' ' VAL . 55.2 t -104.97 145.46 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 30' ' ' ASP . . . -123.33 106.9 1.03 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.588 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.632 ' HB2' HG11 ' A' ' 36' ' ' VAL . 68.4 t90 -105.91 101.76 11.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.33 . . . . 0.0 110.898 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' B' ' 28' ' ' GLY . 1.2 m-20 -71.4 137.84 83.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.363 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.13 -10.38 27.28 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.189 1.926 . . . . 0.0 112.285 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -113.53 -47.63 2.98 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.891 0.377 . . . . 0.0 111.104 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -90.58 21.06 4.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.732 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 62.87 -133.94 43.72 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.182 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' B' ' 47' ' ' ILE . 2.3 m-85 -73.29 178.52 4.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.957 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 22' ' ' GLY . 0.7 OUTLIER 177.71 58.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.415 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.034 HG22 HG13 ' B' ' 21' ' ' VAL . 59.5 t -65.49 132.34 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.35 -33.49 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -144.45 81.75 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.266 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.57 HD11 ' CG ' ' B' ' 42' ' ' PHE . 3.0 mt -95.36 -172.84 2.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.698 ' HB2' HD12 ' B' ' 38' ' ' LEU . 6.8 t70 -90.74 140.38 26.42 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.363 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' B' ' 39' ' ' ARG . 1.7 Cg_endo -42.87 -50.41 6.13 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.814 2.343 . . . . 0.0 112.237 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -54.4 6.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.722 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' B' ' 35' ' ' ASP . 51.5 mt -53.02 -25.04 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' B' ' 36' ' ' PRO . 7.4 mtt-85 -54.57 -45.38 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.215 0.531 . . . . 0.0 109.817 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.41 -46.49 63.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.192 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER -63.88 -33.12 74.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.903 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.764 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -66.27 -53.85 31.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 48' ' ' SER . 14.8 m -62.9 -26.99 69.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.578 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' B' ' 41' ' ' LEU . 3.0 ptm180 -90.67 -21.86 21.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.59 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 41' ' ' LEU . . . -102.06 69.7 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.07 -27.65 9.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.708 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.534 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.9 mm -95.59 36.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.347 0.594 . . . . 0.0 110.511 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 4.6 p -86.46 -144.6 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.759 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -42.02 -26.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 58.28 107.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.902 0.382 . . . . 0.0 111.457 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -88.75 175.4 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.761 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -167.65 36.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.087 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.508 HG22 ' O ' ' B' ' 53' ' ' THR . 21.0 m -96.76 8.39 44.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -56.92 155.42 8.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.915 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -179.83 -83.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.64 127.3 32.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.07 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 15.2 p -105.9 29.25 6.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 151.92 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.918 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.425 ' PA ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -147.67 133.47 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.014 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 52' ' ' THR . 67.7 m -139.4 126.11 20.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.813 HG12 HG23 ' A' ' 173' ' ' ILE . 4.9 mp -94.25 138.81 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.032 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 0.1 OUTLIER -99.85 110.38 22.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.063 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.401 ' SG ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -120.87 140.59 51.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.537 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG12 HG23 ' A' ' 75' ' ' THR . 3.3 p -143.97 136.75 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.33 123.46 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.156 0.503 . . . . 0.0 110.78 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -120.93 136.82 56.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.061 -178.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.95 153.11 6.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.693 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.78 117.57 35.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.25 170.19 11.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.547 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.14 73.35 4.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -77.23 -2.57 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.754 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' HA3' ' H8 ' ' A' ' 181' ' ' GCP . . . 76.38 76.04 0.84 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.745 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.84 -44.7 74.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.709 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 35' ' ' THR . 91.7 m -78.49 -13.45 59.83 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 t -75.58 -63.2 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' HB2' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -75.98 -39.43 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.882 -176.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 16' ' ' LYS . 31.6 mt -54.11 -41.44 68.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.9 mm -77.08 -42.86 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.996 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -64.91 -10.92 32.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.47 179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.4 t80 -90.03 -56.28 3.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.636 0.255 . . . . 0.0 111.189 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 20' ' ' LEU . 1.2 t -87.38 -31.79 19.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.642 0.258 . . . . 0.0 111.599 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 ' OG1' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -100.28 -12.42 19.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 60.05 23.96 13.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.47 161.17 17.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 110.991 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 37.8 t80 -126.51 87.61 56.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.75 157.4 48.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.657 2.238 . . . . 0.0 112.492 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.38 -8.82 6.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.069 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 137.45 44.94 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.74 0.305 . . . . 0.0 110.956 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' O ' HG22 ' A' ' 33' ' ' VAL . 1.2 t80 -138.45 98.99 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.309 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -172.66 -66.38 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.71 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.617 ' CD ' HG23 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -73.9 -161.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.741 2.294 . . . . 0.0 111.796 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 2.3 m 81.72 116.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.211 0.529 . . . . 0.0 111.711 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' B' ' 23' ' ' TRP . 83.7 t -137.47 -49.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.898 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' B' ' 42' ' ' PHE . 31.8 t80 -159.28 90.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.667 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -107.14 123.93 48.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.138 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.49 119.27 38.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.899 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CE1' ' CD2' ' B' ' 17' ' ' HIS . 30.8 m-85 -113.89 158.73 20.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.621 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.16 119.61 22.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 55' ' ' LEU . 11.7 t -102.64 161.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.714 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.476 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 53.7 m -128.57 130.48 47.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.598 HG21 HG22 ' B' ' 9' ' ' ILE . 1.3 p -157.73 158.71 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.274 0.559 . . . . 0.0 111.98 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.432 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -81.64 88.69 6.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.742 -178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 51' ' ' TYR . 44.2 mt -99.53 100.77 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.466 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -3.33 87.34 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.745 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.69 27.3 2.16 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.676 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.63 136.79 6.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.624 0.25 . . . . 0.0 111.309 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 36.8 Cg_endo -66.07 66.29 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.703 2.268 . . . . 0.0 112.029 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.755 ' HB2' HD12 ' A' ' 46' ' ' ILE . 13.1 m-30 -56.53 -176.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.0 110.726 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 3' ' ' THR . 4.8 m -124.62 110.44 14.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.994 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 173' ' ' ILE . 3.4 tm? -85.75 112.17 20.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.019 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.48 111.71 3.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.287 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 42' ' ' VAL . 76.0 mt -95.29 120.05 34.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 6.3 m-85 -123.38 139.56 53.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 4.6 p30 -128.48 121.45 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 HG22 ' OG ' ' A' ' 71' ' ' SER . 3.6 p -105.02 149.4 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.17 86.98 7.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.6 97.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.54 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -174.33 178.73 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.49 -25.8 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.02 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -35.59 79.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.88 22.86 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.329 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.86 -25.84 63.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 110.623 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -56.93 -39.87 75.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.337 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 67' ' ' LEU . 3.9 pp -115.98 17.42 15.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.637 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -75.78 -45.14 4.07 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 25.6 Cg_exo -61.78 -24.29 77.23 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.267 1.978 . . . . 0.0 112.237 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' B' ' 41' ' ' LEU . 52.0 mt -66.13 -10.68 43.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.824 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' HG22 ' A' ' 58' ' ' THR . 33.1 t -92.75 17.18 10.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.1 m-85 -134.12 39.12 0.45 Allowed Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 73.4 Cg_exo -38.59 -61.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.497 2.131 . . . . 0.0 112.611 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.41 52.33 1.74 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.734 HG21 ' CE1' ' A' ' 78' ' ' PHE . 99.0 m -46.1 124.06 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.644 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.798 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 3.7 m-20 -90.42 -26.62 19.78 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.755 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.9 p -154.37 174.09 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.114 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' A' ' 75' ' ' THR . 88.8 m-85 -136.61 121.46 18.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -89.01 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.418 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 97' ' ' TRP . 5.8 t -88.86 88.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.894 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.489 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 4.0 m -80.43 110.43 15.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 93' ' ' VAL . 1.7 p90 -118.88 151.41 38.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.525 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -77.6 112.73 14.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG11 ' HD2' ' A' ' 120' ' ' ARG . 87.1 t -65.14 -30.84 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -94.09 38.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 t -157.53 99.8 1.89 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.054 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.89 -21.81 22.0 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.432 2.088 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 m -63.98 -53.9 42.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 -50.06 65.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' HD22 ' A' ' 145' ' ' LEU . 41.5 t80 -49.19 -38.38 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.215 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -64.66 -56.69 12.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.75 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 94.4 m-20 -64.74 -39.65 93.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.205 0.526 . . . . 0.0 110.199 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 89' ' ' SER . 39.0 t -45.11 -42.34 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.835 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 -19.94 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.354 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 19.6 mt-10 -139.83 59.15 1.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' ASN . 2.1 tptm 173.15 -56.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.521 ' CZ3' ' CA ' ' A' ' 10' ' ' GLY . 16.6 m95 -70.58 -53.73 14.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.404 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.015 HG21 HD13 ' A' ' 149' ' ' LEU . 98.6 t -72.05 -59.19 2.9 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.968 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 8.2 Cg_endo -49.74 -29.2 19.33 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.355 2.036 . . . . 0.0 112.516 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.14 -33.93 76.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 78' ' ' PHE . 1.4 mt -85.93 -40.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.009 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' VAL . 10.2 p -57.98 -30.8 66.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.59 67.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.718 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.81 -44.85 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.755 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 93.9 m -148.94 90.53 4.75 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.18 -28.35 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.707 2.271 . . . . 0.0 112.826 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.575 ' HD3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -71.35 -26.01 62.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.244 -178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.575 HG23 ' HD3' ' A' ' 107' ' ' LYS . 4.6 p -64.89 147.29 98.38 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.714 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.794 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.1 Cg_endo -61.36 158.95 33.32 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 23.6 m-85 -143.48 96.63 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.726 HD12 HG23 ' A' ' 152' ' ' VAL . 3.3 tp -72.43 116.95 13.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.143 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.41 90.04 5.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.348 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 25.2 t -86.25 119.38 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.636 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -100.8 109.17 3.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.833 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.8 m -98.82 172.25 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.086 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.51 ' H ' HG22 ' A' ' 115' ' ' THR . 1.5 mt-30 71.04 42.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.044 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -78.37 -34.32 18.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.143 0.497 . . . . 0.0 110.014 178.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.512 ' CG ' HD23 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -52.27 -23.24 5.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.421 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.643 HD12 HG21 ' A' ' 125' ' ' THR . 0.2 OUTLIER -92.38 -37.9 12.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.797 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -60.63 -29.0 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.37 . . . . 0.0 110.731 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.55 16.07 24.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.976 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' C ' HD12 ' A' ' 126' ' ' ILE . 43.9 t0 -123.02 95.6 45.91 Favored Pre-proline 0 C--N 1.333 -0.11 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.873 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.45 -32.5 8.04 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.603 2.202 . . . . 0.0 112.319 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -53.12 -34.07 55.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.643 HG21 HD12 ' A' ' 119' ' ' LEU . 13.0 p -96.02 -44.18 7.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.243 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.797 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.5 mt -54.52 -43.34 63.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.177 178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.25 -25.22 51.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' SER . 14.5 ttmt -63.51 -45.84 88.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -90.37 -25.85 20.23 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.751 178.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.63 -24.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.676 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -104.22 -21.99 13.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.408 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.0 m-80 -83.82 -14.42 51.36 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 98.35 31.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.675 0.79 . . . . 0.0 111.892 177.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.845 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -125.71 142.18 51.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' CE ' ' N ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -140.23 150.87 63.02 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.531 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 77.0 Cg_endo -77.54 169.28 21.28 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.634 2.223 . . . . 0.0 111.998 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 141' ' ' THR . 27.5 mm -97.67 133.51 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -78.57 156.4 78.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.45 -37.55 72.89 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 112.118 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -74.29 -39.8 62.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 25.7 m -59.99 -44.18 94.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.726 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -70.99 -39.2 72.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.555 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -51.22 -58.49 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.176 0.513 . . . . 0.0 110.337 178.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -40.96 -51.41 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.253 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.757 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -57.93 -44.74 87.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.62 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.45 -29.36 49.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.662 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.54 -28.93 14.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.968 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.02 -31.71 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.015 HD13 HG21 ' A' ' 98' ' ' VAL . 1.9 mt -105.98 20.21 19.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 57.93 27.38 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.73 129.17 40.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.828 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 175' ' ' ALA . 9.0 m -48.59 -34.64 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.41 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.54 141.76 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -80.47 122.62 27.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.773 HG21 HG13 ' A' ' 168' ' ' VAL . 18.9 m -130.99 177.16 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.775 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.472 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -150.51 136.83 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.768 0.318 . . . . 0.0 111.453 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 6.1 p -146.74 136.07 22.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.021 0.439 . . . . 0.0 111.151 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 t -136.01 114.46 11.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 19' ' ' LEU . . . -69.94 -18.88 63.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.676 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.512 HD23 ' CG ' ' A' ' 118' ' ' ASP . 17.7 tp -62.34 -51.55 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.327 . . . . 0.0 111.024 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.1 m -114.0 0.45 14.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.794 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 6.7 mt-30 70.06 22.26 5.77 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.743 0.306 . . . . 0.0 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.03 110.15 6.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.54 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 59.83 24.04 59.71 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.006 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.542 HD21 ' HB2' ' A' ' 19' ' ' LEU . 2.1 tm? -60.45 -46.65 89.28 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.411 0.284 . . . . 0.0 111.757 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -86.91 -47.21 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -43.96 -44.82 7.42 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.773 HG13 HG21 ' A' ' 155' ' ' VAL . 48.0 t -52.76 -56.02 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.26 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.758 ' O ' HD12 ' A' ' 173' ' ' ILE . 83.2 m-85 -54.32 -43.09 70.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.952 0.406 . . . . 0.0 110.709 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.465 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.7 OUTLIER -54.9 -32.27 60.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.883 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.688 ' HB3' HD11 ' A' ' 111' ' ' LEU . 2.2 mp0 -76.05 -39.03 56.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.482 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -53.69 -67.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.752 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.813 HG23 HG12 ' A' ' 4' ' ' ILE . 3.3 mp -46.11 -55.86 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.17 0.51 . . . . 0.0 110.625 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -49.99 -28.65 7.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.168 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -85.28 -54.98 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.775 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -52.77 -42.32 64.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.725 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 173' ' ' ILE . 22.7 mt -67.69 -173.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.473 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 9.2 pt-20 -169.99 162.09 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.964 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 1.9 Cg_endo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 122.883 2.389 . . . . 0.0 112.051 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 3.6 tttp -129.88 28.4 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.252 0.548 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 15.0 mmmt -73.69 112.99 10.32 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.918 0.866 . . . . 0.0 111.421 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -87.12 149.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.251 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.4 p -129.49 -169.06 2.04 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.457 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -77.01 -26.99 54.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.49 44.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -78.9 -66.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.434 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.598 HG22 HG21 ' A' ' 44' ' ' VAL . 1.9 mt -53.41 98.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.455 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.66 -135.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.73 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.28 119.69 67.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.441 0.162 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 50.9 Cg_endo -66.71 134.42 35.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.155 1.903 . . . . 0.0 111.566 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 42' ' ' VAL . 7.4 t -158.7 -151.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.981 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.88 37.9 53.61 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.272 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -44.92 112.72 0.46 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.3 tttt -117.95 108.17 14.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.851 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.575 ' CD2' ' CE1' ' A' ' 40' ' ' TYR . 4.1 t-160 -75.83 85.22 2.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.645 HG22 ' HG2' ' B' ' 16' ' ' LYS . 2.2 t -70.76 -57.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.689 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 13.8 t -123.23 158.22 31.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.379 . . . . 0.0 111.097 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -160.28 131.72 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.618 HG22 HD21 ' B' ' 34' ' ' LEU . 27.0 t -103.9 150.16 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.069 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.4 92.4 0.55 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.809 ' HB2' HG21 ' A' ' 36' ' ' VAL . 35.2 t90 -105.76 100.05 9.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 0.0 111.569 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -91.82 138.56 24.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.285 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.49 -8.1 22.01 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.33 2.02 . . . . 0.0 112.663 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.86 -27.48 8.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.721 0.296 . . . . 0.0 111.154 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.82 -27.78 9.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.349 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.1 -156.83 19.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.338 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 5.3 m-85 -62.43 174.92 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.378 . . . . 0.0 110.939 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.6 OUTLIER -174.01 61.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.675 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.721 HG13 HD23 ' B' ' 34' ' ' LEU . 3.7 t -65.67 113.11 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.523 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.55 -35.67 3.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.57 59.41 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.345 . . . . 0.0 111.437 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.721 HD23 HG13 ' B' ' 31' ' ' VAL . 0.8 OUTLIER -95.38 168.26 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.615 178.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.44 144.36 86.49 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -45.31 -33.35 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.11 1.873 . . . . 0.0 112.226 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.77 -57.36 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.607 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' B' ' 34' ' ' LEU . 20.4 mt -53.32 -27.03 21.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' B' ' 34' ' ' LEU . 0.2 OUTLIER -53.28 -46.14 69.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.234 178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.24 -45.29 18.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.187 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -53.18 -39.08 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.638 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 2.4 m-85 -65.11 -56.52 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.7 t -53.71 -27.56 28.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 110.15 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -90.8 -21.87 21.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.694 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -101.83 71.94 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.56 -34.14 4.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.544 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.596 HD12 ' OE1' ' B' ' 51' ' ' GLN . 1.1 mm -92.1 46.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.146 0.498 . . . . 0.0 110.111 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' B' ' 49' ' ' GLU . 81.0 p -97.96 -87.2 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.491 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 4.1 mt-10 -97.01 -24.39 15.82 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 49' ' ' GLU . . . 170.31 148.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.149 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.596 ' OE1' HD12 ' B' ' 47' ' ' ILE . 3.7 mt-30 -92.41 161.04 14.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.0 mt -50.66 167.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.35 109.45 0.99 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.36 0.6 . . . . 0.0 110.108 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t0 57.94 87.04 0.07 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.94 100.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.972 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -74.24 110.76 8.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 120.16 26.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -69.32 112.23 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 tttp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.005 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.463 ' H8 ' ' HA3' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -55.25 131.52 45.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -134.82 128.11 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.876 HG13 HD21 ' A' ' 177' ' ' LEU . 4.1 mp -94.19 122.68 45.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.411 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -91.16 85.52 5.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.919 0.39 . . . . 0.0 110.475 -179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 124.97 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.953 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG11 ' CE1' ' A' ' 72' ' ' TYR . 3.7 t -123.88 135.78 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.97 0.414 . . . . 0.0 111.199 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 20' ' ' LEU . 19.7 t -86.83 114.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -108.24 137.87 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.195 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 155.29 139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.523 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.06 123.44 49.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.865 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.42 -114.84 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -178.65 111.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.239 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 5.3 m -129.92 -48.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 140.61 41.8 0.07 OUTLIER Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.181 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.722 ' O ' HD23 ' A' ' 19' ' ' LEU . 3.9 mppt? -71.27 -56.39 6.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.0 111.026 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.725 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 m -50.28 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 1.3 m -44.64 -32.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.871 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -82.38 -34.62 28.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD11 HG21 ' A' ' 8' ' ' VAL . 52.1 mt -57.18 -43.27 82.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.575 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.463 HG22 ' OG1' ' A' ' 25' ' ' THR . 35.4 mm -70.05 -61.85 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.896 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 p -53.0 -23.28 7.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.545 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 3.9 t80 -64.47 -57.59 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.55 -17.86 21.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.463 ' OG1' HG22 ' A' ' 21' ' ' ILE . 10.1 p -102.43 -22.07 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 t30 67.48 17.25 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.084 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.85 120.89 25.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -83.07 115.65 60.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.719 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.8 168.85 20.41 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.353 2.035 . . . . 0.0 112.235 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.03 -3.65 8.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.694 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 151.44 5.74 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.823 0.344 . . . . 0.0 110.782 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -123.43 100.54 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 33' ' ' VAL . 14.8 p 178.56 125.46 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.51 152.42 40.47 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.377 2.051 . . . . 0.0 112.194 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -83.91 144.87 28.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 5.8 p -116.59 -46.62 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.682 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' B' ' 21' ' ' VAL . 15.2 t80 -171.78 91.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.363 . . . . 0.0 111.177 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 1.1 m-20 -124.19 105.6 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.556 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.73 118.58 37.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.267 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -116.86 161.42 19.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.885 178.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -131.42 119.97 22.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.41 . . . . 0.0 111.41 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' CG2' HD11 ' A' ' 55' ' ' LEU . 12.1 t -103.5 142.28 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.554 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.1 m -105.13 113.34 26.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.454 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG22 ' HA ' ' B' ' 12' ' ' PRO . 9.5 t -124.61 157.58 32.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.353 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.0 mmt -89.55 88.93 7.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.536 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -103.54 127.81 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.287 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.06 27.37 67.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.545 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.48 78.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 143.7 43.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.829 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.44 83.92 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 3.2 m-85 -81.76 -176.79 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 m -142.36 103.11 4.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.925 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' C ' ' A' ' 53' ' ' LEU . 3.4 tm? -77.38 104.15 7.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.86 108.88 2.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.494 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD11 ' CG2' ' A' ' 42' ' ' VAL . 9.9 mt -90.49 113.38 25.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -110.99 128.49 55.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -120.19 108.14 13.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.756 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.5 p -95.25 172.19 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -89.61 155.62 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.8 -17.35 11.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.753 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.28 -170.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.98 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -113.61 -19.23 11.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.263 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.5 -30.59 67.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.474 ' HD2' HD21 ' A' ' 67' ' ' LEU . 9.5 m-85 -85.37 10.46 12.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.612 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -52.67 -28.32 21.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.743 0.306 . . . . 0.0 110.961 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -45.58 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.007 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.2 pp -96.4 20.73 10.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -78.67 -52.71 1.3 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.855 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 58.5 Cg_endo -73.11 -0.69 9.46 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.309 2.006 . . . . 0.0 112.997 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.766 ' O ' HD21 ' B' ' 38' ' ' LEU . 2.2 mp -77.16 1.35 18.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m -115.55 17.08 16.48 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.517 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 7.2 m-85 -129.68 38.14 0.42 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.1 Cg_exo -40.6 -35.62 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.185 1.924 . . . . 0.0 112.482 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -168.66 45.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.973 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 53.2 m -45.06 137.08 4.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.968 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.66 -72.57 0.52 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.992 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -104.66 174.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' H ' HG22 ' A' ' 77' ' ' VAL . 44.3 m-85 -139.42 126.81 21.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.676 0.275 . . . . 0.0 111.074 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD23 HG21 ' A' ' 113' ' ' VAL . 2.3 mt -93.94 97.51 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.094 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.832 HG13 ' CE3' ' A' ' 97' ' ' TRP . 79.5 t -92.37 85.57 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.941 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.564 ' SG ' HG11 ' A' ' 113' ' ' VAL . 7.4 m -93.77 111.43 23.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CB ' HG21 ' A' ' 93' ' ' VAL . 22.5 p90 -112.37 159.55 18.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.523 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 123.51 25.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 137' ' ' ILE . 86.4 t -68.33 -33.76 62.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.639 HG21 ' CD2' ' A' ' 119' ' ' LEU . 17.2 m -94.65 36.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.322 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -151.16 85.21 5.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -51.13 -25.9 18.14 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.607 2.205 . . . . 0.0 112.356 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -67.44 -39.8 85.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.058 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.868 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.6 p -70.12 -43.56 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.531 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 40.1 t80 -66.65 -39.54 88.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.369 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -60.86 -26.79 67.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 96' ' ' LYS . 1.6 m-20 -87.66 -29.73 20.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 89' ' ' SER . 79.5 t -62.15 -41.91 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HB3' HD13 ' A' ' 145' ' ' LEU . 4.4 pttp -74.78 -20.5 59.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.622 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -146.78 63.07 1.19 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.66 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 171.4 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.832 ' CE3' HG13 ' A' ' 80' ' ' VAL . 12.8 m95 -70.32 -57.13 5.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.604 0.24 . . . . 0.0 111.311 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.905 ' O ' HG23 ' A' ' 102' ' ' THR . 96.2 t -68.19 -46.01 39.81 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 66.9 Cg_exo -50.95 -48.2 22.06 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.203 1.935 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -50.86 -36.73 39.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.729 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.7 -40.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.905 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.6 p -63.48 -28.41 69.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.086 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -23.51 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.988 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -111.98 -46.35 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.034 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.22 81.6 15.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.61 1.43 9.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 0.0 113.1 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -29.99 11.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.911 0.386 . . . . 0.0 110.62 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.3 p -58.25 142.88 80.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.289 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.857 ' HB2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -53.29 142.67 56.14 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.776 2.317 . . . . 0.0 111.865 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 21.4 m-85 -132.44 97.51 4.12 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 152' ' ' VAL . 2.2 tp -75.07 128.59 35.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.609 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 146' ' ' ALA . 1.2 tt -91.61 108.14 19.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.77 0.319 . . . . 0.0 110.466 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.96 HG21 HD23 ' A' ' 79' ' ' LEU . 48.0 t -106.84 152.02 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 111.992 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -141.79 111.0 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.431 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -108.91 175.68 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 111.255 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 80.74 49.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.901 -179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.756 HD11 ' C ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -77.68 -30.09 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.142 0.496 . . . . 0.0 109.954 178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -43.38 -52.8 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.498 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.639 ' CD2' HG21 ' A' ' 85' ' ' VAL . 2.4 mp -65.47 -44.29 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.7 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -56.71 -28.4 60.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.85 18.78 20.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.659 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.634 ' OD2' HG23 ' A' ' 125' ' ' THR . 19.3 t70 -121.27 87.01 44.02 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.762 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' N ' HD12 ' A' ' 126' ' ' ILE . 94.8 Cg_exo -41.32 -40.11 4.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -50.84 -30.85 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.018 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.634 HG23 ' OD2' ' A' ' 122' ' ' ASP . 38.8 p -95.5 -46.51 6.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.321 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.7 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.0 mt -53.66 -39.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.16 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -80.55 -23.52 39.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.445 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' SER . 8.3 ttmt -66.8 -41.15 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.097 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -95.63 -23.61 16.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -46.86 -24.21 0.55 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.764 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -105.32 -20.37 13.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.501 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 6.7 m-80 -83.85 -15.45 48.17 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 97.16 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 111.993 177.299 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.902 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -118.34 141.7 48.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.87 157.59 73.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.909 0.385 . . . . 0.0 111.714 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 97.3 Cg_endo -85.5 139.56 6.87 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.913 2.409 . . . . 0.0 112.134 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 mm -76.83 130.78 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 0.0 111.014 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.7 p -90.45 156.51 45.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -46.37 -43.95 21.05 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.386 2.057 . . . . 0.0 111.987 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -47.98 -69.61 0.12 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.55 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -41.02 -60.81 1.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.555 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -53.18 -50.11 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.38 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.467 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -45.14 -42.01 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.159 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mt -73.84 -37.06 64.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.393 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -53.61 -28.26 31.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -33.64 11.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.554 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -38.59 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.032 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 98' ' ' VAL . 3.7 mt -91.84 19.54 6.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.55 22.33 8.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -61.85 130.57 46.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.84 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 111' ' ' LEU . 15.8 m -49.51 -32.47 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.249 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt 173.17 155.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 27.2 t80 -101.7 137.26 40.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.825 HG21 HG13 ' A' ' 168' ' ' VAL . 26.1 m -145.2 135.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.615 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -121.17 141.65 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.371 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.892 ' SG ' HG21 ' A' ' 168' ' ' VAL . 22.0 p -167.06 178.47 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.203 0.525 . . . . 0.0 111.619 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -135.85 157.39 46.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.28 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 19' ' ' LEU . . . -98.8 -25.68 14.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 111.218 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.557 HD23 ' OD2' ' A' ' 118' ' ' ASP . 28.4 tp -83.23 -33.65 26.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.958 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.44 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 73.34 24.58 2.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.024 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 0.7 OUTLIER -62.16 104.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.411 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 54.64 21.85 23.11 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.187 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -56.44 -67.68 0.28 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -55.91 -35.79 66.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.173 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -62.34 -29.16 70.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.892 HG21 ' SG ' ' A' ' 157' ' ' CYS . 97.3 t -63.3 -54.44 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.329 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.795 ' O ' HD12 ' A' ' 173' ' ' ILE . 79.0 m-85 -57.77 -38.86 76.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.91 -29.19 40.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -30.72 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.34 -68.96 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.795 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.0 mp -48.44 -50.49 12.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.135 0.493 . . . . 0.0 110.637 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.8 tp -51.52 -29.38 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.262 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.604 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.6 -46.98 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.15 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -46.01 -38.44 7.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.524 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.876 HD21 HG13 ' A' ' 4' ' ' ILE . 33.3 mt -89.46 -165.86 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.943 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.1 pt-20 -167.45 165.73 8.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.146 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.483 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.1 Cg_endo . . . . . 0 C--O 1.249 1.034 0 C-N-CA 122.652 2.234 . . . . 0.0 112.055 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.738 0.304 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 179' ' ' PRO . 5.4 tttp -145.1 26.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 111.095 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 5.6 mmmt -74.19 117.38 15.92 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 121.734 0.778 . . . . 0.0 111.713 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.8 mm -88.55 148.44 4.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.021 175.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.5 p -130.12 -176.96 4.11 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.165 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -72.85 -28.65 62.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.837 0.351 . . . . 0.0 110.71 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.29 -2.14 46.54 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 61.6 m-20 -79.34 -67.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.595 0.236 . . . . 0.0 111.133 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.762 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -53.63 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.544 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.43 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.536 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.69 137.11 32.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.601 0.239 . . . . 0.0 110.652 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 44' ' ' VAL . 37.3 Cg_endo -65.71 162.38 34.79 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.336 2.024 . . . . 0.0 112.16 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 8.7 p 176.54 -175.87 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.69 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.42 33.72 58.94 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.491 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 17.6 t80 -44.65 123.97 3.98 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.34 . . . . 0.0 110.973 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 ttpt -121.01 132.42 54.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.139 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 20' ' ' HIS . 3.4 t-160 -91.6 85.03 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.619 HG22 ' CE ' ' B' ' 16' ' ' LYS . 9.0 t -71.58 -35.67 57.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.461 -175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 1.1 p -159.06 136.6 10.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.206 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' CE1' ' B' ' 17' ' ' HIS . 27.2 t-80 -136.5 126.3 25.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.811 HG13 HG22 ' B' ' 31' ' ' VAL . 79.3 t -113.41 108.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.647 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -90.64 94.51 1.98 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.833 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.443 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 37.5 t90 -88.94 99.86 12.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.302 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -89.05 136.21 30.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.616 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.89 -5.6 17.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.388 2.059 . . . . 0.0 112.822 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -111.32 -25.28 9.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.677 0.275 . . . . 0.0 111.285 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -108.21 -27.15 10.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.299 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.55 92.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.766 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 34.8 m-85 60.84 131.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.119 0.485 . . . . 0.0 111.504 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 22' ' ' GLY . 2.0 t0 -145.82 55.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.335 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.811 HG22 HG13 ' B' ' 21' ' ' VAL . 54.1 t -65.14 129.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -116.03 -25.62 7.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -142.58 77.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.454 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.67 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.36 -176.75 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.398 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.604 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -92.82 147.81 34.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.918 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.52 -46.47 33.2 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.55 2.167 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.23 -38.18 56.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.766 HD21 ' O ' ' A' ' 70' ' ' LEU . 7.8 mt -71.41 -29.11 64.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.785 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -52.46 -33.26 43.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.499 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.02 -42.67 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.926 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 8.3 mt -71.03 -51.61 24.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -49.98 -58.36 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.688 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -54.72 -28.12 45.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -91.39 -17.23 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.31 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -100.9 69.38 1.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.58 29.28 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.59 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.526 ' CD1' ' CZ ' ' B' ' 29' ' ' PHE . 1.2 mm -97.64 26.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 0.0 110.567 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER -102.01 -24.97 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.522 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -101.43 -25.46 13.92 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.72 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.98 -4.76 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.096 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 49.7 -164.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.775 0.322 . . . . 0.0 110.972 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 -42.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.458 HG22 ' O ' ' B' ' 53' ' ' THR . 9.0 m -101.24 9.58 41.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.081 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 51.34 86.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.759 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 118.31 3.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 66.47 121.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 31.0 m -81.47 119.83 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.3 91.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.034 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.424 ' H8 ' ' HA2' ' A' ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -84.42 155.27 22.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.877 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.9 m -138.71 133.06 31.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.865 HG12 HG23 ' A' ' 173' ' ' ILE . 3.0 mp -98.89 127.37 51.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.643 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.99 82.89 1.83 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.285 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.6 p -96.87 147.08 24.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.234 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.556 HG11 ' CE2' ' A' ' 78' ' ' PHE . 8.1 p -126.69 135.23 64.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.606 HG12 ' HD2' ' A' ' 16' ' ' LYS . 13.7 t -86.51 109.14 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 HH21 ' A' ' 68' ' ' ARG . 0.7 OUTLIER -114.0 150.31 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.428 -178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 158.1 142.63 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.735 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -110.41 95.88 5.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 154.16 6.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.81 82.73 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 81' ' ' CYS . 33.2 m -94.92 -33.12 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.083 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.44 ' HA2' ' H8 ' ' A' ' 181' ' ' GCP . . . 122.7 47.13 0.27 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.761 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' O ' HD23 ' A' ' 19' ' ' LEU . 9.5 mtmm -78.61 -49.86 12.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 111.439 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.8 m -63.6 -51.11 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.87 0.367 . . . . 0.0 111.386 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -43.29 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.603 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 -36.69 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.492 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' A' ' 169' ' ' PHE . 29.9 mt -58.29 -39.26 78.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 27' ' ' LYS . 51.5 mm -74.37 -42.77 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.522 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' C ' HD21 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -72.91 -5.52 38.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.461 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' CE2' ' A' ' 169' ' ' PHE . 20.4 t80 -88.93 -72.72 0.53 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.737 0.303 . . . . 0.0 111.11 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -81.02 -30.01 34.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.444 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -11.77 20.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 54.02 24.14 4.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.787 0.327 . . . . 0.0 111.033 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB3' HG22 ' A' ' 21' ' ' ILE . 5.0 tppp? -111.79 150.78 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.718 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 46.0 t80 -113.75 106.31 53.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.014 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.02 152.36 28.03 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.93 -10.16 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.14 171.49 0.72 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.904 0.383 . . . . 0.0 111.125 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.567 ' C ' HG23 ' A' ' 33' ' ' VAL . 5.1 p90 -130.58 -168.84 2.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG23 ' C ' ' A' ' 32' ' ' TYR . 4.8 t 84.56 131.89 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.86 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -40.35 153.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.698 2.266 . . . . 0.0 112.851 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 m -77.56 -27.72 51.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.986 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 ' CE1' ' B' ' 29' ' ' PHE . 62.1 t 68.42 -75.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' HG23 ' B' ' 21' ' ' VAL . 92.7 t80 -171.58 107.74 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.087 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -114.39 159.67 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.514 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -139.8 118.93 12.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.876 0.37 . . . . 0.0 111.466 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.1 OUTLIER -129.61 160.16 34.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.096 178.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -139.52 120.15 14.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 44' ' ' VAL . 9.8 t -102.8 149.03 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.587 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.0 m -112.06 107.13 15.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.458 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.746 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -120.37 156.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.404 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 mmt -91.45 88.68 6.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.215 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.655 HD13 HG21 ' A' ' 173' ' ' ILE . 21.1 mt -103.3 130.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.455 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.34 73.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.496 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.13 26.07 71.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.64 151.49 39.35 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.578 0.227 . . . . 0.0 111.036 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.63 101.87 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.604 2.203 . . . . 0.0 112.257 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 2' ' ' GLN . 3.1 m-85 -96.38 178.75 5.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 m -140.77 104.55 4.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.874 HD13 ' CG1' ' A' ' 173' ' ' ILE . 22.8 tp -75.97 101.67 5.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.52 102.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD21 HD21 ' A' ' 53' ' ' LEU . 5.2 mt -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.96 0.409 . . . . 0.0 111.508 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 29.9 m-85 -140.79 123.14 15.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.412 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.64 110.32 21.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 111.198 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.1 p -94.62 160.36 14.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' HB1' HE21 ' A' ' 61' ' ' GLN . . . -59.9 -173.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.59 23.34 3.43 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.557 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.422 HE21 ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -127.61 176.93 7.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.989 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.29 -25.25 17.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -17.51 58.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.357 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -109.42 23.86 13.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -10.37 59.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.486 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 7.3 mmp_? -72.17 -41.39 67.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.665 0.269 . . . . 0.0 111.355 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' B' ' 42' ' ' PHE . 3.8 pp -114.82 9.45 16.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 59.9 ttt180 -78.12 -46.34 2.2 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.394 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 24.3 Cg_exo -61.78 -19.47 65.56 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.283 1.989 . . . . 0.0 112.255 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -47.17 -27.72 1.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.691 -179.095 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -103.17 17.25 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.619 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 8.4 m-30 -91.89 -46.27 0.35 Allowed Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 87.6 Cg_exo -47.24 -29.3 9.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.385 2.057 . . . . 0.0 112.452 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -119.01 69.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.746 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 82.4 m -138.63 134.1 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.02 0.438 . . . . 0.0 111.441 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.64 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 4.8 m-20 -96.37 -57.99 2.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.412 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 109' ' ' PRO . 4.0 p -120.12 172.65 6.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.691 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' H ' HG22 ' A' ' 77' ' ' VAL . 33.6 m-85 -132.99 127.23 33.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.789 0.328 . . . . 0.0 111.113 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 2.9 mp -91.7 104.11 16.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.532 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 97' ' ' TRP . 12.1 t -99.98 91.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 56.5 m -92.53 111.72 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CD2' HG21 ' A' ' 93' ' ' VAL . 2.3 p90 -107.62 167.54 9.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.497 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 117.24 27.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.399 . . . . 0.0 111.241 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 73.2 t -68.89 -30.12 45.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.727 HG11 ' HB2' ' A' ' 119' ' ' LEU . 4.6 m -93.82 35.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.571 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -153.79 103.88 2.5 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.876 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.83 -14.92 39.4 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -72.59 -53.84 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.62 -48.85 68.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.996 0.427 . . . . 0.0 110.106 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.811 ' CZ ' HG22 ' A' ' 141' ' ' THR . 75.9 t80 -48.71 -39.08 23.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.278 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 27.8 mm-40 -64.62 -56.82 11.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 53.7 m-20 -63.65 -39.35 94.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.924 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 89' ' ' SER . 14.5 t -39.92 -41.93 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' HD11 ' A' ' 149' ' ' LEU . 3.8 pttt -89.54 -24.32 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.249 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 3.7 mm-40 -132.77 54.02 1.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 174.9 -52.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 23.2 m95 -69.14 -61.08 1.94 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 102' ' ' THR . 60.5 t -75.89 -45.19 3.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_exo -52.74 -35.96 71.01 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.237 1.958 . . . . 0.0 112.242 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.51 -36.51 76.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 98' ' ' VAL . 12.8 pt -92.06 -41.4 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.237 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.949 HG23 ' O ' ' A' ' 98' ' ' VAL . 14.9 p -52.61 -30.9 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.164 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -39.68 58.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.648 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -30.45 56.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 110.381 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 73.7 m -154.94 83.54 3.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.391 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.23 4.82 5.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.843 2.362 . . . . 0.0 113.224 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -27.31 10.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.169 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 17.4 p -73.58 139.88 78.18 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.301 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.882 ' HB2' HG23 ' A' ' 77' ' ' VAL . 12.1 Cg_endo -52.85 159.83 4.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.04 2.494 . . . . 0.0 112.475 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.622 ' H ' HG13 ' A' ' 152' ' ' VAL . 19.9 m-85 -141.8 103.11 4.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.567 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.754 HD12 HG23 ' A' ' 152' ' ' VAL . 4.2 tp -77.52 144.8 37.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.99 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.663 HD22 ' HB2' ' A' ' 146' ' ' ALA . 13.0 tp -113.18 93.81 4.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.579 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 44.4 t -94.68 136.35 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.887 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.95 108.46 1.74 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.761 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.9 m -100.91 172.32 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.26 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.754 ' HB3' HD23 ' A' ' 119' ' ' LEU . 2.5 mm-40 74.65 54.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.116 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.48 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -85.83 -33.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 110.433 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -54.83 -32.44 60.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.84 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 116' ' ' GLN . 0.7 OUTLIER -76.13 -42.96 45.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.728 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.9 -30.39 67.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.89 0.376 . . . . 0.0 110.74 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.72 15.59 28.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.225 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.547 ' C ' HD12 ' A' ' 126' ' ' ILE . 65.9 t0 -118.07 92.1 41.56 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-O 120.754 0.311 . . . . 0.0 110.56 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -41.63 -30.02 0.92 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.622 2.215 . . . . 0.0 112.335 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 p -53.16 -32.69 49.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 44.9 p -96.43 -44.38 7.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.728 HD11 ' O ' ' A' ' 120' ' ' ARG . 3.6 mt -61.52 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.775 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.4 -29.97 62.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.722 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 124' ' ' SER . 23.1 ttpt -70.05 -31.28 68.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.125 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.4 pp -93.68 -29.32 15.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.681 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.425 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -50.65 -21.78 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.469 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -106.79 -18.62 13.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 5.4 m-80 -90.74 -17.28 26.97 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 94.92 25.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.471 0.708 . . . . 0.0 112.842 176.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.744 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.9 tt0 -99.14 167.87 10.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -161.28 125.4 2.01 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.491 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 120' ' ' ARG . 15.5 Cg_exo -65.42 162.02 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.091 1.861 . . . . 0.0 111.441 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.5 mm -97.21 143.39 12.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 111.36 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.0 p -93.47 159.33 35.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.55 -36.87 98.55 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.497 2.131 . . . . 0.0 112.295 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.55 -35.85 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.984 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.811 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 6.0 m -70.71 -41.84 71.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -67.36 -44.39 79.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -56.1 9.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.041 0.448 . . . . 0.0 110.773 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -43.26 -48.34 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.145 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.668 HD22 ' CE1' ' A' ' 90' ' ' PHE . 7.1 mp -61.34 -45.42 94.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.082 0.468 . . . . 0.0 109.971 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.94 -28.81 54.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.78 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -96.58 -26.22 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.971 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.96 -32.58 63.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.717 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 94' ' ' LYS . 2.6 mt -102.02 19.48 18.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.7 mttt 59.64 21.53 10.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.175 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -56.89 134.3 55.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.361 . . . . 0.0 110.943 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.864 HG11 ' HB1' ' A' ' 175' ' ' ALA . 23.4 m -55.96 -35.64 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.587 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -178.0 151.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.573 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 8.0 t80 -99.12 130.59 45.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.061 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.913 HG21 HG13 ' A' ' 168' ' ' VAL . 28.7 m -143.76 134.81 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 111.529 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -105.24 141.59 36.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.308 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.915 ' SG ' HG21 ' A' ' 168' ' ' VAL . 9.8 p -163.09 150.35 13.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 112.287 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.428 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.1 167.74 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.871 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.66 -46.75 6.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 111.236 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.458 HD12 ' HN1' ' A' ' 181' ' ' GCP . 10.6 mt -52.02 -51.33 58.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 0.0 111.128 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -90.15 -36.4 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.923 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 76.16 24.4 1.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.775 0.321 . . . . 0.0 110.854 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -68.86 110.78 4.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.659 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.677 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 63.46 21.78 64.97 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 19' ' ' LEU . 52.5 tp -60.05 -35.89 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.954 0.407 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' HE2' ' CD ' ' B' ' 12' ' ' PRO . 48.5 tttm -80.86 -50.24 10.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.477 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -44.36 -41.41 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.843 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.915 HG21 ' SG ' ' A' ' 157' ' ' CYS . 25.0 t -52.68 -59.76 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.56 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.783 ' O ' HD12 ' A' ' 173' ' ' ILE . 97.3 m-85 -55.67 -33.84 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.804 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.542 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.646 ' HB3' HD11 ' A' ' 111' ' ' LEU . 61.3 mm-40 -82.47 -36.71 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.47 -63.4 1.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.874 ' CG1' HD13 ' A' ' 53' ' ' LEU . 2.9 mp -50.34 -53.5 11.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.617 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' B' ' 4' ' ' ILE . 22.5 tp -52.19 -32.91 38.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.64 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -84.06 -46.37 12.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -54.98 -58.55 7.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 4' ' ' ILE . 29.3 mt -58.33 -172.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.072 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.6 pt-20 -160.35 168.3 12.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.533 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.5 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.643 2.229 . . . . 0.0 112.152 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 179' ' ' PRO . 20.5 tttt -139.41 25.79 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.8 mmmt -71.79 115.6 11.18 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.826 0.822 . . . . 0.0 111.748 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -83.9 150.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.174 175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.416 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 19.7 p -129.87 -177.04 4.12 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.651 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -73.56 -28.22 61.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.79 -1.86 45.38 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' B' ' 5' ' ' SER . 67.8 m-20 -78.91 -67.82 0.71 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.746 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -52.87 98.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.649 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.65 -150.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.714 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 135.24 39.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.66 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 44' ' ' VAL . 49.8 Cg_endo -69.16 155.66 67.27 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.417 2.078 . . . . 0.0 112.491 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.15 -171.58 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.56 34.16 49.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.745 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 65.6 t80 -42.82 127.2 3.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.744 0.307 . . . . 0.0 111.029 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 ttpp -123.01 111.17 16.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.089 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 85.32 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.663 HG22 ' NZ ' ' B' ' 16' ' ' LYS . 19.9 t -72.08 -33.45 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.459 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -167.72 144.22 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 111.559 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.91 129.56 19.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.783 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.002 HG13 HG22 ' B' ' 31' ' ' VAL . 44.8 t -108.92 145.31 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -128.86 96.63 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.403 ' CB ' HG21 ' A' ' 36' ' ' VAL . 53.0 t90 -97.02 107.9 20.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.361 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 135.11 43.88 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.4 -5.94 16.63 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.293 1.995 . . . . 0.0 112.626 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -112.97 -32.09 6.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -107.87 -22.57 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.351 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.42 -158.84 18.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.127 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 36' ' ' VAL . 2.9 m-85 -58.8 146.89 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 3.1 t70 -149.97 57.7 0.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.678 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.002 HG22 HG13 ' B' ' 21' ' ' VAL . 72.0 t -65.58 137.52 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.581 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.06 -35.77 3.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.08 75.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.488 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.654 HD12 HG11 ' B' ' 31' ' ' VAL . 2.6 mt -87.24 168.81 12.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -72.89 155.41 90.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.39 -58.17 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.552 2.168 . . . . 0.0 112.111 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -32.68 73.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.529 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.912 HD12 ' HB2' ' B' ' 35' ' ' ASP . 27.0 mt -69.62 -34.74 74.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.739 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -47.53 -40.26 18.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.011 0.434 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.5 OUTLIER -75.56 -49.31 18.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.071 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' B' ' 45' ' ' ALA . 14.4 mt -65.76 -52.85 47.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.232 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.2 -59.36 2.68 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.486 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 70.0 m -54.24 -25.94 26.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.578 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' B' ' 41' ' ' LEU . 0.0 OUTLIER -91.4 -21.43 20.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.385 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' B' ' 41' ' ' LEU . . . -101.74 72.17 1.35 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.04 17.68 Favored Glycine 0 C--N 1.319 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.593 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.606 HD11 ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -97.84 28.45 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.289 0.566 . . . . 0.0 110.362 179.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 43' ' ' SER . 1.3 t -100.76 5.36 43.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 2.2 mt-10 -69.57 -10.98 60.4 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 69.1 8.74 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.71 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -170.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.935 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.97 153.16 18.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' B' ' 54' ' ' ASP . 2.6 t -129.11 -125.5 0.22 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.075 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' B' ' 53' ' ' THR . 3.7 m-20 -65.88 116.33 6.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.94 127.97 34.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -71.71 154.97 40.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -30.28 6.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.61 98.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.507 ' PB ' ' HE2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.834 0.35 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.26 143.6 31.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 24.829999999999998 110.91 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' THR . 53.0 m -143.38 138.75 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.483 . . . . 25.719999999999999 110.906 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' CD1' HG23 ' A' ' 173' ' ' ILE . 2.7 mp -100.25 136.69 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 24.190000000000001 110.994 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 75' ' ' THR . 16.6 tptp -98.91 121.38 40.78 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.13 -0.486 . . . . 25.460000000000001 109.961 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -131.65 137.07 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 14.300000000000001 111.351 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 72' ' ' TYR . 2.7 p -130.57 118.78 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 16.300000000000001 110.135 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 16' ' ' LYS . 2.8 t -86.46 109.21 18.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.24 0.543 . . . . 6.1699999999999999 110.732 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.83 142.59 25.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.418 -0.81 . . . . 5.79 111.107 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . 176.16 168.37 36.26 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.77 -0.729 . . . . 7.2699999999999996 112.464 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 m-20 -59.19 139.57 56.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 21.84 111.114 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -61.26 82.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 8.6400000000000006 112.404 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' O ' H5'2 ' A' ' 181' ' ' GCP . . . 177.77 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 12.93 111.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' CD ' ' A' ' 16' ' ' LYS . 5.3 m -56.45 168.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 12.76 111.11 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' H ' HG21 ' A' ' 115' ' ' THR . . . -102.88 47.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 13.699999999999999 112.519 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -54.37 -42.05 69.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 9.6899999999999995 111.104 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.595 ' HA ' HD12 ' A' ' 20' ' ' LEU . 85.4 m -76.37 -44.96 34.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.392 . . . . 18.190000000000001 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -42.35 65.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 17.050000000000001 111.153 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.95 -37.43 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 13.42 110.537 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 17' ' ' THR . 8.2 mt -56.74 -36.1 69.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 16.969999999999999 110.803 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.29 -47.67 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.982 -0.554 . . . . 17.0 111.558 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -75.89 -7.11 53.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.287 . . . . 16.43 111.652 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.525 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 13.8 t80 -83.88 -28.1 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.719 0.295 . . . . 21.149999999999999 110.596 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -108.1 -23.83 11.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 18.940000000000001 111.621 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 p -114.6 -12.43 12.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.947 0.351 . . . . 30.5 111.947 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' SER . 2.1 t-20 59.58 23.98 12.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.791 0.329 . . . . 34.789999999999999 110.833 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 122.16 34.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 24.600000000000001 111.065 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -76.4 116.63 57.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 23.109999999999999 110.811 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.66 167.2 27.65 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.427 2.085 . . . . 29.510000000000002 112.459 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.61 -7.13 8.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 41.890000000000001 111.667 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -53.41 171.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 43.869999999999997 110.931 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CD2' HG23 ' A' ' 33' ' ' VAL . 5.2 p90 -137.38 -169.39 2.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.21 -0.45 . . . . 23.27 109.87 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.685 HG23 ' CD2' ' A' ' 32' ' ' TYR . 12.8 t 70.94 108.33 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.928 -0.578 . . . . 21.530000000000001 111.035 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -48.78 142.17 19.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.42 2.08 . . . . 15.4 112.43 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 36' ' ' VAL . 2.0 m -83.09 170.99 14.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 20.140000000000001 110.894 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' B' ' 23' ' ' TRP . 59.5 t -109.3 -45.94 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 23.469999999999999 111.082 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -170.74 91.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 31.059999999999999 111.056 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.99 120.15 39.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 36.280000000000001 110.437 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -112.1 119.06 37.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 41.530000000000001 111.555 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.94 161.93 19.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.954 -0.566 . . . . 31.02 109.864 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.882 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -128.58 119.21 24.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.425 . . . . 24.329999999999998 110.97 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' B' ' 12' ' ' PRO . 8.1 t -103.29 154.02 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.2 m -122.16 94.95 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.61 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 9' ' ' ILE . 2.6 t -102.28 153.05 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.137 -0.483 . . . . 27.280000000000001 111.197 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.4 mmt -91.14 88.61 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 35.5 110.317 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.636 HD12 ' CB ' ' A' ' 51' ' ' TYR . 32.2 mt -101.15 139.65 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.437 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 50.96 25.28 9.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.853 -0.689 . . . . 24.620000000000001 112.601 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.39 19.48 66.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 28.449999999999999 112.573 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -142.82 151.61 57.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.695 0.283 . . . . 0.0 110.939 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.48 105.56 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.54 2.16 . . . . 25.879999999999999 112.238 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.636 ' CB ' HD12 ' A' ' 46' ' ' ILE . 3.3 m-85 -102.87 122.82 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 26.190000000000001 110.937 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 3' ' ' THR . 35.1 m -80.36 111.88 17.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 29.100000000000001 110.936 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 173' ' ' ILE . 24.1 tp -83.79 124.98 31.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 19.32 110.992 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 107.52 3.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 16.780000000000001 112.343 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.42 111.61 23.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 20.41 111.072 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 14.2 m-85 -123.84 114.48 19.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 19.059999999999999 111.029 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -99.67 115.61 29.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.473 . . . . 14.960000000000001 110.676 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -91.87 146.63 23.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 11.77 111.01 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.0 178.45 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 9.6099999999999994 111.074 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.56 -170.17 21.12 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 9.8800000000000008 112.623 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 58.85 -172.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 24.239999999999998 110.974 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -106.28 -14.57 15.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 32.149999999999999 111.572 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -49.01 -37.22 19.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.826 0.346 . . . . 27.510000000000002 111.122 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.26 29.93 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 14.69 110.672 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -72.17 -26.95 62.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 24.670000000000002 111.243 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -39.61 58.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 46.119999999999997 110.893 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 67' ' ' LEU . 1.3 pp -97.09 8.85 43.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 18.940000000000001 111.608 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 31.2 ttt-85 -77.2 -45.13 2.76 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.543 0.201 . . . . 19.91 111.543 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 46.6 Cg_exo -54.87 -19.62 19.9 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.183 1.922 . . . . 19.93 112.331 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' B' ' 41' ' ' LEU . 5.3 mp -66.31 -9.34 31.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 22.690000000000001 111.992 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.3 m -102.19 17.28 23.75 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.974 0.361 . . . . 20.390000000000001 111.974 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.766 ' HE1' HG21 ' A' ' 7' ' ' VAL . 14.2 m-85 -128.42 35.93 0.32 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.85 0.685 . . . . 25.010000000000002 112.85 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 84.8 Cg_exo -40.56 -31.1 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.234 1.956 . . . . 18.16 112.575 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -174.72 54.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.826 -0.624 . . . . 45.259999999999998 109.986 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.89 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 4.3 m -41.59 116.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.792 -0.64 . . . . 20.66 112.375 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.851 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 6.6 m-20 -93.16 -18.29 22.74 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.997 -0.547 . . . . 22.870000000000001 110.623 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 109' ' ' PRO . 2.7 p -161.66 173.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.559 0.219 . . . . 16.510000000000002 110.452 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.89 ' CZ ' HG21 ' A' ' 75' ' ' THR . 48.6 m-85 -137.46 116.86 12.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.736 0.303 . . . . 16.420000000000002 111.668 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 6.9 mp -92.18 104.43 16.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 14.58 110.336 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 93' ' ' VAL . 47.9 t -96.44 86.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.386 -0.37 . . . . 13.09 111.195 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' HG11 ' A' ' 113' ' ' VAL . 44.0 m -86.31 111.25 20.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 7.6200000000000001 110.454 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CB ' HG21 ' A' ' 93' ' ' VAL . 18.6 p90 -118.44 142.69 47.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 13.210000000000001 110.863 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 24.0 m -60.57 120.16 9.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.427 . . . . 7.7199999999999998 111.008 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 115' ' ' THR . 72.0 t -65.34 -32.26 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 16.969999999999999 111.038 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.9 28.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 8.5700000000000003 111.235 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER -139.87 99.71 7.46 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 16.260000000000002 110.648 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 25.7 Cg_endo -61.65 -13.75 31.79 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.317 2.011 . . . . 14.83 112.545 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.4 p -75.23 -61.58 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.773 0.32 . . . . 13.029999999999999 111.118 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 93' ' ' VAL . 66.4 m -48.31 -47.85 36.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 16.82 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CE2' HD22 ' A' ' 145' ' ' LEU . 1.7 t80 -64.5 -41.98 96.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 14.56 110.277 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -28.37 63.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.495 . . . . 32.299999999999997 110.319 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.5 m-20 -91.21 -37.72 13.16 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.001 -0.545 . . . . 17.640000000000001 110.215 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 89' ' ' SER . 64.3 t -47.64 -46.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.121 -0.491 . . . . 13.449999999999999 110.762 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -79.2 -22.88 44.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.688 -0.687 . . . . 21.16 110.65 178.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -140.75 65.99 1.39 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 111.992 0.367 . . . . 24.600000000000001 111.992 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.17 -57.35 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.944 0.35 . . . . 21.09 111.944 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' C ' ' A' ' 10' ' ' GLY . 78.7 m95 -79.46 -53.18 7.14 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 121.122 -0.231 . . . . 17.559999999999999 111.615 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 102' ' ' THR . 69.5 t -58.52 -60.01 11.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.047 -0.261 . . . . 22.34 110.896 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 9.7 Cg_endo -52.6 -24.25 22.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.156 1.904 . . . . 18.300000000000001 111.758 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -33.66 69.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.963 -0.562 . . . . 19.289999999999999 110.889 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.777 HD12 ' CD1' ' A' ' 110' ' ' PHE . 11.5 pt -90.07 -35.83 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.384 . . . . 22.129999999999999 110.894 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 98' ' ' VAL . 28.6 p -51.98 -28.31 16.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.005 0.431 . . . . 31.07 110.248 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.74 -36.43 57.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 45.039999999999999 110.256 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.0 45.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.989 -0.55 . . . . 27.469999999999999 110.489 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.3 m -169.97 94.28 0.5 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.967 -0.56 . . . . 24.829999999999998 110.788 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.39 4.73 6.04 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.608 2.205 . . . . 25.039999999999999 112.866 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -30.72 9.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.941 0.4 . . . . 46.100000000000001 110.59 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 5.7 p -57.59 156.89 15.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 26.629999999999999 111.347 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 77' ' ' VAL . 71.6 Cg_endo -76.1 155.28 37.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.011 2.474 . . . . 18.600000000000001 111.59 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.777 ' CD1' HD12 ' A' ' 101' ' ' ILE . 10.0 m-85 -139.22 107.56 5.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.289 0.478 . . . . 40.719999999999999 112.289 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.792 HD12 ' CG2' ' A' ' 152' ' ' VAL . 1.6 tp -81.85 140.3 34.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 19.739999999999998 110.935 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.36 89.49 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 10.789999999999999 110.549 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.511 HG11 ' SG ' ' A' ' 81' ' ' CYS . 27.5 t -88.0 150.14 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.273 -0.422 . . . . 9.4600000000000009 111.676 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.3 112.73 1.03 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.046 -0.597 . . . . 9.3000000000000007 111.987 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.8 m -102.73 173.1 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 15.23 111.282 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.797 ' CG ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 73.15 58.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.047 -0.524 . . . . 21.949999999999999 110.778 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -88.84 -38.55 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.059 -0.519 . . . . 32.060000000000002 110.985 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -24.47 56.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.988 -0.551 . . . . 23.920000000000002 111.394 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.797 HD12 ' CG ' ' A' ' 116' ' ' GLN . 91.2 mt -79.89 -46.67 16.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 26.850000000000001 110.878 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.856 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -57.31 -26.26 60.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 30.25 110.798 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.42 15.64 25.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.058 -0.519 . . . . 41.909999999999997 110.978 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.89 94.91 48.71 Favored Pre-proline 0 C--O 1.231 0.129 0 CA-C-O 120.734 0.302 . . . . 44.479999999999997 110.916 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.44 -30.54 8.53 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.366 2.044 . . . . 38.350000000000001 111.952 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -32.16 67.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 39.350000000000001 111.009 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.723 HG21 HD22 ' A' ' 119' ' ' LEU . 16.0 p -94.18 -46.99 6.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 38.759999999999998 109.912 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.856 HD11 ' O ' ' A' ' 120' ' ' ARG . 7.2 mt -54.73 -38.51 43.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 32.710000000000001 110.118 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.31 -24.04 43.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -67.9 -40.98 83.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -97.56 -21.88 16.83 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.429 -0.35 . . . . 37.560000000000002 111.271 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -47.78 -24.94 1.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.957 0.408 . . . . 32.729999999999997 110.319 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -98.42 -25.96 14.62 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.8 -0.636 . . . . 38.119999999999997 111.0 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 26.7 m-80 -79.41 -16.32 56.37 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 121.383 -0.127 . . . . 42.579999999999998 111.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 132' ' ' ASN . 0.9 OUTLIER 95.26 25.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.342 0.657 . . . . 40.969999999999999 111.817 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.856 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -108.28 144.29 35.98 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.238 -0.653 . . . . 33.280000000000001 109.238 175.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 151.35 72.29 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 24.899999999999999 111.791 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 95.8 Cg_endo -80.35 152.01 20.49 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.689 2.259 . . . . 17.710000000000001 111.954 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 mm -88.05 121.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.339 -0.391 . . . . 15.6 111.145 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -71.5 153.86 93.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 15.279999999999999 110.921 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.74 -43.56 45.61 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.387 2.058 . . . . 16.66 111.599 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.64 -70.24 0.13 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 26.050000000000001 111.506 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.5 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 3.2 m -39.32 -42.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.625 -0.716 . . . . 24.600000000000001 111.715 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -70.9 -48.32 54.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 24.949999999999999 110.59 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 146' ' ' ALA . 3.8 tm-20 -51.85 -56.61 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 28.390000000000001 110.358 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.36 -50.98 5.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 38.969999999999999 110.976 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 90' ' ' PHE . 6.9 mp -56.86 -45.68 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 21.739999999999998 109.907 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.78 -27.95 8.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.783 -0.644 . . . . 25.300000000000001 110.597 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -95.13 -38.19 10.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 31.18 110.636 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -66.63 -35.78 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 32.659999999999997 110.916 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 98' ' ' VAL . 6.0 mt -94.93 20.17 9.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 18.489999999999998 111.194 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.6 26.37 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 24.100000000000001 110.949 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -65.06 137.79 57.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 15.08 110.873 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.962 HG11 ' HB1' ' A' ' 175' ' ' ALA . 10.5 m -48.74 -36.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 21.399999999999999 110.963 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 176.84 172.57 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 18.59 111.376 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 19.7 t80 -112.52 132.04 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 24.530000000000001 110.755 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 168' ' ' VAL . 24.1 m -141.98 141.67 28.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 21.629999999999999 111.475 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -123.7 124.13 42.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 22.43 110.257 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.954 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -146.3 152.36 39.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.253 0.549 . . . . 17.100000000000001 112.052 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.8 t -135.58 152.35 51.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.341 -0.845 . . . . 13.880000000000001 109.914 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.17 -30.23 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 8.2699999999999996 111.119 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.656 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -76.25 -45.74 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.197 0.522 . . . . 13.52 110.344 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m -86.63 -31.72 20.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.499 -0.773 . . . . 16.469999999999999 111.25 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 66.28 27.72 10.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 22.699999999999999 110.858 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.69 115.05 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 48.84 25.61 5.11 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.63 -0.795 . . . . 14.550000000000001 112.38 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.757 HD12 HD12 ' A' ' 19' ' ' LEU . 44.4 tp -48.94 -47.14 43.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 14.75 111.316 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -47.61 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 24.77 111.281 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -48.77 -35.69 14.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 26.550000000000001 111.333 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.954 HG21 ' SG ' ' A' ' 157' ' ' CYS . 45.1 t -60.41 -63.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 22.120000000000001 111.476 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' CB ' ' CZ ' ' A' ' 23' ' ' TYR . 75.7 m-85 -54.82 -32.57 60.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 19.68 110.735 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -27.99 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 32.18 110.748 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.681 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.8 mt-10 -81.84 -35.72 29.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 21.449999999999999 110.921 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.4 -64.06 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 10.77 111.045 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.892 HD11 HD22 ' A' ' 53' ' ' LEU . 88.9 mt -49.08 -57.51 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 20.210000000000001 110.255 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.4 tp -49.85 -29.28 7.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.627 -0.715 . . . . 19.699999999999999 110.204 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.962 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.65 -46.1 12.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.599 . . . . 13.52 111.018 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -59.07 -36.01 74.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 10.539999999999999 111.139 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' B' ' 4' ' ' ILE . 27.1 mt -82.28 -175.13 5.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 15.24 111.057 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -167.24 162.4 10.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.484 -178.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.878 2.385 . . . . 0.0 112.187 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.912 0.387 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 1.4 tttp -130.95 28.32 4.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.246 0.546 . . . . 0.0 111.018 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 14.7 mmmt -73.92 115.71 13.7 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.755 0.788 . . . . 0.0 111.417 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.3 mm -91.96 144.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.113 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.7 p -125.74 -180.0 4.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.668 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -69.25 -25.92 64.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.875 0.369 . . . . 0.0 110.972 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.66 -1.95 45.66 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -79.45 -67.72 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.613 0.244 . . . . 0.0 111.132 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.823 HG22 HG11 ' A' ' 44' ' ' VAL . 2.4 mt -54.03 98.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.723 0.296 . . . . 0.0 110.694 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.99 -155.61 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.432 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.07 133.08 43.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.445 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.6 Cg_endo -55.44 168.84 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.388 2.059 . . . . 0.0 112.035 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 1.7 p 174.34 155.14 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.569 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.18 33.19 26.8 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -41.95 113.24 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.917 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 5.1 tptm -115.19 106.32 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.008 -177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -71.13 85.82 0.75 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.77 -51.71 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.001 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -147.26 145.59 29.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.442 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -142.01 121.95 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.745 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 31' ' ' VAL . 34.1 t -108.06 152.02 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -137.76 127.58 3.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.696 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.569 ' HB2' HG21 ' A' ' 36' ' ' VAL . 34.0 t90 -111.58 100.67 9.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.647 0.26 . . . . 0.0 111.154 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -83.56 133.49 46.76 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.05 -10.31 24.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.134 1.889 . . . . 0.0 112.412 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -113.65 -49.41 2.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.117 0.484 . . . . 0.0 110.654 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -91.88 -2.18 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.788 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.3 -156.0 51.89 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.835 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.511 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 4.3 m-85 -58.46 152.9 16.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.95 0.405 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' B' ' 22' ' ' GLY . 10.6 t70 -146.05 55.45 1.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 21' ' ' VAL . 77.2 t -65.21 126.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.1 -25.86 8.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -147.96 75.6 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.514 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.627 HD12 HG11 ' B' ' 31' ' ' VAL . 2.9 mt -91.28 -179.83 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.159 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.882 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -88.51 148.41 42.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.499 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.92 -50.57 11.12 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.419 2.079 . . . . 0.0 112.091 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 -29.74 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.882 HD12 ' HB2' ' B' ' 35' ' ' ASP . 42.8 mt -75.2 -29.09 60.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -39.68 62.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.739 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -45.45 48.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.209 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.525 ' HB3' HD21 ' A' ' 70' ' ' LEU . 13.9 mt -69.43 -44.35 71.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.346 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.25 -61.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 5.1 m -60.84 -20.85 62.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -90.63 -16.12 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.8 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -91.65 -91.6 0.15 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.96 -19.37 10.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.621 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.625 ' N ' HD13 ' B' ' 47' ' ' ILE . 0.7 OUTLIER -91.1 46.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.653 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.8 t -100.42 21.71 12.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.934 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.08 -8.07 41.78 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.031 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.06 -0.97 15.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.72 -174.84 2.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.822 0.344 . . . . 0.0 111.147 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.55 135.27 34.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -177.64 114.03 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.309 0.576 . . . . 0.0 110.087 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.12 162.62 23.6 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.034 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.7 -24.08 13.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 60.88 22.12 12.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.276 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -96.25 26.28 4.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.99 124.32 27.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tttt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.921 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.473 H5'2 ' O ' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.793 0.33 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -108.73 150.9 26.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.0 m -142.58 124.54 15.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.965 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.611 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.7 mp -94.32 126.87 46.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -99.63 69.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.2 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 53' ' ' LEU . 17.3 p -86.46 150.3 24.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.418 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 75' ' ' THR . 17.9 t -134.41 144.32 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.306 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 39.5 t -90.8 139.09 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.198 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 103.59 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -138.11 154.44 22.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.521 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 84.82 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' HG22 ' A' ' 14' ' ' VAL . . . 56.44 -125.12 37.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.641 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.02 97.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 0.0 111.393 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 12' ' ' GLY . 17.3 m -144.25 26.36 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' HA3' ' N7 ' ' A' ' 181' ' ' GCP . . . 59.32 60.19 9.28 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.184 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 20' ' ' LEU . 22.0 mtmm -68.88 -66.67 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 111.593 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 6.3 m -72.15 -14.11 61.73 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.69 -63.75 1.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.9 -35.16 72.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 -175.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 16' ' ' LYS . 35.1 mt -58.48 -41.39 85.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 17' ' ' THR . 18.9 mm -77.34 -42.7 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.439 ' C ' HD21 ' A' ' 165' ' ' LEU . 12.5 p -68.22 -13.49 62.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.496 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.515 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 50.5 t80 -87.15 -33.57 19.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 110.579 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 42' ' ' VAL . 42.1 p -96.1 -29.4 14.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.237 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -106.73 -0.44 23.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.784 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 49.87 26.4 1.94 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.822 0.344 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -136.59 148.77 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.367 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -91.85 107.03 19.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.314 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.91 154.88 73.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.31 2.007 . . . . 0.0 112.074 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -20.33 10.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.282 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -53.76 155.19 3.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.0 110.974 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 6.6 t80 -141.38 113.98 8.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 12.4 p -160.77 137.15 6.3 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.974 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 81.7 Cg_exo -44.63 147.76 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.445 2.097 . . . . 0.0 112.277 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.5 m -134.83 153.89 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 ' HB ' ' B' ' 21' ' ' VAL . 1.8 p -131.61 -39.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.372 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HE2' ' HG ' ' A' ' 71' ' ' SER . 53.7 t80 -170.55 137.6 1.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 3.2 m-20 -149.07 129.8 14.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -115.47 121.3 42.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 111.445 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.8 OUTLIER -124.8 165.25 18.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.367 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.43 120.55 18.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 111.156 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 24' ' ' THR . 9.3 t -102.91 146.15 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.602 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 13' ' ' SER . 4.9 m -111.23 108.26 17.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.729 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 3.5 t -121.28 158.78 23.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.035 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.4 mmt -89.4 88.12 7.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.346 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HB2' ' A' ' 51' ' ' TYR . 9.7 mt -101.32 119.61 49.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.444 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.79 78.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.551 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.81 45.0 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.556 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.39 144.87 17.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.935 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.08 84.22 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.823 ' HB2' HD12 ' A' ' 46' ' ' ILE . 3.2 m-85 -80.26 -178.06 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.033 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 40.5 m -141.58 118.27 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.897 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 173' ' ' ILE . 30.7 tp -85.46 132.49 34.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.04 101.77 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.201 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 42' ' ' VAL . 59.9 mt -89.53 114.6 26.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 0.0 111.486 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.41 132.49 45.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 28.4 t70 -121.03 129.16 53.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p -101.2 155.63 17.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.0 -179.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.748 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.35 29.56 3.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.448 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -126.75 -179.48 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.396 . . . . 0.0 111.172 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -99.03 -28.02 13.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.821 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -25.32 67.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.163 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -94.91 26.26 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -69.2 -29.2 67.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.829 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -60.51 -47.37 86.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.751 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 67' ' ' LEU . 3.0 pp -105.59 23.66 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.005 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 9.2 ttt180 -76.32 -59.67 1.04 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.436 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 72' ' ' TYR . 31.8 Cg_endo -63.93 -21.49 68.74 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.47 2.114 . . . . 0.0 112.535 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.714 HD21 ' CB ' ' B' ' 41' ' ' LEU . 1.0 OUTLIER -49.34 -24.81 2.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' HE2' ' A' ' 37' ' ' PHE . 14.6 m -94.81 17.47 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 19.9 m-85 -119.68 43.53 0.55 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 34.4 Cg_endo -64.12 95.77 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.154 1.903 . . . . 0.0 112.019 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 46.04 35.36 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.768 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 7' ' ' VAL . 30.8 m -42.31 131.07 3.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.964 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.5 OUTLIER -73.24 -70.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.228 178.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.0 p -113.77 174.92 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.252 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' H ' HG22 ' A' ' 77' ' ' VAL . 41.2 m-85 -139.91 151.95 46.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.974 0.416 . . . . 0.0 111.9 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.88 ' CD2' HG21 ' A' ' 113' ' ' VAL . 4.7 mt -111.49 104.62 13.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.192 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 93' ' ' VAL . 20.1 t -101.09 86.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.573 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.6 m -86.38 111.32 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.797 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.836 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -115.3 130.27 56.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.615 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -53.88 115.69 2.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.434 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' THR . 99.5 t -61.64 -29.94 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.678 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.923 HG11 HD12 ' A' ' 119' ' ' LEU . 5.2 m -91.34 20.6 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.292 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 t -149.33 105.17 3.32 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' ' CE ' ' A' ' 135' ' ' LYS . 37.4 Cg_endo -66.8 -19.03 53.39 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.386 2.058 . . . . 0.0 112.671 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -55.77 -61.73 2.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.117 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.966 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.2 t -54.3 -46.64 72.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.021 0.438 . . . . 0.0 110.102 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.71 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 4.8 t80 -59.22 -37.22 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.161 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' PRO . 1.5 mm-40 -62.1 -30.44 71.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.514 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.2 m-20 -90.3 -40.63 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.071 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 89' ' ' SER . 95.6 t -48.2 -34.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.135 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 145' ' ' LEU . 34.0 pttt -89.53 -22.33 22.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.659 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.28 61.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.806 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.9 mttt 174.32 -51.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.502 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 73.5 m95 -84.12 -28.75 27.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.899 ' O ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.15 -62.25 6.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.5 -178.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.711 ' HD3' HG23 ' A' ' 98' ' ' VAL . 34.2 Cg_endo -69.61 -40.9 4.99 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.041 2.494 . . . . 0.0 113.6 -178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 8.0 pt-20 -46.1 -27.87 1.06 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.231 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -96.12 -36.17 6.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.718 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 98' ' ' VAL . 5.7 p -64.44 -27.89 69.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.092 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -29.69 69.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 110.533 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.48 -37.36 10.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.644 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' THR . 82.3 m -154.26 92.83 2.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 4.47 6.25 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 113.004 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -30.53 7.69 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -52.97 140.26 41.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.891 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.838 ' HB2' HG23 ' A' ' 77' ' ' VAL . 21.4 Cg_endo -58.84 149.52 77.57 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.691 2.261 . . . . 0.0 112.458 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 11.9 m-85 -135.67 95.99 3.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.798 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.821 HD12 HG23 ' A' ' 152' ' ' VAL . 2.5 tp -73.06 117.61 15.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD23 ' CD1' ' A' ' 154' ' ' TYR . 16.6 tp -84.06 98.98 10.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.88 HG21 ' CD2' ' A' ' 79' ' ' LEU . 39.2 t -94.03 150.53 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.094 -177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -132.96 114.96 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.539 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -102.48 173.31 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.839 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' H ' HG22 ' A' ' 115' ' ' THR . 13.2 mm100 80.13 47.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.441 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.588 HD11 ' CA ' ' A' ' 157' ' ' CYS . 2.2 mt -75.27 -57.15 6.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.146 0.498 . . . . 0.0 110.485 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.485 ' OD2' ' N2 ' ' A' ' 181' ' ' GCP . 0.7 OUTLIER -54.56 -28.71 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.341 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.923 HD12 HG11 ' A' ' 85' ' ' VAL . 2.3 tm? -79.91 -41.39 26.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.01 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.574 ' O ' HD11 ' A' ' 126' ' ' ILE . 4.2 ttp180 -53.76 -24.31 14.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.403 177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.07 13.11 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.021 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.39 86.29 1.08 Allowed Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.875 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.71 -35.66 30.76 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.327 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -41.27 46.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.739 -178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.606 HG21 HD21 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -92.58 -42.74 9.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.07 0.462 . . . . 0.0 110.264 -179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.574 HD11 ' O ' ' A' ' 120' ' ' ARG . 29.4 mt -55.87 -48.01 78.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.84 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.86 -27.68 62.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.112 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -77.5 -27.03 51.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.787 0.327 . . . . 0.0 110.677 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 130' ' ' ALA . 4.6 pp -98.18 -31.51 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.078 0.466 . . . . 0.0 111.067 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -42.07 -27.44 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.879 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.01 24.42 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.509 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.7 m-80 -121.61 -33.1 3.68 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.0 OUTLIER 168.79 -28.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.622 ' C ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -99.01 176.82 5.44 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.044 0.45 . . . . 0.0 112.028 -176.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.45 ' CE ' ' HG3' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -176.43 148.21 0.85 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.874 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 71.9 Cg_endo -77.88 140.77 18.56 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.7 2.267 . . . . 0.0 112.737 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.1 mm -88.5 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.72 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 141' ' ' THR . 11.3 p -85.81 140.23 35.35 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.251 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.16 -34.58 48.7 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.518 2.145 . . . . 0.0 112.295 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.38 -34.93 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.755 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.502 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 48.9 m -67.11 -43.6 82.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.642 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.36 -50.61 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.724 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.92 -37.27 66.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.308 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 50.7 tttt -51.74 -42.95 62.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.71 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -76.57 -40.41 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.197 178.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.7 -30.92 14.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.738 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 11.3 ptp180 -94.5 -38.72 10.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.263 0.554 . . . . 0.0 110.374 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.64 -36.8 85.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.957 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 98' ' ' VAL . 6.5 mt -94.58 18.7 10.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.384 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 57.99 20.06 6.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.453 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -59.38 135.21 57.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.908 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.923 HG11 ' HB1' ' A' ' 175' ' ' ALA . 11.6 m -50.11 -35.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.452 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.37 151.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.244 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.607 ' CD1' HD23 ' A' ' 112' ' ' LEU . 24.0 t80 -96.22 127.52 42.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.405 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.93 154.21 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.45 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' OE1' HG21 ' A' ' 84' ' ' VAL . 2.0 tt0 -131.48 132.12 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.092 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.817 ' SG ' HG21 ' A' ' 168' ' ' VAL . 4.7 p -138.6 163.53 31.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.402 0.62 . . . . 0.0 112.235 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t -136.69 161.24 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -108.76 -31.67 7.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 0.0 110.56 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.647 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.2 tm? -65.41 -49.53 68.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.244 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -99.3 -23.83 15.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.432 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 74.25 19.77 2.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -62.28 115.09 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 60.77 17.37 49.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.401 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.454 HD12 HD12 ' A' ' 19' ' ' LEU . 57.7 tp -55.39 -37.81 68.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 111.187 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 9.7 ptpp? -85.2 -40.66 16.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.473 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -25.15 2.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.469 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.817 HG21 ' SG ' ' A' ' 157' ' ' CYS . 21.3 t -66.4 -59.71 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.109 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' A' ' 23' ' ' TYR . 45.4 m-85 -62.89 -26.32 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.97 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' HD13 ' B' ' 9' ' ' ILE . 8.0 t0 -64.01 -51.24 65.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.353 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.701 ' HB3' HD11 ' A' ' 111' ' ' LEU . 1.1 mp0 -69.39 -40.37 77.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -52.46 -65.14 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.425 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 53' ' ' LEU . 90.3 mt -49.13 -51.74 12.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.069 0.462 . . . . 0.0 110.295 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.57 HD12 ' HB ' ' B' ' 4' ' ' ILE . 13.0 tp -51.7 -31.15 24.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.373 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.923 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -87.86 -45.73 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.923 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -55.73 -31.27 62.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.773 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 173' ' ' ILE . 36.0 mt -87.92 -171.9 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.827 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 16.2 pt-20 -165.89 162.44 12.8 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.998 -177.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.485 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.2 Cg_endo . . . . . 0 C--O 1.248 1.025 0 C-N-CA 122.99 2.46 . . . . 0.0 112.069 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.726 0.298 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -133.92 26.77 3.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.438 . . . . 0.0 111.188 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.42 116.99 13.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.74 0.781 . . . . 0.0 111.648 179.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.57 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.0 mm -87.12 147.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.19 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.0 p -130.13 150.73 51.26 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.089 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.28 -28.53 1.32 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.5 -2.64 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -80.18 -66.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.569 0.223 . . . . 0.0 111.343 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.523 HG22 HG11 ' A' ' 44' ' ' VAL . 2.9 mp -50.38 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.796 0.332 . . . . 0.0 110.835 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.61 -154.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.753 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.05 139.1 32.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 110.825 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.5 Cg_endo -56.87 160.9 11.28 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.534 2.156 . . . . 0.0 111.814 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 175.04 152.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.952 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 36.27 20.68 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.797 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 18.7 t80 -41.07 117.32 0.85 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 111.057 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.8 tptt -115.89 105.37 12.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.854 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -71.02 85.12 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.64 -60.79 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.408 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.38 161.87 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -160.93 127.53 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.951 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.83 HG13 HG22 ' B' ' 31' ' ' VAL . 22.1 t -107.04 123.74 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -101.85 94.88 1.26 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.001 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 48.4 t90 -96.67 92.75 6.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.6 OUTLIER -75.91 140.28 70.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.487 179.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.6 -10.89 27.42 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.186 1.924 . . . . 0.0 112.386 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -113.43 -48.65 2.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.4 4.94 44.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.95 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 66.58 -149.81 51.57 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.385 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 8.0 m-85 -63.34 161.16 14.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 0.0 111.119 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.4 t0 -163.04 59.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.809 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.83 HG22 HG13 ' B' ' 21' ' ' VAL . 78.2 t -68.07 106.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.944 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -99.04 -25.71 14.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.874 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -151.36 80.0 1.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.524 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.787 HD11 ' CD2' ' B' ' 42' ' ' PHE . 1.9 mt -92.58 -175.18 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.593 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.666 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.1 OUTLIER -89.11 140.97 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.615 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.13 -43.4 58.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.441 2.094 . . . . 0.0 112.269 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -41.05 33.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' B' ' 35' ' ' ASP . 15.2 mt -67.73 -33.24 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.71 -41.81 44.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.1 OUTLIER -69.3 -41.8 76.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.142 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.714 ' CB ' HD21 ' A' ' 70' ' ' LEU . 14.1 mt -76.71 -34.01 58.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.688 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.787 ' CD2' HD11 ' B' ' 34' ' ' LEU . 0.3 OUTLIER -56.03 -61.04 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.629 0.252 . . . . 0.0 110.499 -179.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 21.3 t -60.34 -22.24 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.542 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -89.87 -13.06 37.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.968 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -99.0 -92.34 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.18 -18.82 15.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.379 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.558 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.6 mm -92.28 41.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.11 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.5 t -79.18 -150.19 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.447 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 4.2 mt-10 -40.2 -29.72 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 68.72 10.99 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -49.25 167.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 0.0 110.972 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.47 25.63 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.895 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 43.1 p -105.05 -122.17 0.22 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.013 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.01 83.19 0.22 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.904 0.383 . . . . 0.0 110.994 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.87 -82.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -74.07 133.31 42.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.68 -62.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p 47.48 90.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.035 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.485 ' N2 ' ' OD2' ' A' ' 118' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.54 141.96 39.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 24.829999999999998 110.68 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.2 m -142.56 144.09 32.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.293 -0.412 . . . . 25.719999999999999 111.142 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -102.16 121.62 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 24.190000000000001 110.563 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -90.34 80.06 6.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.169 -0.469 . . . . 25.460000000000001 110.729 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.92 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 14.300000000000001 110.654 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.526 HG23 HG23 ' A' ' 75' ' ' THR . 2.4 t -131.36 133.54 62.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.269 -0.423 . . . . 16.300000000000001 110.594 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' CD ' ' A' ' 16' ' ' LYS . 43.9 t -86.16 113.22 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 6.1699999999999999 110.843 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.86 140.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 5.79 111.462 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 164.78 126.8 0.84 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.709 -0.678 . . . . 7.2699999999999996 112.528 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -96.05 106.71 18.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.829 0.347 . . . . 21.84 110.937 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.69 -119.64 2.34 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.657 -0.783 . . . . 8.6400000000000006 112.624 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -167.07 113.58 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 12.93 111.141 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 15' ' ' GLY . 16.0 m -114.33 -45.36 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 12.76 111.069 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 125.65 31.96 0.79 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 13.699999999999999 112.868 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' CD ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -70.6 -39.37 73.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.772 0.32 . . . . 9.6899999999999995 110.834 179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 20' ' ' LEU . 90.2 m -56.13 -33.88 65.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 18.190000000000001 110.426 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -72.28 -23.76 61.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 17.050000000000001 110.783 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.93 -40.44 15.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 13.42 110.201 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 19' ' ' LEU . 6.3 mt -52.43 -42.69 64.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 16.969999999999999 110.367 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 25' ' ' THR . 30.2 mm -69.26 -52.29 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 17.0 111.165 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.484 ' OG ' HD21 ' A' ' 165' ' ' LEU . 88.3 p -67.26 -12.28 59.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 16.43 111.549 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 10.6 t80 -76.62 -54.66 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.687 0.28 . . . . 21.149999999999999 111.501 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.836 HG21 ' CD1' ' B' ' 15' ' ' PHE . 14.6 t -99.76 -18.08 17.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 18.940000000000001 112.126 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 21' ' ' ILE . 1.3 p -102.87 -17.03 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 30.5 111.567 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 67.52 15.33 9.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.672 -0.24 . . . . 34.789999999999999 111.441 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' SER . 7.7 tptm -110.17 143.6 40.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.8 0.333 . . . . 24.600000000000001 110.857 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.37 101.88 25.71 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 23.109999999999999 110.879 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.57 163.65 37.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.43 2.086 . . . . 29.510000000000002 111.736 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.53 -40.17 1.61 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.484 -0.325 . . . . 41.890000000000001 111.202 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.58 145.14 15.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 43.869999999999997 111.082 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' C ' HG22 ' A' ' 33' ' ' VAL . 27.5 t80 -129.41 101.72 6.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 23.27 110.439 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -172.92 -60.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 21.530000000000001 111.452 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.628 ' CD ' HG23 ' A' ' 33' ' ' VAL . 48.5 Cg_endo -69.88 120.65 7.38 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.38 2.053 . . . . 15.4 112.948 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' PHE . 18.9 m -163.5 -85.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 20.140000000000001 110.187 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 ' N ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 47.24 -84.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.458 0.474 . . . . 23.469999999999999 110.995 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.704 ' N ' HG22 ' A' ' 36' ' ' VAL . 41.8 t80 -155.18 124.61 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 31.059999999999999 110.843 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 0.3 OUTLIER -142.71 140.61 31.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 36.280000000000001 110.832 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 3.6 t-20 -115.05 118.01 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 41.530000000000001 111.145 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 2.0 m-85 -115.19 161.0 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 31.02 109.927 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -135.27 120.11 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 24.329999999999998 111.149 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' B' ' 12' ' ' PRO . 15.8 t -109.25 142.31 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.947 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.6 m -103.13 124.42 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.343 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.912 HG11 HG22 ' B' ' 9' ' ' ILE . 6.3 t -135.19 155.96 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 27.280000000000001 111.489 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' N ' HG12 ' A' ' 44' ' ' VAL . 5.6 mmt -86.43 88.2 7.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.579 . . . . 35.5 110.026 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 HG12 HG23 ' B' ' 9' ' ' ILE . 20.0 mt -103.97 126.0 58.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.371 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.89 33.14 84.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.717 -0.754 . . . . 24.620000000000001 112.682 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.24 32.39 79.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 28.449999999999999 112.535 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -153.7 153.55 29.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.77 113.81 3.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.51 2.14 . . . . 25.879999999999999 112.244 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -116.24 176.33 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 26.190000000000001 110.856 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.7 m -134.18 132.32 39.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 29.100000000000001 110.656 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 173' ' ' ILE . 20.6 tp -98.54 112.6 24.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 19.32 111.023 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.13 93.53 0.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.768 -0.729 . . . . 16.780000000000001 111.997 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.7 mp -84.81 133.31 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 20.41 111.294 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 83.6 m-85 -145.24 120.91 10.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 19.059999999999999 111.142 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 1.2 p30 -105.64 127.15 52.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 14.960000000000001 110.56 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 p -101.31 166.12 10.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 11.77 111.218 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' TYR . . . -81.7 146.58 29.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 9.6099999999999994 110.933 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.64 -25.11 21.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 9.8800000000000008 112.418 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -61.85 150.57 36.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.926 0.393 . . . . 24.239999999999998 111.151 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.25 -28.09 62.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.058 -0.519 . . . . 32.149999999999999 110.812 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -28.01 68.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.508 . . . . 27.510000000000002 110.917 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 11.4 m-85 -85.29 -6.17 59.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 14.69 111.562 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 52.0 t0 -54.18 -22.21 10.81 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.687 0.279 . . . . 24.670000000000002 111.493 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -67.15 -48.8 66.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.513 -0.312 . . . . 46.119999999999997 111.214 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 67' ' ' LEU . 2.4 pp -96.58 18.66 13.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 18.940000000000001 111.452 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -80.06 -50.04 1.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 19.91 111.25 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 72' ' ' TYR . 51.4 Cg_exo -55.61 -17.96 18.94 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.711 2.274 . . . . 19.93 112.775 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mp -51.29 -23.03 3.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 22.690000000000001 111.718 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.4 t -119.24 17.43 13.12 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.699 0.259 . . . . 20.390000000000001 111.699 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 8.3 m-30 -88.0 -42.85 0.49 Allowed Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 112.553 0.575 . . . . 25.010000000000002 112.553 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 58.2 Cg_endo -74.63 140.64 26.81 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.73 1.62 . . . . 18.16 112.444 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.36 22.11 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 45.259999999999998 110.957 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 97.2 m -78.46 131.07 36.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 20.66 111.081 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.785 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 0.8 OUTLIER -87.21 -21.58 25.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 22.870000000000001 111.211 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 78' ' ' PHE . 2.7 p -168.94 172.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.676 0.274 . . . . 16.510000000000002 110.333 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 75' ' ' THR . 46.3 m-85 -138.67 142.11 39.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.855 0.36 . . . . 16.420000000000002 111.152 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 113' ' ' VAL . 5.0 mt -105.43 101.03 10.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 14.58 110.871 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.439 HG13 ' HE3' ' A' ' 97' ' ' TRP . 12.9 t -96.85 86.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.638 -0.71 . . . . 13.09 110.674 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.459 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 19.5 m -88.2 111.33 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 7.6200000000000001 111.077 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -103.96 161.6 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.338 -0.392 . . . . 13.210000000000001 110.838 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 14' ' ' VAL . 21.2 m -87.32 104.76 16.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 7.7199999999999998 111.059 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 137' ' ' ILE . 53.2 t -54.34 -36.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 16.969999999999999 111.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 m -93.15 39.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 8.5700000000000003 111.125 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.3 OUTLIER -156.42 97.25 2.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 16.260000000000002 110.85 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.41 -35.51 54.98 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.392 2.061 . . . . 14.83 112.074 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -31.84 61.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 13.029999999999999 110.795 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.22 -43.0 58.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 16.82 110.537 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.756 ' CZ ' HG22 ' A' ' 141' ' ' THR . 40.2 t80 -63.52 -46.69 84.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.021 -0.536 . . . . 14.56 111.093 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.07 -43.97 91.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 32.299999999999997 110.941 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 96' ' ' LYS . 38.8 m-20 -79.53 -31.07 42.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 17.640000000000001 110.355 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 89' ' ' SER . 1.4 t -48.29 -47.32 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.726 -0.67 . . . . 13.449999999999999 110.223 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 149' ' ' LEU . 35.8 pttt -83.61 -23.4 31.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.797 -0.638 . . . . 21.16 111.157 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 7.4 mm-40 -137.76 64.66 1.51 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 121.038 -0.265 . . . . 24.600000000000001 111.672 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 2.0 tptt 171.63 -61.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 21.09 111.295 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.523 ' CZ3' ' HA2' ' A' ' 10' ' ' GLY . 20.2 m95 -66.74 -50.7 61.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 17.559999999999999 111.469 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.907 HG11 ' HB3' ' A' ' 149' ' ' LEU . 89.1 t -75.11 -60.29 1.2 Allowed Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 111.976 0.361 . . . . 22.34 111.976 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 98' ' ' VAL . 7.8 Cg_endo -50.83 -27.37 20.26 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.377 2.052 . . . . 18.300000000000001 112.491 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm-40 -62.08 -37.42 84.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.388 -0.369 . . . . 19.289999999999999 110.81 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.22 -25.27 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.175 -0.466 . . . . 22.129999999999999 111.567 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 81.1 p -60.95 -26.43 67.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 31.07 111.408 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -26.69 64.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 45.039999999999999 110.879 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.89 -37.25 8.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 27.469999999999999 110.697 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 79.0 m -152.97 84.22 4.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 24.829999999999998 110.862 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.85 -3.42 8.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.859 2.373 . . . . 25.039999999999999 113.216 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 -29.36 12.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 46.100000000000001 110.72 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.9 p -59.13 159.01 15.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 26.629999999999999 111.296 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HG2' HG23 ' A' ' 77' ' ' VAL . 58.6 Cg_endo -71.16 155.58 60.87 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.767 2.312 . . . . 18.600000000000001 111.724 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 14.8 m-85 -142.42 101.54 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 40.719999999999999 111.461 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.777 HD12 HG23 ' A' ' 152' ' ' VAL . 5.3 tp -72.85 125.95 28.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 19.739999999999998 110.537 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.592 HD23 ' CD1' ' A' ' 154' ' ' TYR . 11.8 tp -92.78 107.98 19.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.921 0.391 . . . . 10.789999999999999 110.331 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.606 HG21 ' CD2' ' A' ' 79' ' ' LEU . 58.0 t -109.89 144.65 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 9.4600000000000009 111.757 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.12 113.97 1.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.904 -0.589 . . . . 9.3000000000000007 111.912 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.576 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.6 m -105.56 175.22 5.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.729 0.3 . . . . 15.23 111.281 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.576 ' H ' HG22 ' A' ' 115' ' ' THR . 4.5 mm-40 78.04 58.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.151 -0.477 . . . . 21.949999999999999 110.884 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -88.17 -31.16 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.057 -0.519 . . . . 32.060000000000002 110.621 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.97 -35.54 4.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.871 -0.604 . . . . 23.920000000000002 111.181 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.7 mt -88.54 -37.6 15.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 26.850000000000001 110.184 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.687 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -58.56 -26.69 63.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.811 -0.631 . . . . 30.25 110.434 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.23 16.39 26.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 41.909999999999997 110.991 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 125' ' ' THR . 47.9 t0 -116.33 87.7 20.97 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 44.479999999999997 110.362 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.97 -50.87 5.91 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.823 2.349 . . . . 38.350000000000001 112.898 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -44.63 -34.6 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.389 . . . . 39.350000000000001 111.477 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.427 HG23 ' OD2' ' A' ' 122' ' ' ASP . 7.1 p -90.97 -45.08 8.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.331 -0.395 . . . . 38.759999999999998 110.85 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.799 HG23 ' HG3' ' A' ' 136' ' ' PRO . 10.6 mt -54.48 -46.71 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 32.710000000000001 110.594 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.98 -21.42 56.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 27.7 ttmt -69.86 -45.87 66.8 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -96.76 -21.43 17.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 37.560000000000002 111.591 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.816 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -41.11 -28.34 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.378 0.51 . . . . 32.729999999999997 112.378 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 3.1 mtmt -131.19 25.47 4.88 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.061 0.393 . . . . 38.119999999999997 112.061 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 7.4 m-80 -115.81 -30.42 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.975 -0.29 . . . . 42.579999999999998 111.57 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 168.26 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.079 0.466 . . . . 40.969999999999999 111.771 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.493 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -108.28 153.53 23.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.73 -0.668 . . . . 33.280000000000001 111.355 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -147.43 139.53 14.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.67 . . . . 24.899999999999999 110.32 179.216 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HG3' HG23 ' A' ' 126' ' ' ILE . 64.9 Cg_endo -74.38 139.03 25.5 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.428 2.085 . . . . 17.710000000000001 112.256 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 84' ' ' VAL . 17.9 mm -88.14 128.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 15.6 111.008 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -80.68 154.89 73.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 15.279999999999999 111.176 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -57.02 -32.71 93.95 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.569 2.179 . . . . 16.66 112.273 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.39 -33.39 65.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 26.050000000000001 110.697 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.756 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 94.8 m -70.04 -42.76 72.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 24.600000000000001 110.769 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 154' ' ' TYR . . . -64.8 -38.89 92.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.054 -0.521 . . . . 24.949999999999999 110.784 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -55.93 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.082 0.468 . . . . 28.390000000000001 110.19 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -41.74 -47.34 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.565 -0.743 . . . . 38.969999999999999 111.254 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.2 mt -66.83 -39.85 87.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 21.739999999999998 110.281 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.4 -26.59 63.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 25.300000000000001 110.851 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -31.73 13.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 31.18 110.78 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -24.8 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 32.659999999999997 111.067 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.907 ' HB3' HG11 ' A' ' 98' ' ' VAL . 1.3 mt -108.26 19.17 20.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 18.489999999999998 111.327 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 58.55 24.42 11.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 24.100000000000001 111.323 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -60.83 131.51 50.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 15.08 110.932 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.777 HG23 HD12 ' A' ' 111' ' ' LEU . 20.6 m -55.24 -31.68 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.319 -0.4 . . . . 21.399999999999999 111.252 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 171.02 147.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 18.59 110.702 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.592 ' CD1' HD23 ' A' ' 112' ' ' LEU . 70.5 t80 -95.99 135.77 37.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.067 0.46 . . . . 24.530000000000001 111.212 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 30.3 m -143.6 164.96 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 21.629999999999999 111.257 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 1.2 tt0 -126.26 161.66 27.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 22.43 110.649 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 168' ' ' VAL . 2.1 p -164.26 146.0 8.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 17.100000000000001 111.338 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . 1.4 t -135.31 134.9 40.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 13.880000000000001 110.64 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.88 -19.18 37.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.469 -0.332 . . . . 8.2699999999999996 111.474 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.93 -30.59 14.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.746 0.308 . . . . 13.52 111.125 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -108.84 -24.77 11.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.378 -0.374 . . . . 16.469999999999999 111.403 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 165' ' ' LEU . 2.8 mt-30 70.42 18.57 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 22.699999999999999 111.091 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HD3' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -61.57 100.56 0.14 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.748 0.309 . . . . 0.0 110.724 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.16 16.0 59.41 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.759 -0.734 . . . . 14.550000000000001 112.563 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.849 HD12 HD12 ' A' ' 19' ' ' LEU . 55.0 tp -48.53 -31.02 5.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.869 0.366 . . . . 14.75 111.142 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -87.4 -51.2 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.025 -0.534 . . . . 24.77 111.476 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.39 -29.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 26.550000000000001 111.9 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 155' ' ' VAL . 64.1 t -69.98 -47.32 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.527 -0.306 . . . . 22.120000000000001 111.789 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 173' ' ' ILE . 39.5 m-85 -69.58 -32.66 71.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.08 0.467 . . . . 19.68 110.413 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 9' ' ' ILE . 18.2 t70 -56.05 -51.95 66.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.638 -0.71 . . . . 32.18 110.985 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.41 ' HB3' HD11 ' A' ' 111' ' ' LEU . 27.5 mm-40 -69.57 -36.39 76.24 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.502 -0.317 . . . . 21.449999999999999 111.538 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.733 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -51.03 -57.45 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.736 -0.386 . . . . 10.77 110.094 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 1.059 HD11 HD22 ' A' ' 53' ' ' LEU . 4.2 mt -57.22 -53.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.319 0.58 . . . . 20.210000000000001 109.812 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.669 HD23 ' HB ' ' B' ' 4' ' ' ILE . 0.6 OUTLIER -46.0 -61.84 1.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.217 -0.901 . . . . 19.699999999999999 109.718 178.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -54.27 -52.69 60.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 13.52 111.435 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 76' ' ' ASP . . . -43.13 -55.98 3.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.963 0.411 . . . . 10.539999999999999 111.592 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.468 ' HB2' HG13 ' B' ' 4' ' ' ILE . 26.7 mt -66.14 -173.58 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.922 -0.581 . . . . 15.24 110.471 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.9 OUTLIER -162.85 173.46 4.37 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 6.6 Cg_endo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.192 1.928 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.693 0.282 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.45 ' HD3' HD22 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -114.67 22.38 13.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.378 0.609 . . . . 0.0 111.113 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -70.62 112.74 7.09 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 121.863 0.839 . . . . 0.0 111.698 178.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.669 ' HB ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -88.36 151.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.012 175.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p -130.46 158.18 40.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.625 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -50.53 -25.98 4.69 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.558 -177.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.44 -2.09 46.12 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.94 -67.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.521 0.201 . . . . 0.0 111.003 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.912 HG22 HG11 ' A' ' 44' ' ' VAL . 1.4 mp -51.93 98.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 110.379 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.09 -145.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.828 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.92 128.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.536 0.207 . . . . 0.0 110.771 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.707 ' HA ' HG22 ' A' ' 44' ' ' VAL . 39.1 Cg_exo -58.59 161.97 13.62 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.442 2.095 . . . . 0.0 111.865 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t 170.92 165.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.08 34.21 27.33 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.247 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.836 ' CD1' HG21 ' A' ' 24' ' ' THR . 17.7 t80 -42.79 116.25 0.85 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 111.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.855 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.0 ttpt -116.96 115.84 26.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 84.81 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.67 -59.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.589 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.432 ' HA ' ' ND2' ' B' ' 33' ' ' ASN . 6.0 t -130.69 151.01 51.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.818 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -151.02 136.17 17.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.976 HG13 HG22 ' B' ' 31' ' ' VAL . 24.3 t -118.06 134.47 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -107.01 104.31 2.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -103.15 99.1 8.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 111.144 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 28' ' ' GLY . 23.0 m-20 -81.33 138.42 48.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.301 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.63 -11.14 27.7 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.2 1.933 . . . . 0.0 112.39 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -113.56 -43.45 3.32 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 0.0 110.815 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.65 23.35 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.374 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 54.27 -142.63 31.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.88 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.83 -174.01 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.715 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' B' ' 22' ' ' GLY . 0.4 OUTLIER 173.3 60.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.976 HG22 HG13 ' B' ' 21' ' ' VAL . 48.2 t -65.66 145.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.734 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -125.35 -49.59 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 19' ' ' SER . 22.7 p-10 -130.69 66.39 1.52 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.467 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.723 HD11 ' CD2' ' B' ' 42' ' ' PHE . 4.0 mt -77.81 176.68 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.268 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.939 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.8 OUTLIER -86.41 155.89 56.81 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.725 0.298 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.57 -50.81 11.5 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.462 2.108 . . . . 0.0 111.995 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.468 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.939 HD12 ' HB2' ' B' ' 35' ' ' ASP . 83.7 mt -56.35 -33.68 65.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.62 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -50.01 -53.43 26.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -53.23 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.03 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 45' ' ' ALA . 8.8 mt -57.9 -43.45 86.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.364 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.723 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.3 m-85 -51.07 -55.87 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.802 0.334 . . . . 0.0 110.805 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 2.7 m -67.98 -19.88 64.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -14.05 33.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.889 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -95.5 -94.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -100.17 -18.29 22.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.455 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.512 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.2 mm -94.64 45.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.012 0.434 . . . . 0.0 111.13 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 43' ' ' SER . 31.3 p -80.18 -153.23 0.08 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -42.2 -28.39 0.19 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.78 12.59 6.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 63.58 161.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.782 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.56 53.11 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.8 p -89.2 -118.81 0.05 Allowed 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.174 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' B' ' 55' ' ' ALA . 0.4 OUTLIER 63.96 172.34 0.18 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.798 0.332 . . . . 0.0 110.91 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 54' ' ' ASP . . . 73.03 50.54 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.965 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -106.64 -76.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.18 116.61 22.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.091 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -94.71 25.84 3.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.461 " H3'" ' CG ' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.783 0.325 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.63 135.03 34.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 24.829999999999998 110.855 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.4 m -139.87 126.65 20.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 25.719999999999999 111.018 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.907 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.31 160.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 24.190000000000001 110.614 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' HG22 ' A' ' 4' ' ' ILE . 4.4 mmtt -128.59 80.62 1.98 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.588 0.709 . . . . 25.460000000000001 110.653 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -86.76 110.59 20.02 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.617 -1.174 . . . . 14.300000000000001 110.428 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 56' ' ' PHE . 8.5 p -117.57 134.27 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 16.300000000000001 110.759 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.43 122.72 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.045 0.45 . . . . 6.1699999999999999 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.06 137.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.74 -0.664 . . . . 5.79 111.131 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' CA ' ' CZ3' ' A' ' 97' ' ' TRP . . . 158.02 155.64 7.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 7.2699999999999996 112.791 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.09 102.47 11.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 21.84 110.772 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.19 -128.75 3.65 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 8.6400000000000006 112.336 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -124.24 -63.67 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 12.93 111.053 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' ALA . 34.2 m 44.44 33.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.501 . . . . 12.76 111.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' HA2' ' O1A' ' A' ' 181' ' ' GCP . . . 44.74 63.56 2.46 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.987 -0.625 . . . . 13.699999999999999 113.013 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.553 ' O ' HD23 ' A' ' 19' ' ' LEU . 13.1 mttp -63.31 -70.87 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.171 0.434 . . . . 9.6899999999999995 112.171 -178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.586 ' OG1' HG21 ' A' ' 35' ' ' THR . 97.8 m -68.2 -47.75 67.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.118 0.414 . . . . 18.190000000000001 112.118 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' SG ' " H2'" ' A' ' 181' ' ' GCP . 54.1 t -42.65 -41.62 3.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.524 -0.307 . . . . 17.050000000000001 111.618 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.127 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -73.63 -34.46 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.621 -0.511 . . . . 13.42 109.621 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 17' ' ' THR . 13.3 mt -63.66 -33.66 76.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 16.969999999999999 110.531 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.5 -56.0 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 17.0 111.082 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 162' ' ' GLN . 0.6 OUTLIER -63.22 -14.64 51.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 16.43 111.447 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 2.3 t80 -70.98 -57.36 4.63 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.82 0.343 . . . . 21.149999999999999 111.125 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.484 HG21 ' CE1' ' B' ' 15' ' ' PHE . 1.6 t -89.23 -26.81 21.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 18.940000000000001 111.961 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.2 p -95.81 -17.14 21.4 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.58 0.215 . . . . 30.5 111.58 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.97 21.68 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 34.789999999999999 111.087 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.48 128.81 17.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 24.600000000000001 111.183 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.474 ' CD1' ' O ' ' A' ' 29' ' ' PRO . 13.4 t80 -70.28 133.48 87.41 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.984 -0.553 . . . . 23.109999999999999 110.216 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 29.6 Cg_endo -63.61 -165.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.675 2.25 . . . . 29.510000000000002 112.741 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.5 t -146.87 -45.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 41.890000000000001 110.655 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 169.38 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 43.869999999999997 110.724 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -136.54 110.45 8.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 23.27 111.107 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.63 135.49 1.95 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.256 -0.429 . . . . 21.530000000000001 111.096 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' VAL . 36.6 Cg_exo -59.29 121.44 9.91 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.422 2.081 . . . . 15.4 112.419 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.586 HG21 ' OG1' ' A' ' 17' ' ' THR . 1.4 m -56.83 -41.84 78.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 20.140000000000001 110.472 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 34' ' ' PRO . 2.5 t 69.71 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.728 -0.669 . . . . 23.469999999999999 110.561 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -169.68 90.79 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.817 -0.628 . . . . 31.059999999999999 110.388 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 t0 -116.92 125.76 51.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.994 -0.548 . . . . 36.280000000000001 110.651 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 117.65 34.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.22 -0.445 . . . . 41.530000000000001 110.998 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' B' ' 15' ' ' PHE . 0.9 OUTLIER -112.5 153.99 26.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 31.02 109.947 178.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -123.9 118.99 28.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 24.329999999999998 111.017 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 6.8 t -105.56 147.22 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.387 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.0 m -113.02 102.9 10.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.514 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.864 HG11 HG22 ' B' ' 9' ' ' ILE . 2.9 t -111.38 154.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 27.280000000000001 111.279 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.1 mmt -88.36 88.36 7.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 35.5 110.27 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' B' ' 4' ' ' ILE . 5.7 mt -105.03 132.9 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.378 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.77 17.82 67.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.806 -0.711 . . . . 24.620000000000001 112.879 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.62 -9.91 73.25 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.589 -0.815 . . . . 28.449999999999999 113.025 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -125.41 149.79 65.6 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.89 0.345 . . . . 0.0 110.969 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.41 11.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.134 . . . . 25.879999999999999 112.126 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 46' ' ' ILE . 3.9 m-30 -108.92 -175.06 2.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 26.190000000000001 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -134.45 100.21 4.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 29.100000000000001 110.667 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.886 HD13 HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.5 124.51 24.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 19.32 111.199 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' CD2' ' A' ' 53' ' ' LEU . . . -90.79 96.74 2.24 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.667 -0.778 . . . . 16.780000000000001 111.547 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD11 HD13 ' A' ' 53' ' ' LEU . 2.9 mm? -85.69 128.54 34.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 20.41 111.107 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 22.1 m-85 -130.06 138.77 50.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.291 -0.413 . . . . 19.059999999999999 111.119 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -130.19 122.03 27.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.523 . . . . 14.960000000000001 110.738 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.6 p -92.6 155.36 17.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 11.77 110.929 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.9 -64.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 9.6099999999999994 111.12 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.01 -152.8 24.97 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.684 -0.769 . . . . 9.8800000000000008 112.42 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 62' ' ' GLU . 3.1 mt-30 66.03 21.11 11.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.592 0.234 . . . . 24.239999999999998 111.33 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 37.5 tp10 67.15 -60.14 0.37 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.176 -0.465 . . . . 32.149999999999999 112.095 178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 61' ' ' GLN . 2.1 m-20 -46.38 -28.68 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 27.510000000000002 111.731 -178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' OH ' ' CD2' ' B' ' 23' ' ' TRP . 7.4 m-85 -99.97 21.51 12.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 14.69 111.49 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -71.61 -22.72 61.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.404 . . . . 24.670000000000002 111.066 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -49.32 71.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 46.119999999999997 111.383 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.7 pp -102.53 18.39 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 18.940000000000001 111.589 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 47.6 ttp180 -79.92 -55.01 0.85 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.133 0.42 . . . . 19.91 112.133 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -67.34 -6.87 17.41 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.259 1.973 . . . . 19.93 113.361 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.565 HD13 ' CB ' ' B' ' 41' ' ' LEU . 15.6 mt -52.68 -25.33 10.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.825 0.345 . . . . 22.690000000000001 110.835 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.4 p -99.57 10.55 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 20.390000000000001 111.633 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 12.0 m-30 -85.4 -46.65 0.62 Allowed Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 111.485 0.18 . . . . 25.010000000000002 111.485 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 93.4 Cg_exo -43.66 -38.01 8.83 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.335 2.023 . . . . 18.16 112.141 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -112.57 71.86 0.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 45.259999999999998 110.615 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -135.05 155.84 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 20.66 111.171 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 108' ' ' THR . 60.1 m-20 -119.65 -64.77 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 22.870000000000001 109.669 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.3 p -104.53 175.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.78 -0.645 . . . . 16.510000000000002 110.507 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' CE2' HG23 ' A' ' 101' ' ' ILE . 29.4 m-85 -140.62 130.62 24.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.729 0.3 . . . . 16.420000000000002 111.116 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD23 HG21 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -100.26 97.67 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.95 0.405 . . . . 14.58 111.109 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.788 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.3 t -89.28 85.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.571 . . . . 13.09 110.602 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.475 ' O ' ' CH2' ' A' ' 97' ' ' TRP . 92.8 m -86.64 111.34 20.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 7.6200000000000001 110.452 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.631 ' CB ' HG21 ' A' ' 93' ' ' VAL . 13.6 p90 -122.59 132.35 54.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 13.210000000000001 111.194 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -53.43 124.1 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 7.7199999999999998 110.904 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' THR . 95.2 t -67.67 -33.95 65.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 16.969999999999999 111.089 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 119' ' ' LEU . 29.5 m -92.36 34.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 8.5700000000000003 111.724 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 78.85 8.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.473 -0.331 . . . . 16.260000000000002 110.98 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.2 -28.19 7.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.515 2.143 . . . . 14.83 112.482 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -44.01 97.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 13.029999999999999 111.043 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.763 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.5 p -66.37 -44.91 81.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 16.82 109.765 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 145' ' ' LEU . 16.2 t80 -60.08 -44.02 95.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.605 -0.725 . . . . 14.56 110.453 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.44 -28.44 63.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 32.299999999999997 110.181 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 96' ' ' LYS . 36.0 m-20 -87.05 -33.73 19.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.377 0.608 . . . . 17.640000000000001 109.748 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 89' ' ' SER . 70.7 t -54.71 -43.31 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.683 -0.69 . . . . 13.449999999999999 110.551 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.806 ' HB3' HD13 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -75.97 -21.25 57.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.917 -0.583 . . . . 21.16 110.606 177.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -144.21 67.46 1.27 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.468 -0.333 . . . . 24.600000000000001 111.575 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER 167.48 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.619 -0.264 . . . . 21.09 111.305 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.788 ' CE3' HG13 ' A' ' 80' ' ' VAL . 15.4 m95 -70.24 -51.31 31.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.713 0.292 . . . . 17.559999999999999 111.158 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.935 HG11 HD22 ' A' ' 149' ' ' LEU . 92.0 t -71.58 -60.13 2.72 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.464 -0.335 . . . . 22.34 111.836 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 1.2 Cg_endo -43.34 -35.73 5.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.604 2.203 . . . . 18.300000000000001 112.326 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -31.92 72.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 19.289999999999999 111.027 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.651 HG23 ' CE2' ' A' ' 78' ' ' PHE . 8.7 mt -85.45 -40.69 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.179 -0.464 . . . . 22.129999999999999 111.185 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.3 p -53.2 -32.58 48.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 31.07 111.279 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -33.7 76.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.362 -0.381 . . . . 45.039999999999999 110.822 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -89.43 -37.36 14.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.511 . . . . 27.469999999999999 110.886 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.474 ' HB2' HG23 ' A' ' 108' ' ' THR . 1.3 p -162.33 93.36 1.28 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 24.829999999999998 110.863 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.6 4.9 5.97 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.649 2.232 . . . . 25.039999999999999 113.045 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -31.33 7.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 46.100000000000001 111.073 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 105' ' ' CYS . 17.4 p -53.23 142.28 38.46 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 26.629999999999999 111.352 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.748 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.3 Cg_endo -55.84 145.5 72.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.032 2.488 . . . . 18.600000000000001 112.242 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.632 ' H ' HG13 ' A' ' 152' ' ' VAL . 39.0 m-85 -128.24 106.79 9.27 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 40.719999999999999 111.901 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.495 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -85.94 118.11 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 19.739999999999998 110.237 177.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 154' ' ' TYR . 20.4 tp -92.62 114.85 27.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.342 . . . . 10.789999999999999 110.827 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.86 HG21 HD23 ' A' ' 79' ' ' LEU . 59.3 t -113.78 141.41 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.047 0.451 . . . . 9.4600000000000009 111.76 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.86 107.46 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.663 -0.699 . . . . 9.3000000000000007 111.545 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.4 m -98.21 175.72 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 15.23 111.615 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.749 ' HG3' HD22 ' A' ' 119' ' ' LEU . 1.2 tp60 77.91 48.42 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.095 -0.502 . . . . 21.949999999999999 110.946 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.551 HD11 ' CA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -83.89 -39.59 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.996 -0.547 . . . . 32.060000000000002 110.608 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -48.52 -26.53 2.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.086 -0.506 . . . . 23.920000000000002 110.849 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 116' ' ' GLN . 1.1 mp -83.69 -44.95 13.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.14 0.495 . . . . 26.850000000000001 110.094 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.713 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -54.52 -26.21 30.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.531 -0.759 . . . . 30.25 110.691 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.43 12.29 31.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 41.909999999999997 111.033 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' C ' HD12 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -110.81 93.9 18.43 Favored Pre-proline 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 44.479999999999997 110.746 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.5 -28.19 5.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.586 2.191 . . . . 38.350000000000001 112.355 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.3 -31.4 72.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 39.350000000000001 110.773 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.45 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.5 p -95.79 -45.65 6.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 38.759999999999998 110.138 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 120' ' ' ARG . 6.9 mt -56.75 -35.12 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 32.710000000000001 110.273 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -81.68 -26.19 34.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.616 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -66.79 -44.68 80.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.308 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.935 HD13 ' O ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -90.8 -23.3 20.65 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.799 -0.361 . . . . 37.560000000000002 110.967 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -48.57 -23.92 1.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.908 0.385 . . . . 32.729999999999997 110.284 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -101.42 -22.01 14.66 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.946 -0.57 . . . . 38.119999999999997 111.106 178.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 16.2 m-80 -90.9 -8.22 49.99 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.197 0.443 . . . . 42.579999999999998 112.197 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 90.26 19.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.193 0.597 . . . . 40.969999999999999 112.561 174.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.935 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -103.15 144.8 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.768 -0.827 . . . . 33.280000000000001 108.768 174.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.48 155.83 57.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 24.899999999999999 111.726 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 72.2 Cg_endo -78.05 126.12 7.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.717 2.278 . . . . 17.710000000000001 112.004 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 mm -58.02 126.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.414 -0.357 . . . . 15.6 111.019 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.9 p -70.42 154.94 94.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 15.279999999999999 110.843 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 32.7 Cg_endo -63.7 -27.12 68.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.583 2.189 . . . . 16.66 112.207 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.4 -42.27 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 26.050000000000001 110.742 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 52.4 m -58.38 -38.89 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 24.600000000000001 110.477 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -74.03 -44.19 55.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 24.949999999999999 110.757 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.42 -35.93 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 28.390000000000001 110.516 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 65.4 tttt -54.75 -43.36 72.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 38.969999999999999 110.378 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 90' ' ' PHE . 6.1 mt -70.39 -48.12 57.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 21.739999999999998 109.831 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.711 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.77 -28.01 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.663 -0.698 . . . . 25.300000000000001 110.74 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.17 -31.61 13.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 31.18 110.701 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.444 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 2.2 t70 -74.59 -29.51 61.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 32.659999999999997 110.628 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 HG11 ' A' ' 98' ' ' VAL . 2.0 mt -99.57 16.37 23.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.857 -0.61 . . . . 18.489999999999998 111.444 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt 60.68 20.65 10.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.622 -0.263 . . . . 24.100000000000001 111.532 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -55.51 144.97 24.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.812 0.339 . . . . 15.08 110.714 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 34.1 m -62.07 -30.92 49.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.456 . . . . 21.399999999999999 111.185 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 172.46 153.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 18.59 111.051 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 112' ' ' LEU . 19.7 t80 -100.84 133.43 45.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.093 -0.503 . . . . 24.530000000000001 110.718 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.006 HG21 HG13 ' A' ' 168' ' ' VAL . 19.1 m -142.18 156.16 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 21.629999999999999 111.386 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -128.17 140.39 51.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.042 -0.526 . . . . 22.43 110.297 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.878 ' SG ' HG21 ' A' ' 168' ' ' VAL . 1.8 p -165.11 151.65 10.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.504 0.669 . . . . 17.100000000000001 112.763 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' HG13 ' A' ' 117' ' ' ILE . 1.3 t -135.27 151.76 50.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.769 -1.105 . . . . 13.880000000000001 108.922 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.06 -7.13 52.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.275 -0.57 . . . . 8.2699999999999996 112.432 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.3 tm? -79.19 -51.46 9.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.061 0.458 . . . . 13.52 110.497 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -98.95 -19.88 17.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.677 -0.692 . . . . 16.469999999999999 111.431 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 22' ' ' SER . 2.6 mt-30 72.53 21.68 3.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.508 -0.314 . . . . 22.699999999999999 111.262 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.43 107.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.713 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 55.71 20.77 26.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.575 -0.821 . . . . 14.550000000000001 112.567 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.127 HD13 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -59.6 -73.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.034 0.445 . . . . 14.75 111.3 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -52.5 -32.49 40.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.749 -0.659 . . . . 24.77 111.113 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.09 -41.44 99.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.525 -0.761 . . . . 26.550000000000001 111.412 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.006 HG13 HG21 ' A' ' 155' ' ' VAL . 55.7 t -56.26 -53.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 22.120000000000001 111.255 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.581 ' CD2' ' CG ' ' A' ' 23' ' ' TYR . 55.7 m-85 -52.97 -35.23 58.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.371 . . . . 19.68 110.816 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.28 -30.66 68.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.037 -0.529 . . . . 32.18 110.49 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -82.47 -35.72 27.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 21.449999999999999 111.043 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.3 -62.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.481 -0.327 . . . . 10.77 110.575 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.907 HG23 HG12 ' A' ' 4' ' ' ILE . 9.9 mt -51.17 -49.47 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.15 0.5 . . . . 20.210000000000001 110.189 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.3 tp -52.56 -30.06 28.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.609 -0.723 . . . . 19.699999999999999 110.489 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.25 -42.78 10.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.999 -0.546 . . . . 13.52 111.108 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.28 -49.88 31.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.095 -0.502 . . . . 10.539999999999999 111.357 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.456 HD21 HG13 ' A' ' 4' ' ' ILE . 4.1 mt -76.32 -169.0 1.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.547 . . . . 15.24 111.299 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 1.3 pt-20 -162.33 163.01 19.07 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.511 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.475 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.8 Cg_endo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 122.747 2.298 . . . . 0.0 112.181 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -126.11 25.18 6.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 1.8 mmmm -73.36 117.36 15.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.726 0.774 . . . . 0.0 111.738 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 174' ' ' LEU . 1.9 mm -86.14 148.14 4.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.998 174.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.3 p -129.06 -165.28 1.49 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -83.29 -32.57 26.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.847 0.356 . . . . 0.0 111.059 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -1.33 48.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.327 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.51 -66.18 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.472 0.177 . . . . 0.0 111.444 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.864 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -50.5 96.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.96 -155.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.282 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.08 129.91 52.16 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.491 0.186 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.5 Cg_endo -66.54 161.48 41.12 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.351 2.034 . . . . 0.0 111.999 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.8 p -179.3 179.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.34 39.65 96.43 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.466 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 40' ' ' TYR . 3.0 t80 -44.94 117.29 1.29 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.769 0.319 . . . . 0.0 110.65 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 2.9 tptm -113.26 112.22 23.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.025 -176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.18 85.88 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.665 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.2 t -72.15 -52.66 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.546 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -128.09 164.44 22.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.79 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -156.28 109.46 2.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.957 0.408 . . . . 0.0 111.478 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.541 HG22 HG22 ' B' ' 31' ' ' VAL . 78.6 t -111.76 120.64 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.236 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -120.14 106.3 1.18 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.096 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.608 ' H ' HG21 ' A' ' 36' ' ' VAL . 43.3 t90 -95.21 89.79 5.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.727 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' B' ' 28' ' ' GLY . 0.8 OUTLIER -72.25 132.21 84.39 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.458 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.35 -17.0 37.76 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.144 1.896 . . . . 0.0 112.234 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -113.5 -48.54 2.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.513 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -89.89 20.38 4.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' B' ' 24' ' ' ASP . . . 51.2 -147.1 9.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.441 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.534 ' CE1' HD12 ' B' ' 47' ' ' ILE . 11.8 m-85 -72.18 146.12 47.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 111.185 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' B' ' 22' ' ' GLY . 1.6 t0 -135.48 43.33 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.635 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.607 HG11 HD12 ' B' ' 34' ' ' LEU . 66.2 t -64.96 124.53 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.59 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -110.29 -38.08 5.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -138.16 70.39 1.39 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.571 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.607 HD12 HG11 ' B' ' 31' ' ' VAL . 1.8 mt -81.96 165.9 20.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.85 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.7 OUTLIER -68.25 156.14 90.76 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.05 -53.48 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.489 2.126 . . . . 0.0 112.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.1 -44.23 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' B' ' 35' ' ' ASP . 34.3 mt -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 0.0 OUTLIER -55.56 -50.71 69.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.781 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -34.76 77.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.565 ' CB ' HD13 ' A' ' 70' ' ' LEU . 23.0 mt -75.74 -25.37 56.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' B' ' 34' ' ' LEU . 0.5 OUTLIER -64.8 -70.68 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.605 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 33.7 t -54.14 -22.83 12.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.649 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 44' ' ' ARG . 8.4 ttt180 -90.48 -17.32 27.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.369 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -92.34 -92.14 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.83 -16.68 21.06 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.534 HD12 ' CE1' ' B' ' 29' ' ' PHE . 1.4 mm -92.08 43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.441 . . . . 0.0 111.035 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.2 t -87.97 -146.3 0.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.663 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 3.7 mt-10 -47.65 -22.47 0.51 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 75.58 136.64 0.06 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.949 0.404 . . . . 0.0 111.289 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 65.78 153.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.286 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.76 132.73 40.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.483 HG22 ' O ' ' B' ' 53' ' ' THR . 12.2 m -120.47 8.96 10.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.75 -167.8 0.05 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.81 167.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.972 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -142.28 -53.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -81.13 139.91 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.87 155.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.01 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.869 179.837 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.542 ' N1 ' ' HB2' ' A' ' 160' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -100.69 142.48 32.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.0 m -142.95 134.91 26.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 173' ' ' ILE . 4.5 mp -94.51 130.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -93.68 80.29 4.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.0 121.35 30.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.147 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.583 HG11 ' HE1' ' A' ' 72' ' ' TYR . 2.3 t -129.06 126.88 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.373 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.893 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -86.41 148.52 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 110.986 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.61 111.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.97 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' CH2' ' A' ' 97' ' ' TRP . . . -141.11 171.28 24.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.604 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 97' ' ' TRP . 39.4 t0 -88.3 132.8 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.935 0.397 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 47.68 -96.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.756 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.907 ' HB1' H5'2 ' A' ' 181' ' ' GCP . . . -141.41 133.03 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 81' ' ' CYS . 5.2 m -133.98 -50.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 14' ' ' VAL . . . 139.17 39.4 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.826 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.893 ' HB2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -80.87 -28.19 36.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.384 . . . . 0.0 110.775 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 m -84.31 -49.21 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.953 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.3 m -57.33 -26.9 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.467 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.703 ' O ' HG23 ' A' ' 24' ' ' THR . 22.3 mt -53.35 -36.53 61.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.899 0.38 . . . . 0.0 110.636 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.06 -44.16 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.94 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.6 m -72.15 -6.34 42.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CG ' ' CD2' ' A' ' 169' ' ' PHE . 57.2 t80 -100.09 -33.74 10.35 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.736 0.303 . . . . 0.0 110.998 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 20' ' ' LEU . 6.2 p -95.82 -33.55 12.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.261 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.4 p -105.63 -16.64 14.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.467 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.13 18.78 5.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.221 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -123.56 155.51 37.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.895 0.379 . . . . 0.0 110.69 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.35 100.38 47.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.091 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.99 156.8 51.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.468 2.112 . . . . 0.0 112.069 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.64 -17.73 14.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.437 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.54 138.16 34.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 111.24 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.0 t80 -131.05 106.26 8.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.456 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG12 ' HD3' ' A' ' 34' ' ' PRO . 1.2 t 169.04 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.674 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD3' HG12 ' A' ' 33' ' ' VAL . 99.2 Cg_exo -46.52 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.643 2.229 . . . . 0.0 112.956 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.416 ' CG2' ' O2G' ' A' ' 181' ' ' GCP . 2.4 m -172.44 98.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.391 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 35' ' ' THR . 57.8 t -159.59 -61.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.481 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.565 ' CZ ' HD13 ' B' ' 38' ' ' LEU . 65.5 t80 -171.37 90.52 0.13 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.134 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 2.3 m-20 -111.61 114.47 27.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.617 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.413 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -106.27 118.01 35.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.368 -179.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.426 ' OH ' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -121.66 152.25 39.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.823 177.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -124.52 119.05 28.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 111.123 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 44' ' ' VAL . 9.9 t -103.2 141.39 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -103.52 110.82 23.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' B' ' 12' ' ' PRO . 11.0 t -124.72 159.0 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.227 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.458 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.9 mmt -89.65 88.59 7.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.62 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' HB ' ' CG ' ' A' ' 51' ' ' TYR . 68.3 mt -104.33 117.13 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.3 16.43 80.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.741 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.86 15.4 67.72 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.859 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 5.1 mt-10 -139.48 149.4 60.02 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.678 0.275 . . . . 0.0 111.032 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 49' ' ' GLU . 24.4 Cg_exo -62.16 102.46 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.513 2.142 . . . . 0.0 112.174 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.5 m-85 -99.43 -179.13 4.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 19.7 m -139.99 114.4 9.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.841 HD13 HG12 ' A' ' 173' ' ' ILE . 28.2 tp -82.66 131.69 35.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 4' ' ' ILE . . . -91.46 101.13 2.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.432 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 20' ' ' LEU . 3.2 mm? -86.63 127.86 34.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' CE2' ' OD1' ' A' ' 39' ' ' ASN . 27.3 m-85 -136.27 145.96 46.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.149 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.84 116.94 22.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.461 HG23 HG12 ' A' ' 7' ' ' VAL . 46.3 p -92.38 171.56 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.005 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.55 116.92 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.012 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.29 -27.61 11.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.481 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.61 151.58 32.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.49 -16.59 21.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.409 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.62 -28.26 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.925 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 68' ' ' ARG . 78.8 m-85 -81.01 3.9 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.607 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.07 -29.29 8.57 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 111.053 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' O ' ' HB1' ' B' ' 45' ' ' ALA . 26.5 mmt180 -60.93 -46.99 88.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' B' ' 42' ' ' PHE . 4.5 pp -115.24 20.26 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 26.0 ttt180 -76.41 -58.05 1.24 Allowed Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 15.5 Cg_endo -58.04 -17.34 30.88 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.282 1.988 . . . . 0.0 112.619 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' B' ' 41' ' ' LEU . 14.5 mt -62.19 -16.9 56.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -90.59 10.67 24.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' HE1' HG11 ' A' ' 7' ' ' VAL . 13.3 m-85 -125.4 42.12 0.72 Allowed Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 91.9 Cg_exo -40.5 -30.44 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.337 2.025 . . . . 0.0 112.364 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -175.08 49.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.978 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.674 HG21 ' CE1' ' A' ' 78' ' ' PHE . 89.7 m -42.93 122.01 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.946 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -83.6 -67.9 0.75 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 109' ' ' PRO . 2.6 p -105.68 173.89 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE1' HG21 ' A' ' 75' ' ' THR . 45.3 m-85 -137.25 117.23 13.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.952 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.49 HD23 HG21 ' A' ' 113' ' ' VAL . 2.5 mp -92.77 101.41 13.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.718 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 93' ' ' VAL . 39.0 t -95.98 91.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB2' HG21 ' A' ' 14' ' ' VAL . 9.2 m -89.68 111.77 22.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.618 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' HG21 ' A' ' 93' ' ' VAL . 23.8 p90 -116.11 155.8 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.799 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.41 ' HA ' ' HG3' ' A' ' 116' ' ' GLN . 40.6 m -74.77 122.19 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG11 ' HD2' ' A' ' 120' ' ' ARG . 89.6 t -70.53 -31.33 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.39 31.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.03 97.42 1.67 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.877 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.57 -18.78 27.15 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.57 2.18 . . . . 0.0 112.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.8 p -58.12 -70.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.159 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.92 ' O ' HG23 ' A' ' 93' ' ' VAL . 29.4 t -48.42 -45.15 35.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 145' ' ' LEU . 6.4 t80 -60.52 -40.68 92.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.348 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -60.52 -32.25 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.635 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 96' ' ' LYS . 37.2 m-80 -87.16 -32.58 19.76 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.347 0.594 . . . . 0.0 109.959 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -55.3 -43.89 73.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.222 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.667 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.7 pttt -77.18 -20.11 55.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.095 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -148.37 60.73 1.09 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 178.78 -53.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 90.1 m95 -85.0 -33.67 22.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.002 ' O ' HG23 ' A' ' 102' ' ' THR . 58.1 t -81.46 -46.68 1.09 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.844 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 36.4 Cg_exo -59.24 -37.56 90.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.357 2.038 . . . . 0.0 112.075 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -56.19 -32.37 64.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.005 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' CD1' ' A' ' 110' ' ' PHE . 12.6 pt -95.06 -40.7 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.064 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 1.002 HG23 ' O ' ' A' ' 98' ' ' VAL . 20.7 p -51.11 -26.08 6.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -79.66 -33.11 41.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.785 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -88.1 -42.08 12.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 99.7 m -149.4 83.09 6.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.726 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 -1.42 10.53 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.679 2.253 . . . . 0.0 112.983 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.05 -29.82 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.838 0.351 . . . . 0.0 110.794 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.7 p -58.72 139.0 86.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.337 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.769 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.39 146.42 51.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.904 2.403 . . . . 0.0 112.029 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.661 ' H ' HG13 ' A' ' 152' ' ' VAL . 31.0 m-85 -129.14 104.07 7.34 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.835 0.35 . . . . 0.0 111.781 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -83.24 129.0 34.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.775 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 154' ' ' TYR . 3.2 tt -101.37 101.73 12.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.298 . . . . 0.0 110.641 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 79' ' ' LEU . 42.2 t -102.47 152.61 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.905 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -134.45 125.94 3.99 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.947 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -118.21 175.46 5.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.793 0.33 . . . . 0.0 111.36 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 80.31 47.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.296 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 158' ' ' SER . 0.2 OUTLIER -81.33 -24.42 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.573 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.433 ' OD2' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -44.77 -52.51 8.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.204 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.7 mt -75.57 -36.89 60.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.782 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.748 ' HD2' HG11 ' A' ' 84' ' ' VAL . 8.6 ttt180 -55.79 -30.59 61.59 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.164 0.507 . . . . 0.0 110.772 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.71 11.84 32.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.243 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.2 OUTLIER -117.27 94.84 46.12 Favored Pre-proline 0 CA--C 1.528 0.102 0 CA-C-O 120.652 0.263 . . . . 0.0 110.908 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' N ' HD12 ' A' ' 126' ' ' ILE . 57.7 Cg_exo -51.68 -43.78 48.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.563 2.175 . . . . 0.0 112.318 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 93.4 p -52.9 -32.31 44.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.043 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.96 -43.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.953 0.406 . . . . 0.0 110.441 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 19.6 mt -55.2 -41.65 61.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -81.16 -22.74 38.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.898 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 124' ' ' SER . 6.8 ttpp -66.28 -46.68 76.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.491 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.1 pp -94.71 -23.22 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.845 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -48.13 -24.65 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.54 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -119.46 9.2 11.5 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 4.7 m-80 -104.61 -31.8 9.24 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.34 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 0.1 OUTLIER 165.61 -26.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 170.44 9.01 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.644 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.75 142.33 2.45 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.704 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.41 131.63 17.91 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.588 2.192 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.0 mm -77.84 126.35 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 5.1 p -70.48 155.4 93.47 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.3 Cg_endo -62.15 -31.81 83.0 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.539 2.159 . . . . 0.0 111.917 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.34 -40.3 81.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 91.0 m -60.23 -54.54 44.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.84 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -63.02 -49.68 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -51.81 -44.84 63.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.691 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' CG ' HD23 ' A' ' 145' ' ' LEU . 3.2 ptpt -51.17 -44.21 61.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 109.979 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.83 HD11 ' CE2' ' A' ' 90' ' ' PHE . 7.1 mt -65.49 -43.98 88.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.922 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -50.34 -28.0 7.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.18 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -97.86 -34.87 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.824 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 149' ' ' LEU . 77.7 m-20 -72.69 -34.07 66.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.838 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -90.48 16.08 9.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.93 -178.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mttt 60.46 17.71 7.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.683 0.278 . . . . 0.0 110.878 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -62.82 143.11 57.88 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.846 0.355 . . . . 0.0 110.99 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.772 HG11 ' HB1' ' A' ' 175' ' ' ALA . 32.5 m -60.99 -31.46 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.358 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.98 170.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.928 0.394 . . . . 0.0 111.275 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.644 ' HD1' HD22 ' A' ' 112' ' ' LEU . 17.2 t80 -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.622 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 168' ' ' VAL . 24.5 m -142.47 160.28 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.02 0.438 . . . . 0.0 111.64 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' OE2' ' NH1' ' A' ' 120' ' ' ARG . 24.6 mt-10 -131.08 161.62 31.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.589 ' HB3' HG21 ' A' ' 168' ' ' VAL . 1.7 p -160.53 147.03 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.166 0.508 . . . . 0.0 112.117 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.421 ' HB2' HD12 ' A' ' 117' ' ' ILE . 7.2 t -132.63 138.76 47.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.54 -27.42 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.761 0.315 . . . . 0.0 111.68 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' CD2' ' OD2' ' A' ' 118' ' ' ASP . 18.0 tp -82.04 -29.97 31.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.453 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -113.11 -15.19 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.737 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 63.45 23.39 13.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.711 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -62.83 101.28 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 65.75 14.92 61.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.684 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.884 HD12 HD12 ' A' ' 19' ' ' LEU . 51.3 tp -47.88 -36.55 12.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.299 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -83.96 -49.03 9.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.42 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.04 -44.0 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.63 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 155' ' ' VAL . 59.0 t -53.3 -61.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.278 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.898 ' O ' HD12 ' A' ' 173' ' ' ILE . 57.1 m-85 -55.12 -37.97 67.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.02 -43.87 82.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -40.03 72.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.756 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.81 -67.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 169' ' ' PHE . 2.9 mp -48.11 -55.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.117 0.484 . . . . 0.0 110.589 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.0 tp -49.18 -28.81 4.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.552 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.772 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.55 -41.47 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.14 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -48.71 -49.99 35.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.301 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.737 HD22 ' HE2' ' B' ' 2' ' ' LYS . 49.8 mt -77.89 -167.01 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.074 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 12.6 pt-20 -164.46 163.23 14.95 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.239 -178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.472 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 5.0 Cg_exo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.671 2.247 . . . . 0.0 112.185 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.661 0.267 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.737 ' HE2' HD22 ' A' ' 177' ' ' LEU . 3.2 tttp -148.68 27.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.027 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 12.6 mmmt -72.07 119.84 16.83 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.815 0.816 . . . . 0.0 111.735 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.6 mm -89.93 146.75 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.042 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.414 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 20.2 p -130.13 151.3 50.81 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.869 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 -26.88 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.689 0.28 . . . . 0.0 111.385 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.64 -2.63 44.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' B' ' 5' ' ' SER . 92.7 m-20 -79.72 -66.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.576 0.227 . . . . 0.0 111.398 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.639 HG22 HG11 ' A' ' 44' ' ' VAL . 2.6 mt -49.08 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.328 . . . . 0.0 110.762 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.9 -149.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.57 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.29 137.6 27.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.648 0.261 . . . . 0.0 110.79 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.826 ' HA ' HG22 ' A' ' 44' ' ' VAL . 42.1 Cg_endo -66.26 160.2 46.28 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.403 2.069 . . . . 0.0 112.0 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t 172.91 152.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.956 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.48 40.09 7.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.583 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 24' ' ' THR . 3.0 t80 -44.14 114.26 0.65 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.891 0.376 . . . . 0.0 110.799 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 24.1 tptt -112.76 110.56 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.821 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 85.78 0.94 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.85 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -72.94 -22.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.772 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -171.53 164.71 6.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.814 0.34 . . . . 0.0 111.028 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -164.52 125.62 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.302 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.091 HG13 HG22 ' B' ' 31' ' ' VAL . 41.0 t -112.57 143.37 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.94 100.12 0.55 Allowed Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.997 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 85.4 t90 -103.48 101.05 10.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.85 0.357 . . . . 0.0 111.141 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.82 133.53 48.7 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.96 -6.96 19.93 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.159 1.906 . . . . 0.0 112.734 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -112.42 -28.48 7.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.723 0.296 . . . . 0.0 111.335 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -111.03 -26.66 9.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.299 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -164.21 19.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.249 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 14.2 m-85 -50.9 162.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' B' ' 22' ' ' GLY . 11.6 t70 -167.86 51.91 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.091 HG22 HG13 ' B' ' 21' ' ' VAL . 77.9 t -65.42 118.05 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.758 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -102.59 -26.42 13.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -148.42 85.26 1.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.527 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.674 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.5 171.67 8.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.344 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.565 ' CB ' HD12 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -70.86 147.22 94.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.79 -47.3 27.07 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.479 2.119 . . . . 0.0 112.289 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -41.25 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.565 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 8.6 mt -66.39 -26.66 67.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' B' ' 34' ' ' LEU . 1.7 mtp180 -55.26 -35.61 65.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.527 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.55 -37.09 25.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.889 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.479 ' HB3' HD13 ' A' ' 70' ' ' LEU . 21.0 mt -72.52 -46.7 53.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -56.32 -58.74 6.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.694 0.283 . . . . 0.0 110.56 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 15.0 m -51.15 -27.46 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.052 0.453 . . . . 0.0 110.454 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 -22.12 20.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.971 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -101.55 70.39 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.81 -29.04 9.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.692 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 mm -95.75 35.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.23 0.538 . . . . 0.0 110.525 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.43 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.3 OUTLIER -101.4 -22.32 14.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -99.08 -22.75 15.54 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.9 -84.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.046 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 50.03 -163.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.13 63.45 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.536 HG22 ' O ' ' B' ' 53' ' ' THR . 28.5 m -109.79 6.51 23.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.109 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -106.81 27.48 8.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.776 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . 63.46 15.97 9.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -70.63 108.11 4.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.821 0.343 . . . . 0.0 110.821 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.431 ' O ' HG22 ' B' ' 57' ' ' THR . 10.7 m -155.73 35.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.7 t -50.99 94.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 mttm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.907 H5'2 ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.808 0.337 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.5 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 2.7 mm-40 -141.6 151.93 43.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.989 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.1 m -143.19 135.02 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.96 ' CD1' HG23 ' A' ' 173' ' ' ILE . 3.6 mt -106.18 138.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 81.6 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.026 0.441 . . . . 0.0 110.829 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 53' ' ' LEU . 14.9 m -92.73 154.75 18.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.589 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG12 HG21 ' A' ' 75' ' ' THR . 10.4 p -139.97 137.94 38.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.958 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.56 125.07 40.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.2 118.87 52.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.103 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' CH2' ' A' ' 97' ' ' TRP . . . -175.26 156.1 21.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.65 -0.785 . . . . 0.0 112.546 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.842 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.9 p30 -49.29 142.38 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 111.116 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . -50.4 136.68 26.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.67 61.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 ' O ' ' A' ' 11' ' ' ASP . 2.5 m -111.61 -34.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.49 49.91 0.16 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.609 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.62 -64.94 1.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.0 m -50.16 -32.13 15.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.067 0.46 . . . . 0.0 110.167 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -57.65 -70.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.986 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -80.78 -19.97 43.63 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.894 -178.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.3 mt -59.84 -36.26 76.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.993 0.425 . . . . 0.0 109.979 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.6 mm -85.1 -36.6 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.606 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -72.41 -23.53 61.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 169' ' ' PHE . 6.2 t80 -82.98 -25.49 32.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.637 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' LEU . 16.9 p -104.84 -32.15 8.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.728 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 p -122.87 -20.93 5.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.42 25.94 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.899 0.38 . . . . 0.0 110.76 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 109.77 17.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -68.0 112.11 9.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.644 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.47 172.54 15.48 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.371 2.047 . . . . 0.0 112.249 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -52.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.686 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 149.87 31.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.936 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' C ' HG22 ' A' ' 33' ' ' VAL . 10.5 p90 -155.98 120.8 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.6 -64.85 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.603 ' CD ' HG23 ' A' ' 33' ' ' VAL . 69.1 Cg_endo -74.54 65.71 5.61 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.533 2.155 . . . . 0.0 112.556 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 37' ' ' PHE . 70.4 m -118.22 -79.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' B' ' 23' ' ' TRP . 38.3 t 64.05 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.308 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.752 ' O ' HG23 ' B' ' 21' ' ' VAL . 28.0 t80 -155.35 107.55 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' B' ' 20' ' ' HIS . 18.9 m-20 -124.59 126.27 45.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 3.2 t-20 -104.34 118.58 36.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.049 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -112.37 165.59 12.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.554 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -134.2 119.88 19.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 44' ' ' VAL . 12.1 t -105.06 143.28 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.113 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.0 m -109.15 111.73 23.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.332 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HG22 ' B' ' 9' ' ' ILE . 6.9 t -122.16 159.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.497 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 11.0 mmt -94.34 88.94 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.585 ' CD1' HG21 ' A' ' 173' ' ' ILE . 21.1 mt -105.14 136.51 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.7 78.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.598 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 17.51 75.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -143.81 155.39 59.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.88 126.47 13.93 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HB3' ' A' ' 2' ' ' GLN . 2.3 m-85 -114.66 -171.91 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.789 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -150.52 92.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.025 HD22 HD11 ' A' ' 173' ' ' ILE . 32.8 tp -75.96 137.59 40.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.24 131.36 10.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.246 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.9 mm? -117.03 113.04 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.172 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -118.94 111.98 19.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -89.93 122.77 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.0 p -100.34 154.96 18.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 36' ' ' VAL . . . -101.28 -177.29 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.58 -170.55 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.6 -176.44 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.671 0.272 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 67.42 -61.06 0.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.505 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -61.05 2.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -94.92 28.45 2.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -27.81 60.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -47.73 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.343 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.0 pp -92.89 16.08 13.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.701 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 32.5 ttt180 -82.47 -46.94 0.93 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.91 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 40.1 Cg_exo -56.41 -25.27 56.69 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.323 2.015 . . . . 0.0 112.26 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.759 HD22 HD13 ' B' ' 41' ' ' LEU . 19.5 mt -68.3 -15.43 63.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.654 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.0 t -88.94 17.59 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 55.0 m-85 -128.46 47.45 2.77 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 76.6 Cg_exo -50.68 88.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.139 1.892 . . . . 0.0 112.245 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 72' ' ' TYR . 1.2 tp60 46.48 44.49 13.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.985 0.421 . . . . 0.0 110.813 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.765 HG21 HG12 ' A' ' 7' ' ' VAL . 48.5 m -44.81 146.1 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.977 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 108' ' ' THR . 3.5 m-20 -91.88 -69.92 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.183 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.877 HG23 ' HB2' ' A' ' 109' ' ' PRO . 3.1 p -108.43 175.96 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.296 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' H ' HG22 ' A' ' 77' ' ' VAL . 65.5 m-85 -140.35 121.52 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 111.781 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.76 100.25 11.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.494 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.18 101.59 12.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.6 m -92.42 111.23 22.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.605 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 6.1 p90 -120.95 149.47 42.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.0 m -72.58 119.55 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.167 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' OE2' ' A' ' 156' ' ' GLU . 89.7 t -72.82 -31.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.6 m -94.64 28.19 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.916 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.93 107.78 3.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.78 -15.65 48.28 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.338 2.025 . . . . 0.0 112.394 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -57.65 8.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.905 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -50.44 -49.92 53.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.253 178.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.857 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 38.4 t80 -51.99 -35.91 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.819 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.42 -52.35 63.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -74.05 -26.33 60.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.367 178.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 89' ' ' SER . 37.1 t -54.37 -42.6 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.165 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HA ' HD11 ' A' ' 149' ' ' LEU . 28.1 pttt -97.47 -11.25 24.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.711 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -135.82 36.32 2.86 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -170.34 -62.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.531 ' CH2' ' N ' ' A' ' 11' ' ' ASP . 89.3 m95 -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.837 HG11 ' HB3' ' A' ' 149' ' ' LEU . 48.7 t -88.64 -45.11 0.45 Allowed Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 34.8 Cg_exo -59.01 -28.65 88.49 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.281 1.987 . . . . 0.0 112.454 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.72 -30.65 67.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.601 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 110' ' ' PHE . 2.9 pt -95.9 -31.28 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.577 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 98' ' ' VAL . 71.6 p -62.5 -26.17 68.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 0.0 110.573 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 -33.31 22.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -81.97 -36.11 28.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.034 0.445 . . . . 0.0 110.2 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 65.8 m -154.67 90.86 3.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.356 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 8.03 4.07 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.772 2.315 . . . . 0.0 113.288 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -29.55 8.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.385 . . . . 0.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.474 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 12.8 p -63.91 131.6 94.99 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.088 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.877 ' HB2' HG23 ' A' ' 77' ' ' VAL . 18.7 Cg_endo -56.43 154.79 28.2 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.533 2.155 . . . . 0.0 111.838 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 101' ' ' ILE . 19.7 m-85 -135.81 107.87 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.219 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.684 HD22 ' HB2' ' A' ' 172' ' ' ALA . 5.2 tp -81.39 124.27 29.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.352 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 145' ' ' LEU . 1.6 tt -91.92 83.74 5.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.397 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 155' ' ' VAL . 9.8 t -86.22 127.63 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 111.683 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -105.93 114.31 4.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.762 178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.7 m -94.0 172.1 8.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.314 -178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.514 ' H ' HG22 ' A' ' 115' ' ' THR . 24.0 mt-30 65.72 60.48 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.167 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -84.2 -37.12 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.555 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.17 -42.44 14.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.348 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 26.2 mt -71.99 -42.05 66.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.742 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -55.04 -26.57 38.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.81 17.39 22.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.04 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.559 ' HB3' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -113.58 80.04 4.59 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.79 0.328 . . . . 0.0 110.818 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 99.6 Cg_exo -42.31 -48.83 6.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.668 2.245 . . . . 0.0 112.523 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 66.4 m -48.67 -34.72 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.2 p -89.97 -46.58 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.389 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.742 HD11 ' O ' ' A' ' 120' ' ' ARG . 20.2 mt -51.54 -48.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 123' ' ' PRO . 1.3 mt-10 -73.64 -23.41 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.126 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 124' ' ' SER . 3.9 ttmm -69.46 -45.97 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -95.34 -21.89 18.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.477 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.716 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -44.05 -26.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.964 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -128.51 23.12 5.91 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.3 m-80 -115.66 -30.83 6.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.06 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.149 0.499 . . . . 0.0 111.41 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.555 ' HB3' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -101.1 156.78 17.22 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.179 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.63 140.11 9.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.84 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.621 ' HG3' HG23 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -75.29 146.44 31.63 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.562 2.175 . . . . 0.0 112.39 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.14 122.16 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -71.39 162.17 74.29 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.55 -35.97 97.97 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.096 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.07 -51.11 34.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.648 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 32.6 m -54.6 -46.63 73.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.19 -56.66 7.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.573 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -50.17 -35.0 24.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.339 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -53.55 -53.11 56.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.012 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 6.9 mt -59.57 -45.71 91.05 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -56.79 -24.49 50.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.13 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -97.47 -38.68 9.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.075 0.464 . . . . 0.0 110.411 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.495 ' HB2' HD23 ' A' ' 149' ' ' LEU . 12.4 m-20 -70.15 -38.59 75.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.036 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.837 ' HB3' HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -87.88 13.47 10.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.369 -178.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.8 mttt 60.34 18.37 7.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.598 0.237 . . . . 0.0 111.028 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -60.04 140.18 56.98 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.2 m -54.46 -35.48 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.352 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.63 159.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.986 0.422 . . . . 0.0 111.598 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.421 ' CD1' HD22 ' A' ' 112' ' ' LEU . 18.1 t80 -96.37 128.11 42.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 168' ' ' VAL . 23.1 m -133.04 171.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.393 . . . . 0.0 111.645 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' HG21 ' A' ' 84' ' ' VAL . 2.8 tt0 -152.11 122.09 7.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.806 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.485 ' SG ' HG11 ' A' ' 168' ' ' VAL . 3.8 p -137.2 139.97 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.184 0.516 . . . . 0.0 111.78 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' HG13 ' A' ' 117' ' ' ILE . 1.4 t -136.07 114.35 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.084 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . . . -64.29 -19.59 65.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 0.0 111.384 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.34 -48.23 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.172 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 m -105.03 -15.97 14.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.528 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 75.52 24.19 1.38 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.775 0.321 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -68.33 108.32 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.56 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 55.2 23.9 34.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.095 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 19' ' ' LEU . 1.3 tm? -43.34 -57.03 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.664 0.269 . . . . 0.0 111.654 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -82.67 -40.86 20.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.012 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 4.0 m-20 -46.26 -42.0 13.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.08 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 155' ' ' VAL . 51.6 t -60.47 -55.58 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.384 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 19' ' ' LEU . 42.8 m-85 -56.82 -40.52 76.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.86 0.362 . . . . 0.0 110.335 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.455 ' O ' HD13 ' B' ' 9' ' ' ILE . 3.9 m-20 -52.21 -35.04 48.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.437 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.47 -30.98 67.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.485 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.684 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -59.53 -63.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.305 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 1.025 HD11 HD22 ' A' ' 53' ' ' LEU . 4.0 mt -47.37 -57.39 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.273 0.559 . . . . 0.0 110.096 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -48.1 -27.56 2.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.652 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -91.56 -38.02 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.464 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.5 ' HA ' ' HG3' ' A' ' 109' ' ' PRO . . . -57.96 -50.05 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.001 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' B' ' 4' ' ' ILE . 7.4 mp -61.55 -117.57 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.298 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 177' ' ' LEU . 3.4 pt-20 153.18 161.97 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 0.0 110.247 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.2 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.6 2.2 . . . . 0.0 111.903 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 8.4 mttt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.71 0.291 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.505 ' HE3' HD23 ' A' ' 177' ' ' LEU . 2.2 tmtp? -142.11 21.58 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.601 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.05 117.57 12.71 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.985 0.898 . . . . 0.0 111.872 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.623 ' HB ' HD12 ' A' ' 174' ' ' LEU . 3.0 mm -79.41 152.87 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.804 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.41 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 21.0 p -131.13 150.82 51.98 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.213 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -48.11 -27.27 2.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 111.224 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.3 -6.88 52.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 5' ' ' SER . 82.8 m-20 -79.84 -64.68 1.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.658 0.266 . . . . 0.0 111.223 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.855 HG22 HG11 ' A' ' 44' ' ' VAL . 1.8 mt -55.66 99.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.725 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.91 -152.89 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.334 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.08 138.91 30.62 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.615 0.245 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.762 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.2 Cg_endo -60.34 161.88 18.91 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.445 2.096 . . . . 0.0 112.032 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.411 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.2 m 179.86 -173.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.753 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.23 31.58 42.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.08 118.28 0.98 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.242 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -115.89 138.44 51.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.234 -177.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -100.06 84.81 2.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.39 -19.53 18.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.94 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 41.3 t -174.05 164.5 4.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 0.0 111.187 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . 0.405 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 26.0 t60 -163.79 131.15 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.0 HG13 HG22 ' B' ' 31' ' ' VAL . 28.6 t -113.76 141.47 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -125.95 100.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.935 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.648 ' HB2' HG21 ' A' ' 36' ' ' VAL . 49.7 t90 -92.82 95.09 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.833 0.349 . . . . 0.0 111.243 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.96 140.28 37.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.68 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 -5.7 16.34 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -111.03 -25.63 9.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.094 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -108.33 -25.97 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.273 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.53 91.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.304 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 23' ' ' TRP . 27.4 m-85 64.04 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.846 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' B' ' 22' ' ' GLY . 50.2 t0 -146.45 51.67 1.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.495 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 1.0 HG22 HG13 ' B' ' 21' ' ' VAL . 55.9 t -65.13 122.72 16.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.717 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.54 -27.25 7.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.985 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -137.34 74.27 1.48 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.403 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.63 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -96.41 156.27 16.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.255 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.433 ' CB ' HD12 ' B' ' 38' ' ' LEU . 15.6 t70 -59.19 139.06 88.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.7 -42.37 14.78 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.875 2.384 . . . . 0.0 112.262 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.3 -50.95 10.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.079 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 70' ' ' LEU . 37.7 mt -58.37 -23.87 58.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 23.0 mtp85 -60.03 -43.65 95.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.675 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.7 OUTLIER -75.11 -33.34 61.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.914 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.759 HD13 HD22 ' A' ' 70' ' ' LEU . 23.0 mt -75.73 -47.04 27.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' B' ' 34' ' ' LEU . 1.5 m-85 -50.07 -63.35 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.337 . . . . 0.0 110.694 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 44.6 m -51.81 -24.1 5.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.738 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -90.69 -24.91 20.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.671 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.65 71.34 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.14 -29.11 7.87 Favored Glycine 0 C--N 1.319 -0.407 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.844 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.7 mm -94.41 34.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 0.0 110.886 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.414 ' CA ' ' O ' ' B' ' 43' ' ' SER . 1.1 t -86.46 -144.57 0.11 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.888 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.65 -25.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . 59.85 113.51 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 170.49 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mp -137.11 36.35 2.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.449 HG22 ' O ' ' B' ' 53' ' ' THR . 9.3 m -99.18 9.11 44.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.048 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -55.47 121.24 8.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.018 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -160.14 100.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -49.51 134.06 19.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' B' ' 58' ' ' SER . 9.7 t -90.69 -165.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.412 ' N ' ' OG1' ' B' ' 57' ' ' THR . 0.5 OUTLIER 58.45 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.995 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 mtmm . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.878 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.464 ' N7 ' ' SG ' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.794 0.33 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.2 147.5 49.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.118 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 98.7 m -142.64 135.9 28.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 173' ' ' ILE . 5.3 mp -94.41 138.38 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -95.16 62.84 2.56 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.54 0.686 . . . . 0.0 109.687 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.14 116.56 23.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.848 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 56' ' ' PHE . 41.1 t -131.82 143.79 39.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.711 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 16' ' ' LYS . 39.5 t -86.3 136.76 22.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.884 0.374 . . . . 0.0 110.81 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -126.13 140.64 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' CE3' ' A' ' 97' ' ' TRP . . . 161.81 149.93 5.8 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.755 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.07 103.26 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.336 . . . . 0.0 110.651 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.27 -116.09 0.72 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.464 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.684 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -152.19 137.39 17.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.962 0.411 . . . . 0.0 111.429 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -161.88 -110.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.575 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.7 45.39 0.11 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.278 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HG3' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -79.77 -29.63 40.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.569 0.223 . . . . 0.0 111.513 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' ' HG2' ' A' ' 16' ' ' LYS . 56.4 m -77.82 -30.1 50.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.709 0.29 . . . . 0.0 111.342 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -30.52 62.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.095 HD12 HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -83.31 -36.68 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.81 -179.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.3 mt -53.1 -44.63 67.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 110.608 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.48 -42.49 83.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.176 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASN . 87.3 p -79.09 -6.5 56.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.019 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.793 ' HB2' HD11 ' A' ' 165' ' ' LEU . 30.1 t80 -89.59 -21.64 22.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.129 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.518 ' CB ' ' CD1' ' B' ' 15' ' ' PHE . 19.5 p -108.11 -32.3 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.638 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.2 p -118.26 -1.31 11.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' SER . 37.5 t-20 55.51 25.3 7.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.853 0.358 . . . . 0.0 110.572 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 122.17 46.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . 25.2 t80 -81.38 111.05 21.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.138 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 28' ' ' PHE . 20.2 Cg_endo -60.46 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.635 2.223 . . . . 0.0 112.884 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -35.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.549 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.24 168.24 0.1 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.647 0.261 . . . . 0.0 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.33 -168.52 1.34 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.365 0.603 . . . . 0.0 110.594 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 1.6 t 47.68 47.96 5.25 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.421 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 27.2 Cg_endo -93.7 -168.95 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.476 2.117 . . . . 0.0 112.77 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m 71.48 -137.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.543 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.76 HG12 ' OH ' ' A' ' 64' ' ' TYR . 14.1 t 78.03 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.131 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' B' ' 38' ' ' LEU . 78.8 t80 -172.14 91.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.055 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 4.8 m-20 -104.33 122.94 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.211 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.86 117.7 34.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.995 0.426 . . . . 0.0 111.5 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 55' ' ' LEU . 3.6 m-85 -126.04 164.72 20.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.08 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.889 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -138.39 119.37 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG23 HD11 ' A' ' 55' ' ' LEU . 17.5 t -106.24 139.56 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.557 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -103.15 109.92 21.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.607 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' B' ' 12' ' ' PRO . 8.2 t -121.74 157.07 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.974 0.416 . . . . 0.0 111.326 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.407 ' N ' HG12 ' A' ' 44' ' ' VAL . 16.7 mmt -93.76 89.2 6.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG12 HG23 ' B' ' 9' ' ' ILE . 17.8 mt -100.73 131.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.363 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.11 20.18 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.97 35.66 30.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.705 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.88 156.23 32.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.706 0.289 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 109.15 2.76 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.486 2.124 . . . . 0.0 112.112 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -111.95 -178.97 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 11.0 m -142.77 110.25 5.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 173' ' ' ILE . 2.8 tm? -78.28 121.29 24.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.05 101.51 1.71 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.66 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD11 HG23 ' A' ' 42' ' ' VAL . 71.0 mt -85.19 114.72 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.737 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HB2' HG22 ' A' ' 7' ' ' VAL . 87.6 m-85 -131.69 129.38 40.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.616 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -116.47 138.45 51.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 71' ' ' SER . 53.4 p -119.17 153.53 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 111.837 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HB3' ' CG ' ' A' ' 64' ' ' TYR . . . -79.47 -176.8 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.92 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.73 -117.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.025 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -155.08 23.81 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 111.488 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.29 -47.29 2.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.101 0.477 . . . . 0.0 110.027 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.38 -27.5 41.89 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.938 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.76 ' OH ' HG12 ' A' ' 36' ' ' VAL . 3.6 m-30 -99.74 21.28 12.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -57.49 -29.01 63.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.03 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.12 -49.52 5.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.681 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.2 pp -95.25 30.63 2.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 3.3 ttp180 -63.79 -58.49 14.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.421 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 34.5 Cg_endo -66.37 -7.66 18.26 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.633 2.222 . . . . 0.0 113.158 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 41' ' ' LEU . 1.5 mp -75.18 -12.22 60.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 58' ' ' THR . 0.5 OUTLIER -99.93 14.5 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' HG21 ' A' ' 58' ' ' THR . 8.0 m-85 -144.58 41.28 0.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 71.4 Cg_exo -36.62 -47.0 1.31 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.855 2.37 . . . . 0.0 112.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.7 46.74 0.32 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.4 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -51.01 151.43 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 176' ' ' ALA . 2.1 t0 -112.09 -65.17 1.2 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 3.0 p -97.19 174.45 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.04 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.588 ' H ' HG22 ' A' ' 77' ' ' VAL . 39.8 m-85 -142.99 119.89 11.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 111.017 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 113' ' ' VAL . 2.8 mp -90.45 104.77 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.978 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.9 t -96.42 95.21 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.477 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 82.8 m -87.61 110.91 20.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HG21 ' A' ' 93' ' ' VAL . 1.1 p90 -115.91 157.83 23.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.124 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.35 105.94 17.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.71 -30.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' A' ' 119' ' ' LEU . 27.3 m -95.7 40.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.051 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 t -157.09 99.51 1.97 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.816 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' HG2' ' A' ' 135' ' ' LYS . 66.0 Cg_exo -51.23 -35.55 53.12 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.414 2.076 . . . . 0.0 112.216 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -55.67 -45.46 77.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -60.99 -44.78 96.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.539 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 145' ' ' LEU . 72.7 t80 -61.05 -37.98 84.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.907 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.39 -53.23 38.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.784 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 96' ' ' LYS . 21.6 m120 -67.81 -40.2 83.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.073 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 89' ' ' SER . 1.8 t -41.28 -47.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.637 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.557 ' HA ' HD21 ' A' ' 149' ' ' LEU . 8.7 ptmt -82.68 -23.89 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -138.43 64.76 1.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.723 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' N ' ' HG2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER 170.28 -54.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CE3' ' HA2' ' A' ' 10' ' ' GLY . 21.3 m95 -73.05 -50.98 19.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.708 0.29 . . . . 0.0 111.206 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 ' CB ' HD22 ' A' ' 149' ' ' LEU . 70.6 t -71.46 -59.81 2.96 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.496 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 7.9 Cg_endo -50.22 -24.86 12.2 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.267 1.978 . . . . 0.0 112.265 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.18 -36.96 83.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.446 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 97' ' ' TRP . 2.5 mp -84.28 -42.56 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 23.7 p -52.45 -27.7 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.32 -25.71 66.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.766 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -111.59 -38.76 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.88 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.3 m -143.88 82.27 11.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.62 2.66 8.19 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.797 2.331 . . . . 0.0 113.341 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -34.25 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.693 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 4.7 p -55.44 139.85 66.22 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.021 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.4 Cg_endo -54.26 151.56 28.56 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.799 2.333 . . . . 0.0 111.848 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.512 ' H ' HG13 ' A' ' 152' ' ' VAL . 18.0 m-85 -134.61 104.89 6.25 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD22 HG23 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -77.32 131.88 38.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.25 177.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.51 HD23 ' CD1' ' A' ' 154' ' ' TYR . 13.6 tp -100.66 100.87 11.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.754 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.733 HG21 HD23 ' A' ' 79' ' ' LEU . 39.7 t -94.09 133.52 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.862 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -114.29 116.67 3.88 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.882 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 116' ' ' GLN . 1.5 m -110.34 174.52 5.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.334 . . . . 0.0 111.223 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.549 ' H ' HG22 ' A' ' 115' ' ' THR . 0.9 OUTLIER 74.98 58.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.027 179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -89.02 -24.99 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' HD22 ' A' ' 119' ' ' LEU . 9.7 m-20 -45.84 -51.93 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.499 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.636 ' HB2' HG11 ' A' ' 85' ' ' VAL . 2.3 mm? -75.89 -37.54 58.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -53.59 -29.4 37.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 17.7 21.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.233 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 125' ' ' THR . 1.4 m-20 -117.46 79.29 11.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -44.0 -36.2 8.15 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.571 2.181 . . . . 0.0 112.374 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 13.7 t -58.09 -33.14 68.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 122' ' ' ASP . 5.7 p -93.49 -44.66 8.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.766 HG23 ' HG3' ' A' ' 136' ' ' PRO . 29.3 mt -51.35 -47.63 34.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.683 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.53 -26.28 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.034 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.5 ttmt -64.67 -43.96 91.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.603 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 130' ' ' ALA . 1.3 pp -97.88 -22.34 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.414 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -45.76 -26.52 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.743 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -127.07 23.11 6.57 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' LEU . 3.1 m-80 -116.58 -30.33 5.87 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.353 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 166.76 -29.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.099 0.476 . . . . 0.0 111.668 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.42 170.78 7.74 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.491 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -173.37 135.29 0.68 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.41 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.766 ' HG3' HG23 ' A' ' 126' ' ' ILE . 63.9 Cg_endo -74.82 171.71 17.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.373 2.049 . . . . 0.0 112.356 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -111.06 137.74 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.8 p -80.56 154.33 73.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.685 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 28.7 Cg_endo -62.21 -25.79 77.15 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.164 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -78.28 -27.76 47.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.296 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.656 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 71.7 m -73.94 -42.46 60.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.873 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -65.78 -43.06 89.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.45 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -49.57 -54.55 17.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.383 0.611 . . . . 0.0 110.004 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -45.93 -29.14 1.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.085 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -80.92 -43.54 19.65 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.439 0.638 . . . . 0.0 109.427 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.718 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -54.31 -26.86 31.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.398 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 2.1 ptm180 -95.0 -37.54 11.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.053 0.454 . . . . 0.0 111.0 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.41 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 2.1 t70 -72.67 -29.94 63.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.695 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 98' ' ' VAL . 9.0 mt -96.41 18.24 14.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.345 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt 55.95 20.45 4.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.61 134.21 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 110' ' ' PHE . 19.6 m -55.01 -37.85 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.307 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.64 160.07 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.26 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.51 ' CD1' HD23 ' A' ' 112' ' ' LEU . 6.2 t80 -105.8 128.39 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.64 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.946 HG21 HG23 ' A' ' 168' ' ' VAL . 35.1 m -139.27 179.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.47 170.03 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.998 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' C ' HD11 ' A' ' 117' ' ' ILE . 30.2 p -157.74 136.63 11.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.394 0.616 . . . . 0.0 112.617 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 163' ' ' LYS . 1.6 t -135.71 114.76 12.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.278 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 165' ' ' LEU . . . -78.86 -0.35 30.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.8 tp -100.32 -40.57 7.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 111.077 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.5 m -117.61 -5.86 11.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.736 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 70.77 19.71 5.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.689 0.28 . . . . 0.0 111.219 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.537 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -69.03 91.43 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.74 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.858 ' O ' HG12 ' A' ' 168' ' ' VAL . . . 91.39 -20.94 37.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.361 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.095 HD13 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -44.27 -51.97 7.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 112.03 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -81.32 -35.8 30.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.535 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -62.43 -51.0 69.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.142 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.946 HG23 HG21 ' A' ' 155' ' ' VAL . 2.0 p -46.75 -57.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.515 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.904 ' O ' HD12 ' A' ' 173' ' ' ILE . 37.3 m-85 -50.54 -37.9 41.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.07 0.462 . . . . 0.0 110.331 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' HD13 ' B' ' 9' ' ' ILE . 0.1 OUTLIER -64.61 -32.15 73.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 178.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB3' HD21 ' A' ' 111' ' ' LEU . 5.8 mm-40 -77.72 -45.41 24.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.552 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -52.17 -64.58 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.535 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.954 HG23 HG12 ' A' ' 4' ' ' ILE . 3.5 mt -50.36 -56.31 4.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.244 0.545 . . . . 0.0 110.139 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.668 HD12 ' HB ' ' B' ' 4' ' ' ILE . 12.7 tp -47.98 -27.22 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.526 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -89.56 -50.2 6.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.419 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.677 ' HB2' ' HB ' ' A' ' 77' ' ' VAL . . . -47.65 -48.61 28.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.355 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.566 HD12 HG13 ' B' ' 4' ' ' ILE . 15.0 mt -70.71 -170.77 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.8 OUTLIER -161.04 166.61 14.99 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.56 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 178' ' ' GLU . 6.9 Cg_endo . . . . . 0 C--O 1.249 1.048 0 C-N-CA 122.598 2.199 . . . . 0.0 112.042 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.777 0.323 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 178' ' ' GLU . 4.5 tttp -135.65 26.2 3.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.469 . . . . 0.0 111.185 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -71.06 117.84 13.07 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.031 0.919 . . . . 0.0 112.251 179.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.668 ' HB ' HD12 ' A' ' 174' ' ' LEU . 2.1 mm -86.85 150.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.948 174.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.422 ' N ' ' OD2' ' B' ' 8' ' ' ASP . 23.4 p -130.06 -176.2 3.86 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.117 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -73.51 -28.96 62.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.932 0.396 . . . . 0.0 110.636 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.04 -1.47 45.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' B' ' 5' ' ' SER . 75.8 m-20 -78.61 -67.73 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.58 0.229 . . . . 0.0 111.453 -178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.764 HG22 HG11 ' A' ' 44' ' ' VAL . 2.0 mp -50.59 96.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.823 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.96 -164.29 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.89 136.06 54.94 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.649 0.261 . . . . 0.0 110.624 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.827 ' HA ' HG22 ' A' ' 44' ' ' VAL . 18.1 Cg_endo -59.12 161.89 15.14 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.301 2.001 . . . . 0.0 111.824 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.451 ' H ' HG13 ' A' ' 42' ' ' VAL . 1.5 t 177.65 164.22 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.917 0.389 . . . . 0.0 111.024 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.6 38.8 61.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.676 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.518 ' CD1' ' CB ' ' A' ' 24' ' ' THR . 16.1 t80 -41.8 113.05 0.38 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.888 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.889 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 20.5 tptt -114.53 101.94 9.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.913 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -69.17 85.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.3 t -70.06 -22.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.729 -177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -174.88 162.33 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.45 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -150.69 121.49 7.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.611 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.692 HG13 HG22 ' B' ' 31' ' ' VAL . 96.8 t -107.35 141.45 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.145 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -126.0 100.7 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.545 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.416 ' CG ' ' N ' ' B' ' 24' ' ' ASP . 40.3 t90 -77.56 163.0 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.146 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CG ' ' B' ' 23' ' ' TRP . 0.4 OUTLIER -171.09 133.01 0.89 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.35 -6.96 16.79 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.3 2.0 . . . . 0.0 112.959 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -109.37 -26.18 10.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.374 . . . . 0.0 110.794 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -110.16 -20.53 12.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 85.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' B' ' 47' ' ' ILE . 53.5 m-85 62.67 130.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.052 0.453 . . . . 0.0 111.252 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 22' ' ' GLY . 6.0 t70 -139.02 55.89 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.952 HG11 HD12 ' B' ' 34' ' ' LEU . 54.3 t -65.27 124.9 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.179 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.76 -27.99 12.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.806 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -151.35 81.5 1.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.642 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.952 HD12 HG11 ' B' ' 31' ' ' VAL . 0.2 OUTLIER -88.04 179.02 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.516 ' H ' HD23 ' B' ' 34' ' ' LEU . 0.2 OUTLIER -74.81 148.58 85.08 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.654 0.264 . . . . 0.0 110.969 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 39' ' ' ARG . 75.2 Cg_exo -50.8 -51.08 11.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.55 2.167 . . . . 0.0 112.349 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -49.53 23.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 37' ' ' PHE . 17.6 mt -59.67 -29.32 67.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.917 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' B' ' 36' ' ' PRO . 23.0 mtp180 -52.97 -35.79 59.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.422 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' B' ' 44' ' ' ARG . 0.4 OUTLIER -81.95 -42.38 19.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.733 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 70' ' ' LEU . 27.7 mt -66.71 -54.74 19.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.005 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -50.65 -55.52 16.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.908 0.385 . . . . 0.0 110.272 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.449 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 3.9 m -54.52 -24.16 19.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.654 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -91.72 -25.11 19.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.007 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -102.01 72.63 1.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' C ' HD13 ' B' ' 47' ' ' ILE . . . 93.56 -31.99 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.496 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.601 ' N ' HD13 ' B' ' 47' ' ' ILE . 1.1 mm -93.91 38.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.615 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.435 ' CA ' ' O ' ' B' ' 43' ' ' SER . 0.0 OUTLIER -100.64 0.75 39.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.178 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.8 -11.83 61.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.123 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.85 106.07 7.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.286 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -106.78 -164.74 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.45 110.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.422 HG22 ' O ' ' B' ' 53' ' ' THR . 5.9 m -102.79 9.07 39.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.051 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -52.02 103.94 0.07 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.951 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.22 136.53 50.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.217 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 52.35 178.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.2 -83.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.734 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.31 64.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.135 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.932 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . 0.669 ' O1B' HG23 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 1.7 mm-40 -124.92 142.45 51.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 24.829999999999998 110.926 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 52' ' ' THR . 84.8 m -140.92 134.03 29.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 25.719999999999999 111.024 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.72 ' CG1' HD21 ' A' ' 177' ' ' LEU . 4.6 mp -98.45 122.71 50.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 24.190000000000001 111.085 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.31 82.21 5.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.97 0.414 . . . . 25.460000000000001 110.105 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' HG22 ' A' ' 4' ' ' ILE . 7.1 m -86.91 122.49 30.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 14.300000000000001 110.239 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 HG23 HG23 ' A' ' 75' ' ' THR . 2.5 t -114.54 126.23 72.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.163 -0.471 . . . . 16.300000000000001 110.774 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 16' ' ' LYS . 2.7 t -86.2 118.27 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 110.775 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 142.91 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.839 -0.619 . . . . 5.79 111.358 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 97' ' ' TRP . . . 168.04 159.15 13.08 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.763 -0.653 . . . . 7.2699999999999996 112.381 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -93.41 38.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 21.84 111.149 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 90.95 -171.38 35.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.686 -0.769 . . . . 8.6400000000000006 112.634 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 70.96 -160.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 12.93 111.109 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 83' ' ' SER . 33.2 m 44.87 -170.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.288 -0.415 . . . . 12.76 110.904 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.636 ' H ' HG21 ' A' ' 115' ' ' THR . . . -134.56 63.29 0.61 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.151 -1.023 . . . . 13.699999999999999 113.259 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 8' ' ' VAL . 4.3 ptpt -69.92 -49.08 55.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 9.6899999999999995 110.035 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.752 ' HA ' HD12 ' A' ' 20' ' ' LEU . 59.2 m -64.24 -29.89 70.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.666 -0.494 . . . . 18.190000000000001 109.666 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -38.49 91.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 17.050000000000001 111.204 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' CE2' ' A' ' 169' ' ' PHE . 2.0 pp -87.96 -24.16 23.65 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 13.42 112.036 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 17' ' ' THR . 30.5 mt -52.24 -45.33 65.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.169 0.509 . . . . 16.969999999999999 110.251 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.479 HG22 ' OG1' ' A' ' 25' ' ' THR . 17.2 mm -79.83 -45.81 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.68 -0.691 . . . . 17.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 165' ' ' LEU . 1.6 m -66.71 -21.78 66.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 16.43 111.291 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 169' ' ' PHE . 19.7 t80 -77.18 -45.57 26.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.389 -0.369 . . . . 21.149999999999999 111.403 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -99.79 -24.28 14.73 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.218 0.451 . . . . 18.940000000000001 112.218 -177.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.479 ' OG1' HG22 ' A' ' 21' ' ' ILE . 1.5 p -105.07 -19.6 13.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.053 -0.259 . . . . 30.5 111.617 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 71.12 15.22 6.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.637 -0.256 . . . . 34.789999999999999 111.438 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -104.21 160.69 14.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.901 0.381 . . . . 24.600000000000001 110.758 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -110.24 95.28 21.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 23.109999999999999 110.8 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.62 -174.56 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.48 2.12 . . . . 29.510000000000002 112.116 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 t -149.29 -46.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 41.890000000000001 111.169 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -55.95 134.0 51.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 43.869999999999997 111.164 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' C ' HG22 ' A' ' 33' ' ' VAL . 13.4 p90 -154.5 120.46 5.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 23.27 110.704 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -169.44 -64.61 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 21.530000000000001 111.054 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.532 ' CD ' HG23 ' A' ' 33' ' ' VAL . 30.1 Cg_endo -66.23 -82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.514 2.143 . . . . 15.4 112.916 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 35' ' ' THR . 69.9 m 56.16 23.47 7.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.807 0.337 . . . . 20.140000000000001 110.877 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' B' ' 29' ' ' PHE . 20.8 t -51.68 -63.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.276 -0.42 . . . . 23.469999999999999 110.987 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' B' ' 38' ' ' LEU . 69.2 t80 -160.07 91.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 31.059999999999999 111.066 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.424 ' CB ' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -103.84 105.12 15.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 36.280000000000001 110.412 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' B' ' 19' ' ' SER . 7.3 t-20 -104.81 124.11 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.079 0.466 . . . . 41.530000000000001 111.633 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -126.03 167.77 14.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.713 -0.676 . . . . 31.02 109.766 178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB3' ' HB3' ' B' ' 16' ' ' LYS . . . -133.63 119.12 19.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.976 0.417 . . . . 24.329999999999998 110.908 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' H ' ' B' ' 13' ' ' SER . 13.4 t -105.18 140.25 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 88.7 m -103.75 113.5 27.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG11 HG22 ' B' ' 9' ' ' ILE . 6.1 t -121.95 157.67 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.194 -0.457 . . . . 27.280000000000001 111.426 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.412 ' N ' HG12 ' A' ' 44' ' ' VAL . 6.3 mmt -93.6 88.53 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 35.5 110.484 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 51' ' ' TYR . 31.9 mt -102.58 132.02 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.282 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.08 32.71 81.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 24.620000000000001 112.472 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.76 19.65 76.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.764 . . . . 28.449999999999999 112.452 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -142.43 152.11 59.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.99 125.92 10.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.554 2.169 . . . . 25.879999999999999 112.389 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.565 ' CB ' HD12 ' A' ' 46' ' ' ILE . 6.1 m-85 -116.75 -175.23 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 26.190000000000001 110.77 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.607 ' O ' HG23 ' A' ' 3' ' ' THR . 2.3 m -140.09 97.6 3.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 29.100000000000001 110.991 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 173' ' ' ILE . 2.0 tt -65.67 119.15 10.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 19.32 111.014 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -85.88 89.1 1.6 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.715 . . . . 16.780000000000001 112.018 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 53' ' ' LEU . 52.0 mt -79.91 113.06 17.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 20.41 111.333 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' HG23 ' A' ' 8' ' ' VAL . 97.0 m-85 -123.19 124.6 43.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 19.059999999999999 111.031 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' CG ' HD11 ' A' ' 20' ' ' LEU . 2.3 t70 -116.83 128.41 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 14.960000000000001 110.725 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.2 p -107.46 156.68 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 11.77 111.029 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -49.6 -77.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 9.6099999999999994 111.123 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.2 -29.98 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 9.8800000000000008 112.446 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -89.38 151.88 21.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 24.239999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.47 -22.17 63.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 32.149999999999999 111.188 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -53.57 -34.87 59.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 27.510000000000002 111.07 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 68' ' ' ARG . 15.3 m-85 -99.06 15.0 27.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 14.69 111.541 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -53.45 -24.43 12.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 24.670000000000002 111.084 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' C ' ' HB1' ' B' ' 45' ' ' ALA . 2.1 mmt85 -68.39 -54.21 18.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 46.119999999999997 111.318 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 67' ' ' LEU . 2.8 pp -103.06 9.42 38.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 18.940000000000001 111.929 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 14.1 ttt-85 -74.87 -58.28 1.67 Allowed Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.74 0.274 . . . . 19.91 111.74 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 16.8 Cg_endo -59.4 -13.67 21.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.38 2.053 . . . . 19.93 112.943 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.831 HD21 ' HB3' ' B' ' 41' ' ' LEU . 0.5 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.704 0.288 . . . . 22.690000000000001 111.501 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 t -97.53 -1.49 43.9 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.068 0.396 . . . . 20.390000000000001 112.068 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.7 m-30 -75.6 -47.41 4.11 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 111.567 0.21 . . . . 25.010000000000002 111.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 85.7 Cg_exo -42.39 121.66 2.09 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.609 2.206 . . . . 18.16 113.003 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 55.17 58.26 4.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 45.259999999999998 111.79 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.619 HG23 HG23 ' A' ' 7' ' ' VAL . 18.3 m -96.74 130.34 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.324 -0.398 . . . . 20.66 110.363 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.742 ' CG ' ' HB1' ' A' ' 176' ' ' ALA . 9.5 t0 -69.38 -70.09 0.3 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.304 -0.407 . . . . 22.870000000000001 110.953 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 78' ' ' PHE . 7.2 p -121.07 160.5 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.404 -0.362 . . . . 16.510000000000002 110.754 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' HG22 ' A' ' 77' ' ' VAL . 48.4 m-85 -121.7 118.23 28.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 16.420000000000002 111.278 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 113' ' ' VAL . 3.6 mp -89.35 109.01 19.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 14.58 111.115 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.76 HG13 ' CE3' ' A' ' 97' ' ' TRP . 94.0 t -99.37 88.19 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 13.09 110.597 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 15.3 m -84.05 111.55 19.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.294 -0.412 . . . . 7.6200000000000001 110.739 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' CG ' HG21 ' A' ' 93' ' ' VAL . 7.1 p90 -126.51 136.19 52.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.404 . . . . 13.210000000000001 110.907 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -54.6 128.41 32.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 7.7199999999999998 111.379 -179.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 92.8 t -72.24 -32.44 42.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 16.969999999999999 110.725 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 119' ' ' LEU . 34.3 m -93.38 38.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 8.5700000000000003 111.102 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 11.0 t -144.22 97.68 5.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 16.260000000000002 110.94 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 37.9 Cg_endo -65.82 -14.19 43.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.481 2.121 . . . . 14.83 112.549 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.56 -46.22 16.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.546 -0.297 . . . . 13.029999999999999 110.992 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.8 t -62.55 -45.02 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 16.82 109.899 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.732 ' CZ ' HD11 ' A' ' 145' ' ' LEU . 52.2 t80 -58.69 -34.44 71.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.695 . . . . 14.56 110.672 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.7 -28.43 64.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.933 -0.576 . . . . 32.299999999999997 109.72 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 2.6 m-20 -82.58 -45.09 15.04 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.119 -0.697 . . . . 17.640000000000001 109.119 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 89' ' ' SER . 59.8 t -48.02 -43.29 10.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.186 -0.916 . . . . 13.449999999999999 111.395 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.621 ' HB3' HD13 ' A' ' 145' ' ' LEU . 8.2 pttt -71.91 -26.25 62.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.72 -0.673 . . . . 21.16 110.804 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -149.88 70.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 24.600000000000001 110.883 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 173.22 -55.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 21.09 110.872 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.76 ' CE3' HG13 ' A' ' 80' ' ' VAL . 13.5 m95 -73.59 -58.3 3.4 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.887 0.375 . . . . 17.559999999999999 110.588 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 102' ' ' THR . 59.9 t -59.88 -58.24 20.86 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.115 -0.493 . . . . 22.34 111.891 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.2 Cg_endo -49.2 -34.02 29.67 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.362 2.041 . . . . 18.300000000000001 112.297 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.33 -32.46 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 19.289999999999999 110.807 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.4 mt -88.1 -40.67 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 22.129999999999999 111.428 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 98' ' ' VAL . 7.1 p -55.52 -26.77 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 31.07 111.153 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -68.51 -22.85 64.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 45.039999999999999 111.139 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -110.56 -41.24 4.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 27.469999999999999 110.994 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 61.6 m -145.41 80.95 10.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 24.829999999999998 110.894 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.67 -2.42 12.58 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.623 2.216 . . . . 25.039999999999999 113.024 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -34.9 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.895 0.379 . . . . 46.100000000000001 110.6 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 6.8 p -56.03 141.25 68.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.512 . . . . 26.629999999999999 111.038 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.1 159.36 9.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.631 2.221 . . . . 18.600000000000001 111.729 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 31.4 m-85 -136.74 94.69 3.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 40.719999999999999 111.62 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -72.25 115.75 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 19.739999999999998 110.471 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.979 HD23 ' CD1' ' A' ' 154' ' ' TYR . 10.8 tp -88.98 99.56 12.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 10.789999999999999 110.866 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 HD23 ' A' ' 79' ' ' LEU . 58.0 t -89.19 135.13 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 9.4600000000000009 111.366 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 156' ' ' GLU . . . -118.88 107.2 1.37 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.851 -0.69 . . . . 9.3000000000000007 112.084 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.636 HG21 ' H ' ' A' ' 15' ' ' GLY . 1.7 m -107.12 174.52 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.864 0.364 . . . . 15.23 111.172 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER 73.46 49.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 21.949999999999999 110.774 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.684 HD12 ' HB3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -85.45 -32.25 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 32.060000000000002 110.571 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.644 ' OD1' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -49.26 -26.01 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 23.920000000000002 111.15 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.771 ' HB2' HG11 ' A' ' 85' ' ' VAL . 1.2 mm? -82.28 -42.58 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 26.850000000000001 110.948 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.695 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -53.6 -30.28 41.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.956 0.408 . . . . 30.25 110.674 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.1 16.89 23.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 41.909999999999997 111.129 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.936 ' OD2' HG23 ' A' ' 125' ' ' THR . 38.6 t70 -114.51 83.42 8.69 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.503 -0.317 . . . . 44.479999999999997 110.604 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' CB ' ' OE1' ' A' ' 127' ' ' GLU . 96.0 Cg_exo -43.01 -31.84 2.48 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.618 2.212 . . . . 38.350000000000001 112.335 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.3 t -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.409 . . . . 39.350000000000001 110.81 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.936 HG23 ' OD2' ' A' ' 122' ' ' ASP . 39.8 p -95.35 -45.91 6.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 38.759999999999998 110.241 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.695 HD11 ' O ' ' A' ' 120' ' ' ARG . 4.9 mt -58.82 -40.99 81.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.686 -0.688 . . . . 32.710000000000001 110.55 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' OE1' ' CB ' ' A' ' 123' ' ' PRO . 35.3 mt-10 -73.63 -30.47 62.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.224 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -32.68 67.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.293 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.814 HD13 ' O ' ' A' ' 134' ' ' GLN . 3.7 pp -89.78 -30.42 17.99 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.939 -0.573 . . . . 37.560000000000002 110.457 177.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 129' ' ' LEU . . . -49.57 -22.69 1.35 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.726 . . . . 32.729999999999997 110.713 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.19 -17.58 14.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.14 -0.482 . . . . 38.119999999999997 111.334 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 11.2 m-80 -92.3 -16.99 25.34 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 111.719 0.266 . . . . 42.579999999999998 111.719 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 1.2 mptt 95.8 23.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.089 0.774 . . . . 40.969999999999999 113.089 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.814 ' O ' HD13 ' A' ' 129' ' ' LEU . 1.4 mt-30 -97.26 163.09 13.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.337 -0.986 . . . . 33.280000000000001 108.337 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 152.04 20.3 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.17 -0.612 . . . . 24.899999999999999 112.392 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 92.3 Cg_endo -87.25 152.99 8.06 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.968 2.445 . . . . 17.710000000000001 111.921 178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mm -91.33 131.19 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 15.6 111.008 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -88.65 161.88 40.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.279999999999999 111.261 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -33.4 98.59 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.636 2.224 . . . . 16.66 112.309 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.25 -47.04 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 26.050000000000001 110.977 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 88.8 m -54.5 -55.6 27.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 24.600000000000001 110.864 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -59.58 -44.63 93.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 24.949999999999999 110.854 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -50.67 -50.9 53.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 28.390000000000001 110.818 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -43.54 3.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 38.969999999999999 111.119 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 4.6 mt -73.85 -47.26 39.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 21.739999999999998 110.038 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -51.82 -25.09 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 25.300000000000001 111.12 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -95.12 -34.88 12.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 31.18 110.731 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 147' ' ' ARG . 14.4 t0 -77.51 -24.2 50.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 32.659999999999997 110.733 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 98' ' ' VAL . 5.1 mt -98.99 15.61 25.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 18.489999999999998 111.329 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.82 19.75 11.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.678 -0.237 . . . . 24.100000000000001 111.406 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 146' ' ' ALA . . . -67.15 136.84 55.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.758 0.314 . . . . 15.08 110.758 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.91 HG11 ' HB1' ' A' ' 175' ' ' ALA . 31.1 m -59.23 -34.46 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 21.399999999999999 111.434 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 173.21 158.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.855 0.36 . . . . 18.59 111.358 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.979 ' CD1' HD23 ' A' ' 112' ' ' LEU . 23.7 t80 -104.43 123.49 47.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 24.530000000000001 110.83 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.833 ' CG2' HG13 ' A' ' 168' ' ' VAL . 25.2 m -132.79 144.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 21.629999999999999 111.29 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -107.49 159.69 16.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 22.43 110.486 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 168' ' ' VAL . 2.9 p -164.5 146.09 8.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 17.100000000000001 111.685 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' HD13 ' A' ' 165' ' ' LEU . 35.3 t -135.74 155.79 49.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 13.880000000000001 110.49 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.41 -21.55 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.525 -0.307 . . . . 8.2699999999999996 111.139 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.0 tp -98.47 -31.79 11.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 13.52 110.798 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 162' ' ' GLN . 2.3 m -103.28 -9.78 19.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 16.469999999999999 111.568 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 161' ' ' THR . 14.1 pt20 45.98 29.27 0.73 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 22.699999999999999 111.333 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.684 ' HB3' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -67.27 93.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.88 19.61 75.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.561 -0.828 . . . . 14.550000000000001 112.165 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.654 HD11 ' CB ' ' A' ' 19' ' ' LEU . 48.3 tp -41.08 -51.25 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.098 0.407 . . . . 14.75 112.098 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 4.7 mtpm? -83.02 -37.34 24.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 24.77 111.45 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -46.59 -30.6 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 26.550000000000001 111.411 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.833 HG13 ' CG2' ' A' ' 155' ' ' VAL . 97.6 t -72.06 -61.51 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 22.120000000000001 111.122 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.915 ' CE2' HD13 ' A' ' 19' ' ' LEU . 48.6 m-85 -51.09 -25.69 5.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 19.68 110.33 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' HD13 ' B' ' 9' ' ' ILE . 2.3 m-20 -75.53 -39.81 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.802 -0.635 . . . . 32.18 110.45 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CG ' HG11 ' A' ' 155' ' ' VAL . 3.2 mt-10 -67.9 -44.09 77.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 21.449999999999999 110.616 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.1 -61.3 2.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 10.77 110.663 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.7 mt -52.03 -56.02 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.169 0.509 . . . . 20.210000000000001 110.058 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' B' ' 9' ' ' ILE . 12.1 tp -49.11 -32.95 10.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 19.699999999999999 110.562 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.91 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -83.11 -42.93 16.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 13.52 111.142 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 76' ' ' ASP . . . -56.5 -53.48 56.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 10.539999999999999 111.072 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.72 HD21 ' CG1' ' A' ' 4' ' ' ILE . 12.6 mt -61.56 -160.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 15.24 110.705 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -177.87 161.91 1.31 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.777 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.47 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 1.3 Cg_endo . . . . . 0 C--O 1.249 1.064 0 C-N-CA 122.821 2.347 . . . . 0.0 112.184 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.654 0.264 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.424 ' N ' ' OXT' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -162.49 32.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 111.118 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.47 ' HG2' ' HB3' ' A' ' 179' ' ' PRO . 3.6 mmmt -72.9 117.08 14.17 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.852 0.834 . . . . 0.0 111.641 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 177' ' ' LEU . 2.0 mm -84.61 148.66 4.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.104 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 21.2 p -130.44 151.87 50.46 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.196 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 174' ' ' LEU . 5.5 mtmt -48.43 -25.74 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.659 0.266 . . . . 0.0 111.512 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.16 -2.91 45.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -80.78 -65.62 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.585 0.231 . . . . 0.0 111.098 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.861 HG22 HG11 ' A' ' 44' ' ' VAL . 2.1 mt -51.06 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.538 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.23 -160.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.651 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.09 133.53 60.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.525 0.202 . . . . 0.0 110.488 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.66 ' HA ' HG22 ' A' ' 44' ' ' VAL . 19.6 Cg_endo -60.02 167.56 7.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.443 2.095 . . . . 0.0 112.297 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 42' ' ' VAL . 20.0 p 175.08 -176.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.725 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 36.5 73.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.867 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -41.6 119.09 1.19 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.771 0.319 . . . . 0.0 110.983 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.907 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.5 tptm -121.5 111.37 17.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 112.049 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -75.44 85.38 2.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.459 HG22 ' HG3' ' B' ' 16' ' ' LYS . 2.4 t -71.19 -29.14 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.674 -177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 6.9 t -173.0 154.44 2.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 111.045 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -157.03 131.77 8.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 31' ' ' VAL . 4.4 t -110.67 134.49 52.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 30' ' ' ASP . . . -117.48 92.81 0.56 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.709 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 29' ' ' PHE . 52.4 t90 -96.05 92.5 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.977 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 28' ' ' GLY . 2.5 m-20 -84.36 144.34 43.33 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.65 -9.84 21.49 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -112.65 -30.81 6.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.862 0.363 . . . . 0.0 110.959 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.15 -21.09 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.263 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 24' ' ' ASP . . . 84.47 -158.66 34.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.173 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' B' ' 47' ' ' ILE . 8.0 m-85 -60.16 144.68 49.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.891 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 22' ' ' GLY . 7.1 t0 -140.78 49.03 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.929 HG22 HG13 ' B' ' 21' ' ' VAL . 78.0 t -65.67 112.51 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.684 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -26.82 12.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.667 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -143.65 78.53 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.495 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.641 HD12 HG11 ' B' ' 31' ' ' VAL . 1.3 mt -94.6 165.22 12.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.215 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.864 ' HB2' HD12 ' B' ' 38' ' ' LEU . 0.6 OUTLIER -71.65 150.08 93.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.289 . . . . 0.0 110.709 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.41 -52.62 7.8 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.506 2.138 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' B' ' 41' ' ' LEU . 0.7 OUTLIER -70.23 -44.19 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.525 179.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' B' ' 35' ' ' ASP . 88.8 mt -62.98 -26.58 68.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 -56.87 -45.48 82.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.442 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -29.51 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD21 ' A' ' 70' ' ' LEU . 18.2 mt -78.27 -45.15 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.344 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 67' ' ' LEU . 5.7 m-85 -56.18 -59.4 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.573 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' B' ' 47' ' ' ILE . 34.5 t -55.4 -24.67 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 0.0 110.442 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -17.41 26.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.827 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -97.59 -90.2 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.66 -17.01 15.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.444 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.465 ' N ' HD13 ' B' ' 47' ' ' ILE . 2.6 mm -92.54 34.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.424 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -74.35 -150.49 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.242 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 2.0 mt-10 -42.57 -27.58 0.17 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 49' ' ' GLU . . . 68.22 -78.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 63.21 -177.9 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.81 -159.25 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.19 112.57 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.329 0.585 . . . . 0.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.72 119.81 7.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.027 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.49 -24.55 10.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.43 100.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.454 ' O ' HG22 ' B' ' 57' ' ' THR . 21.5 m -112.64 45.63 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.58 87.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GCP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_